0001071739-22-000361.txt : 20221025 0001071739-22-000361.hdr.sgml : 20221025 20221024210631 ACCESSION NUMBER: 0001071739-22-000361 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 73 CONFORMED PERIOD OF REPORT: 20220930 FILED AS OF DATE: 20221025 DATE AS OF CHANGE: 20221024 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CENTENE CORP CENTRAL INDEX KEY: 0001071739 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 041406317 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-31826 FILM NUMBER: 221327019 BUSINESS ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 BUSINESS PHONE: 3147254477 MAIL ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 10-Q 1 cnc-20220930.htm 10-Q cnc-20220930
0001071739--12-312022Q3FALSEhttp://fasb.org/us-gaap/2022#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2022#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2022#AccountsPayableAndAccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2022#AccountsPayableAndAccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent00010717392022-01-012022-09-3000010717392022-10-14xbrli:shares00010717392022-09-30iso4217:USD00010717392021-12-31iso4217:USDxbrli:shares0001071739us-gaap:HealthCarePremiumMember2022-07-012022-09-300001071739us-gaap:HealthCarePremiumMember2021-07-012021-09-300001071739us-gaap:HealthCarePremiumMember2022-01-012022-09-300001071739us-gaap:HealthCarePremiumMember2021-01-012021-09-300001071739us-gaap:ServiceMember2022-07-012022-09-300001071739us-gaap:ServiceMember2021-07-012021-09-300001071739us-gaap:ServiceMember2022-01-012022-09-300001071739us-gaap:ServiceMember2021-01-012021-09-3000010717392022-07-012022-09-3000010717392021-07-012021-09-3000010717392021-01-012021-09-300001071739us-gaap:CommonStockMember2022-06-300001071739us-gaap:CommonStockMember2022-03-310001071739us-gaap:CommonStockMember2021-12-310001071739us-gaap:CommonStockMember2022-09-300001071739us-gaap:TreasuryStockCommonMember2022-03-310001071739us-gaap:TreasuryStockCommonMember2022-06-300001071739us-gaap:TreasuryStockCommonMember2021-12-310001071739us-gaap:TreasuryStockCommonMember2022-09-300001071739us-gaap:AdditionalPaidInCapitalMember2021-12-310001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001071739us-gaap:RetainedEarningsMember2021-12-310001071739us-gaap:NoncontrollingInterestMember2021-12-310001071739us-gaap:RetainedEarningsMember2022-01-012022-03-310001071739us-gaap:NoncontrollingInterestMember2022-01-012022-03-3100010717392022-01-012022-03-310001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310001071739us-gaap:CommonStockMember2022-01-012022-03-310001071739us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310001071739us-gaap:TreasuryStockCommonMember2022-01-012022-03-310001071739us-gaap:AdditionalPaidInCapitalMember2022-03-310001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310001071739us-gaap:RetainedEarningsMember2022-03-310001071739us-gaap:NoncontrollingInterestMember2022-03-3100010717392022-03-310001071739us-gaap:RetainedEarningsMember2022-04-012022-06-300001071739us-gaap:NoncontrollingInterestMember2022-04-012022-06-3000010717392022-04-012022-06-300001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-012022-06-300001071739us-gaap:CommonStockMember2022-04-012022-06-300001071739us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-300001071739us-gaap:TreasuryStockCommonMember2022-04-012022-06-300001071739us-gaap:AdditionalPaidInCapitalMember2022-06-300001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300001071739us-gaap:RetainedEarningsMember2022-06-300001071739us-gaap:NoncontrollingInterestMember2022-06-3000010717392022-06-300001071739us-gaap:RetainedEarningsMember2022-07-012022-09-300001071739us-gaap:NoncontrollingInterestMember2022-07-012022-09-300001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-012022-09-300001071739us-gaap:CommonStockMember2022-07-012022-09-300001071739us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-300001071739us-gaap:TreasuryStockCommonMember2022-07-012022-09-300001071739us-gaap:AdditionalPaidInCapitalMember2022-09-300001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-09-300001071739us-gaap:RetainedEarningsMember2022-09-300001071739us-gaap:NoncontrollingInterestMember2022-09-300001071739us-gaap:CommonStockMember2021-06-300001071739us-gaap:CommonStockMember2020-12-310001071739us-gaap:CommonStockMember2021-03-310001071739us-gaap:CommonStockMember2021-09-300001071739us-gaap:TreasuryStockCommonMember2020-12-310001071739us-gaap:TreasuryStockCommonMember2021-09-300001071739us-gaap:TreasuryStockCommonMember2021-06-300001071739us-gaap:TreasuryStockCommonMember2021-03-310001071739us-gaap:AdditionalPaidInCapitalMember2020-12-310001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001071739us-gaap:RetainedEarningsMember2020-12-310001071739us-gaap:NoncontrollingInterestMember2020-12-3100010717392020-12-310001071739us-gaap:RetainedEarningsMember2021-01-012021-03-310001071739us-gaap:NoncontrollingInterestMember2021-01-012021-03-3100010717392021-01-012021-03-310001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-03-310001071739us-gaap:CommonStockMember2021-01-012021-03-310001071739us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310001071739us-gaap:TreasuryStockCommonMember2021-01-012021-03-310001071739us-gaap:AdditionalPaidInCapitalMember2021-03-310001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-310001071739us-gaap:RetainedEarningsMember2021-03-310001071739us-gaap:NoncontrollingInterestMember2021-03-3100010717392021-03-310001071739us-gaap:RetainedEarningsMember2021-04-012021-06-300001071739us-gaap:NoncontrollingInterestMember2021-04-012021-06-3000010717392021-04-012021-06-300001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-04-012021-06-300001071739us-gaap:CommonStockMember2021-04-012021-06-300001071739us-gaap:AdditionalPaidInCapitalMember2021-04-012021-06-300001071739us-gaap:TreasuryStockCommonMember2021-04-012021-06-300001071739us-gaap:AdditionalPaidInCapitalMember2021-06-300001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-06-300001071739us-gaap:RetainedEarningsMember2021-06-300001071739us-gaap:NoncontrollingInterestMember2021-06-3000010717392021-06-300001071739us-gaap:RetainedEarningsMember2021-07-012021-09-300001071739us-gaap:NoncontrollingInterestMember2021-07-012021-09-300001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-07-012021-09-300001071739us-gaap:CommonStockMember2021-07-012021-09-300001071739us-gaap:AdditionalPaidInCapitalMember2021-07-012021-09-300001071739us-gaap:TreasuryStockCommonMember2021-07-012021-09-300001071739us-gaap:AdditionalPaidInCapitalMember2021-09-300001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-09-300001071739us-gaap:RetainedEarningsMember2021-09-300001071739us-gaap:NoncontrollingInterestMember2021-09-3000010717392021-09-300001071739cnc:MagellanHealthMember2022-01-042022-01-040001071739cnc:MagellanHealthMember2022-01-040001071739cnc:MagellanHealthMember2022-07-012022-09-300001071739cnc:MagellanHealthMember2022-01-012022-09-300001071739cnc:MagellanHealthMembercnc:MeasurementPeriodAdjustmentToIntangibleAssetsMember2022-07-012022-09-300001071739cnc:MagellanHealthMemberus-gaap:ContractualRightsMember2022-01-040001071739cnc:MagellanHealthMemberus-gaap:ContractualRightsMember2022-01-042022-01-040001071739us-gaap:InsuranceContractsAcquiredInBusinessCombinationMembercnc:MagellanHealthMember2022-01-040001071739us-gaap:InsuranceContractsAcquiredInBusinessCombinationMembercnc:MagellanHealthMember2022-01-042022-01-040001071739cnc:MagellanHealthMemberus-gaap:TradeNamesMember2022-01-040001071739cnc:MagellanHealthMemberus-gaap:TradeNamesMember2022-01-042022-01-040001071739us-gaap:DevelopedTechnologyRightsMembercnc:MagellanHealthMember2022-01-040001071739us-gaap:DevelopedTechnologyRightsMembercnc:MagellanHealthMember2022-01-042022-01-040001071739cnc:PANTHERxRareMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2022-07-142022-07-140001071739cnc:SpanishAndCentralEuropeanBusinessesMemberus-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember2022-09-300001071739cnc:SpanishAndCentralEuropeanBusinessesMemberus-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember2022-07-012022-09-300001071739us-gaap:USTreasuryAndGovernmentMember2022-09-300001071739us-gaap:USTreasuryAndGovernmentMember2021-12-310001071739us-gaap:CorporateDebtSecuritiesMember2022-09-300001071739us-gaap:CorporateDebtSecuritiesMember2021-12-310001071739cnc:RestrictedCertificatesOfDepositMember2022-09-300001071739cnc:RestrictedCertificatesOfDepositMember2021-12-310001071739cnc:RestrictedCashEquivalentsMember2022-09-300001071739cnc:RestrictedCashEquivalentsMember2021-12-310001071739us-gaap:BankTimeDepositsMember2022-09-300001071739us-gaap:BankTimeDepositsMember2021-12-310001071739us-gaap:MunicipalBondsMember2022-09-300001071739us-gaap:MunicipalBondsMember2021-12-310001071739us-gaap:AssetBackedSecuritiesMember2022-09-300001071739us-gaap:AssetBackedSecuritiesMember2021-12-310001071739us-gaap:ResidentialMortgageBackedSecuritiesMember2022-09-300001071739us-gaap:ResidentialMortgageBackedSecuritiesMember2021-12-310001071739us-gaap:CommercialMortgageBackedSecuritiesMember2022-09-300001071739us-gaap:CommercialMortgageBackedSecuritiesMember2021-12-310001071739cnc:RatedSecuritiesMembercnc:InvestmentSecuritiesMemberus-gaap:ExternalCreditRatingInvestmentGradeMember2022-01-012022-09-30xbrli:pure0001071739us-gaap:CommercialMortgageBackedSecuritiesMember2022-01-012022-09-30cnc:position0001071739us-gaap:InvestmentsMember2022-09-300001071739us-gaap:DepositsMember2022-09-300001071739us-gaap:InvestmentsMember2021-12-310001071739us-gaap:DepositsMember2021-12-310001071739us-gaap:FairValueInputsLevel1Member2022-09-300001071739us-gaap:FairValueInputsLevel2Member2022-09-300001071739us-gaap:FairValueInputsLevel3Member2022-09-300001071739us-gaap:AvailableforsaleSecuritiesMemberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel1Member2022-09-300001071739us-gaap:FairValueInputsLevel2Memberus-gaap:AvailableforsaleSecuritiesMemberus-gaap:USTreasuryAndGovernmentMember2022-09-300001071739us-gaap:AvailableforsaleSecuritiesMemberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel3Member2022-09-300001071739us-gaap:AvailableforsaleSecuritiesMemberus-gaap:USTreasuryAndGovernmentMember2022-09-300001071739us-gaap:CorporateDebtSecuritiesMemberus-gaap:AvailableforsaleSecuritiesMemberus-gaap:FairValueInputsLevel1Member2022-09-300001071739us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateDebtSecuritiesMemberus-gaap:AvailableforsaleSecuritiesMember2022-09-300001071739us-gaap:CorporateDebtSecuritiesMemberus-gaap:AvailableforsaleSecuritiesMemberus-gaap:FairValueInputsLevel3Member2022-09-300001071739us-gaap:CorporateDebtSecuritiesMemberus-gaap:AvailableforsaleSecuritiesMember2022-09-300001071739us-gaap:AvailableforsaleSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:MunicipalBondsMember2022-09-300001071739us-gaap:FairValueInputsLevel2Memberus-gaap:AvailableforsaleSecuritiesMemberus-gaap:MunicipalBondsMember2022-09-300001071739us-gaap:AvailableforsaleSecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MunicipalBondsMember2022-09-300001071739us-gaap:AvailableforsaleSecuritiesMemberus-gaap:MunicipalBondsMember2022-09-300001071739us-gaap:AvailableforsaleSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:BankTimeDepositsMember2022-09-300001071739us-gaap:FairValueInputsLevel2Memberus-gaap:AvailableforsaleSecuritiesMemberus-gaap:BankTimeDepositsMember2022-09-300001071739us-gaap:AvailableforsaleSecuritiesMemberus-gaap:BankTimeDepositsMemberus-gaap:FairValueInputsLevel3Member2022-09-300001071739us-gaap:AvailableforsaleSecuritiesMemberus-gaap:BankTimeDepositsMember2022-09-300001071739us-gaap:AvailableforsaleSecuritiesMemberus-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel1Member2022-09-300001071739us-gaap:FairValueInputsLevel2Memberus-gaap:AvailableforsaleSecuritiesMemberus-gaap:AssetBackedSecuritiesMember2022-09-300001071739us-gaap:AvailableforsaleSecuritiesMemberus-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Member2022-09-300001071739us-gaap:AvailableforsaleSecuritiesMemberus-gaap:AssetBackedSecuritiesMember2022-09-300001071739us-gaap:AvailableforsaleSecuritiesMemberus-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel1Member2022-09-300001071739us-gaap:FairValueInputsLevel2Memberus-gaap:AvailableforsaleSecuritiesMemberus-gaap:ResidentialMortgageBackedSecuritiesMember2022-09-300001071739us-gaap:AvailableforsaleSecuritiesMemberus-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Member2022-09-300001071739us-gaap:AvailableforsaleSecuritiesMemberus-gaap:ResidentialMortgageBackedSecuritiesMember2022-09-300001071739us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:AvailableforsaleSecuritiesMemberus-gaap:FairValueInputsLevel1Member2022-09-300001071739us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:AvailableforsaleSecuritiesMember2022-09-300001071739us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:AvailableforsaleSecuritiesMemberus-gaap:FairValueInputsLevel3Member2022-09-300001071739us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:AvailableforsaleSecuritiesMember2022-09-300001071739us-gaap:AvailableforsaleSecuritiesMemberus-gaap:FairValueInputsLevel1Member2022-09-300001071739us-gaap:FairValueInputsLevel2Memberus-gaap:AvailableforsaleSecuritiesMember2022-09-300001071739us-gaap:AvailableforsaleSecuritiesMemberus-gaap:FairValueInputsLevel3Member2022-09-300001071739us-gaap:AvailableforsaleSecuritiesMember2022-09-300001071739us-gaap:CashAndCashEquivalentsMemberus-gaap:DepositsMemberus-gaap:FairValueInputsLevel1Member2022-09-300001071739us-gaap:FairValueInputsLevel2Memberus-gaap:CashAndCashEquivalentsMemberus-gaap:DepositsMember2022-09-300001071739us-gaap:CashAndCashEquivalentsMemberus-gaap:DepositsMemberus-gaap:FairValueInputsLevel3Member2022-09-300001071739us-gaap:CashAndCashEquivalentsMemberus-gaap:DepositsMember2022-09-300001071739us-gaap:CertificatesOfDepositMemberus-gaap:DepositsMemberus-gaap:FairValueInputsLevel1Member2022-09-300001071739us-gaap:CertificatesOfDepositMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DepositsMember2022-09-300001071739us-gaap:CertificatesOfDepositMemberus-gaap:DepositsMemberus-gaap:FairValueInputsLevel3Member2022-09-300001071739us-gaap:CertificatesOfDepositMemberus-gaap:DepositsMember2022-09-300001071739us-gaap:CorporateDebtSecuritiesMemberus-gaap:DepositsMemberus-gaap:FairValueInputsLevel1Member2022-09-300001071739us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateDebtSecuritiesMemberus-gaap:DepositsMember2022-09-300001071739us-gaap:CorporateDebtSecuritiesMemberus-gaap:DepositsMemberus-gaap:FairValueInputsLevel3Member2022-09-300001071739us-gaap:CorporateDebtSecuritiesMemberus-gaap:DepositsMember2022-09-300001071739us-gaap:DepositsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:MunicipalBondsMember2022-09-300001071739us-gaap:FairValueInputsLevel2Memberus-gaap:DepositsMemberus-gaap:MunicipalBondsMember2022-09-300001071739us-gaap:DepositsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MunicipalBondsMember2022-09-300001071739us-gaap:DepositsMemberus-gaap:MunicipalBondsMember2022-09-300001071739us-gaap:DepositsMemberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel1Member2022-09-300001071739us-gaap:FairValueInputsLevel2Memberus-gaap:DepositsMemberus-gaap:USTreasuryAndGovernmentMember2022-09-300001071739us-gaap:DepositsMemberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel3Member2022-09-300001071739us-gaap:DepositsMemberus-gaap:USTreasuryAndGovernmentMember2022-09-300001071739us-gaap:DepositsMemberus-gaap:FairValueInputsLevel1Member2022-09-300001071739us-gaap:FairValueInputsLevel2Memberus-gaap:DepositsMember2022-09-300001071739us-gaap:DepositsMemberus-gaap:FairValueInputsLevel3Member2022-09-300001071739us-gaap:FairValueInputsLevel1Member2021-12-310001071739us-gaap:FairValueInputsLevel2Member2021-12-310001071739us-gaap:FairValueInputsLevel3Member2021-12-310001071739us-gaap:AvailableforsaleSecuritiesMemberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel1Member2021-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:AvailableforsaleSecuritiesMemberus-gaap:USTreasuryAndGovernmentMember2021-12-310001071739us-gaap:AvailableforsaleSecuritiesMemberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel3Member2021-12-310001071739us-gaap:AvailableforsaleSecuritiesMemberus-gaap:USTreasuryAndGovernmentMember2021-12-310001071739us-gaap:CorporateDebtSecuritiesMemberus-gaap:AvailableforsaleSecuritiesMemberus-gaap:FairValueInputsLevel1Member2021-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateDebtSecuritiesMemberus-gaap:AvailableforsaleSecuritiesMember2021-12-310001071739us-gaap:CorporateDebtSecuritiesMemberus-gaap:AvailableforsaleSecuritiesMemberus-gaap:FairValueInputsLevel3Member2021-12-310001071739us-gaap:CorporateDebtSecuritiesMemberus-gaap:AvailableforsaleSecuritiesMember2021-12-310001071739us-gaap:AvailableforsaleSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:MunicipalBondsMember2021-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:AvailableforsaleSecuritiesMemberus-gaap:MunicipalBondsMember2021-12-310001071739us-gaap:AvailableforsaleSecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MunicipalBondsMember2021-12-310001071739us-gaap:AvailableforsaleSecuritiesMemberus-gaap:MunicipalBondsMember2021-12-310001071739us-gaap:AvailableforsaleSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:BankTimeDepositsMember2021-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:AvailableforsaleSecuritiesMemberus-gaap:BankTimeDepositsMember2021-12-310001071739us-gaap:AvailableforsaleSecuritiesMemberus-gaap:BankTimeDepositsMemberus-gaap:FairValueInputsLevel3Member2021-12-310001071739us-gaap:AvailableforsaleSecuritiesMemberus-gaap:BankTimeDepositsMember2021-12-310001071739us-gaap:AvailableforsaleSecuritiesMemberus-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel1Member2021-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:AvailableforsaleSecuritiesMemberus-gaap:AssetBackedSecuritiesMember2021-12-310001071739us-gaap:AvailableforsaleSecuritiesMemberus-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Member2021-12-310001071739us-gaap:AvailableforsaleSecuritiesMemberus-gaap:AssetBackedSecuritiesMember2021-12-310001071739us-gaap:AvailableforsaleSecuritiesMemberus-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel1Member2021-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:AvailableforsaleSecuritiesMemberus-gaap:ResidentialMortgageBackedSecuritiesMember2021-12-310001071739us-gaap:AvailableforsaleSecuritiesMemberus-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Member2021-12-310001071739us-gaap:AvailableforsaleSecuritiesMemberus-gaap:ResidentialMortgageBackedSecuritiesMember2021-12-310001071739us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:AvailableforsaleSecuritiesMemberus-gaap:FairValueInputsLevel1Member2021-12-310001071739us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:AvailableforsaleSecuritiesMember2021-12-310001071739us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:AvailableforsaleSecuritiesMemberus-gaap:FairValueInputsLevel3Member2021-12-310001071739us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:AvailableforsaleSecuritiesMember2021-12-310001071739us-gaap:AvailableforsaleSecuritiesMemberus-gaap:FairValueInputsLevel1Member2021-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:AvailableforsaleSecuritiesMember2021-12-310001071739us-gaap:AvailableforsaleSecuritiesMemberus-gaap:FairValueInputsLevel3Member2021-12-310001071739us-gaap:AvailableforsaleSecuritiesMember2021-12-310001071739us-gaap:CashAndCashEquivalentsMemberus-gaap:DepositsMemberus-gaap:FairValueInputsLevel1Member2021-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:CashAndCashEquivalentsMemberus-gaap:DepositsMember2021-12-310001071739us-gaap:CashAndCashEquivalentsMemberus-gaap:DepositsMemberus-gaap:FairValueInputsLevel3Member2021-12-310001071739us-gaap:CashAndCashEquivalentsMemberus-gaap:DepositsMember2021-12-310001071739us-gaap:CertificatesOfDepositMemberus-gaap:DepositsMemberus-gaap:FairValueInputsLevel1Member2021-12-310001071739us-gaap:CertificatesOfDepositMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DepositsMember2021-12-310001071739us-gaap:CertificatesOfDepositMemberus-gaap:DepositsMemberus-gaap:FairValueInputsLevel3Member2021-12-310001071739us-gaap:CertificatesOfDepositMemberus-gaap:DepositsMember2021-12-310001071739us-gaap:CorporateDebtSecuritiesMemberus-gaap:DepositsMemberus-gaap:FairValueInputsLevel1Member2021-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateDebtSecuritiesMemberus-gaap:DepositsMember2021-12-310001071739us-gaap:CorporateDebtSecuritiesMemberus-gaap:DepositsMemberus-gaap:FairValueInputsLevel3Member2021-12-310001071739us-gaap:CorporateDebtSecuritiesMemberus-gaap:DepositsMember2021-12-310001071739us-gaap:DepositsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:MunicipalBondsMember2021-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:DepositsMemberus-gaap:MunicipalBondsMember2021-12-310001071739us-gaap:DepositsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MunicipalBondsMember2021-12-310001071739us-gaap:DepositsMemberus-gaap:MunicipalBondsMember2021-12-310001071739us-gaap:DepositsMemberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel1Member2021-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:DepositsMemberus-gaap:USTreasuryAndGovernmentMember2021-12-310001071739us-gaap:DepositsMemberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel3Member2021-12-310001071739us-gaap:DepositsMemberus-gaap:USTreasuryAndGovernmentMember2021-12-310001071739us-gaap:DepositsMemberus-gaap:FairValueInputsLevel1Member2021-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:DepositsMember2021-12-310001071739us-gaap:DepositsMemberus-gaap:FairValueInputsLevel3Member2021-12-310001071739us-gaap:InterestRateSwapMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:FairValueInputsLevel1Member2021-12-310001071739us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel2Memberus-gaap:OtherNoncurrentAssetsMember2021-12-310001071739us-gaap:InterestRateSwapMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:FairValueInputsLevel3Member2021-12-310001071739us-gaap:InterestRateSwapMemberus-gaap:OtherNoncurrentAssetsMember2021-12-310001071739cnc:ComputerSoftwareMember2022-09-300001071739cnc:ComputerSoftwareMember2021-12-310001071739us-gaap:BuildingMember2022-09-300001071739us-gaap:BuildingMember2021-12-310001071739cnc:FurnitureAndOfficeEquipmentMember2022-09-300001071739cnc:FurnitureAndOfficeEquipmentMember2021-12-310001071739us-gaap:LeaseholdImprovementsMember2022-09-300001071739us-gaap:LeaseholdImprovementsMember2021-12-310001071739us-gaap:ComputerEquipmentMember2022-09-300001071739us-gaap:ComputerEquipmentMember2021-12-310001071739us-gaap:LandMember2022-09-300001071739us-gaap:LandMember2021-12-310001071739cnc:RealEstateOwnedAndRelatedFixedAssetsMember2022-07-012022-09-300001071739cnc:RealEstateOwnedAndRelatedFixedAssetsMember2022-01-012022-09-300001071739cnc:FixedAssetsLeasedRealEstateMember2022-07-012022-09-300001071739cnc:FixedAssetsLeasedRealEstateMember2022-01-012022-09-3000010717392022-01-012022-06-300001071739cnc:FourPointTwoFivePercentSeniorNotesDueInTwentyTwentySevenMemberus-gaap:SeniorNotesMember2022-09-300001071739cnc:FourPointTwoFivePercentSeniorNotesDueInTwentyTwentySevenMemberus-gaap:SeniorNotesMember2021-12-310001071739cnc:A2300Million245SeniorNotsDueJuly2028Memberus-gaap:SeniorNotesMember2022-09-300001071739cnc:A2300Million245SeniorNotsDueJuly2028Memberus-gaap:SeniorNotesMember2021-12-310001071739us-gaap:SeniorNotesMembercnc:A3500Million4625SeniorNotesDueDecember2029Member2022-09-300001071739us-gaap:SeniorNotesMembercnc:A3500Million4625SeniorNotesDueDecember2029Member2021-12-310001071739cnc:A2200Million375SeniorNotesDueFebruary2030Memberus-gaap:SeniorNotesMember2022-09-300001071739cnc:A2200Million375SeniorNotesDueFebruary2030Memberus-gaap:SeniorNotesMember2021-12-310001071739us-gaap:SeniorNotesMembercnc:A2200Million300SeniorNotesDueOctober2030Member2022-09-300001071739us-gaap:SeniorNotesMembercnc:A2200Million300SeniorNotesDueOctober2030Member2021-12-310001071739cnc:A2200Million250SeniorNotesDueMarch2031Memberus-gaap:SeniorNotesMember2022-09-300001071739cnc:A2200Million250SeniorNotesDueMarch2031Memberus-gaap:SeniorNotesMember2021-12-310001071739cnc:A1300Million2625SeniorNotesDueAugust2031Memberus-gaap:SeniorNotesMember2022-09-300001071739cnc:A1300Million2625SeniorNotesDueAugust2031Memberus-gaap:SeniorNotesMember2021-12-310001071739cnc:TermLoanCreditAgreementMember2022-09-300001071739cnc:TermLoanCreditAgreementMember2021-12-310001071739us-gaap:RevolvingCreditFacilityMember2022-09-300001071739us-gaap:RevolvingCreditFacilityMember2021-12-310001071739cnc:DebtTotalMemberus-gaap:CreditAvailabilityConcentrationRiskMemberus-gaap:LondonInterbankOfferedRateLIBORMember2022-01-012022-09-300001071739cnc:MagellanHealthMember2022-01-310001071739us-gaap:SeniorNotesMember2022-07-012022-09-300001071739us-gaap:CurrencySwapMember2021-07-3100010717392021-07-012021-07-31iso4217:GBP0001071739us-gaap:CurrencySwapMember2022-03-312022-03-310001071739us-gaap:ForeignLineOfCreditMember2022-05-3100010717392022-05-012022-05-310001071739us-gaap:ForeignLineOfCreditMember2022-01-012022-09-300001071739us-gaap:ConstructionLoanPayableMember2017-10-310001071739us-gaap:LondonInterbankOfferedRateLIBORMembersrt:MaximumMemberus-gaap:ConstructionLoanPayableMember2017-10-012017-10-310001071739us-gaap:LondonInterbankOfferedRateLIBORMembersrt:MinimumMemberus-gaap:ConstructionLoanPayableMember2021-07-012021-07-310001071739us-gaap:ConstructionLoanPayableMember2022-04-012022-04-300001071739us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:ConstructionLoanPayableMember2022-04-012022-04-300001071739us-gaap:SeniorNotesMember2022-09-300001071739us-gaap:SubsequentEventMemberus-gaap:SeniorNotesMember2022-10-250001071739us-gaap:SubsequentEventMemberus-gaap:SeniorNotesMember2022-10-012022-10-2500010717392022-06-012022-06-300001071739us-gaap:CommonStockMembercnc:AcceleratedShareRepurchaseAgreementMember2022-07-012022-09-300001071739us-gaap:CommonStockMembercnc:AcceleratedShareRepurchaseAgreementMember2022-07-012022-07-310001071739us-gaap:CommonStockMemberus-gaap:SubsequentEventMembercnc:AcceleratedShareRepurchaseAgreementMember2022-10-012022-10-250001071739us-gaap:CommonStockMemberus-gaap:SubsequentEventMembercnc:AcceleratedShareRepurchaseAgreementMember2022-07-012022-10-250001071739cnc:ShareRepurchaseAgreementMemberus-gaap:CommonStockMember2022-07-012022-09-300001071739us-gaap:CommonStockMember2022-01-012022-09-300001071739cnc:ShareRepurchaseAgreementMember2022-01-012022-09-300001071739us-gaap:SubsequentEventMember2022-10-012022-10-25cnc:segment0001071739us-gaap:OperatingSegmentsMembercnc:ManagedCareMember2022-07-012022-09-300001071739cnc:SpecialtyServicesMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300001071739cnc:ManagedCareMemberus-gaap:IntersegmentEliminationMember2022-07-012022-09-300001071739cnc:SpecialtyServicesMemberus-gaap:IntersegmentEliminationMember2022-07-012022-09-300001071739us-gaap:IntersegmentEliminationMember2022-07-012022-09-300001071739cnc:ManagedCareMember2022-07-012022-09-300001071739cnc:SpecialtyServicesMember2022-07-012022-09-300001071739us-gaap:OperatingSegmentsMembercnc:ManagedCareMember2021-07-012021-09-300001071739cnc:SpecialtyServicesMemberus-gaap:OperatingSegmentsMember2021-07-012021-09-300001071739cnc:ManagedCareMemberus-gaap:IntersegmentEliminationMember2021-07-012021-09-300001071739cnc:SpecialtyServicesMemberus-gaap:IntersegmentEliminationMember2021-07-012021-09-300001071739us-gaap:IntersegmentEliminationMember2021-07-012021-09-300001071739cnc:ManagedCareMember2021-07-012021-09-300001071739cnc:SpecialtyServicesMember2021-07-012021-09-300001071739us-gaap:OperatingSegmentsMembercnc:ManagedCareMember2022-01-012022-09-300001071739cnc:SpecialtyServicesMemberus-gaap:OperatingSegmentsMember2022-01-012022-09-300001071739cnc:ManagedCareMemberus-gaap:IntersegmentEliminationMember2022-01-012022-09-300001071739cnc:SpecialtyServicesMemberus-gaap:IntersegmentEliminationMember2022-01-012022-09-300001071739us-gaap:IntersegmentEliminationMember2022-01-012022-09-300001071739cnc:ManagedCareMember2022-01-012022-09-300001071739cnc:SpecialtyServicesMember2022-01-012022-09-300001071739us-gaap:OperatingSegmentsMembercnc:ManagedCareMember2021-01-012021-09-300001071739cnc:SpecialtyServicesMemberus-gaap:OperatingSegmentsMember2021-01-012021-09-300001071739cnc:ManagedCareMemberus-gaap:IntersegmentEliminationMember2021-01-012021-09-300001071739cnc:SpecialtyServicesMemberus-gaap:IntersegmentEliminationMember2021-01-012021-09-300001071739us-gaap:IntersegmentEliminationMember2021-01-012021-09-300001071739cnc:ManagedCareMember2021-01-012021-09-300001071739cnc:SpecialtyServicesMember2021-01-012021-09-300001071739us-gaap:PendingLitigationMember2021-12-31cnc:claim0001071739us-gaap:SettledLitigationMember2022-09-30cnc:state0001071739us-gaap:PendingLitigationMember2021-06-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
___________________________________________
FORM 10-Q
____________________________________________
(Mark One)
☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2022
OR
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                  to
____________________________________________
Commission file number: 001-31826
____________________________________________
CENTENE CORPORATION
(Exact name of registrant as specified in its charter)
Delaware42-1406317
(State or other jurisdiction of(I.R.S. Employer
incorporation or organization)Identification Number)
7700 Forsyth Boulevard 
St. Louis,Missouri63105
(Address of principal executive offices)(Zip Code)

Registrant’s telephone number, including area code: (314) 725-4477 
Securities registered pursuant to Section 12(b) of the Act:
Title of Each ClassTrading Symbol(s)Name of Each Exchange on Which Registered
Common Stock $0.001 Par ValueCNCNew York Stock Exchange
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days ☒ Yes ☐ No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files) ☒ Yes ☐ No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer", "accelerated filer", "smaller reporting company", and "emerging growth company" in Rule 12b-2 of the Exchange Act. 
Large Accelerated Filer☒Accelerated filer☐
Non-accelerated filer   ☐Smaller reporting company☐
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  ☐     No  ☒
As of October 14, 2022, the registrant had 566,259,693 shares of common stock outstanding.


CENTENE CORPORATION
QUARTERLY REPORT ON FORM 10-Q
TABLE OF CONTENTS
 PAGE
  
Part I
Financial Information
Item 1.
 
 
 
 
 
 
Item 2.
Item 3.
Item 4.
Part II
Other Information
Item 1.
Item 1A.
Item 2.
Item 6.


CAUTIONARY STATEMENT ON FORWARD-LOOKING STATEMENTS

All statements, other than statements of current or historical fact, contained in this filing are forward-looking statements. Without limiting the foregoing, forward-looking statements often use words such as "believe," "anticipate," "plan," "expect," "estimate," "intend," "seek," "target," "goal," "may," "will," "would," "could," "should," "can," "continue" and other similar words or expressions (and the negative thereof). Centene Corporation and its subsidiaries (Centene, the Company, our or we) intends such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we are including this statement for purposes of complying with these safe-harbor provisions. In particular, these statements include, without limitation, statements about our future operating or financial performance, market opportunity, value creation strategy, competition, expected activities in connection with completed and future acquisitions and dispositions, including statements about the impact of our recently completed acquisition of Magellan Health, Inc. (the Magellan Acquisition), other recent and future acquisitions and dispositions, our investments and the adequacy of our available cash resources. These statements may be found in the various sections of this filing, such as Part I, Item 2. "Management's Discussion and Analysis of Financial Condition and Results of Operations," and Part II, Item 1. "Legal Proceedings."

These forward-looking statements reflect our current views with respect to future events and are based on numerous assumptions and assessments made by us in light of our experience and perception of historical trends, current conditions, business strategies, operating environments, future developments and other factors we believe appropriate. By their nature, forward-looking statements involve known and unknown risks and uncertainties and are subject to change because they relate to events and depend on circumstances that will occur in the future, including economic, regulatory, competitive and other factors that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions.

All forward-looking statements included in this filing are based on information available to us on the date of this filing. Except as may be otherwise required by law, we undertake no obligation to update or revise the forward-looking statements included in this filing, whether as a result of new information, future events or otherwise, after the date of this filing. You should not place undue reliance on any forward-looking statements, as actual results may differ materially from projections, estimates, or other forward-looking statements due to a variety of important factors, variables and events including, but not limited to:

•our ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, including fluctuations in medical utilization rates due to the ongoing impact of COVID-19;
•our ability to maintain or achieve improvement in the Centers for Medicare and Medicaid Services (CMS) Star ratings and maintain or achieve improvement in other quality scores in each case that can impact revenue and future growth;
•the risk that the election of new directors, changes in senior management, and any inability to retain key personnel may create uncertainty or negatively impact our ability to execute quickly and effectively;
•uncertainty as to the expected financial performance of the combined company following the recent completion of the Magellan Acquisition;
•the possibility that the expected synergies and value creation from the Magellan Acquisition or the acquisition of WellCare Health Plans, Inc. (the WellCare Acquisition) or other acquired businesses will not be realized, or will not be realized within the respective expected time periods;
•disruption from the integration of the Magellan Acquisition or the WellCare Acquisition, unexpected costs, or similar risks from other acquisitions or dispositions we may announce or complete from time to time, including potential adverse reactions or changes to business relationships with customers, employees, suppliers or regulators, making it more difficult to maintain business and operational relationships;
•the risk that the closing conditions, including applicable regulatory approvals, for the pending dispositions of Magellan Rx and our Spanish and Central European businesses, may be delayed or not obtained;
•impairments to real estate, investments, goodwill and intangible assets;
•a downgrade of the credit rating of our indebtedness;
•competition;
•membership and revenue declines or unexpected trends;
•changes in healthcare practices, new technologies, and advances in medicine;
•increased healthcare costs;
•changes in economic, political or market conditions;
i
•changes in federal or state laws or regulations, including changes with respect to income tax reform or government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act (collectively referred to as the ACA) and any regulations enacted thereunder that may result from changing political conditions, the current administration or judicial actions;
•rate cuts or other payment reductions or delays by governmental payors and other risks and uncertainties affecting our government businesses;
•our ability to adequately price products;
•tax matters;
•disasters or major epidemics;
•changes in expected contract start dates;
•provider, state, federal, foreign and other contract changes and timing of regulatory approval of contracts;
•the expiration, suspension, or termination of our contracts with federal or state governments (including, but not limited to, Medicaid, Medicare, TRICARE or other customers);
•the difficulty of predicting the timing or outcome of legal or regulatory proceedings or matters, including, but not limited to, our ability to resolve claims and/or allegations made by states with regard to past practices, including at Envolve Pharmacy Solutions, Inc. (Envolve), as our pharmacy benefits manager (PBM) subsidiary, within the reserve estimate we previously recorded and on other acceptable terms, or at all, or whether additional claims, reviews or investigations relating to our PBM business will be brought by states, the federal government or shareholder litigants, or government investigations;
•the timing and extent of benefits from our value creation strategy, including the possibility that the benefits received may be lower than expected, may not occur, or will not be realized within the expected time periods;
•challenges to our contract awards;
•cyber-attacks or other privacy or data security incidents;
•the exertion of management's time and our resources, and other expenses incurred and business changes required in connection with complying with the undertakings in connection with any regulatory, governmental or third party consents or approvals for acquisitions or dispositions;
•any changes in expected closing dates, estimated purchase price and accretion for acquisitions or dispositions;
•restrictions and limitations in connection with our indebtedness;
•the availability of debt and equity financing on terms that are favorable to us;
•inflation; and
•foreign currency fluctuations.

This list of important factors is not intended to be exhaustive. We discuss certain of these matters more fully, as well as certain other factors that may affect our business operations, financial condition and results of operations, in our filings with the Securities and Exchange Commission (SEC), including our annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. Due to these important factors and risks, we cannot give assurances with respect to our future performance, including without limitation our ability to maintain adequate premium levels or our ability to control our future medical and selling, general and administrative costs.
ii

Non-GAAP Financial Presentation

The Company is providing certain non-GAAP financial measures in this report, as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company's operations and measure the Company's performance more consistently across periods. The Company uses the presented non-GAAP financial measures internally in evaluating the Company’s performance and for planning purposes, by allowing management to focus on period-to-period changes in the Company's core business operations, and in determining employee incentive compensation. Therefore, the Company believes that this information is meaningful in addition to the information contained in the GAAP presentation of financial information. The presentation of this additional non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP.

Specifically, the Company believes the presentation of non-GAAP financial information that excludes amortization of acquired intangible assets and acquisition and divestiture related expenses, as well as other items, allows investors to develop a more meaningful understanding of the Company's core performance over time. The tables below provide reconciliations of non-GAAP items ($ in millions, except per share data):
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
GAAP net earnings attributable to Centene$738 $584 $1,415 $748 
Amortization of acquired intangible assets211 198 609 581 
Acquisition and divestiture related expenses30 54 149 141 
Other adjustments (1)
(222)11 1,225 1,427 
Income tax effects of adjustments (2)
(2)(102)(521)(455)
Adjusted net earnings $755 $745 $2,877 $2,442 
GAAP diluted earnings per share (EPS) attributable to Centene$1.27 $0.99 $2.41 $1.27 
Amortization of acquired intangible assets0.36 0.34 1.04 0.98 
Acquisition and divestiture related expenses0.05 0.09 0.25 0.24 
Other adjustments (1)
(0.38)0.01 2.09 2.42 
Income tax effects of adjustments (2)
— (0.17)(0.89)(0.77)
Adjusted diluted EPS$1.30 $1.26 $4.90 $4.14 
(1) Other adjustments include the following pre-tax items:
2022:
(a) for the three months ended September 30, 2022: PANTHERx Rare (PANTHERx) divestiture gain of $490 million, or $0.84 per share ($0.65 after-tax), the impairment of assets associated with the pending divestiture of the Spanish and Central European businesses of $165 million, or $0.28 per share ($0.23 after-tax), real estate impairments of $127 million, or $0.22 per share ($0.16 after-tax), an increase to the previously reported gain on the divestiture of U.S. Medical Management (USMM) due to the finalization of working capital adjustments of $13 million, or $0.02 per share ($0.01 after-tax), gain on debt extinguishment related to the repurchases of senior notes of $10 million, or $0.02 per share ($0.01 after-tax), and an adjustment to the costs related to the PBM legal settlement of $1 million, or $0.00 per share ($0.00 after-tax);

(b) for the nine months ended September 30, 2022: real estate impairments of $1,581 million, or $2.69 per share ($1.98 after-tax), PANTHERx divestiture gain of $490 million, or $0.83 per share ($0.65 after-tax), the impairment of assets associated with the pending divestiture of the Spanish and Central European businesses of $165 million, or $0.28 per share ($0.23 after-tax), gain on debt extinguishment of $23 million, or $0.04 per share ($0.03 after-tax), an increase to the previously reported gain related to the divestiture of USMM due to the finalization of working capital adjustments of $13 million, or $0.02 per share ($0.02 after-tax), and costs related to the PBM legal settlement of $5 million, or $0.01 per share ($0.01 after-tax).
iii
2021:
(a) for the three months ended September 30, 2021: non-cash gain related to the acquisition of the remaining 60% interest of Circle Health of $309 million, or $0.52 per share ($0.52 after-tax), non-cash impairment of our equity method investment in RxAdvance of $229 million, or $0.38 per share ($0.35 after-tax), debt extinguishment costs of $79 million, or $0.13 per share ($0.10 after-tax), PBM legal settlement expense of $11 million, or $0.02 per share ($0.01 after-tax), and severance costs due to a restructuring of $1 million, or $0.00 per share ($0.00 after-tax);

(b) for the nine months ended September 30, 2021: PBM legal settlement expense of $1,261 million, or $2.13 per share ($1.79 after-tax), non-cash gain related to the acquisition of the remaining 60% interest of Circle Health of $309 million, or $0.52 per share ($0.52 after-tax), non-cash impairment of our equity method investment in RxAdvance of $229 million, or $0.39 per share ($0.35 after-tax), debt extinguishment costs of $125 million, or $0.21 per share ($0.16 after-tax), a reduction to the previously reported gain on divestiture of certain products of our Illinois health plan of $62 million, or $0.11 per share ($0.08 after-tax), and severance costs due to a restructuring of $59 million, or $0.10 per share ($0.07 after-tax).

(2) The income tax effects of adjustments are based on the effective income tax rates applicable to each adjustment. The nine months ended September 30, 2022 also include an $18 million, or $0.03 per share, increase to the tax benefit on the previously reported non-cash impairment of our equity method investment in RxAdvance.

Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
GAAP selling, general and administrative expenses$2,846 $2,537 $8,391 $6,910 
Less:
Acquisition and divestiture related expenses28 41 149 126 
Restructuring costs— 1 — 59 
Costs related to the PBM legal settlement1 11 5 11 
Real estate optimization3 — 7 — 
Adjusted selling, general and administrative expenses$2,814 $2,484 $8,230 $6,714 
Note: Beginning in 2022, we have included a separate line item for depreciation expense on the Consolidated Statements of Operations, which was previously included in selling, general and administrative (SG&A) expenses. Prior period SG&A expenses have been conformed to the current presentation.
iv
PART I
FINANCIAL INFORMATION

Item 1. Financial Statements.
CENTENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(In millions, except shares in thousands and per share data in dollars)
September 30, 2022December 31, 2021
(Unaudited)
ASSETS  
Current assets:  
Cash and cash equivalents$14,987 $13,118 
Premium and trade receivables13,770 12,238 
Short-term investments2,191 1,539 
Other current assets2,327 1,602 
Total current assets33,275 28,497 
Long-term investments14,053 14,043 
Restricted deposits1,205 1,068 
Property, software and equipment, net2,479 3,391 
Goodwill20,040 19,771 
Intangible assets, net7,523 7,824 
Other long-term assets2,597 3,781 
Total assets$81,172 $78,375 
LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS’ EQUITY 
Current liabilities:  
Medical claims liability$16,465 $14,243 
Accounts payable and accrued expenses9,995 8,493 
Return of premium payable2,205 2,328 
Unearned revenue2,416 434 
Current portion of long-term debt249 267 
Total current liabilities31,330 25,765 
Long-term debt18,084 18,571 
Deferred tax liability480 1,407 
Other long-term liabilities5,678 5,610 
Total liabilities55,572 51,353 
Commitments and contingencies
Redeemable noncontrolling interests66 82 
Stockholders’ equity:  
Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at September 30, 2022 and December 31, 2021
— — 
Common stock, $0.001 par value; authorized 800,000 shares; 606,931 issued and 570,091 outstanding at September 30, 2022, and 602,704 issued and 582,479 outstanding at December 31, 2021
1 1 
Additional paid-in capital19,774 19,672 
Accumulated other comprehensive earnings(1,394)77 
Retained earnings9,554 8,139 
Treasury stock, at cost (36,840 and 20,225 shares, respectively)
(2,557)(1,094)
Total Centene stockholders’ equity25,378 26,795 
Nonredeemable noncontrolling interest156 145 
Total stockholders’ equity25,534 26,940 
Total liabilities, redeemable noncontrolling interests and stockholders’ equity$81,172 $78,375 
The accompanying notes to the consolidated financial statements are an integral part of these statements. 
1
CENTENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(In millions, except shares in thousands and per share data in dollars)
(Unaudited)
 Three Months Ended September 30,Nine Months Ended September 30,
 2022202120222021
Revenues:
Premium$31,848 $28,876 $95,247 $83,436 
Service1,878 1,638 6,679 4,054 
Premium and service revenues33,726 30,514 101,926 87,490 
Premium tax2,139 1,892 7,060 5,924 
Total revenues35,865 32,406 108,986 93,414 
Expenses:  
Medical costs28,111 25,430 83,261 73,210 
Cost of services1,571 1,355 5,658 3,510 
Selling, general and administrative expenses2,846 2,537 8,391 6,910 
Depreciation expense150 147 470 414 
Amortization of acquired intangible assets211 198 609 581 
Premium tax expense2,211 1,965 7,258 6,129 
Impairment289 229 1,739 229 
Legal settlement— — — 1,250 
Total operating expenses35,389 31,861 107,386 92,233 
Earnings from operations476 545 1,600 1,181 
Other income (expense):  
Investment and other income692 424 786 566 
Debt extinguishment10 (79)26 (125)
Interest expense(169)(170)(491)(503)
Earnings before income tax1,009 720 1,921 1,119 
Income tax expense269 139 500 376 
Net earnings740 581 1,421 743 
(Earnings) loss attributable to noncontrolling interests(2)3 (6)5 
Net earnings attributable to Centene Corporation$738 $584 $1,415 $748 

Net earnings per common share attributable to Centene Corporation:
Basic earnings per common share$1.29 $1.00 $2.44 $1.28 
Diluted earnings per common share$1.27 $0.99 $2.41 $1.27 

Weighted average number of common shares outstanding:
Basic573,961 583,244 580,277 582,636 
Diluted580,607 590,702 587,084 590,154 

The accompanying notes to the consolidated financial statements are an integral part of these statements.
2
CENTENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS)
(In millions)
(Unaudited)
 Three Months Ended September 30,Nine Months Ended September 30,
 2022202120222021
Net earnings$740 $581 $1,421 $743 
Reclassification adjustment, net of tax3 1 12 (16)
Change in unrealized gain (loss) on investments, net of tax(383)(47)(1,267)(125)
Foreign currency translation adjustments(101)(17)(216)(20)
Other comprehensive earnings (loss)(481)(63)(1,471)(161)
Comprehensive earnings (loss)259 518 (50)582 
Comprehensive (earnings) loss attributable to noncontrolling interests(2)3 (6)5 
Comprehensive earnings (loss) attributable to Centene Corporation$257 $521 $(56)$587 

The accompanying notes to the consolidated financial statements are an integral part of these statements.

3
CENTENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(In millions, except shares in thousands and per share data in dollars)
(Unaudited)
Three and Nine Months Ended September 30, 2022
 Centene Stockholders’ Equity  
 Common Stock   Treasury Stock  
 
$0.001 Par
Value
Shares
AmtAdditional
Paid-in
Capital		Accumulated
Other
Comprehensive Earnings
(Loss)		Retained
Earnings
$0.001 Par
Value
Shares
AmtNon-redeemable
Non-
controlling
Interest		Total
Balance, December 31, 2021602,704 $1 $19,672 $77 $8,139 20,225 $(1,094)$145 $26,940 
Comprehensive Earnings:         
Net earnings (loss)— — — — 849 — — (1)848 
Other comprehensive loss, net of $(171) tax
— — — (562)— — — — (562)
Common stock issued for employee benefit plans3,221 — 28 — — — — — 28 
Fair value of unvested equity awards in connection with acquisition— — 60 — — — — — 60 
Common stock repurchases— — — — — 846 (71)— (71)
Stock compensation expense— — 70 — — — — — 70 
Balance, March 31, 2022605,925 $1 $19,830 $(485)$8,988 21,071 $(1,165)$144 $27,313 
Comprehensive Earnings:         
Net earnings (loss)— — — — (172)— — (3)(175)
Other comprehensive loss, net of $(106) tax
— — — (428)— — — — (428)
Common stock issued for employee benefit plans519 — 10 — — — — — 10 
Common stock repurchases— — — — — 4,249 (349)— (349)
Stock compensation expense— — 59 — — — — — 59 
Balance, June 30, 2022606,444 $1 $19,899 $(913)$8,816 25,320 $(1,514)$141 $26,430 
Comprehensive Earnings:
Net earnings (loss)— — — — 738 — — (2)736 
Other comprehensive loss, net of $(120) tax
— — — (481)— — — — (481)
Common stock issued for employee benefit plans487 — 24 — — — — — 24 
Common stock repurchases— — (200)— — 11,520 (1,043)— (1,243)
Stock compensation expense— — 51 — — — — — 51 
Reclassification to non-redeemable noncontrolling interest— — — — — — — 17 17 
Balance, September 30, 2022606,931 $1 $19,774 $(1,394)$9,554 36,840 $(2,557)$156 $25,534 

4
Three and Nine Months Ended September 30, 2021
 Centene Stockholders’ Equity  
 Common Stock   Treasury Stock  
 
$0.001 Par
Value
Shares
AmtAdditional
Paid-in
Capital		Accumulated
Other
Comprehensive Earnings
(Loss)		Retained
Earnings
$0.001 Par
Value
Shares
AmtNon-redeemable
 Non-
controlling
Interest		Total
Balance, December 31, 2020598,249 $1 $19,459 $337 $6,792 16,770 $(816)$112 $25,885 
Comprehensive Earnings:         
Net earnings (loss)— — — — 699 — — (5)694 
Other comprehensive loss, net of $(49) tax
— — — (161)— — — — (161)
Common stock issued for employee benefit plans1,675 — 9 — — — — — 9 
Common stock repurchases(316)— (19)— — 156 (10)— (29)
Stock compensation expense— — 51 — — — — — 51 
Contribution from noncontrolling interest— — — — — — — 9 9 
Balance, March 31, 2021599,608 $1 $19,500 $176 $7,491 16,926 $(826)$116 $26,458 
Comprehensive Earnings:         
Net earnings (loss)— — — — (535)— — (3)(538)
Other comprehensive earnings, net of $19 tax
— — — 63 — — — — 63 
Common stock issued for employee benefit plans390 — 9 — — — — — 9 
Common stock repurchases(10)— — — — 60 (4)— (4)
Stock compensation expense— — 36 — — — — — 36 
Contribution from noncontrolling interest— — — — — — — 21 21 
Balance, June 30, 2021599,988 $1 $19,545 $239 $6,956 16,986 $(830)$134 $26,045 
Comprehensive Earnings:
Net earnings (loss)— — — — 584 — — (8)576 
Other comprehensive loss, net of $(15) tax
— — — (63)— — — — (63)
Common stock issued for employee benefit plans720 — 9 — — — — — 9 
Common stock repurchases— — — — — 222 (15)— (15)
Stock compensation expense— — 40 — — — — — 40 
Contribution from noncontrolling interest— — — — — — — 5 5 
Divestiture of noncontrolling interests— — — — — — (10)(10)
Acquisition resulting in noncontrolling interests— — — — — — 3 3 
Balance, September 30, 2021600,708 $1 $19,594 $176 $7,540 17,208 $(845)$124 $26,590 

The accompanying notes to the consolidated financial statements are an integral part of these statements.
5
CENTENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In millions, unaudited)
 Nine Months Ended September 30,
 20222021
Cash flows from operating activities:  
Net earnings$1,421 $743 
Adjustments to reconcile net earnings to net cash provided by operating activities
Depreciation and amortization1,178 1,098 
Stock compensation expense180 127 
Impairment1,739 229 
(Gain) loss on debt extinguishment(26)125 
(Gain) on acquisition(2)(309)
Deferred income taxes(682)(143)
(Gain) loss on divestitures(503)62 
Other adjustments, net164 (6)
Changes in assets and liabilities  
Premium and trade receivables(1,274)(1,723)
Other assets152 (124)
Medical claims liabilities1,976 1,661 
Unearned revenue1,964 (169)
Accounts payable and accrued expenses686 993 
Other long-term liabilities863 964 
Other operating activities, net1 2 
Net cash provided by operating activities7,837 3,530 
Cash flows from investing activities:  
Capital expenditures(771)(662)
Purchases of investments(5,118)(5,253)
Sales and maturities of investments2,842 4,069 
Acquisitions, net of cash acquired(1,457)(534)
Divestiture proceeds, net of divested cash1,362 (62)
Net cash used in investing activities(3,142)(2,442)
Cash flows from financing activities:  
Proceeds from long-term debt357 9,247 
Payments and repurchases of long-term debt(1,202)(7,411)
Common stock repurchases(1,663)(49)
Payments for debt extinguishment(14)(157)
Debt issuance costs— (72)
Other financing activities, net57 39 
Net cash (used in) provided by financing activities(2,465)1,597 
Effect of exchange rate changes on cash, cash equivalents, and restricted cash(37)(8)
Net increase in cash, cash equivalents, and restricted cash and cash equivalents2,193 2,677 
Cash and cash equivalents reclassified from (to) held for sale(192)— 
Cash, cash equivalents, and restricted cash and cash equivalents, beginning of period
13,214 10,957 
Cash, cash equivalents, and restricted cash and cash equivalents, end of period
$15,215 $13,634 
Supplemental disclosures of cash flow information:  
Interest paid$462 $479 
Income taxes paid$448 $477 
The following table provides a reconciliation of cash, cash equivalents, and restricted cash and cash equivalents reported within the Consolidated Balance Sheets to the totals above:
September 30,
20222021
Cash and cash equivalents$14,987 $13,423 
Restricted cash and cash equivalents, included in restricted deposits228 211 
Total cash, cash equivalents, and restricted cash and cash equivalents$15,215 $13,634 
The accompanying notes to the consolidated financial statements are an integral part of these statements.
6
CENTENE CORPORATION AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

1. Organization and Operations

Basis of Presentation

The accompanying interim financial statements have been prepared under the presumption that users of the interim financial information have either read or have access to the audited financial statements included in the Form 10-K for the fiscal year ended December 31, 2021. The unaudited interim financial statements herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, footnote disclosures that would substantially duplicate the disclosures contained in the December 31, 2021 audited financial statements have been omitted from these interim financial statements, where appropriate. In the opinion of management, these financial statements reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for a fair presentation of the results of the interim periods presented.

Certain 2021 amounts in the consolidated financial statements and notes to the consolidated financial statements have been reclassified to conform to the 2022 presentation. Beginning in 2022, the Company has included a separate line item for depreciation expense on the Consolidated Statement of Operations, which was previously included in selling, general and administrative (SG&A) expenses. Prior period SG&A expense ratios have also been conformed to the current presentation. These reclassifications have no effect on net earnings or stockholders’ equity as previously reported.

On January 4, 2022, the Company acquired all of the issued and outstanding shares of Magellan Health, Inc. (Magellan) (the Magellan Acquisition). The acquisition was accounted for as a business combination. See Note 2. Acquisitions and Divestitures for further details.

Accounting Guidance Not Yet Adopted

The Company has determined that there are no recently issued accounting pronouncements that will have a material impact on its consolidated financial position, results of operations, or cash flows.

2. Acquisitions and Divestitures

Magellan Acquisition

On January 4, 2022, the Company acquired all of the issued and outstanding shares of Magellan. Total consideration for the acquisition was $2,491 million, consisting of $2,431 million in cash and $60 million related to the fair value of replacement equity awards associated with pre-combination service. The purchase price has been adjusted to reflect the net effective settlement of preexisting relationships between the Company and Magellan of $70 million. The Company recognized $8 million and $100 million of acquisition related expenses related to Magellan for the three and nine months ended September 30, 2022, respectively.

The Magellan Acquisition was accounted for as a business combination using the acquisition method of accounting that requires assets acquired and liabilities assumed to be recognized at fair value as of the acquisition date. The significant areas of the assessment of fair value that remain preliminary include identifiable intangible assets and goodwill, premium and related receivables, medical claims liability, and income taxes, and accordingly, the Company has recorded provisional amounts which are subject to adjustment. Measurement period adjustments will be recorded in the period in which they are determined, as if they had been completed at the acquisition date.
7
The Company's preliminary allocation of the fair value of assets acquired and liabilities assumed as of the acquisition date of January 4, 2022 is as follows ($ in millions):
Assets acquired and liabilities assumed 
Cash and cash equivalents
$998 
Premium and related receivables
791 
Short-term investments
144 
Other current assets
194 
Long-term investments
43 
Restricted deposits
7 
Property, software and equipment
90 
Intangible assets (a)
751 
Other long-term assets50 
Total assets acquired 3,068 
Medical claims liability247 
Accounts payable and accrued expenses495 
Return of premium payable53 
Unearned revenue8 
Current portion of long-term debt5 
Long-term debt (b)
542 
Deferred tax liabilities (c)
123 
Other long-term liabilities69 
Total liabilities assumed1,542 
Mezzanine equity32 
Total identifiable net assets1,494 
Goodwill (d)
997 
Total assets acquired and liabilities assumed$2,491 

The Company has made the following preliminary fair value adjustments based on information reviewed through September 30, 2022. Significant fair value adjustments are noted as follows:

(a) The identifiable intangible assets acquired are to be measured at fair value as of the completion of the acquisition. The fair value of intangible assets will be determined primarily using variations of the income approach, which is based on the present value of the future after-tax cash flows attributable to each identified intangible asset. Other valuation methods, including the market approach and cost approach, will be considered in estimating the fair value. The identifiable intangible assets include purchased contract rights, trade names, provider contracts, and developed technologies. The Company has estimated the fair value of intangible assets to be $751 million with a weighted average life of 13 years. The Company adjusted its estimate of the identifiable intangible assets during the third quarter, resulting in additional amortization of $15 million.

The fair values and weighted average useful lives for identifiable intangible assets acquired are as follows:
Fair ValueWeighted Average Useful Life (in years)
Purchased contract rights$470 13
Provider contracts100 15
Trade names80 17
Developed technologies101 5
Total intangible assets acquired$751 13

8
(b) Debt is required to be measured at fair value under the acquisition method of accounting. The fair value of Magellan's Senior Notes and Credit Agreement assumed in the acquisition was $535 million. In January 2022, the Company paid off Magellan's debt acquired in the transaction using Magellan's cash on hand.

(c) The preliminary deferred tax liabilities are presented net of $116 million of deferred tax assets.

(d) Goodwill is estimated at $997 million and primarily relates to synergies expected from the acquisition and the assembled workforce of Magellan. The assignment of goodwill to the Company’s respective segments has not been completed at this time, but the majority of goodwill is expected to be allocated to the Specialty segment. The majority of the goodwill is not deductible for income tax purposes.

PANTHERx Rare Divestiture

On July 14, 2022, the Company completed the previously announced sale of PANTHERx Rare (PANTHERx) for $1,373 million. The Company recognized a gain of $490 million, or $382 million after-tax, which is included in investment and other income on the Consolidated Statements of Operations.

Spanish and Central European Divestiture

On July 25, 2022, as part of the Company’s previously announced review of strategic alternatives for its international portfolio, the Company announced it has signed a definitive agreement to sell its ownership stakes in its Spanish and Central European businesses, including Ribera Salud, Torrejón Salud, and Pro Diagnostics Group.

As of September 30, 2022, the assets and liabilities of the Spanish and Central European businesses were considered held for sale resulting in $666 million of assets held for sale in Other Current Assets and $582 million of liabilities held for sale in Accounts Payable and Accrued Expenses on the Consolidated Balance Sheet. The majority of the held for sale assets were previously reported as cash and cash equivalents, premium and trade receivables, and property, software and equipment. During the third quarter, the Company recorded an impairment charge primarily related to intangible assets and goodwill associated with the pending divestiture of $165 million, or $138 million after-tax.



9

3. Short-term and Long-term Investments, Restricted Deposits

Short-term and long-term investments and restricted deposits by investment type consist of the following ($ in millions):
 September 30, 2022December 31, 2021
 Amortized
Cost		Gross
Unrealized
Gains		Gross
Unrealized Losses		Fair
Value		Amortized
Cost		Gross
Unrealized
Gains		Gross
Unrealized Losses		Fair
Value
Debt securities:
U.S. Treasury securities and obligations of U.S. government
corporations and agencies
$666 $— $(18)$648 $642 $— $(2)$640 
Corporate securities9,648 1 (897)8,752 8,145 130 (75)8,200 
Restricted certificates of deposit
4 — — 4 4 — — 4 
Restricted cash equivalents
228 — — 228 96 — — 96 
Short-term time deposits
275 — — 275 109 — — 109 
Municipal securities3,980 — (320)3,660 3,398 85 (15)3,468 
Asset-backed securities1,335 — (68)1,267 1,308 5 (5)1,308 
Residential mortgage-backed securities
1,154 — (135)1,019 850 10 (7)853 
Commercial mortgage-backed securities
970 — (96)874 870 13 (10)873 
Equity securities (1)
6 — — 6 326 — — 326 
Private equity investments
551 — — 551 587 — — 587 
Life insurance contracts
165 — — 165 186 — — 186 
Total$18,982 $1 $(1,534)$17,449 $16,521 $243 $(114)$16,650 
(1) Investments in equity securities as of December 31, 2021 primarily consisted of exchange traded funds in fixed income securities.

The Company's investments are debt securities classified as available-for-sale with the exception of equity securities, certain private equity investments and life insurance contracts. The Company's investment policies are designed to provide liquidity, preserve capital and maximize total return on invested assets with the focus on high credit quality securities. The Company limits the size of investment in any single issuer other than U.S. treasury securities and obligations of U.S. government corporations and agencies. As of September 30, 2022, 98% of the Company's investments in rated securities carry an investment grade rating by nationally recognized statistical rating organizations. At September 30, 2022, the Company held certificates of deposit, equity securities, private equity investments, and life insurance contracts, which did not carry a credit rating. Accrued interest income on available-for-sale debt securities was $119 million and $96 million at September 30, 2022 and December 31, 2021, respectively, and is included in other current assets on the Consolidated Balance Sheets.

The Company's residential mortgage-backed securities are primarily issued by the Federal National Mortgage Association, Government National Mortgage Association, or Federal Home Loan Mortgage Corporation, which carry implicit or explicit guarantees of the U.S. government. The Company's commercial mortgage-backed securities are primarily senior tranches with a weighted average rating of AAA and a weighted average duration of 4 years at September 30, 2022.

10
The fair value of available-for-sale debt securities with gross unrealized losses by investment type and length of time that individual securities have been in a continuous unrealized loss position were as follows ($ in millions):
 September 30, 2022December 31, 2021
 Less Than 12 Months12 Months or MoreLess Than 12 Months12 Months or More
 Unrealized LossesFair
Value		Unrealized LossesFair
Value		Unrealized LossesFair
Value		Unrealized LossesFair
Value
U.S. Treasury securities and obligations of U.S. government corporations and agencies
$(14)$556 $(4)$67 $(2)$598 $— $3 
Corporate securities(562)6,737 (335)1,975 (66)4,209 (9)209 
Municipal securities(228)2,998 (92)586 (14)1,173 (1)39 
Asset-backed securities(57)1,094 (11)166 (5)770 — 33 
Residential mortgage-backed securities(86)770 (49)244 (7)472 — 15 
Commercial mortgage-backed securities(59)650 (37)218 (8)380 (2)32 
Total$(1,006)$12,805 $(528)$3,256 $(102)$7,602 $(12)$331 

As of September 30, 2022, the gross unrealized losses were generated from 6,688 positions out of a total of 6,847 positions. The change in fair value of available-for-sale debt securities is primarily a result of movement in interest rates subsequent to the purchase of the security.

For each security in an unrealized loss position, the Company assesses whether it intends to sell the security or if it is more likely than not the Company will be required to sell the security before recovery of the amortized cost basis for reasons such as liquidity, contractual, or regulatory purposes. If the security meets this criterion, the decline in fair value is recorded in earnings. The Company does not intend to sell these securities prior to maturity and it is not likely that the Company will be required to sell these securities prior to maturity; therefore, the Company did not record an impairment for these securities.

In addition, the Company monitors available-for-sale debt securities for credit losses. Certain investments have experienced a decline in fair value due to changes in credit quality, market interest rates and/or general economic conditions. The Company recognizes an allowance when evidence demonstrates that the decline in fair value is credit related. Evidence of a credit related loss may include rating agency actions, adverse conditions specifically related to the security, or failure of the issuer of the security to make scheduled payments.

The contractual maturities of short-term and long-term debt securities and restricted deposits are as follows ($ in millions):
 September 30, 2022December 31, 2021
 InvestmentsRestricted DepositsInvestmentsRestricted Deposits
 Amortized
Cost		Fair
Value		Amortized
Cost		Fair
Value		Amortized
Cost		Fair
Value		Amortized
Cost		Fair
Value
One year or less$2,053 $2,029 $521 $518 $1,390 $1,396 $368 $368 
One year through five years7,296 6,752 518 482 6,212 6,294 460 457 
Five years through ten years4,077 3,496 241 205 3,647 3,681 244 243 
Greater than ten years95 85 — — 73 78 — — 
Asset-backed securities3,459 3,160 — — 3,028 3,034 — — 
Total$16,980 $15,522 $1,280 $1,205 $14,350 $14,483 $1,072 $1,068 
 
Actual maturities may differ from contractual maturities due to call or prepayment options. Equity securities, private equity investments and life insurance contracts are excluded from the table above because they do not have a contractual maturity. The Company has an option to redeem at amortized cost substantially all of the securities included in the greater than ten years category listed above.
11

4. Fair Value Measurements

Assets and liabilities recorded at fair value in the Consolidated Balance Sheets are categorized based upon observable or unobservable inputs used to estimate fair value. Level inputs are as follows:
Level Input:Input Definition:
Level IInputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.
 
Level IIInputs other than quoted prices included in Level I that are observable for the asset or liability through corroboration with market data at the measurement date.
 
Level IIIUnobservable inputs that reflect management's best estimate of what market participants would use in pricing the asset or liability at the measurement date.

The following table summarizes fair value measurements by level at September 30, 2022, for assets and liabilities measured at fair value on a recurring basis ($ in millions):
 Level ILevel IILevel IIITotal
Assets    
Cash and cash equivalents$14,987 $— $— $14,987 
Investments:    
U.S. Treasury securities and obligations of U.S. government corporations and agencies$313 $— $— $313 
Corporate securities— 8,721 — 8,721 
Municipal securities— 3,053 — 3,053 
Short-term time deposits— 275 — 275 
Asset-backed securities— 1,267 — 1,267 
Residential mortgage-backed securities— 1,019 — 1,019 
Commercial mortgage-backed securities— 874 — 874 
Equity securities4 2 — 6 
Total investments$317 $15,211 $— $15,528 
Restricted deposits:    
Cash and cash equivalents$228 $— $— $228 
Certificates of deposit— 4 — 4 
Corporate securities— 31 — 31 
Municipal securities
— 607 — 607 
U.S. Treasury securities and obligations of U.S. government corporations and agencies
335 — — 335 
Total restricted deposits$563 $642 $— $1,205 
Total assets at fair value$15,867 $15,853 $— $31,720 
12

The following table summarizes fair value measurements by level at December 31, 2021, for assets and liabilities measured at fair value on a recurring basis ($ in millions):
 Level ILevel IILevel IIITotal
Assets    
Cash and cash equivalents$13,118 $— $— $13,118 
Investments:    
U.S. Treasury securities and obligations of U.S. government corporations and agencies$171 $— $— $171 
Corporate securities— 8,170 — 8,170 
Municipal securities— 2,999 — 2,999 
Short-term time deposits— 109 — 109 
Asset backed securities— 1,308 — 1,308 
Residential mortgage backed securities— 853 — 853 
Commercial mortgage backed securities— 873 — 873 
Equity securities324 2 — 326 
Total investments$495 $14,314 $— $14,809 
Restricted deposits:    
Cash and cash equivalents$96 $— $— $96 
Certificates of deposit— 4 — 4 
Corporate securities— 30 — 30 
Municipal securities
— 469 — 469 
U.S. Treasury securities and obligations of U.S. government corporations and agencies
469 — — 469 
Total restricted deposits$565 $503 $— $1,068 
Other long-term assets:
Interest rate swap agreements$— $15 $— $15 
Total assets at fair value$14,178 $14,832 $— $29,010 
 
The Company utilizes matrix-pricing services to estimate fair value for securities which are not actively traded on the measurement date. The Company designates these securities as Level II fair value measurements. In addition, the aggregate carrying amount of the Company's private equity investments and life insurance contracts, which approximates fair value, was $716 million and $773 million as of September 30, 2022 and December 31, 2021, respectively.

5. Property, Software and Equipment

Property, software and equipment consist of the following ($ in millions):
 September 30, 2022December 31, 2021
Computer software$2,211 $1,825 
Building641 1,116 
Furniture and office equipment407 753 
Leasehold improvements454 732 
Computer hardware648 617 
Land178 248 
Property, software and equipment, at cost4,539 5,291 
Less: accumulated depreciation(2,060)(1,900)
Property, software and equipment, net$2,479 $3,391 
13
During the second quarter of 2022, in connection with the adoption of a more modern, flexible work environment, the Company undertook a real estate optimization initiative to evaluate future real estate needs and downsize its real estate footprint for owned and leased properties. As a result of this evaluation, during the second quarter of 2022, the Company substantially changed the use or abandoned various properties and assessed for impairment. The Company engaged a third-party real estate specialist to determine the fair value of its owned properties. The valuation primarily considered comparable properties in each market as well as future cash flows.

As a result of the optimization, the Company has recognized impairment charges related to owned real estate of $57 million and $763 million for the three and nine months ended September 30, 2022, respectively. The Company also recognized impairment on fixed assets related to leased real estate of $14 million and $237 million for the three and nine months ended September 30, 2022, respectively. These impairments are primarily related to the Managed Care segment. The remainder of the $1,574 million charge relates to right-of-use (ROU) asset impairments, which is included within Other Long-term assets on the balance sheet, refer to Note 9. Leases.

6. Medical Claims Liability

The following table summarizes the change in medical claims liability ($ in millions):
Nine Months Ended September 30,
20222021
Balance, January 1$14,243 $12,438 
Less: Reinsurance recoverable23 23 
Balance, January 1, net14,220 12,415 
Acquisitions and divestitures 249 — 
Incurred related to:
Current year84,457 74,736 
Prior years(1,196)(1,526)
Total incurred83,261 73,210 
Paid related to:
Current year70,305 62,205 
Prior years10,968 9,344 
Total paid81,273 71,549 
Balance, September 30, net
16,457 14,076 
Plus: Reinsurance recoverable8 23 
Balance, September 30
$16,465 $14,099 

Reinsurance recoverables related to medical claims are included in premium and trade receivables. Changes in estimates of incurred claims for prior years are primarily attributable to reserving under moderately adverse conditions. The impact from COVID-19 on healthcare utilization and medical claims submission patterns continues to provide increased estimation uncertainty on the incurred but not reported liability. Additionally, as a result of minimum health benefits ratio (HBR) and other return of premium programs, the Company recorded $121 million and $438 million as a reduction to premium revenue in the nine months ended September 30, 2022 and 2021, respectively.

Incurred but not reported (IBNR) plus expected development on reported claims as of September 30, 2022 was $11,130 million. Total IBNR plus expected development on reported claims represents estimates for claims incurred but not reported, development on reported claims, and estimates for the costs necessary to process unpaid claims at the end of each period. The Company estimates its liability using actuarial methods that are commonly used by health insurance actuaries and meet Actuarial Standards of Practice. These actuarial methods consider factors such as historical data for payment patterns, cost trends, product mix, seasonality, utilization of healthcare services, and other relevant factors.

14

7. Affordable Care Act

The Affordable Care Act established risk spreading premium stabilization programs as well as a minimum annual medical loss ratio (MLR) and cost sharing reductions.

The Company's net receivables (payables) for each of the programs are as follows ($ in millions):
September 30, 2022December 31, 2021
Risk adjustment receivable$1,068 $522 
Risk adjustment payable(652)(536)
Minimum medical loss ratio(69)(196)
Cost sharing reduction receivable10 69 
Cost sharing reduction payable(81)(42)

In June 2022, CMS announced the final risk adjustment transfers for the 2021 benefit year. As a result of the announcement, the Company increased its risk adjustment net receivables by $403 million from December 31, 2021. After consideration of minimum MLR and other related impacts, the net pre-tax benefit recognized was approximately $368 million in the nine months ended September 30, 2022.

8. Debt
 
Debt consists of the following ($ in millions):
 September 30, 2022December 31, 2021
$2,500 million 4.25% Senior Notes due December 15, 2027
$2,403 $2,484 
$2,300 million 2.45% Senior Notes due July 15, 2028
2,304 2,304 
$3,500 million 4.625% Senior Notes due December 15, 2029
3,324 3,500 
$2,000 million 3.375% Senior Notes due February 15, 2030
2,000 2,000 
$2,200 million 3.00% Senior Notes due October 15, 2030
2,200 2,200 
$2,200 million 2.50% Senior Notes due March 1, 2031
2,200 2,200 
$1,300 million 2.625% Senior Notes due August 1, 2031
1,300 1,300 
Total senior notes15,731 15,988 
Term loan facility2,196 2,195 
Revolving credit agreement120 149 
Construction loan payable181 184 
Finance leases and other258 493 
Debt issuance costs(153)(171)
Total debt18,333 18,838 
Less current portion(249)(267)
 Long-term debt$18,084 $18,571 

Of the Company's total debt, approximately 15% is variable rate debt tied to London Interbank Offered Rate (LIBOR). The debt agreements that may be impacted by the discontinuation of LIBOR include provisions that the Company believes are sufficient to transition from the existing LIBOR rates to the prevailing successor market rates as necessary.

Senior Notes

In connection with the Magellan Acquisition in January 2022, the Company redeemed Magellan’s existing outstanding 4.4% Senior Notes due 2024 and paid off the existing Credit Agreement using Magellan’s cash on hand. The Company recognized an immaterial net pre-tax gain on extinguishment including related fees and expenses and the write-off of the unamortized premium.

15
During the third quarter of 2022, the Company utilized a portion of the proceeds from the PANTHERx divestiture to repurchase $83 million of its par value Senior Notes due 2027 and $176 million of its par value Senior Notes due 2029 through the Company’s debt repurchase program. The Company recognized a $10 million gain on the redemptions of the notes.

Foreign Currency Swap

In order to manage the foreign exchange risk associated with an intercompany note receivable related to the Circle Health acquisition, the Company entered into a foreign currency swap agreement for a notional amount of $705 million, to purchase £509 million. The swap agreement was formally designated and qualified as a fair value hedge. All gains and losses due to changes in the fair value of the foreign currency swap completely offset changes in the remeasurement of the intercompany note receivable within investment and other income in the Consolidated Statement of Operations, resulting in no net impact to the Consolidated Statement of Operations.

On March 31, 2022, the foreign currency swap settled in connection with its expiration, and the Company received cash proceeds of $35 million. The Company does not hold or issue any derivative instruments for trading or speculative purposes.

Circle Health Debt Refinancing

In May 2022, the Company refinanced certain debt agreements for its Circle Health subsidiary with a new £250 million credit facility maturing in May 2025. The Company recognized a $13 million pre-tax gain on the extinguishment of the existing debt. As of September 30, 2022, £180 million was drawn on the facility, which is included within Finance leases and other in the table above. The new facility is guaranteed by the Company and has similar borrowing rates and covenants to the Company's Revolving Credit Agreement.

Construction Loan

In October 2017, the Company executed a $200 million non-recourse construction loan to fund the expansion of the Company's corporate headquarters. Until final completion of the construction project, which occurred in July 2021, the loan bore interest based on one month LIBOR plus 2.70%, which reduced to LIBOR plus 2.00% at the time construction was completed. The agreement contains financial and non-financial covenants similar to those contained in the Company Credit Facility. The Company guaranteed completion of the construction project associated with the loan. As of September 30, 2022, the Company had $181 million in borrowings outstanding under the loan, which is included in the current portion of long-term debt.

In April 2022, the Company extended the term of the loan for an additional one year. The extension reduced interest on the loan to the Secured Overnight Financing Rate (SOFR) plus 1.85% and matures in April 2023.

Debt Repurchase Program

In June 2022, the Company's Board of Directors authorized a new $1,000 million debt repurchase program in preparation for future debt reductions as part of the Company’s strategic value creation initiatives. During the quarter ended September 30, 2022, the Company repurchased $259 million of its par value senior notes, as described above, for $247 million.

As of September 30, 2022, there was $753 million available under the program. In October 2022, the Company repurchased an additional $58 million of its par value senior notes for $53 million.

9. Leases

The following table sets forth the ROU assets and lease liabilities ($ in millions):
 September 30, 2022December 31, 2021
Assets
ROU assets (recorded within other long-term assets)$2,456 $3,566 
Liabilities
Short-term (recorded within accounts payable and accrued expenses)$193 $204 
Long-term (recorded within other long-term liabilities)3,038 3,619 
Total lease liabilities$3,231 $3,823 
16
As part of the real estate optimization initiative as described in Note 5. Property, Software and Equipment, the Company vacated and abandoned various domestic leased properties. As a result, the Company assessed the ROU assets for impairment. The Company engaged a third-party real estate specialist to determine the recoverability of the leased properties. The valuation primarily considered comparable leased properties in each market and the assessment of potential future rental income that could be generated by the ROU assets.

As a result of the optimization, the Company recognized $53 million and $574 million of ROU asset impairments in the three and nine months ended September 30, 2022, respectively, primarily related to the Managed Care segment. The remainder of the $1,574 million charge was recorded within Property, Software and Equipment, refer to Note 5. Property, Software and Equipment.

As of September 30, 2022, the weighted average remaining lease term for the Company was 20.1 years. The lease liabilities as of September 30, 2022 reflect a weighted average discount rate of 5.6%.

10. Stockholders' Equity

In June 2022, the Company's Board of Directors authorized an additional $3,000 million to the Company’s existing stock repurchase program for its common stock, for a total $4,000 million, in preparation for closing of the Magellan Rx and PANTHERx divestitures as well as planning for the future.

During the third quarter of 2022, the Company entered into an accelerated share repurchase (ASR) agreement with Bank of America to purchase $1,000 million of the Company's common stock in aggregate under the Company’s stock repurchase program. In July 2022, 8.6 million shares were delivered to the Company, representing 80% of the notional amount under the ASR. In October 2022, an additional 3.0 million shares were delivered upon settlement of the ASR based upon the volume-weighted average price (VWAP) over the term of the agreement, less a discount. In total, 11.6 million shares were purchased through the $1,000 million ASR.

The Company also repurchased an additional 2.9 million shares for $240 million during the third quarter. The remaining common stock repurchases relate to the purchase of shares to satisfy tax withholding requirements in connection with employee equity awards.

During the nine months ended September 30, 2022, the Company has repurchased a total of 15.7 million shares of Centene common stock for $1,384 million, exclusive of the $200 million unsettled portion under the ASR. As of September 30, 2022, the Company had a remaining amount of $2,216 million available under the Company’s stock repurchase program.

In October 2022, the Company repurchased an additional 828 thousand shares for $66 million.

17

11. Earnings Per Share

The following table sets forth the calculation of basic and diluted net earnings per common share ($ in millions, except per share data in dollars and shares in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
 2022202120222021
Earnings attributable to Centene Corporation$738 $584 $1,415 $748 
Shares used in computing per share amounts: 
Weighted average number of common shares outstanding573,961 583,244 580,277 582,636 
Common stock equivalents (as determined by applying the treasury stock method)6,646 7,458 6,807 7,518 
Weighted average number of common shares and potential dilutive common shares outstanding580,607 590,702 587,084 590,154 
  
Net earnings per common share attributable to Centene Corporation:
Basic earnings per common share$1.29 $1.00 $2.44 $1.28 
Diluted earnings per common share$1.27 $0.99 $2.41 $1.27 

The calculation of diluted earnings per common share for the three months ended September 30, 2022 and 2021 excludes 152 thousand shares and 111 thousand shares, respectively, related to anti-dilutive stock options, restricted stock, and restricted stock units.

The calculation of diluted earnings per common share for the nine months ended September 30, 2022 and 2021 excludes the impact of 193 thousand shares and 57 thousand shares, respectively, related to anti-dilutive stock options, restricted stock, and restricted stock units.

12. Segment Information

Centene operates in two segments: Managed Care and Specialty Services. The Managed Care segment consists of Centene's health plans, including all of the functions needed to operate them. The Specialty Services segment consists of Centene's specialty companies offering auxiliary healthcare services and products. Factors used in determining the reportable business segments include the nature of operating activities, the existence of separate senior management teams, and the type of information presented to the Company's chief operating decision-maker to evaluate all results of operations.

Segment information for the three months ended September 30, 2022, is as follows ($ in millions):
 Managed 
Care		Specialty
Services		EliminationsConsolidated
Total
Total revenues from external customers$33,722 $2,143 $— $35,865 
Total revenues from internal customers2 3,264 (3,266)— 
Total revenues$33,724 $5,407 $(3,266)$35,865 
Earnings from operations$527 $(51)$— $476 

Segment information for the three months ended September 30, 2021, is as follows ($ in millions):
 Managed 
Care		Specialty
Services		EliminationsConsolidated
Total
Total revenues from external customers$30,888 $1,518 $— $32,406 
Total revenues from internal customers1 3,209 (3,210)— 
Total revenues$30,889 $4,727 $(3,210)$32,406 
Earnings from operations$699 $(154)$— $545 
18
Segment information for the nine months ended September 30, 2022, follows ($ in millions):
 Managed CareSpecialty
Services		EliminationsConsolidated
Total
Total revenues from external customers$101,428 $7,558 $— $108,986 
Total revenues from internal customers6 9,939 (9,945)— 
Total revenues$101,434 $17,497 $(9,945)$108,986 
Earnings from operations$1,634 $(34)$— $1,600 

Segment information for the nine months ended September 30, 2021, follows ($ in millions):
 Managed CareSpecialty
Services		EliminationsConsolidated
Total
Total revenues from external customers$89,078 $4,336 $— $93,414 
Total revenues from internal customers4 9,217 (9,221)— 
Total revenues$89,082 $13,553 $(9,221)$93,414 
Earnings from operations$1,240 $(59)$— $1,181 

13. Contingencies

Overview

The Company is routinely subjected to legal and regulatory proceedings in the normal course of business. These matters can include, without limitation:

•periodic compliance and other reviews and investigations by various federal and state regulatory agencies with respect to requirements applicable to the Company's business, including, without limitation, those related to payment of out-of-network claims, submissions to CMS for risk adjustment payments, or the False Claims Act, the calculation of minimum MLR and rebates related thereto, submissions to state agencies related to payments or state false claims acts, pre-authorization penalties, timely review of grievances and appeals, timely and accurate payment of claims, and the Health Insurance Portability and Accountability Act of 1996 and other federal and state fraud, waste and abuse laws;

•litigation arising out of general business activities, such as tax matters, disputes related to healthcare benefits coverage or reimbursement, putative securities class actions, and medical malpractice, privacy, real estate, intellectual property and employment-related claims; and

•disputes regarding reinsurance arrangements, claims arising out of the acquisition or divestiture of various assets, class actions, and claims relating to the performance of contractual and non-contractual obligations to providers, members, employer groups and others, including, but not limited to, the alleged failure to properly pay claims and challenges to the manner in which the Company processes claims, claims related to network adequacy and claims alleging that the Company has engaged in unfair business practices.

Among other things, these matters may result in awards of damages, fines or penalties, which could be substantial, and/or could require changes to the Company's business. The Company intends to vigorously defend itself against legal and regulatory proceedings to which it is currently a party; however, these proceedings are subject to many uncertainties. In some of the cases pending against the Company, substantial non-economic or punitive damages are being sought.

The Company records reserves and accrues costs for certain legal proceedings and regulatory matters to the extent that it determines an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. While such reserves and accrued costs reflect the Company's best estimate of the probable loss for such matters, the recorded amounts may differ materially from the actual amount of any such losses. In some cases, no estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made because of the inherently unpredictable nature of legal and regulatory proceedings, which may be exacerbated by various factors, including but not limited to, they may involve indeterminate claims for monetary damages or may involve fines, penalties or punitive damages; present novel legal theories or legal uncertainties; involve disputed facts; represent a shift in regulatory policy; involve a large number of parties, claimants or regulatory bodies; are in the early stages of the proceedings; involve a number of separate proceedings and/or a wide range of potential outcomes; or result in a change of business practices.

19
As of the date of this report, amounts accrued for legal proceedings and regulatory matters were not material, except for the reserve estimate as described below with respect to claims or potential claims involving services provided by Envolve Pharmacy Solutions, Inc. (Envolve), as the Company's pharmacy benefits manager (PBM) subsidiary. It is possible that in a particular quarter or annual period the Company's financial condition, results of operations, cash flow and/or liquidity could be materially adversely affected by an ultimate unfavorable resolution of or development in legal and/or regulatory proceedings, including as described below. Except for the proceedings discussed below, the Company believes that the ultimate outcome of any of the regulatory and legal proceedings that are currently pending against it should not have a material adverse effect on financial condition, results of operations, cash flow, or liquidity.

California

On October 20, 2015, the Company's California subsidiary, Health Net of California, Inc. (Health Net California), was named as a defendant in a California taxpayer action filed in Los Angeles County Superior Court, captioned as Michael D. Myers v. State Board of Equalization, Dave Jones, Insurance Commissioner of the State of California, Betty T. Yee, Controller of the State of California, et al., Los Angeles Superior Court Case No. BS158655. This action is brought under a California statute that permits an individual taxpayer to sue a governmental agency when the taxpayer believes the agency has failed to enforce governing law. Plaintiff contends that Health Net California, a California licensed Health Care Service Plan (HCSP), is an "insurer" for purposes of taxation despite acknowledging it is not an "insurer" under regulatory law. Under California law, "insurers" must pay a gross premiums tax (GPT), calculated as 2.35% on gross premiums. As a licensed HCSP, Health Net California has paid the California Corporate Franchise Tax (CFT), the tax generally paid by California businesses. Plaintiff contends that Health Net California must pay the GPT rather than the CFT. Plaintiff seeks a writ of mandate directing the California taxing agencies to collect the GPT, and seeks an order requiring Health Net California to pay GPT, interest and penalties for a period dating to eight years prior to the October 2015 filing of the complaint. This lawsuit is being coordinated with similar lawsuits filed against other entities (collectively, Related Actions). In March 2018, the Court overruled the Company's demurrer seeking to dismiss the complaint and denied the Company's motion to strike allegations seeking retroactive relief. In August 2018, the trial court stayed all the Related Actions pending determination of a writ of mandate by the California Court of Appeals in two of the Related Actions. In March 2019, the California Court of Appeals denied the writ of mandate. The defendants in those Related Actions sought review by the California Supreme Court, which declined to review the matter. Upon the return of the matter to the Los Angeles County Superior Court, motions for summary judgment were scheduled. Health Net California's motion for summary judgment was heard by the Court in March 2020. In March 2020, the Court granted Health Net California's motion for summary judgment. In September 2020, the plaintiff appealed the Court's decision. The Company intends to continue its vigorous defense against these claims; however, this matter is subject to many uncertainties, and an adverse outcome in this matter could potentially have a materially adverse impact on the Company's financial position, results of operations and cash flows.

Beginning in April 2021, several lawsuits have been filed against the Company and its subsidiaries, alleging that the defendants failed to prevent Health Net members' personal and health data from being exposed in connection with a data breach involving Accellion's File Transfer Appliance. The Company denies any wrongdoing and is seeking indemnification from Accellion for these claims. In December 2021, the plaintiffs in three of the pending actions filed a motion for preliminary approval of a settlement with the Company and its subsidiaries, which, if approved by the court, should resolve most or all of the pending litigation. In addition, claims related to these lawsuits are anticipated to be covered in part by the Company's insurance carrier. As a result, while these matters are subject to many uncertainties, the Company does not believe that an adverse outcome in these matters is likely to have a materially adverse impact on the Company’s financial position, results of operations and cash flows.

20
Pharmacy Benefits Management Matters

On March 11, 2021, the State of Ohio filed a civil action against the Company and the Company's subsidiaries, Buckeye Health Plan Community Solutions, Inc. and Envolve, in Franklin County Court of Common Pleas, captioned as Ohio Department of Medicaid, et al. v. Centene Corporation, et al. The complaint alleged breaches of contract with the Ohio Department of Medicaid relating to the provision of PBM services and violations of Ohio law relating to such contracts, including among other things, by (i) seeking payment for services already reimbursed, (ii) not accurately disclosing to the Ohio Department of Medicaid the true cost of the PBM services and (iii) inflating dispensing fees for prescription drugs. The plaintiffs sought an undisclosed sum of money in damages, penalties, and possible termination of the contract with Buckeye Health Plan.

The Company has reached no-fault agreements with the Attorney Generals in 13 states, including Ohio, to resolve claims and/or allegations made by the states related to services provided by Envolve. As a result of the settlement, the Ohio Attorney General’s litigation against the Company was dismissed. Additionally, the Company is in discussions to bring final resolution to similar concerns in other affected states. Consistent with those discussions, the Company recorded a reserve estimate of $1,250 million in the second quarter of 2021 related to this issue, inclusive of the above settlements and rebates that the Company determined in the course of the matter are payable across products. Additional claims, reviews or investigations relating to the Company's PBM business across products may be brought by other states, the federal government or shareholder litigants, and there is no guarantee the Company will have the ability to settle such claims with other states within the reserve estimate the Company has recorded and on other acceptable terms, or at all. This matter is subject to many uncertainties, and an adverse outcome in this matter could have an adverse impact on the Company's financial position, results of operations and cash flows.
21

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the related notes included elsewhere in this filing. The discussion contains forward-looking statements that involve known and unknown risks and uncertainties.

EXECUTIVE OVERVIEW

General

We are a leading healthcare enterprise that is committed to helping people live healthier lives. We take a local approach - with local brands and local teams - to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals.

Results of operations depend on our ability to manage expenses associated with health benefits (including estimated costs incurred) and selling, general and administrative (SG&A) costs. We measure operating performance based upon two key ratios. The health benefits ratio (HBR) represents medical costs as a percentage of premium revenues, excluding premium tax revenues that are separately billed, and reflects the direct relationship between the premiums received and the medical services provided. The SG&A expense ratio represents SG&A costs as a percentage of premium and service revenues, excluding premium taxes separately billed.

Value Creation Plan

As introduced in June 2021, our Value Creation Plan is designed to drive margin expansion by leveraging our scale and generating sustainable profitable growth. In addition to creating shareholder value, this plan is an ongoing effort to modernize and improve how we work in order to propel our organization to new levels of success and elevate the member and provider experiences. The three major pillars of the Value Creation Plan are: SG&A expense savings, gross margin expansion, and strategic capital management. The first pillar, SG&A expense savings, includes initiatives targeting improving productivity, driving efficiencies, and reducing costs throughout the organization, including real estate optimization. The second pillar, gross margin expansion, relates to initiatives including bid discipline, clinical initiatives, quality improvement, and pharmacy cost management. The third pillar, strategic capital management, focuses on value-creating capital deployment activities such as stock repurchases, portfolio optimization, and debt and investment management.
From an operational perspective, we continue to move forward with our Value Creation Plan, including the streamlining of certain operations, such as key call centers and utilization management, evaluating our real estate footprint, and seeking opportunities for platform consolidation. We are assessing our portfolio and are focused on making strategic decisions and investments to create additional value in the short term and to seek opportunities that position the organization for long-term strength, profitability, growth, and innovation.

In the second quarter of 2022, following a strategic review of our real estate portfolio and the adoption of a more modern, flexible work environment, we initiated a reduction of our real estate footprint. As a result, in 2022 we have incurred $1.6 billion related to the impairment of leased and owned real estate and related fixed assets. We incurred impairments of $763 million related to owned real estate, $574 million related to leased real estate, and $237 million related to associated fixed assets. We anticipate additional future charges of approximately $100 million related to real estate optimization. This represents an approximate 70% decrease in domestic leased space and is expected to result in annualized lease expense savings of approximately $200 million.

Additionally, as part of our ongoing portfolio review, during 2022 we completed the divestiture of PANTHERx Rare (PANTHERx) and entered into definitive agreements to sell Magellan Rx as well as our ownership stakes in our Spanish and Central European businesses. In preparation for these transactions as well as planning for the future, our Board of Directors authorized a $3.0 billion increase to our stock repurchase program and a new $1.0 billion debt repurchase program during the second quarter of 2022.

During the nine months ended September 30, 2022, we have repurchased $1.4 billion of Centene common stock through the stock repurchase program, exclusive of the $200 million unsettled portion under the ASR, and $259 million of our senior notes through the debt repurchase program. As of September 30, 2022, $2.2 billion was available under the stock repurchase program and $753 million was available under the debt repurchase program.

22
During the fourth quarter of 2022, we signed a multi-year contract with Express Scripts, Inc. to provide our pharmacy benefit services, commencing in 2024. The new pharmacy benefits management (PBM) contract is expected to drive significant value in 2024 and beyond.

COVID-19 Trends and Uncertainties

The impact of COVID-19 on our business in both the short-term and long-term is uncertain and difficult to predict. The outlook for the remainder of 2022 depends on future developments, including but not limited to: the length and severity of the outbreak (including new variants, which may be more contagious, more severe or less responsive to treatment or vaccines), the effectiveness of containment actions, the timing and effectiveness of vaccinations and achievement of herd immunity, and the timing and rate at which members return to accessing healthcare. The pandemic and these future developments have impacted and will continue to affect our membership and medical utilization. From the onset of the pandemic in March 2020, our Medicaid membership has increased by 3.0 million members (excluding the new North Carolina and Missouri membership). The public health emergency (PHE) extension for COVID-19 has been extended to January 2023 with redeterminations eligible to begin in February 2023. However, the PHE may be extended beyond January 2023. Our Ambetter Health product covers the majority of our Medicaid states, and we believe we are among the best positioned in the healthcare market to capture those transitioning coverage through redeterminations. Our execution plan is well-thought out and we remain agile in working with our state partners and are prepared to support our members and promote continuity of coverage when redeterminations resume.

We continue to watch external trends closely, as COVID-19 costs could increase based upon macro trends. New variants and additional waves of the pandemic could create new dynamics and uncertainties around our expectations.

We are confident we have the team, systems, expertise, and financial strength to continue to effectively navigate this challenging pandemic landscape.

Regulatory Trends and Uncertainties

The United States government, policymakers, and healthcare experts continue to discuss and debate various elements of the United States healthcare model. We remain focused on the promise of delivering access to high-quality, affordable healthcare to all of our members and believe we are well positioned to meet the needs of the changing healthcare landscape.

In contrast to previous executive and legislative efforts to restrict or limit certain provisions of the Affordable Care Act (ACA), the American Rescue Act, enacted on March 11, 2021, contained provisions aimed at leveraging Medicaid and the Health Insurance Marketplace to expand health insurance coverage and affordability to consumers. The American Rescue Act authorized an additional $1.9 trillion in federal spending to address the COVID-19 PHE, and contained several provisions designed to increase coverage of certain healthcare services, expand eligibility and benefits, incentivize state Medicaid expansion, and adjust federal financing for state Medicaid programs, the ultimate impact of which remain uncertain. The American Rescue Act enhanced eligibility for the advance premium tax credit for certain enrollees in the Health Insurance Marketplace. The Inflation Reduction Act, enacted on August 16, 2022, extended the enhanced eligibility for the advance premium tax credit for Marketplace members through the 2025 tax year.

In October 2022, the Treasury Department issued a final rule to address the family glitch in the ACA, which relates to determining who is eligible for premium subsidies. We see this as a significant step in making Marketplace more affordable for working families.

We have more than three decades of experience, spanning seven presidents from both sides of the aisle, in delivering high-quality healthcare services on behalf of states and the federal government to under-insured and uninsured families, commercial organizations and military families. This expertise has allowed us to deliver cost effective services to our government sponsors and our members. While healthcare experts maintain focus on personalized healthcare technology, we continue to make strategic decisions to accelerate development of new software platforms and analytical capabilities. We continue to believe we have both the capacity and capability to successfully navigate industry changes to the benefit of our members, customers and shareholders.

23
Third Quarter 2022 Highlights

Our financial performance for the third quarter of 2022 is summarized as follows:
•Managed care membership of 26.8 million, an increase of 1.2 million members, or 5% year-over-year.
•Total revenues of $35.9 billion, representing 11% growth year-over-year.
•Premium and service revenues of $33.7 billion, representing 11% growth year-over-year.
•HBR of 88.3%, compared to 88.1% for the third quarter of 2021.
•SG&A expense ratio of 8.4%, compared to 8.3% for the third quarter of 2021.
•Adjusted SG&A expense ratio of 8.3%, compared to 8.1% for the third quarter of 2021.
•Operating cash flows of $3.3 billion for the third quarter of 2022.
•Adjusted diluted earnings per share (EPS) of $1.30, compared to $1.26 for the third quarter of 2021.
A reconciliation from GAAP diluted EPS to adjusted diluted EPS is highlighted below, and additional detail is provided above under the heading "Non-GAAP Financial Presentation":
Three Months Ended September 30,
20222021
GAAP diluted EPS attributable to Centene$1.27 $0.99 
Amortization of acquired intangible assets0.36 0.34 
Acquisition and divestiture related expenses0.05 0.09 
Other adjustments (1)
(0.38)0.01 
Income tax effects of adjustments (2)
— (0.17)
Adjusted diluted EPS$1.30 $1.26 
(1) Other adjustments include the following pre-tax items:

(a) for the three months ended September 30, 2022: PANTHERx divestiture gain of $490 million, or $0.84 per share ($0.65 after-tax), the impairment of assets associated with the pending divestiture of the Spanish and Central European businesses of $165 million, or $0.28 per share ($0.23 after-tax), real estate impairments of $127 million, or $0.22 per share ($0.16 after-tax), an increase to the previously reported gain on the divestiture of U.S. Medical Management (USMM) due to the finalization of working capital adjustments of $13 million, or $0.02 per share ($0.01 after-tax), gain on debt extinguishment related to the repurchases of senior notes of $10 million, or $0.02 per share ($0.01 after-tax), and an adjustment to the costs related to the PBM legal settlement of $1 million, or $0.00 per share ($0.00 after-tax);

(b) for the three months ended September 30, 2021: non-cash gain related to the acquisition of the remaining 60% interest of Circle Health of $309 million, or $0.52 per share ($0.52 after-tax), non-cash impairment of our equity method investment in RxAdvance of $229 million, or $0.38 per share ($0.35 after-tax), debt extinguishment costs of $79 million, or $0.13 per share ($0.10 after-tax), PBM legal settlement expense of $11 million, or $0.02 per share ($0.01 after-tax), and severance costs due to a restructuring of $1 million, or $0.00 per share ($0.00 after-tax).

(2) The income tax effects of adjustments are based on the effective income tax rates applicable to each adjustment.

Current and Future Operating Drivers

The following items contributed to our results of operations in the current year:

•Circle Health. In July 2021, we acquired the remaining interest in our equity method investment in Circle Health, one of the U.K.'s largest independent operators of hospitals.

•Commercial. In 2022, we introduced our Health Insurance Marketplace product, Ambetter Health, into five new states, as well as expanded coverage to 274 new counties across 13 existing states. We now serve members in 27 states across the country in 1,480 counties. Additionally, we introduced three new Ambetter Health product offerings to address growing needs of our members: Ambetter Value, Ambetter Select, and Ambetter Virtual Access.
24

•Eligibility Redeterminations. Revenue growth was driven by organic Medicaid growth due to the ongoing suspension of eligibility redeterminations as well as Medicare membership growth during the annual enrollment period.

•Hawaii. In July 2021, we began operating under two new statewide contracts in Hawaii to continue administering covered services to eligible Medicaid and Children's Health Insurance Program (CHIP) members for medically necessary medical, behavioral health, and long-term services and support and to continue administering services through the Community Care Services program in partnership with the Hawaii Department of Human Services' Med-QUEST Division.

•Magellan Health, Inc. (Magellan). In January 2022, we acquired all of the issued and outstanding shares of Magellan for approximately $2.5 billion.

•Medicare Advantage. We experienced strong Medicare membership growth during the 2022 annual enrollment period. In 2022, we introduced WellCare into three new states, as well as expanded coverage to 327 new counties across existing states. We now serve members in 36 states across the country in 1,575 counties.

•Missouri. In July 2022, our subsidiary, Home State Health, commenced the MO HealthNet Managed Care General Plan and Specialty Plan contracts. Under the General Plan, Home State will continue serving multiple MO HealthNet programs including Children's Health Insurance members and the state's newly implemented Medicaid expansion population, across all regions of Missouri. Additionally, as the sole provider of the newly awarded Specialty Plan, Home State now serves approximately 51,000 foster children and children receiving adoption subsidy assistance.

•North Carolina. In July 2021, WellCare of North Carolina commenced operations under a new statewide contract in North Carolina providing Medicaid managed care services. In addition, we also began operating under a new contract to provide Medicaid managed care services in three regions in North Carolina through our provider-led North Carolina joint venture, Carolina Complete Health.

•Ohio. In October 2022, Ohio pharmacy services were carved out in connection with the state's transition of pharmacy services from managed care to a single PBM.

•PANTHERx. In July 2022, we completed the previously announced sale of PANTHERx. The divestiture illustrates our continued progress on the Value Creation Plan.

In addition, we have been negatively impacted by the previously disclosed carve out of California pharmacy services effective January 2022, which occurred in connection with the state’s transition of pharmacy services from managed care to fee for service, and the decrease in the number of our Medicare members in a 4.0 star or above plan for the 2021 rating year (2022 revenue year).

We expect the following items to impact to our future results of operations:

•We have continued to execute on key Value Creation Plan initiatives including the award of the new PBM contract commencing in 2024, the portfolio review, real estate optimization, stock and debt repurchases, along with ongoing focus on quality improvement actions. We expect these actions will drive future margin expansion, create shareholder value, and improve the experience for our members and providers.

•In October 2022, we announced that our Health Insurance Marketplace product, Ambetter Health, will expand into Alabama and extend its footprint by more than 60 counties across 12 existing states in 2023. We also announced our updated brand name, Ambetter Health, reflecting our commitment to putting better health at the forefront of our mission. In total, the Marketplace plan will be available in more than 1,500 counties across 28 states in 2023.

•In October 2022, the Centers for Medicare and Medicaid Services (CMS) published updated Medicare Star quality ratings for the 2023 rating year, which impacts the 2024 revenue year. The decrease in Star quality ratings is driven by the expiration of certain disaster relief provisions as well as deterioration in select metrics. Over the past year, our leadership team launched a multi-year plan to build and improve quality across the enterprise with a strong focus on enhanced patient experience and access to care. We expect to begin to see the results of these efforts with the 2024 rating year (2025 revenue year).

25
•In September 2022, Centene's Nebraska subsidiary, Nebraska Total Care, was awarded the Nebraska Department of Health and Human Services statewide Medicaid managed care contract. Under the new contract, Nebraska Total Care will continue serving the state's Medicaid Managed Care Program, known as Heritage Health. The new contract term is five years and includes the option for two, one-year renewals. The contract is anticipated to begin in January 2024, subject to the resolution of third-party protests.

•In September 2022, Centene's Texas subsidiary, Superior HealthPlan (Superior), was awarded a new, six-year contract by the Texas Health and Human Services Commission to continue providing youth in foster care with healthcare coverage through the STAR Health Medicaid program. Superior has been the sole provider of STAR Health coverage since the program launched in 2008. The contract is anticipated to begin in September 2023.

•In August 2022, we announced California Department of Health Care Services awarded our subsidiary, Health Net of California, contracts to continue serving members in nine counties across California. However, Health Net of California was not awarded contracts in Los Angeles, Sacramento and Kern counties. We are actively protesting the decision to protect our members and their access to quality healthcare. The contracts are anticipated to begin in January 2024, subject to the resolution of the protest process.

•In August 2022, Centene's Mississippi subsidiary, Magnolia Health Plan (Magnolia), was awarded the Mississippi Division of Medicaid contract. Under the new contract, Magnolia will continue serving the state's Coordinated Care Organization Program, which will consist of the Mississippi Coordinated Access Network and the Mississippi Children's Health Insurance Program. The contract is anticipated to begin in July 2023, subject to the resolution of third-party protests.

•In July 2022, as part of our previously announced review of strategic alternatives for our international portfolio, we signed a definitive agreement to sell our ownership stakes in our Spanish and Central European businesses, including Ribera Salud, Torrejón Salud, and Pro Diagnostics Group. The transaction is expected to close by the end of 2022.

•In July 2022, we announced our subsidiary, Delaware First Health, was awarded contracts for the statewide Medicaid Managed Care programs. The new contracts are anticipated to begin in January 2023.

•In May 2022, we signed a definitive agreement to sell Magellan Rx as part of our ongoing portfolio review. The transaction is expected to close by the end of 2022, pending regulatory approvals.

•In March 2022, we announced our subsidiary, Managed Health Services, was selected by the Indiana Department of Administration to continue serving Hoosier Healthwise and Health Indiana Plan members with Medicaid and Medicaid alternative managed care and care coordination services. The new contract is anticipated to begin in January 2023.

•In February 2022, our Louisiana subsidiary, Louisiana Healthcare Connections, was awarded a Medicaid contract by the Louisiana Department of Health to continue administering quality, integrated healthcare services to members across the state. The contract is expected to commence in January 2023.

•In August 2021, we announced that our North Carolina subsidiaries, Carolina Complete Health and WellCare of North Carolina, will coordinate physical and/or other health services with Local Management Entities/Managed Care Organizations under the state's new Tailored Plans. The Tailored Plans, which are expected to launch in April 2023, are integrated health plans designed for individuals with significant behavioral health needs and intellectual/developmental disabilities.

•In August 2021, our Ohio subsidiary, Buckeye Health Plan, was awarded a Medicaid contract by the Ohio Department of Medicaid to continue servicing members with quality healthcare, coordinated services, and benefits. The contract is expected to commence in December 2022.

•We expect Medicaid eligibility redeterminations to begin in February 2023, although it could be further extended.

•We may be negatively impacted by potential Medicaid state rate actions and risk corridor mechanisms as a result of the COVID-19 pandemic.
26

MEMBERSHIP

From September 30, 2021 to September 30, 2022, we increased our managed care membership by 1.2 million, or 5%. The following table sets forth our membership by line of business:
 September 30,
2022		December 31,
2021		September 30,
2021
Traditional Medicaid (1)
14,000,100 13,328,400 13,202,500 
High Acuity Medicaid (2)
1,698,100 1,686,100 1,566,000 
Total Medicaid15,698,200 15,014,500 14,768,500 
Commercial Marketplace2,087,800 2,140,500 2,177,000 
Commercial Group439,800 462,100 468,500 
Total Commercial2,527,600 2,602,600 2,645,500 
Medicare (3)
1,517,900 1,252,200 1,248,300 
Medicare PDP4,186,200 4,070,500 4,064,400 
Total at-risk membership (4)
23,929,900 22,939,800 22,726,700 
TRICARE eligibles2,832,300 2,874,700 2,874,700 
Total
26,762,200 25,814,500 25,601,400 
(1) Membership includes Temporary Assistance for Needy Families (TANF), Medicaid Expansion, Children's Health Insurance Program (CHIP), Foster Care, and Behavioral Health.
(2) Membership includes Aged, Blind, and Disabled (ABD), Intellectual and Developmental Disabilities (IDD), Long-Term Services and Supports (LTSS), and Medicare-Medicaid Plans (MMP) Duals.
(3) Membership includes Medicare Advantage and Medicare Supplement.
(4) Membership includes 1,285,600, 1,178,000, and 1,168,400 dual-eligible beneficiaries for the periods ending September 30, 2022, December 31, 2021, and September 30, 2021, respectively.

27

RESULTS OF OPERATIONS

The following discussion and analysis is based on our Consolidated Statements of Operations, which reflect our results of operations for the three and nine months ended September 30, 2022 and 2021, prepared in accordance with generally accepted accounting principles in the United States. 

Summarized comparative financial data for the three and nine months ended September 30, 2022 and 2021 is as follows ($ in millions, except per share data in dollars):
Three Months Ended September 30,Nine Months Ended September 30,
 20222021% Change20222021% Change
Premium$31,848 $28,876 10 %$95,247 $83,436 14 %
Service1,878 1,638 15 %6,679 4,054 65 %
Premium and service revenues33,726 30,514 11 %101,926 87,490 17 %
Premium tax2,139 1,892 13 %7,060 5,924 19 %
Total revenues35,865 32,406 11 %108,986 93,414 17 %
Medical costs28,111 25,430 11 %83,261 73,210 14 %
Cost of services1,571 1,355 16 %5,658 3,510 61 %
Selling, general and administrative expenses2,846 2,537 12 %8,391 6,910 21 %
Depreciation expense150 147 2 %470 414 14 %
Amortization of acquired intangible assets211 198 7 %609 581 5 %
Premium tax expense2,211 1,965 13 %7,258 6,129 18 %
Impairment289 229 26 %1,739 229 n.m.
Legal settlement— — n.m.— 1,250 n.m.
Earnings from operations476 545 (13)%1,600 1,181 35 %
Investment and other income692 424 63 %786 566 39 %
Debt extinguishment10 (79)n.m.26 (125)n.m.
Interest expense(169)(170)1 %(491)(503)2 %
Earnings before income tax1,009 720 40 %1,921 1,119 72 %
Income tax expense269 139 94 %500 376 33 %
Net earnings740 581 27 %1,421 743 91 %
(Earnings) loss attributable to noncontrolling interests(2)3 n.m.(6)5 n.m.
Net earnings attributable to Centene Corporation$738 $584 26 %$1,415 $748 89 %
Diluted earnings per common share attributable to Centene Corporation$1.27 $0.99 28 %$2.41 $1.27 90 %
n.m.: not meaningful


28
Three Months Ended September 30, 2022 Compared to Three Months Ended September 30, 2021

Total Revenues

The following table sets forth supplemental revenue information for the three months ended September 30, ($ in millions):
20222021% Change
Medicaid$23,293 $21,624 8 %
Commercial4,292 4,383 (2)%
Medicare (1)
5,639 4,322 30 %
Other2,641 2,077 27 %
Total Revenues$35,865 $32,406 11 %
(1) Medicare includes Medicare Advantage, Medicare Supplement, and Medicare Prescription Drug Plan (PDP).

Total revenues increased 11% in the three months ended September 30, 2022 over the corresponding period in 2021, driven by organic Medicaid growth, primarily due to the ongoing suspension of eligibility redeterminations, 22% membership growth in the Medicare business, and our acquisition of Magellan, partially offset by the PANTHERx divestiture.

Operating Expenses

Medical Costs/HBR

The HBR for the three months ended September 30, 2022, was 88.3%, compared to 88.1% in the same period in 2021. The HBR for the third quarter of 2022 was unfavorably impacted by a return to more normalized Medicaid utilization compared to the third quarter of 2021. The increase is partially offset by the impact of Marketplace and Medicare healthcare affordability initiatives as well as disciplined Marketplace pricing.

Cost of Services

Cost of services increased by $216 million in the three months ended September 30, 2022, compared to the corresponding period in 2021, driven by the Magellan business, partially offset by the PANTHERx divestiture. The cost of service ratio for the three months ended September 30, 2022, was 83.7%, compared to 82.7% in the same period in 2021. The increase in the cost of service ratio was driven by recent acquisitions and divestitures.

Selling, General & Administrative Expenses

The SG&A expense ratio was 8.4% for the third quarter of 2022, compared to 8.3% in the third quarter of 2021. The adjusted SG&A expense ratio was 8.3% for the third quarter of 2022, compared to 8.1% in the third quarter of 2021. The increases were due to the addition of Magellan, which operates at a higher SG&A expense ratio due to the nature of its business, and the PANTHERx divestiture. Increases were also driven by costs associated with Medicare marketing and value creation investment spending, partially offset by savings due to real estate optimization efforts and the leveraging of expenses over higher revenues as a result of increased membership.

Impairment

During the third quarter of 2022, we recorded impairment charges of $289 million, including a $165 million charge related to assets associated with the pending divestiture of the Spanish and Central European businesses and $124 million of additional impairments related to our ongoing real estate optimization initiatives, consisting of leased and owned real estate assets and related fixed assets.

During the third quarter of 2021, we recorded a $229 million non-cash impairment of our equity method investment in RxAdvance, a pharmacy benefit manager. The impairment was the result of our focus on simplification of our pharmacy operations.
29
Other Income (Expense)

The following table summarizes the components of other income (expense) for the three months ended September 30, ($ in millions): 
 20222021
Investment and other income$692 $424 
Debt extinguishment10 (79)
Interest expense(169)(170)
Other income (expense), net$533 $175 

Investment and other income. Investment and other income increased by $268 million in the three months ended September 30, 2022 compared to the corresponding period in 2021, driven by the $490 million PANTHERx divestiture gain and higher interest rates. 2021 included a $309 million gain related to the acquisition of the remaining 60% interest of Circle Health.

Debt extinguishment. In the third quarter of 2022, we repurchased $83 million of our 4.25% Senior Notes due 2027 and $176 million of our 4.625% Senior Notes due 2029 through our debt repurchase program, resulting in a pre-tax gain on extinguishment of $10 million.

In August 2021, we redeemed all of our outstanding 5.375% Senior Notes due 2026 and all of WellCare Health Plans, Inc.'s outstanding 5.375% Senior Notes due 2026, including all premiums and accrued interest. We recognized a pre-tax loss on extinguishment of $79 million, including the call premium, the write-off of the unamortized premium and debt issuance costs, and expenses related to the redemptions.

Interest expense. Interest expense decreased by $1 million in the three months ended September 30, 2022, compared to the corresponding period in 2021.

Income Tax Expense

For the three months ended September 30, 2022, we recorded income tax expense of $269 million on pre-tax earnings of $1.0 billion, or an effective tax rate of 26.6%. For the third quarter of 2022, our effective tax rate on adjusted earnings was 26.3%. For the three months ended September 30, 2021, we recorded an income tax expense of $139 million on a pre-tax earnings of $720 million, or an effective tax rate of 19.3%. The effective tax rate for the third quarter of 2021 reflects the non-taxable gain related to the acquisition of the remaining 60% interest of Circle Health. For the third quarter of 2021, our effective tax rate on adjusted earnings was 24.5%.

Segment Results

The following table summarizes our consolidated operating results by segment for the three months ended September 30, ($ in millions):
 20222021% Change
Total Revenues   
Managed Care$33,724 $30,889 9 %
Specialty Services5,407 4,727 14 %
Eliminations(3,266)(3,210)(2)%
Consolidated Total$35,865 $32,406 11 %
Earnings from Operations  
Managed Care$527 $699 (25)%
Specialty Services(51)(154)67 %
Consolidated Total$476 $545 (13)%

Managed Care

Total revenues increased 9% in the three months ended September 30, 2022, compared to the corresponding period in 2021. The increase was due to organic Medicaid growth, partially due to the ongoing suspension of eligibility redeterminations and
30
membership growth in the Medicare business. Earnings from operations decreased $172 million between years primarily as a result of the previously discussed asset impairments and a return to more normalized Medicaid utilization compared to the third quarter of 2021.

Specialty Services

Total revenues increased 14% in the three months ended September 30, 2022, compared to the corresponding period in 2021, primarily due to our acquisition of Magellan, partially offset by the divestiture of PANTHERx. Earnings from operations increased $103 million in the three months ended September 30, 2022, compared to the corresponding period in 2021, primarily due to the prior year impairment of our equity method investment in RxAdvance, a pharmacy benefit manager, in addition to favorable Magellan operations.

Nine Months Ended September 30, 2022 Compared to Nine Months Ended September 30, 2021

Total Revenues

The following table sets forth supplemental revenue information for the nine months ended September 30, ($ in millions):
20222021% Change
Medicaid$69,827 $62,612 12 %
Commercial12,980 12,391 5 %
Medicare (1)
17,035 13,125 30 %
Other9,144 5,286 73 %
Total Revenues$108,986 $93,414 17 %
(1) Medicare includes Medicare Advantage, Medicare Supplement, and Medicare PDP.

Total revenues increased 17% in the nine months ended September 30, 2022, over the corresponding period in 2021 primarily due to Medicaid membership growth resulting from the ongoing suspension of eligibility redeterminations, membership growth in the Medicare business, our acquisitions of Magellan and Circle Health, the commencement of our contracts in North Carolina, additional premium tax revenue and retroactive state directed payments, partially offset by the PANTHERx divestiture.

Operating Expenses

Medical Costs/HBR

The HBR for the nine months ended September 30, 2022 was 87.4%, compared to 87.7% in the same period in 2021. The HBR for 2022 was positively impacted by Marketplace and Medicare healthcare affordability initiatives as well as disciplined Marketplace pricing. These impacts were partially offset by a return to more normalized Medicaid utilization compared to 2021.

Cost of Services

Cost of services increased by $2.1 billion in the nine months ended September 30, 2022, compared to the corresponding period in 2021, driven by the Magellan business, partially offset by the PANTHERx divestiture. The cost of service ratio for the nine months ended September 30, 2022, was 84.7%, compared to 86.6% in the same period in 2021. The decrease in the cost of service ratio was driven by recent acquisitions and divestitures.

31
Selling, General & Administrative Expenses

The SG&A expense ratio for the nine months ended September 30, 2022 was 8.2%, compared to 7.9% for the corresponding period in 2021. The adjusted SG&A expense ratio for the nine months ended September 30, 2022 was 8.1%, compared to 7.7% for the nine months ended September 30, 2021. The increases were due to the additions of the Magellan and Circle Health businesses, which operate at higher SG&A ratios due to the nature of their respective businesses. Increases were also driven by costs associated with Medicare marketing, value creation investment spending, and variable compensation. These impacts were partially offset by the leveraging of expenses over higher revenues as a result of increased membership and reduced restructuring charges compared to 2021.

Impairment

During the nine months ended September 30, 2022, we recorded total impairment charges of $1.7 billion primarily driven by $1.6 billion associated with our ongoing real estate optimization initiative, consisting of leased and owned real estate assets and related fixed assets, along with a $165 million charge related to assets associated with the pending divestiture of the Spanish and Central European businesses.

During the third quarter of 2021, we recorded a $229 million non-cash impairment of our equity method investment in RxAdvance, a pharmacy benefit manager.

Legal Settlement

During the second quarter of 2021, we recorded a legal settlement reserve estimate of $1.25 billion (inclusive of the 13 states with which we have reached no-fault agreements) related to services provided by Envolve Pharmacy Solutions, Inc. (Envolve), our PBM subsidiary, essentially during 2017 and 2018.

Other Income (Expense)

The following table summarizes the components of other income (expense) for the nine months ended September 30, ($ in millions): 
 20222021
Investment and other income$786 $566 
Debt extinguishment26 (125)
Interest expense(491)(503)
Other income (expense), net$321 $(62)

Investment and other income. Investment and other income increased by $220 million in the nine months ended September 30, 2022, compared to the corresponding period in 2021, driven by the $490 million PANTHERx divestiture gain and higher interest rates on larger investment balances, partially offset by decreases in the performance of our deferred compensation investment fund portfolio, which fluctuate with their underlying investments. The losses from our deferred compensation portfolio were substantially offset by decreases in deferred compensation expense, recorded in SG&A expense.

Debt extinguishment. In the third quarter of 2022, we repurchased $83 million of our 4.25% Senior Notes due 2027 and $176 million of our 4.625% Senior Notes due 2029 through our debt repurchase program, resulting in a pre-tax gain on extinguishment of $10 million. In May 2022, we recognized a $13 million pre-tax gain on the extinguishment of debt related to the refinancing of debt for our of Circle Health subsidiary. The 2022 debt extinguishment also includes an immaterial gain related to the redemption of Magellan’s outstanding Senior Notes in January 2022.

In August 2021, we redeemed all of our outstanding 5.375% Senior Notes due 2026 and all of WellCare Health Plans, Inc.'s outstanding 5.375% Senior Notes due 2026, including all premiums and accrued interest. We recognized a pre-tax loss on extinguishment of $79 million, including the call premium, the write-off of the unamortized premium and debt issuance costs, and expenses related to the redemptions. In February 2021, we tendered or redeemed all of our outstanding $2.2 billion 4.75% Senior Notes, due 2025 and recognized a pre-tax loss on extinguishment of approximately $46 million. The loss includes the call premium and the write-off of unamortized premium and debt issuance costs.

Interest expense. Interest expense decreased by $12 million in the nine months ended September 30, 2022, compared to the corresponding period in 2021, driven by our 2022 and 2021 refinancing actions.
32
Income Tax Expense

For the nine months ended September 30, 2022, we recorded income tax expense of $500 million on pre-tax earnings of $1.9 billion, or an effective tax rate of 26.0%. For the nine months ended September 30, 2022, our effective tax rate on adjusted earnings was 26.2%. For the nine months ended September 30, 2021, we recorded income tax expense of $376 million on pre-tax earnings of $1.1 billion, or an effective tax rate of 33.6%, which reflects the partial non-deductibility of the legal settlement reserve.

Segment Results

The following table summarizes our consolidated operating results by segment for the nine months ended September 30, ($ in millions):
 20222021% Change
Total Revenues   
Managed Care$101,434 $89,082 14 %
Specialty Services17,497 13,553 29 %
Eliminations(9,945)(9,221)(8)%
Consolidated Total$108,986 $93,414 17 %
Earnings from Operations  
Managed Care$1,634 $1,240 32 %
Specialty Services(34)(59)42 %
Consolidated Total$1,600 $1,181 35 %

Managed Care

Total revenues increased 14% in the nine months ended September 30, 2022, compared to the corresponding period in 2021, driven by organic Medicaid growth, partially due to the ongoing suspension of eligibility redeterminations, membership growth in the Medicare business, our recent acquisition of Circle Health, the commencement of our contracts in North Carolina, along with premium tax revenue and retroactive state directed payments. Earnings from operations increased $394 million between years primarily as a result of Medicaid and Medicare membership growth, 2021 risk adjustment in 2022, lower traditional utilization in the Marketplace business, profitability growth in the PDP business, and the acquisition of Circle Health, partially offset by the $1.7 billion pre-tax real estate impairment. 2021 was negatively impacted by the legal settlement reserve estimate of $1.25 billion related to services provided by Envolve and higher utilization in the Marketplace business in 2021.

Specialty Services

Total revenues increased 29% in the nine months ended September 30, 2022, compared to the corresponding period in 2021, resulting primarily from our acquisition of Magellan, increased services associated with membership growth in the Managed Care segment, and new contracts in our correctional business. Earnings from operations increased $25 million in the nine months ended September 30, 2022, compared to the corresponding period in 2021, primarily due to favorable Magellan operations and the prior year impairment of our equity method investment in RxAdvance, a pharmacy benefit manager, partially offset by declining operations in our PBM business and a non-recurring item in our federal services business.

LIQUIDITY AND CAPITAL RESOURCES

Shown below is a condensed schedule of cash flows used in the discussion of liquidity and capital resources ($ in millions).
 Nine Months Ended September 30,
 20222021
Net cash provided by operating activities$7,837 $3,530 
Net cash used in investing activities(3,142)(2,442)
Net cash (used in) provided by financing activities(2,465)1,597 
Effect of exchange rate changes on cash and cash equivalents(37)(8)
Net increase in cash, cash equivalents, and restricted cash and cash equivalents$2,193 $2,677 

33
Cash Flows Provided by Operating Activities

Normal operations are funded primarily through operating cash flows and borrowings under our revolving credit facility. Operating activities provided cash of $7.8 billion in the nine months ended September 30, 2022, compared to providing cash of $3.5 billion in the comparable period in 2021. Cash flows provided by operations in 2022 were driven by net earnings before the non-cash real estate impairment charge, an increase in medical claims liabilities, and increases in unearned revenue and accounts payable due to the early receipt of payments from CMS.

Cash flows provided by operations in 2021 were due to net earnings before the legal settlement reserve, an increase in state risk sharing mechanism payables, partially offset by risk adjustment and minimum medical loss ratio (MLR) payments for the Health Insurance Marketplace 2020 plan year.

Cash Flows Used in Investing Activities

Investing activities used cash of $3.1 billion in the nine months ended September 30, 2022, and $2.4 billion in the comparable period in 2021. Cash flows used in investing activities in 2022 primarily consisted of net additions to the investment portfolio of our regulated subsidiaries (including transfers from cash and cash equivalents to long-term investments) and our acquisition of Magellan, partially offset by our PANTHERx divestiture proceeds.

Cash flows used in investing activities in 2021 primarily consisted of the net additions to the investment portfolio of our regulated subsidiaries (including transfers from cash and cash equivalents to long-term investments), acquisition and divestiture activity primarily related to the acquisition of the remaining 60% interest of Circle Health, and capital expenditures.

We spent $771 million and $662 million in the nine months ended September 30, 2022 and 2021, respectively, on capital expenditures for system enhancements, market growth, and our corporate and regional buildings.

As of September 30, 2022, our investment portfolio consisted primarily of fixed-income securities with an average duration of 3.4 years. We had unregulated cash and cash equivalents of $436 million at September 30, 2022, including $49 million in our international subsidiaries, compared to $2.7 billion at December 31, 2021, including $430 million in our international subsidiaries. Unregulated cash was substantially reduced in January 2022 upon the closing of the Magellan Acquisition for the purchase price payment and corresponding closing costs.

Cash Flows Used in Financing Activities

Financing activities used cash of $2.5 billion in the nine months ended September 30, 2022, compared to providing cash of $1.6 billion in the comparable period in 2021. Financing activities in 2022 were driven by stock repurchases of $1.6 billion through our stock repurchase program, the redemption of Magellan's outstanding debt of $535 million assumed in the transaction using Magellan's cash on hand, and senior note debt repurchases of $259 million. In 2021, net financing activities were driven by costs associated with our debt refinancing, offset by increased borrowings.

Liquidity Metrics

In June 2022, our Board of Directors approved an increase to the existing stock repurchase program for Centene’s common stock by $3.0 billion, for a total $4.0 billion. We have approximately $2.2 billion remaining under the program for repurchases as of September 30, 2022.

In July 2022, we remitted $1.0 billion upon entering into an accelerated share repurchase (ASR) agreement to repurchase our common stock under our stock repurchase program using a portion of the proceeds from the PANTHERx divestiture. At inception, we received an initial delivery of approximately 8.6 million shares representing 80% of the $1.0 billion notional amount. In October 2022, an additional 3.0 million shares were delivered upon settlement of the ASR based upon the volume-weighted average price (VWAP) over the term of the agreement, less a discount. In total, 11.6 million shares were purchased through the $1.0 billion ASR.

During the quarter, we also repurchased an additional 2.9 million shares of common stock for $240 million under the stock repurchase program and repurchased $259 million of our par value senior notes, for $247 million, under the debt repurchase program.

34
From time to time, we raise capital through the issuance of debt in the form of senior notes or make decisions to repurchase shares or reduce debt as part of our capital allocation strategy. As of September 30, 2022, we had an aggregate principal amount of $15.7 billion of senior notes issued and outstanding. The indentures governing our various maturities of senior notes contain restrictive covenants. As of September 30, 2022, we were in compliance with all covenants. Refer to Note 8. Debt for further information regarding the issuance and redemption of senior notes and Note 10. Stockholders' Equity for information on stock repurchases.

The credit agreement underlying our Revolving Credit Facility and Term Loan Facility contains customary covenants as well as financial covenants including a minimum fixed charge coverage ratio and a maximum debt-to-EBITDA ratio. Our maximum debt-to-EBITDA ratio under the credit agreement may not exceed 4.0 to 1.0. As of September 30, 2022, we had $120 million of borrowings outstanding under our Revolving Credit Facility, $2.2 billion of borrowings under our Term Loan Facility, and we were in compliance with all covenants. As of September 30, 2022, there were no limitations on the availability of our Revolving Credit Facility as a result of the debt-to-EBITDA ratio.

We had outstanding letters of credit of $211 million as of September 30, 2022, which were not part of our revolving credit facility. The letters of credit bore weighted interest of 0.6% as of September 30, 2022. In addition, we had outstanding surety bonds of $1.4 billion as of September 30, 2022.

At September 30, 2022, we had working capital, defined as current assets less current liabilities, of $1.9 billion, compared to $2.7 billion at December 31, 2021. Working capital was substantially reduced in January 2022 upon the closing of the Magellan Acquisition for the purchase price payment and corresponding closing costs. We manage our short-term and long-term investments with the goal of ensuring that a sufficient portion is held in investments that are highly liquid and can be sold to fund short-term requirements as needed.
 
At September 30, 2022, our debt to capital ratio, defined as total debt divided by the sum of total debt and total equity, was 41.8%, compared to 41.2% at December 31, 2021. Excluding $181 million of non-recourse debt, our debt to capital ratio was 41.6% as of September 30, 2022, compared to $184 million and 40.9% at December 31, 2021. The debt to capital ratio increase was driven by stock repurchases in the quarter. We utilize the debt to capital ratio as a measure, among others, of our leverage and financial flexibility.

2022 Expectations

During the remainder of 2022, we expect to receive net dividends from our insurance subsidiaries of approximately $511 million and spend approximately $300 million in additional capital expenditures. In October 2022, we made additional purchases of $66 million through our stock repurchase program and $58 million of our par value senior notes for $53 million through our debt repurchase program.

If the previously announced divestiture of Magellan Rx closes in 2022, we would have additional proceeds to utilize for additional stock repurchases and debt reduction.

Based on our operating plan, we expect that our available cash, cash equivalents and investments, cash from our operations and cash available under our Revolving Credit Facility will be sufficient to finance our general operations and capital expenditures for at least 12 months from the date of this filing. While we are currently in a strong liquidity position and believe we have adequate access to capital, we may elect to increase borrowings on our Revolving Credit Facility. From time to time we may elect to raise additional funds for these and other purposes, either through issuance of debt or equity, the sale of investment securities or otherwise, as appropriate. In addition, we may strategically pursue refinancing or redemption opportunities to extend maturities and/or improve terms of our indebtedness if we believe such opportunities are favorable to us.

We intend to continue to evaluate strategic actions in connection with our Value Creation Plan, targeting initiatives to improve productivity, efficiencies and reduced organizational costs, as well as capital deployment activities, including stock repurchases, portfolio optimization and the evaluation of refinancing opportunities. In addition to creating shareholder value, this plan encompasses a larger organizational mission to enhance our member and provider experience, improve outcomes for our members, and to initiate new ways of doing business that make Centene a great partner in all aspects of our operations.
35
REGULATORY CAPITAL AND DIVIDEND RESTRICTIONS
 
Our operations are conducted through our subsidiaries. As managed care organizations, most of our subsidiaries are subject to state regulations and other requirements that, among other things, require the maintenance of minimum levels of statutory capital, as defined by each state, and restrict the timing, payment and amount of dividends and other distributions that may be paid to us. Generally, the amount of dividend distributions that may be paid by a regulated subsidiary without prior approval by state regulatory authorities is limited based on the entity's level of statutory net income and statutory capital and surplus.

Our regulated subsidiaries are required to maintain minimum capital requirements prescribed by various regulatory authorities in each of the states in which we operate. During the nine months ended September 30, 2022, we received dividends of $773 million from and made $627 million of capital contributions to our regulated subsidiaries. For our subsidiaries that file with the National Association of Insurance Commissioners (NAIC), the aggregate risk-based capital (RBC) level as of December 31, 2021, which was the most recent date for which reporting was required, was in excess of 350% of the Authorized Control Level. We intend to continue to maintain an aggregate RBC level in excess of 350% of the Authorized Control Level during 2022.

Under the California Knox-Keene Health Care Service Plan Act of 1975, as amended (Knox-Keene), certain of our California subsidiaries must comply with tangible net equity (TNE) requirements. Under these Knox-Keene TNE requirements, actual net worth less certain unsecured receivables and intangible assets must be more than the greater of (i) a fixed minimum amount, (ii) a minimum amount based on premiums or (iii) a minimum amount based on healthcare expenditures, excluding capitated amounts.

Under the New York State Department of Health Codes, Rules and Regulations Title 10, Part 98, our New York subsidiary must comply with contingent reserve requirements. Under these requirements, net worth based upon admitted assets must equal or exceed a minimum amount based on annual net premium income.

The NAIC has adopted rules which set minimum RBC requirements for insurance companies, managed care organizations and other entities bearing risk for healthcare coverage. As of September 30, 2022, each of our health plans was in compliance with the RBC requirements enacted in those states.

As a result of the above requirements and other regulatory requirements, certain of our subsidiaries are subject to restrictions on their ability to make dividend payments, loans or other transfers of cash to their parent companies. Such restrictions, unless amended or waived or unless regulatory approval is granted, limit the use of any cash generated by these subsidiaries to pay our obligations. The maximum amount of dividends that can be paid by our insurance company subsidiaries without prior approval of the applicable state insurance departments is subject to restrictions relating to statutory surplus, statutory income and unassigned surplus.
36

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

INVESTMENTS AND DEBT

As of September 30, 2022, we had short-term investments of $2.2 billion and long-term investments of $15.3 billion, including restricted deposits of $1.2 billion. The short-term investments generally consist of highly liquid securities with maturities between three and 12 months. The long-term investments consist of municipal, corporate and U.S. Treasury securities, government sponsored obligations, life insurance contracts, asset-backed securities, and equity securities, and have maturities greater than one year. Restricted deposits consist of investments required by various state statutes to be deposited or pledged to state agencies. Due to the nature of the states’ requirements, these investments are classified as long-term regardless of the contractual maturity date. Substantially all of our investments are subject to interest rate risk and will decrease in value if market rates increase. Assuming a hypothetical and immediate 1% increase in market interest rates at September 30, 2022, the fair value of our fixed income investments would decrease by approximately $560 million.

For a discussion of the interest rate risk that our investments are subject to, refer to our 10-K for the fiscal year ended December 31, 2021, Part 1, Item 1A, "Risk Factors – Our investment portfolio may suffer losses which could materially and adversely affect our results of operations or liquidity."

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures - We maintain disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (Exchange Act) that are designed to provide reasonable assurance that information required to be disclosed by us in reports that we file or submit under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in SEC rules and forms; and (ii) accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

In connection with the filing of this Form 10-Q, management evaluated, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2022. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of September 30, 2022.

Changes in Internal Control Over Financial Reporting - No change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the quarter ended September 30, 2022 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

On January 4, 2022, we acquired Magellan. Management is currently in the process of evaluating the internal controls and procedures of Magellan and plans to integrate Magellan's internal control over financial reporting with our existing internal control over financial reporting. This integration may lead to changes in the internal control over financial reporting for us or the acquired Magellan business in future periods. Management expects the integration process to continue throughout the year and be completed during 2022.

37
PART II
OTHER INFORMATION


Item 1. Legal Proceedings.

A description of the legal proceedings to which the Company and its subsidiaries are a party is contained in Note 13. Contingencies to the consolidated financial statements included in Part I of this Quarterly Report on Form 10-Q, and is incorporated herein by reference.

Item 1A. Risk Factors.

In addition to the risk factors set forth in Part I - Item 1A - "Risk Factors" of our Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (the "2021 Form 10-K"), investors should carefully consider the following risk factor, which has been updated to reflect the impairment charges related to our real estate portfolio evaluation. This risk should be read in conjunction with the risk factors set forth in the 2021 Form 10-K and the other information contained in this report and our other filings with the Securities and Exchange Commission.

An impairment charge with respect to our real estate portfolio, recorded goodwill and intangible assets could have a material impact on our results of operations.

In connection with the evaluation of our real estate portfolio, we are downsizing our leased space and have evaluated whether the carrying value of our owned real estate may be impaired. As a result, we have incurred a charge of $811 million related to leased real estate and associated fixed asset impairments and a charge of $763 million related to owned real estate impairments through the third quarter of 2022. We anticipate additional future charges of approximately $100 million related to real estate optimization. We also periodically evaluate our goodwill and other intangible assets to determine whether all or a portion of their carrying values may be impaired, in which case a charge to earnings may be necessary. Changes in business strategy, government regulations, or economic or market conditions have resulted and may result in impairments of our real estate portfolio, goodwill and other intangible assets at any time in the future. Our judgments regarding the existence of impairment indicators are based on, among other things, legal factors, market conditions, and operational performance. For example, the non-renewal of our health plan contracts with the state in which they operate may be an indicator of impairment. If an event or events occur that would cause us to revise our estimates and assumptions used in analyzing the value of our goodwill and other intangible assets, such revision could result in a non-cash impairment charge that could have a material impact on our results of operations in the period in which the impairment occurs.
38

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

In June 2022, our Board of Directors approved an additional $3.0 billion to the Company's existing stock repurchase program for its common stock for a total $4.0 billion. The stock repurchase program is effected primarily through regular open-market purchases (which may include repurchase plans designed to comply with Rule 10b5-1 and accelerated share repurchases), the amounts and timing of which are subject to our discretion as part of our capital allocation strategy, and may be based upon general market conditions and the prevailing price and trading volumes of our common stock. No duration has been placed on the repurchase program.

Issuer Purchases of Equity Securities
Third Quarter 2022
(shares in thousands)
Period
 
Total Number of Shares Purchased (1)
Average Price Paid per ShareTotal Number of Shares Purchased as Part of Publicly Announced Plans or Programs
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs ($ in millions) (2)
July 1, 2022 - July 31, 2022 (3)
9,841 $92.15 9,828 $2,350 
August 1, 2022 - August 31, 2022
7 93.52 — 2,350 
September 1, 2022 - September 30, 2022
1,672 81.00 1,658 2,216 
Total11,520 $90.53 11,486 $2,216 
(1) Shares purchased through a publicly announced plan or program and shares relinquished to the Company by certain employees for payment of taxes or option cost upon vesting of restricted stock units or option exercise.
(2) In June 2022, the Company's Board of Directors approved a $3.0 billion increase to the Company's existing stock repurchase program for its common stock. A remaining amount of approximately $2.2 billion is available under the program as of September 30, 2022.
(3) Includes shares repurchased through an accelerated share repurchase (ASR) and represents the spot price at inception but was subsequently settled based on the volume-weighted average price (VWAP) over the term of the agreement. See Note 10. Stockholders’ Equity for additional information.
39

Item 6. Exhibits.
EXHIBIT
NUMBER		 
DESCRIPTION
3.1
3.2
31.1
31.2
32.1
32.2
101The following materials from the Centene Corporation Quarterly Report on Form 10-Q for the quarter ended September 30, 2022, formatted in Inline Extensible Business Reporting Language (iXBRL): (i) the Consolidated Balance Sheets; (ii) the Consolidated Statements of Operations; (iii) the Consolidated Statements of Comprehensive Earnings; (iv) the Consolidated Statements of Stockholders’ Equity; (v) the Consolidated Statements of Cash Flows and (vi) related notes.
104Cover Page Interactive Data File, formatted in iXBRL and contained in Exhibit 101.
40
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized as of October 25, 2022.

 CENTENE CORPORATION
      
 By: /s/ SARAH M. LONDON
 
Chief Executive Officer
(principal executive officer)
 By: /s/ ANDREW L. ASHER
 
Executive Vice President, Chief Financial Officer
(principal financial officer)
 By: /s/ KATIE N. CASSO
 
Senior Vice President, Corporate Controller and Chief Accounting Officer
(principal accounting officer)

41
 EX-31.1 2 a2022093010-qexhibit311.htm EX-31.1 Document

EXHIBIT 31.1

 
CERTIFICATION
 
I, Sarah M. London, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Centene Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
Dated:October 25, 2022 /s/ SARAH M. LONDON
 Chief Executive Officer
(principal executive officer)

 EX-31.2 3 a2022093010-qexhibit312.htm EX-31.2 Document

EXHIBIT 31.2

 
CERTIFICATION
 
I, Andrew L. Asher, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Centene Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated:October 25, 2022  /s/ ANDREW L. ASHER
 
Executive Vice President and Chief Financial Officer
(principal financial officer)

 EX-32.1 4 a2022093010-qexhibit321.htm EX-32.1 Document

EXHIBIT 32.1

 
CERTIFICATION PURSUANT TO 18 U.S.C.  SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Quarterly Report on Form 10-Q of Centene Corporation (the Company) for the period ended September 30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned, Sarah M. London, Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that:
 
(1)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated:October 25, 2022 /s/ SARAH M. LONDON
 Chief Executive Officer
(principal executive officer)

 EX-32.2 5 a2022093010-qexhibit322.htm EX-32.2 Document

EXHIBIT 32.2

 
CERTIFICATION PURSUANT TO 18 U.S.C.  SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Quarterly Report on Form 10-Q of Centene Corporation (the Company) for the period ended September 30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned, Andrew L. Asher, Executive Vice President and Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that:
 
(1)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated:October 25, 2022  /s/ ANDREW L. ASHER
 Executive Vice President and Chief Financial Officer
(principal financial officer)

 EX-101.SCH 6 cnc-20220930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 1001002 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 1002003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1003004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 1004005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS) link:presentationLink link:calculationLink link:definitionLink 1005006 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 1006007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1007008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 2101101 - Disclosure - Organization and Operations link:presentationLink link:calculationLink link:definitionLink 2103102 - Disclosure - Acquisitions and Divestitures link:presentationLink link:calculationLink link:definitionLink 2109103 - Disclosure - Short-term and Long-term Investments, Restricted Deposits link:presentationLink link:calculationLink link:definitionLink 2115104 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 2119105 - Disclosure - Property, Software and Equipment link:presentationLink link:calculationLink link:definitionLink 2123106 - Disclosure - Medical Claims Liability link:presentationLink link:calculationLink link:definitionLink 2127107 - Disclosure - Affordable Care Act link:presentationLink link:calculationLink link:definitionLink 2131108 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 2135109 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 2139110 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 2141111 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 2144112 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 2147113 - Disclosure - Contingencies link:presentationLink link:calculationLink link:definitionLink 2202201 - Disclosure - Organization and Operations (Policies) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - Acquisitions and Divestitures (Tables) link:presentationLink link:calculationLink link:definitionLink 2310302 - Disclosure - Short-term and Long-term Investments, Restricted Deposits (Tables) link:presentationLink link:calculationLink link:definitionLink 2316303 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 2320304 - Disclosure - Property, Software and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 2324305 - Disclosure - Medical Claims Liability (Tables) link:presentationLink link:calculationLink link:definitionLink 2328306 - Disclosure - Affordable Care Act (Tables) link:presentationLink link:calculationLink link:definitionLink 2332307 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 2336308 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 2342309 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2345310 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 2405401 - Disclosure - Acquisitions and Divestitures - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Acquisitions and Divestitures - Schedule of Fair Value of Assets Acquired and Liabilities Assumed (Details) link:presentationLink link:calculationLink link:definitionLink 2407403 - Disclosure - Acquisitions and Divestitures - Identifiable Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2408404 - Disclosure - Acquisitions and Divestitures - Divestitures (Details) link:presentationLink link:calculationLink link:definitionLink 2411405 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - By Investment Type (Details) link:presentationLink link:calculationLink link:definitionLink 2412406 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2413407 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time (Details) link:presentationLink link:calculationLink link:definitionLink 2414408 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Contractual Maturities of Short-Term and Long-Term Investments and Restricted Deposits (Details) link:presentationLink link:calculationLink link:definitionLink 2417409 - Disclosure - Fair Value Measurements - Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 2418410 - Disclosure - Fair Value Measurements - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2421411 - Disclosure - Property, Software and Equipment - Components (Details) link:presentationLink link:calculationLink link:definitionLink 2422412 - Disclosure - Property, Software and Equipment - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2425413 - Disclosure - Medical Claims Liability - Schedule of Change in Medical Claims Liability (Details) link:presentationLink link:calculationLink link:definitionLink 2426414 - Disclosure - Medical Claims Liability - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2429415 - Disclosure - Affordable Care Act - Net Receivables (Payables) for Each of the Ongoing Programs (Details) link:presentationLink link:calculationLink link:definitionLink 2430416 - Disclosure - Affordable Care Act - Additional information (Details) link:presentationLink link:calculationLink link:definitionLink 2433417 - Disclosure - Debt - Schedule of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2433417 - Disclosure - Debt - Schedule of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2434418 - Disclosure - Debt - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2437419 - Disclosure - Leases - ROU Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2438420 - Disclosure - Leases - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2440421 - Disclosure - Stockholders' Equity (Details) link:presentationLink link:calculationLink link:definitionLink 2443422 - Disclosure - Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 2446423 - Disclosure - Segment Information (Details) link:presentationLink link:calculationLink link:definitionLink 2448424 - Disclosure - Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 cnc-20220930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 cnc-20220930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 cnc-20220930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Debt Securities Debt Securities, Available-for-Sale, Amortized Cost [Abstract] One year or less Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One Business Acquisition [Axis] Business Acquisition [Axis] Premium tax expense Premium Tax Expense Premium tax expense, similar assessments and provider pass through payments. Debt Total Debt Total [Member] Debt Total Term loan facility Term Loan Credit Agreement [Member] Term Loan Credit Agreement [Member] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Net earnings Net earnings Net earnings Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Pending claims Loss Contingency, Pending Claims, Number Other long-term liabilities Increase (Decrease) in Other Noncurrent Liabilities Fair value of available-for-sale investments with gross unrealized losses by investment type and length of time Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Property, Plant and Equipment [Abstract] Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Schedule of change in medical claims liability Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block] Debt Instrument [Axis] Debt Instrument [Axis] Property, software and equipment, at cost Property, Plant and Equipment, Gross Impairment associated with pending divestiture, after tax Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down, Net of Tax Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down, Net of Tax Credit facility, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Unearned revenue Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue Proceeds from termination of interest rate swaps Proceeds from Derivative Instrument, Financing Activities Changes in assets and liabilities Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract] Medical claims liability Balance, January 1 Balance, September 30 Liability for Claims and Claims Adjustment Expense Five years through ten years Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 Financial Instruments [Domain] Financial Instruments [Domain] Basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Statistical Measurement [Domain] Statistical Measurement [Domain] Depreciation expense Depreciation Furniture and office equipment Furniture and Office Equipment [Member] Furniture and Office Equipment Weighted-average discount rate for operating leases Operating Lease, Weighted Average Discount Rate, Percent Interest rate Debt Instrument, Interest Rate, Stated Percentage Additional paid-in capital Additional Paid in Capital, Common Stock Extension term Debt Instrument, Extension Term Debt Instrument, Extension Term Risk adjustment payable Affordable Care Act Reinsurance Payable Affordable Care Act Reinsurance, Payable Other adjustments, net Other Noncash Income (Expense) Acquisition resulting in noncontrolling interest Noncontrolling Interest, Increase from Business Combination Common stock repurchases Common stock repurchases Treasury Stock, Value, Acquired, Cost Method Net earnings attributable to Centene Corporation Net Income (Loss) Attributable to Parent Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table] Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table] Anti-dilutive restricted stock and restricted stock units excluded from the calculation of diluted earnings (loss) per common share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount One year through five years Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five Subsequent Event Type [Axis] Subsequent Event Type [Axis] Construction Loan Payable Construction Loan Payable [Member] Reclassification adjustment, net of tax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax Share Repurchase Program [Domain] Share Repurchase Program [Domain] Equity Component [Domain] Equity Component [Domain] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Acquired Finite-Lived Intangible Assets [Line Items] Acquired Finite-Lived Intangible Assets [Line Items] Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward] Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward] Total assets at fair value Assets, Fair Value Disclosure Premium tax Premium Tax Revenue Premium tax revenue, similar assessments and provider pass through payments. Leases Lessee, Operating Leases [Text Block] Cost sharing reduction receivable Affordable Care Act, Cost Sharing Reduction Receivable Affordable Care Act, Cost Sharing Reduction Receivable Total debt Debt and Lease Obligation Risk adjustment and reinsurance pre-tax benefit Affordable Care Act, Risk Adjustment And Reinsurance, Pre-Tax Expense (Benefit) Affordable Care Act, Risk Adjustment And Reinsurance, Pre-Tax Expense (Benefit) Medical claims liability Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Medical Claims Liability Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Medical Claims Liability Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Payments for foreign currency hedge Payments for Hedge, Investing Activities Supplemental disclosures of cash flow information: Supplemental Cash Flow Information [Abstract] Derivative Instrument [Axis] Derivative Instrument [Axis] Risk adjustment receivable Affordable Care Act, Risk Adjustment Receivable Affordable Care Act, Risk Adjustment Receivable Number of operating segments Number of Operating Segments Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Credit facility Long-Term Line of Credit Entity Address, State or Province Entity Address, State or Province Level I Fair Value, Inputs, Level 1 [Member] Reclassification to non-redeemable noncontrolling interest Noncontrolling Interest, Increase from Sale of Parent Equity Interest Organization and Operations Basis of Presentation and Significant Accounting Policies [Text Block] Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Short-term (recorded within accounts payable and accrued expenses) Operating Lease, Liability, Current Derivative asset Derivative Asset Proceeds from sale of business Proceeds from Divestiture of Businesses Premium and related receivables Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Property, software and equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Long-term debt  Long-term debt Long-Term Debt, Excluding Current Maturities Certificates of deposit Certificates of Deposit [Member] Total liabilities Liabilities Short-term time deposits Short-term time deposits Bank Time Deposits [Member] Weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Construction loan payable Loans Payable Adjustment to intangible assets Measurement Period Adjustment To Intangible Assets [Member] Measurement Period Adjustment To Intangible Assets Cash and cash equivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Prior years Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years $3,500 million 4.625% Senior Notes due December 15, 2029 $3,500 Million 4.625% Senior Notes due December 2029 [Member] $3,500 Million 4.625% Senior Notes due December 2029 Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value Hierarchy and NAV [Domain] Fair Value Debt Securities, Held-to-Maturity, Unrealized Loss Position, Fair Value [Abstract] Revolving credit agreement Revolving Credit Facility [Member] Components of Property, Software and Equipment Property, Plant and Equipment [Table Text Block] Mezzanine equity Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Document Type Document Type SOFR Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member] $2,200 million 3.00% Senior Notes due October 15, 2030 $2,200 Million 3.00% Senior Notes Due October 2030 [Member] $2,200 Million 3.00% Senior Notes Due October 2030 Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Assets Assets, Fair Value Disclosure [Abstract] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Segments [Axis] Segments [Axis] Debt Debt Disclosure [Text Block] Product and Service [Domain] Product and Service [Domain] Entity Shell Company Entity Shell Company Deferred income taxes Deferred Income Tax Expense (Benefit) Schedule Of Investments And Restricted Deposits By Type [Axis] Financial Instrument [Axis] Financial Instrument [Axis] Developed technologies Developed Technology Rights [Member] Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Debt repurchase program, amount available under the program Debt Repurchase Program, Remaining Amount Authorized to be Repurchased, Amount Debt Repurchase Program, Remaining Amount Authorized to be Repurchased, Amount Consolidation Items [Domain] Consolidation Items [Domain] Subsequent Event Subsequent Event [Member] Document Period End Date Document Period End Date Debt Securities, Available-for-sale [Table] Debt Securities, Available-for-Sale [Table] Total identifiable net assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Total assets Assets Total paid Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid Debt assumed, aggregate principal Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Long-term Debt, Principal Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Long-term Debt, Principal Debt Disclosure [Abstract] Debt Disclosure [Abstract] Fair value of unvested equity awards in connection with acquisition Shares Issued, Value, Acquisitions, Share-based Payment Arrangement, after Forfeiture Shares Issued, Value, Acquisitions, Share-based Payment Arrangement, after Forfeiture Earnings Per Share [Abstract] Earnings Per Share [Abstract] Leased Real Estate and Fixed Assets Fixed Assets, Leased Real Estate [Member] Fixed Assets, Leased Real Estate Equity securities Equity Securities, FV-NI, Current Interest rate swap agreements Interest Rate Swap [Member] Affordable Care Act [Abstract] Affordable Care Act [Abstract] Affordable Care Act [Abstract] Current portion of long-term debt Less current portion Long-Term Debt, Current Maturities Net cash (used in) provided by financing activities Net Cash Provided by (Used in) Financing Activities Long-term investments Long-Term Investments Stock repurchase program, authorized amount Stock Repurchase Program, Authorized Amount Asset-backed securities Asset-Backed Securities [Member] (Gain) loss on divestitures Gain on disposition of business Gain (Loss) on Disposition of Business Earnings before income tax Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Segments [Domain] Segments [Domain] Earnings Per Share Earnings Per Share [Text Block] One year through five years Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five Less: Reinsurance recoverable Plus: Reinsurance recoverable Reinsurance Recoverable for Unpaid Claims and Claims Adjustments Municipal securities Municipal Bonds [Member] Disposal Group, Disposed of by Sale, Not Discontinued Operations Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member] Other comprehensive earnings (loss), tax (benefit) expense OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax Comprehensive earnings (loss) Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Residential mortgage-backed securities Residential Mortgage-Backed Securities [Member] (Gain) loss on debt extinguishment Gain (Loss) on Extinguishment of Debt Computer hardware Computer Equipment [Member] Cash paid Payments to Acquire Businesses, Gross Derivative Contract [Domain] Derivative Contract [Domain] Assets and Liabilities, Based Upon Observable or Unobservable Inputs, Level Input Definitions Fair Value, Assets and Liabilities, Based Upon Observable or Unobservable Inputs, Input Definitions [Table Text Block] Fair Value, Assets and Liabilities, Based Upon Observable or Unobservable Inputs, Level Input Definitions Entity Registrant Name Entity Registrant Name Total, Amortized Cost Investments, Debt Securities, Equity Method Investments And Other, Amortized Cost Investments, Debt Securities, Equity Method Investments And Other, Amortized Cost Debt redemption amount Debt Instrument, Repurchased Face Amount Insurance [Abstract] Insurance [Abstract] Finance leases and other Finance Lease Liability And Other Finance Lease Liability And Other Premium and trade receivables Premiums and Other Receivables, Net Entity Address, City or Town Entity Address, City or Town Divestiture of noncontrolling interest Noncontrolling Interest, Decrease from Deconsolidation Asset-backed securities Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value Leases [Abstract] Leases [Abstract] Expenses: Operating Expenses [Abstract] Short-duration insurance contracts, Incurred but not reported and expected development on reported claims Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net Total stockholders’ equity Balance Balance Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Share Repurchase Agreement Share Repurchase Agreement [Member] Share Repurchase Agreement Eliminations Intersegment Eliminations [Member] Asset Class [Domain] Asset Class [Domain] Minimum Minimum [Member] Nonredeemable noncontrolling interest Stockholders' Equity Attributable to Noncontrolling Interest One year or less Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Common stock, par value (in dollars per share) Par value (in dollars per share) Common Stock, Par or Stated Value Per Share Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Treasury Stock Treasury Stock, Common [Member] Fair Value Measurements Fair Value Disclosures [Text Block] Unrealized Losses Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract] Trading Symbol Trading Symbol Entity File Number Entity File Number Aggregate carrying amount of life insurance contracts and equity investments, fair value Life Insurance Contracts And Equity Investments, Fair Value Life Insurance Contracts And Equity Investments, Fair Value Treasury stock (in shares) Treasury stock (in shares) Treasury Stock, Common, Shares Accelerated Share Repurchase Agreement Accelerated Share Repurchase Agreement [Member] Accelerated Share Repurchase Agreement Comprehensive (earnings) loss attributable to noncontrolling interests Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Disposal Group Classification [Axis] Disposal Group Classification [Axis] Restricted cash and cash equivalents, included in restricted deposits Restricted Cash and Cash Equivalents Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Premium Health Care, Premium [Member] Cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure LIBOR London Interbank Offered Rate (LIBOR) [Member] Total assets acquired and liabilities assumed Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Percentage of investments in rated securities carry an investment grade rating by nationally recognized statistical rating organizations Concentration Risk, Percentage Total revenues Total revenues Revenues Short-term and Long-term Investments, Restricted Deposits Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Accounts payable and accrued expenses Increase (Decrease) in Accounts Payable and Accrued Liabilities Earnings attributable to Centene Corporation Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent Payments for debt extinguishment Payment for Debt Extinguishment or Debt Prepayment Cost Credit Facility [Domain] Credit Facility [Domain] Fair Value, 12 Months or More Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer Amortization of acquired intangible assets Amortization of Intangible Assets Interest paid Interest Paid, Excluding Capitalized Interest, Operating Activities Basic earnings per common share (in dollars per share) Earnings Per Share, Basic Liabilities held for sale Disposal Group, Including Discontinued Operation, Liabilities Accounts payable and accrued expenses Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable Medical Claims Liability Insurance Disclosure [Text Block] Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss Concentration Risk Type [Domain] Concentration Risk Type [Domain] Total Centene stockholders’ equity Stockholders' Equity Attributable to Parent Number of states where no fault agreements were reached with attorney generals Number of States, No Fault Agreements with Attorney Generals Number of States, No Fault Agreements with Attorney Generals Debt repurchase program, authorized amount Debt Repurchase Program, Authorized Amount Debt Repurchase Program, Authorized Amount Five years through ten years Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 Investments Investments [Member] Entity Interactive Data Current Entity Interactive Data Current Commercial mortgage-backed securities Commercial mortgage-backed securities Commercial Mortgage-Backed Securities [Member] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Net earnings per common share attributable to Centene Corporation: Earnings attributable to Centene Corporation Net Income (Loss) Attributable to Parent [Abstract] Accrued interest income Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss Retained Earnings Retained Earnings [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Investments available-for-sale Available-for-Sale Securities [Member] Litigation Status [Domain] Litigation Status [Domain] Common Stock Common Stock [Member] Common stock issued for employee benefit plans Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture ROU Assets and Liabilities Lease, Cost [Table Text Block] Common stock repurchases Payments for Repurchase of Common Stock Class of Stock [Axis] Class of Stock [Axis] Statement [Table] Statement [Table] Impairment associated with pending divestiture Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down Document Quarterly Report Document Quarterly Report Total assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Current assets: Assets, Current [Abstract] Long-term (recorded within other long-term liabilities) Operating Lease, Liability, Noncurrent Statistical Measurement [Axis] Statistical Measurement [Axis] Restricted certificates of deposit Restricted Certificates Of Deposit [Member] Restricted certificates of deposit [member] Common stock repurchases (in shares) Common stock repurchases (in shares) Treasury Stock, Shares, Acquired Leasehold improvements Leasehold Improvements [Member] Retained earnings Retained Earnings (Accumulated Deficit) Disposal Group Name [Axis] Disposal Group Name [Axis] Greater than ten years Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10 Other operating activities, net Other Operating Activities, Cash Flow Statement External Credit Rating by Grouping [Axis] External Credit Rating by Grouping [Axis] U.S. Treasury securities and obligations of U.S. government corporations and agencies US Treasury and Government [Member] Equity Components [Axis] Equity Components [Axis] Consideration transferred related to fair value of replacement equity awards associated with pre-combination service Business Combination, Consideration Transferred, Other Risk adjustment, increase to net receivables Affordable Care Act, Risk Adjustment, Net Receivable Increase (Decrease) Affordable Care Act, Risk Adjustment, Net Receivable Increase (Decrease) Fair Value, Less Than 12 Months Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months Document Fiscal Year Focus Document Fiscal Year Focus Schedule of Preliminary Fair Values and Weighted Average Useful Lives for Identifiable Intangible Assets Acquired Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Statement [Line Items] Statement [Line Items] Variable Rate [Domain] Variable Rate [Domain] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Selling, general and administrative expenses Selling, General and Administrative Expense Loss Contingencies [Table] Loss Contingencies [Table] ROU assets (recorded within other long-term assets) Operating Lease, Right-of-Use Asset Gross Unrealized Losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Accumulated Other Comprehensive Earnings (Loss) AOCI Attributable to Parent [Member] $2,000 million 3.375% Senior Notes due February 15, 2030 $2,200 Million 3.75% Senior Notes Due February 2030 [Member] $2,200 Million 3.75% Senior Notes Due February 2030 Document Transition Report Document Transition Report Local Phone Number Local Phone Number Life insurance contracts Life Insurance, Corporate or Bank Owned, Amount Earnings from operations Earnings from operations Operating Income (Loss) Accounting Guidance Not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] Litigation Status [Axis] Litigation Status [Axis] Common stock, shares outstanding (in shares) Balance (in shares) Balance (in shares) Common Stock, Shares, Outstanding Affordable Care Act Affordable Care Act Disclosure [Text Block] Affordable Care Act Disclosure [Text Block] Service Service [Member] Goodwill Goodwill Goodwill Goodwill Treasury stock (in shares) Treasury Stock, Shares Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Managed  Care Managed Care [Member] ManagedCareMember Contribution from noncontrolling interest Noncontrolling Interest, Increase from Subsidiary Equity Issuance Adjustments to reconcile net earnings to net cash provided by operating activities Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Total senior notes Senior Notes, Total Senior Notes, Total Income tax expense Income Tax Expense (Benefit) Deferred tax liability Deferred Income Tax Liabilities, Net Restricted deposits Other Restricted Assets, Noncurrent Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Income Statement [Abstract] Income Statement [Abstract] Rated Securities Rated Securities [Member] Rated Securities [Member] Additional Paid-in Capital Additional Paid-in Capital [Member] Document Fiscal Period Focus Document Fiscal Period Focus Net earnings per common share attributable to Centene Corporation: Earnings Per Share, Basic [Abstract] Cost of services Cost of Goods and Services Sold Provider contracts Insurance Contracts Acquired in Business Combination [Member] Diluted (in shares) Weighted average number of common shares and potential dilutive common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Diluted Less: accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Minimum medical loss ratio Affordable Care Act Minimum Medical Loss Ratio Affordable Care Act, Minimum Medical Loss Ratio Loss Contingencies [Line Items] Loss Contingencies [Line Items] Current portion of long-term debt Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-Term Debt Schedule Of Investments And Restricted Deposits By Type [Line Items] Debt Securities, Available-for-sale [Line Items] Debt Securities, Available-for-Sale [Line Items] Accounts payable and accrued expenses Accounts Payable and Accrued Liabilities, Current Common stock, $0.001 par value; authorized 800,000 shares; 606,931 issued and 570,091 outstanding at September 30, 2022, and 602,704 issued and 582,479 outstanding at December 31, 2021 Common Stock, Value, Issued Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Senior Notes Senior Notes [Member] Total, Fair Value Investments, Debt Securities, Equity Securities And Other, Fair Value Investments, Debt Securities, Equity Securities And Other, Fair Value Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Operating Segments Operating Segments [Member] Deferred tax assets Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets (Gain) on acquisition Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Cash, cash equivalents, and restricted cash and cash equivalents, beginning of period Cash, cash equivalents, and restricted cash and cash equivalents, end of period Total cash, cash equivalents, and restricted cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax (Earnings) loss attributable to noncontrolling interests Net Income (Loss) Attributable to Noncontrolling Interest Contingencies Commitments and Contingencies Disclosure [Text Block] Current liabilities: Liabilities, Current [Abstract] Proceeds from long-term debt Proceeds from Issuance of Long-Term Debt Common stock, shares issued (in shares) Common Stock, Shares, Issued Private equity investments Equity Method Investments Unearned revenue Contract with Customer, Liability, Current Acquisition related expenses Business Combination, Acquisition Related Costs Long-term debt Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-Term Debt Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Positions from which gross unrealized losses were generated Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions Amendment Flag Amendment Flag Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities $1,300 million 2.625% Senior Notes due August 1, 2031 $1,300 Million 2.625% Senior Notes due August 2031 [Member] $1,300 Million 2.625% Senior Notes due August 2031 Debt, face amount Debt Instrument, Face Amount Other comprehensive earnings (loss) Other comprehensive earnings (loss) , net of tax Other Comprehensive Income (Loss), Net of Tax Proceeds from credit facility Proceeds from Long-Term Lines of Credit Settlement of pre-existing payables and receivables prior to acquisition Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Costs Comprehensive earnings (loss) attributable to Centene Corporation Comprehensive Income (Loss), Net of Tax, Attributable to Parent PANTHERx Rare PANTHERx Rare [Member] PANTHERx Rare Acquisitions and Divestitures Mergers, Acquisitions and Dispositions Disclosures [Text Block] Total liabilities assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities Segment Information Schedule of Segment Reporting Information, by Segment [Table Text Block] Gross Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Entity Current Reporting Status Entity Current Reporting Status Deferred tax liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Other long-term assets Other Assets, Noncurrent Tangible asset impairment charges Tangible Asset Impairment Charges Paid related to: Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract] Fair Value Fair Value Debt Securities, Available-for-Sale, Excluding Accrued Interest ROU impairment Operating Lease, Impairment Loss Acquisitions and divestitures Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions Schedule of Allocation of the Fair Value of Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Medical claims liabilities Increase (Decrease) in Health Care Insurance Liabilities Intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Liabilities Liabilities [Abstract] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Effect of exchange rate changes on cash, cash equivalents, and restricted cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Property, software and equipment, net Property, software and equipment, net Property, Plant and Equipment, Net Payments and repurchases of long-term debt Repayments of Long-Term Debt External Credit Rating by Grouping [Domain] External Credit Rating by Grouping [Domain] Treasury stock, at cost (36,840 and 20,225 shares, respectively) Treasury Stock, Value Computer software Computer Software [Member] Computer Software Common stock, shares authorized (in shares) Common Stock, Shares Authorized Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Maximum Maximum [Member] Shares repurchased, percentage of notional amount Treasury Stock, Value Acquired, Percentage Of Notional Amount Of Program Treasury Stock, Value Acquired, Percentage Of Notional Amount Of Program Accumulated other comprehensive earnings Accumulated Other Comprehensive Income (Loss), Net of Tax Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Unearned revenue Increase (Decrease) in Contract with Customer, Liability Total current assets Assets, Current Gain on disposition of business, net of tax Gain (Loss) on Disposition of Business, Net of Tax Gain (Loss) on Disposition of Business, Net of Tax Income taxes paid Income Taxes Paid, Net Settled Litigation Settled Litigation [Member] Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Business Acquisition [Line Items] Business Acquisition [Line Items] Entity Small Business Entity Small Business Stockholders' Equity Stockholders' Equity Note Disclosure [Text Block] Senior notes Senior Notes Revenues: Revenues [Abstract] Short-term investments Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Short-term Investments Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Short-term Investments Restricted deposits Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Restricted Deposits Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Restricted Deposits Property, Software and Equipment Property, Plant and Equipment Disclosure [Text Block] Specialty Services Specialty Services [Member] SpecialtyServicesMember Asset-backed securities Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost Schedule of net receivables (payables) related to the Affordable Care Act Programs Schedule Of Receivables (Payables) Related To The Affordable Care Act Programs [Table Text Block] Schedule of Receivables (Payables) Related to the Affordable Care Act Programs Short-term and long-term investments and restricted deposits by investment type Short Term And Long Term Investments And Restricted Deposits By Investment Type [Table Text Block] Short-term and long-term investments and restricted deposits by investment type Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Return of premium payable Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Return Of Premium Payable Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Return Of Premium Payable Title of 12(b) Security Title of 12(b) Security Accelerated share repurchases agreement, amount Accelerated Share Repurchases Agreement, Amount Accelerated Share Repurchases Agreement, Amount Sales and maturities of investments Proceeds from Sale, Maturity and Collection of Investments Short-term investments Short-Term Investments Total operating expenses Costs and Expenses Class of Treasury Stock [Table] Class of Treasury Stock [Table] $2,500 million 4.25% Senior Notes due December 15, 2027 Four Point Two Five Percent Senior Notes, Due In Twenty Twenty Seven [Member] Four Point Two Five Percent Senior Notes, Due In Twenty Twenty Seven [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Business Combination and Asset Acquisition [Abstract] Less Than 12 Months Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss Common stock issued for employee benefit plans (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Debt issuance costs Payments of Debt Issuance Costs Total lease liabilities Operating Lease, Liability Segment Information Segment Reporting Disclosure [Text Block] $2,200 million 2.50% Senior Notes due March 1, 2031 $2,200 Million 2.50% Senior Notes due March 2031 [Member] $2,200 Million 2.50% Senior Notes due March 2031 Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations [Member] Investments, Debt and Equity Securities [Abstract] Investments, Debt and Equity Securities [Abstract] 12 Months or More Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table] Fair Value, Recurring and Nonrecurring [Table] Current year Current Year Claims and Claims Adjustment Expense Purchased contract rights Contractual Rights [Member] Restricted cash equivalents Restricted Cash Equivalents [Member] Restricted Cash Equivalents [Member] Other assets Increase (Decrease) in Other Operating Assets Real Estate Owned and Related Fixed Assets Real Estate Owned and Related Fixed Assets [Member] Real Estate Owned and Related Fixed Assets Contractual maturities of short-term and long-term investments and restricted deposits Investments Classified by Contractual Maturity Date [Table Text Block] Foreign Line of Credit Foreign Line of Credit [Member] External Credit Rating, Investment Grade External Credit Rating, Investment Grade [Member] Entity Filer Category Entity Filer Category Basic (in shares) Weighted average number of common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Basic Stockholders’ equity: Stockholders' equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Prior years Prior Year Claims and Claims Adjustment Expense Commitments and contingencies Commitments and Contingencies Cash and cash equivalents reclassified from (to) held for sale Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations Security Exchange Name Security Exchange Name Weighted Average Useful Life (in years) Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life Derivative agreement Derivative, Notional Amount Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at September 30, 2022 and December 31, 2021 Preferred Stock, Value, Issued Redeemable noncontrolling interests Redeemable Noncontrolling Interest, Equity, Carrying Amount Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Other long-term liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other Schedule of Debt Schedule of Debt [Table Text Block] Premium and service revenues Revenue from Contract with Customer, Excluding Assessed Tax Cash and cash equivalents Cash and Cash Equivalents [Member] Gain on redemption of debt Gain (Loss) on Repurchase of Debt Instrument Cover [Abstract] Cover [Abstract] Pending Litigation Pending Litigation [Member] Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Level III Fair Value, Inputs, Level 3 [Member] Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Segment Reporting [Abstract] Segment Reporting [Abstract] Incurred related to: Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract] Non-redeemable Non- controlling Interest Noncontrolling Interest [Member] Credit Availability Concentration Risk Credit Availability Concentration Risk [Member] Return of premium payable Return of Premium Payable Return of Premium Payable Total liabilities, redeemable noncontrolling interests and stockholders’ equity Liabilities and Equity Current year Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Restricted Deposits Restricted deposits Deposits [Member] Stock repurchase program, remaining available Stock Repurchase Program, Remaining Authorized Repurchase Amount Land Land [Member] Common stock equivalents (as determined by applying the treasury stock method) (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Disposal Group Name [Domain] Disposal Group Name [Domain] Magellan Acquisition Magellan Health [Member] Magellan Health Acquisitions, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Level II Fair Value, Inputs, Level 2 [Member] Medical costs Policyholder Benefits and Claims Incurred, Net, Health Purchases of investments Payments to Acquire Investments Current Fiscal Year End Date Current Fiscal Year End Date Assets held for sale Disposal Group, Including Discontinued Operation, Assets Other current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other Diluted earnings per common share (in dollars per share) Earnings Per Share, Diluted Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Spanish and Central European Businesses Spanish and Central European Businesses [Member] Spanish and Central European Businesses Stock compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Consolidation Items [Axis] Consolidation Items [Axis] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Total current liabilities Liabilities, Current Net earnings (loss) Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest Other current assets Other Assets, Current Greater than ten years Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10 Schedule Of Investments And Restricted Deposits By Type [Table] Schedule of Available-for-Sale Securities [Table] Schedule of Available-for-Sale Securities [Table] Balance, January 1, net Balance, September 30, net Liability for Unpaid Claims and Claims Adjustment Expense, Net Remaining asset impairment charges Other Asset Impairment Charges Share Repurchase Program [Axis] Share Repurchase Program [Axis] Corporate securities Corporate Debt Securities [Member] Other income (expense): Nonoperating Income (Expense) [Abstract] Equity, Class of Treasury Stock [Line Items] Equity, Class of Treasury Stock [Line Items] Weighted average number of common shares outstanding: Shares used in computing per share amounts: Earnings Per Share, Basic, Other Disclosure [Abstract] Entity Address, Address Line One Entity Address, Address Line One Long-term investments Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Long-term Investments Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Long-term Investments Other financing activities, net Proceeds from (Payments for) Other Financing Activities Product and Service [Axis] Product and Service [Axis] Class of Stock [Domain] Class of Stock [Domain] Stock repurchase program, increase to authorized amount Stock Repurchase Program, Increase, Authorized Amount Stock Repurchase Program, Increase, Authorized Amount Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Total incurred Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims Interest expense Interest Expense Investments: Debt Securities, Available-for-Sale [Abstract] Trade names Trade Names [Member] Credit Facility [Axis] Credit Facility [Axis] Investments recorded at fair value that carry rating of AAA Plus, weighted average (in years) Investments Recorded At Fair Value That Carry Rating Of A AA Plus, Weighted Average, Duration Investments Recorded At Fair Value That Carry Rating Of A AA Plus, Weighted Average, Duration Change in unrealized gain (loss) on investments, net of tax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Amounts recorded as an adjustment to premium revenues related to minimum HBR and return of premium programs Amounts Recorded As An Adjustment to Premium Revenues Related to Minimum HBR and Return of Premium Programs Amounts Recorded As An Adjustment To Premium Revenues Related To Minimum HBR and Return Of Premium Programs The following table provides a reconciliation of cash, cash equivalents, and restricted cash and cash equivalents reported within the Consolidated Balance Sheets to the totals above: Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract] Equity [Abstract] Equity [Abstract] Building Building [Member] Investment Securities Investment Securities [Member] Investment Securities Assets acquired and liabilities assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net [Abstract] Entity Tax Identification Number Entity Tax Identification Number Debt issuance costs Unamortized Debt Issuance Expense Other long-term assets: Other Noncurrent Assets [Member] Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost, Fiscal Year Maturity [Abstract] Premium and trade receivables Increase (Decrease) in Premiums Receivable Currency Swap Currency Swap [Member] Legal settlement Litigation Settlement, Expense Net increase in cash, cash equivalents, and restricted cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Investment and other income Investment Income, Nonoperating Entity Central Index Key Entity Central Index Key Other long-term assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Consideration transferred Business Combination, Consideration Transferred Reserve estimate Estimated Litigation Liability Cost sharing reduction payable Affordable Care Act Cost Sharing Reductions, Payable Affordable Care Act Cost Sharing Reductions, Payable City Area Code City Area Code ASSETS Assets Assets [Abstract] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Debt extinguishment Gain (Loss) on Extinguishment of Debt , Including Cash Portion Gain (Loss) on Extinguishment of Debt , Including Cash Portion $2,300 million 2.45% Senior Notes due July 15, 2028 $2,300 Million 2.45% Senior Nots due July 2028 [Member] $2,300 Million 2.45% Senior Nots due July 2028 Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Fair Value Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract] Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Total investment positions Debt Securities, Available -for-Sale, Number of Positions Debt Securities, Available -for-Sale, Number of Positions Asset Class [Axis] Asset Class [Axis] Stock compensation expense Share-Based Payment Arrangement, Noncash Expense Repurchase of senior debt Repayments of Senior Debt Variable Rate [Axis] Variable Rate [Axis] Other long-term liabilities Other Liabilities, Noncurrent Disposal Group Classification [Domain] Disposal Group Classification [Domain] Capital expenditures Payments to Acquire Property, Plant, and Equipment Impairment Asset Impairment Charges Divestiture proceeds, net of divested cash Proceeds from Divestiture of Businesses, Net of Cash Divested Calculation of Basic and Diluted Net Earnings Per Common Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Unsettled portion under ASR Accelerated Share Repurchase Program, Unsettled Amount Accelerated Share Repurchase Program, Unsettled Amount EX-101.PRE 10 cnc-20220930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 11 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Cover - shares
 9 Months Ended
Sep. 30, 2022
Oct. 14, 2022
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2022  
Document Transition Report false  
Entity File Number 001-31826  
Entity Registrant Name CENTENE CORPORATION  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 42-1406317  
Entity Address, Address Line One 7700 Forsyth Boulevard  
Entity Address, City or Town St. Louis,  
Entity Address, State or Province MO  
Entity Address, Postal Zip Code 63105  
City Area Code 314  
Local Phone Number 725-4477  
Title of 12(b) Security Common Stock $0.001 Par Value  
Trading Symbol CNC  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   566,259,693
Entity Central Index Key 0001071739  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q3  
Amendment Flag false  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 14,987 $ 13,118
Premium and trade receivables 13,770 12,238
Short-term investments 2,191 1,539
Other current assets 2,327 1,602
Total current assets 33,275 28,497
Long-term investments 14,053 14,043
Restricted deposits 1,205 1,068
Property, software and equipment, net 2,479 3,391
Goodwill 20,040 19,771
Intangible assets, net 7,523 7,824
Other long-term assets 2,597 3,781
Total assets 81,172 78,375
Current liabilities:    
Medical claims liability 16,465 14,243
Accounts payable and accrued expenses 9,995 8,493
Return of premium payable 2,205 2,328
Unearned revenue 2,416 434
Current portion of long-term debt 249 267
Total current liabilities 31,330 25,765
Long-term debt 18,084 18,571
Deferred tax liability 480 1,407
Other long-term liabilities 5,678 5,610
Total liabilities 55,572 51,353
Commitments and contingencies
Redeemable noncontrolling interests 66 82
Stockholders’ equity:    
Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at September 30, 2022 and December 31, 2021 0 0
Common stock, $0.001 par value; authorized 800,000 shares; 606,931 issued and 570,091 outstanding at September 30, 2022, and 602,704 issued and 582,479 outstanding at December 31, 2021 1 1
Additional paid-in capital 19,774 19,672
Accumulated other comprehensive earnings (1,394) 77
Retained earnings 9,554 8,139
Treasury stock, at cost (36,840 and 20,225 shares, respectively) (2,557) (1,094)
Total Centene stockholders’ equity 25,378 26,795
Nonredeemable noncontrolling interest 156 145
Total stockholders’ equity 25,534 26,940
Total liabilities, redeemable noncontrolling interests and stockholders’ equity $ 81,172 $ 78,375
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Sep. 30, 2022
Dec. 31, 2021
Stockholders' equity    
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized (in shares) 10,000,000 10,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 800,000,000 800,000,000
Common stock, shares issued (in shares) 606,931,000 602,704,000
Common stock, shares outstanding (in shares) 570,091,000 582,479,000
Treasury stock (in shares) 36,840,000 20,225,000
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenues:        
Premium and service revenues $ 33,726 $ 30,514 $ 101,926 $ 87,490
Premium tax 2,139 1,892 7,060 5,924
Total revenues 35,865 32,406 108,986 93,414
Expenses:        
Medical costs 28,111 25,430 83,261 73,210
Cost of services 1,571 1,355 5,658 3,510
Selling, general and administrative expenses 2,846 2,537 8,391 6,910
Depreciation expense 150 147 470 414
Amortization of acquired intangible assets 211 198 609 581
Premium tax expense 2,211 1,965 7,258 6,129
Impairment 289 229 1,739 229
Legal settlement 0 0 0 1,250
Total operating expenses 35,389 31,861 107,386 92,233
Earnings from operations 476 545 1,600 1,181
Other income (expense):        
Investment and other income 692 424 786 566
Debt extinguishment 10 (79) 26 (125)
Interest expense (169) (170) (491) (503)
Earnings before income tax 1,009 720 1,921 1,119
Income tax expense 269 139 500 376
Net earnings 740 581 1,421 743
(Earnings) loss attributable to noncontrolling interests (2) 3 (6) 5
Net earnings attributable to Centene Corporation $ 738 $ 584 $ 1,415 $ 748
Net earnings per common share attributable to Centene Corporation:        
Basic earnings per common share (in dollars per share) $ 1.29 $ 1.00 $ 2.44 $ 1.28
Diluted earnings per common share (in dollars per share) $ 1.27 $ 0.99 $ 2.41 $ 1.27
Weighted average number of common shares outstanding:        
Basic (in shares) 573,961 583,244 580,277 582,636
Diluted (in shares) 580,607 590,702 587,084 590,154
Premium        
Revenues:        
Premium and service revenues $ 31,848 $ 28,876 $ 95,247 $ 83,436
Service        
Revenues:        
Premium and service revenues $ 1,878 $ 1,638 $ 6,679 $ 4,054
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Statement of Comprehensive Income [Abstract]        
Net earnings $ 740 $ 581 $ 1,421 $ 743
Reclassification adjustment, net of tax 3 1 12 (16)
Change in unrealized gain (loss) on investments, net of tax (383) (47) (1,267) (125)
Foreign currency translation adjustments (101) (17) (216) (20)
Other comprehensive earnings (loss) (481) (63) (1,471) (161)
Comprehensive earnings (loss) 259 518 (50) 582
Comprehensive (earnings) loss attributable to noncontrolling interests (2) 3 (6) 5
Comprehensive earnings (loss) attributable to Centene Corporation $ 257 $ 521 $ (56) $ 587
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Millions
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Earnings (Loss)
Retained Earnings
Treasury Stock
Non-redeemable Non- controlling Interest
Balance (in shares) at Dec. 31, 2020   598,249          
Treasury stock (in shares) at Dec. 31, 2020           16,770  
Balance at Dec. 31, 2020 $ 25,885 $ 1 $ 19,459 $ 337 $ 6,792 $ (816) $ 112
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) 694       699   (5)
Other comprehensive earnings (loss) , net of tax (161)     (161)      
Common stock issued for employee benefit plans (in shares)   1,675          
Common stock issued for employee benefit plans 9   9        
Common stock repurchases (in shares)   (316)       (156)  
Common stock repurchases (29)   (19)     $ (10)  
Stock compensation expense 51   51        
Contribution from noncontrolling interest 9           9
Balance (in shares) at Mar. 31, 2021   599,608          
Treasury stock (in shares) at Mar. 31, 2021           16,926  
Balance at Mar. 31, 2021 26,458 $ 1 19,500 176 7,491 $ (826) 116
Balance (in shares) at Dec. 31, 2020   598,249          
Treasury stock (in shares) at Dec. 31, 2020           16,770  
Balance at Dec. 31, 2020 25,885 $ 1 19,459 337 6,792 $ (816) 112
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Other comprehensive earnings (loss) , net of tax (161)            
Balance (in shares) at Sep. 30, 2021   600,708          
Treasury stock (in shares) at Sep. 30, 2021           17,208  
Balance at Sep. 30, 2021 26,590 $ 1 19,594 176 7,540 $ (845) 124
Balance (in shares) at Mar. 31, 2021   599,608          
Treasury stock (in shares) at Mar. 31, 2021           16,926  
Balance at Mar. 31, 2021 26,458 $ 1 19,500 176 7,491 $ (826) 116
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) (538)       (535)   (3)
Other comprehensive earnings (loss) , net of tax 63     63      
Common stock issued for employee benefit plans (in shares)   390          
Common stock issued for employee benefit plans 9   9        
Common stock repurchases (in shares)   (10)       (60)  
Common stock repurchases (4)         $ (4)  
Stock compensation expense 36   36        
Contribution from noncontrolling interest 21           21
Balance (in shares) at Jun. 30, 2021   599,988          
Treasury stock (in shares) at Jun. 30, 2021           16,986  
Balance at Jun. 30, 2021 26,045 $ 1 19,545 239 6,956 $ (830) 134
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) 576       584   (8)
Other comprehensive earnings (loss) , net of tax (63)     (63)      
Common stock issued for employee benefit plans (in shares)   720          
Common stock issued for employee benefit plans 9   9        
Common stock repurchases (in shares)           (222)  
Common stock repurchases (15)         $ (15)  
Stock compensation expense 40   40        
Contribution from noncontrolling interest 5           5
Divestiture of noncontrolling interest (10)           (10)
Acquisition resulting in noncontrolling interest 3           3
Balance (in shares) at Sep. 30, 2021   600,708          
Treasury stock (in shares) at Sep. 30, 2021           17,208  
Balance at Sep. 30, 2021 $ 26,590 $ 1 19,594 176 7,540 $ (845) 124
Balance (in shares) at Dec. 31, 2021 582,479 602,704          
Treasury stock (in shares) at Dec. 31, 2021           20,225  
Balance at Dec. 31, 2021 $ 26,940 $ 1 19,672 77 8,139 $ (1,094) 145
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) 848       849   (1)
Other comprehensive earnings (loss) , net of tax (562)     (562)      
Common stock issued for employee benefit plans (in shares)   3,221          
Common stock issued for employee benefit plans 28   28        
Fair value of unvested equity awards in connection with acquisition 60   60        
Common stock repurchases (in shares)           (846)  
Common stock repurchases (71)         $ (71)  
Stock compensation expense 70   70        
Balance (in shares) at Mar. 31, 2022   605,925          
Treasury stock (in shares) at Mar. 31, 2022           21,071  
Balance at Mar. 31, 2022 $ 27,313 $ 1 19,830 (485) 8,988 $ (1,165) 144
Balance (in shares) at Dec. 31, 2021 582,479 602,704          
Treasury stock (in shares) at Dec. 31, 2021           20,225  
Balance at Dec. 31, 2021 $ 26,940 $ 1 19,672 77 8,139 $ (1,094) 145
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Other comprehensive earnings (loss) , net of tax $ (1,471)            
Balance (in shares) at Sep. 30, 2022 570,091 606,931          
Treasury stock (in shares) at Sep. 30, 2022           36,840  
Balance at Sep. 30, 2022 $ 25,534 $ 1 19,774 (1,394) 9,554 $ (2,557) 156
Balance (in shares) at Mar. 31, 2022   605,925          
Treasury stock (in shares) at Mar. 31, 2022           21,071  
Balance at Mar. 31, 2022 27,313 $ 1 19,830 (485) 8,988 $ (1,165) 144
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) (175)       (172)   (3)
Other comprehensive earnings (loss) , net of tax (428)     (428)      
Common stock issued for employee benefit plans (in shares)   519          
Common stock issued for employee benefit plans 10   10        
Common stock repurchases (in shares)           (4,249)  
Common stock repurchases (349)         $ (349)  
Stock compensation expense 59   59        
Balance (in shares) at Jun. 30, 2022   606,444          
Treasury stock (in shares) at Jun. 30, 2022           25,320  
Balance at Jun. 30, 2022 26,430 $ 1 19,899 (913) 8,816 $ (1,514) 141
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) 736       738   (2)
Other comprehensive earnings (loss) , net of tax (481)     (481)      
Common stock issued for employee benefit plans (in shares)   487          
Common stock issued for employee benefit plans 24   24        
Common stock repurchases (in shares)           (11,520)  
Common stock repurchases (1,243)   (200)     $ (1,043)  
Stock compensation expense 51   51        
Reclassification to non-redeemable noncontrolling interest $ 17           17
Balance (in shares) at Sep. 30, 2022 570,091 606,931          
Treasury stock (in shares) at Sep. 30, 2022           36,840  
Balance at Sep. 30, 2022 $ 25,534 $ 1 $ 19,774 $ (1,394) $ 9,554 $ (2,557) $ 156
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) - USD ($)
$ in Millions
 3 Months Ended
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2021
Dec. 31, 2020
Par value (in dollars per share) $ 0.001           $ 0.001  
Other comprehensive earnings (loss), tax (benefit) expense $ (120) $ (106) $ (171) $ (15) $ 19 $ (49)    
Common Stock                
Par value (in dollars per share) $ 0.001 $ 0.001 $ 0.001 $ 0.001 $ 0.001 $ 0.001 0.001 $ 0.001
Treasury Stock                
Par value (in dollars per share) $ 0.001 $ 0.001 $ 0.001 $ 0.001 $ 0.001 $ 0.001 $ 0.001 $ 0.001
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities:    
Net earnings $ 1,421 $ 743
Adjustments to reconcile net earnings to net cash provided by operating activities    
Depreciation and amortization 1,178 1,098
Stock compensation expense 180 127
Impairment 1,739 229
(Gain) loss on debt extinguishment (26) 125
(Gain) on acquisition (2) (309)
Deferred income taxes (682) (143)
(Gain) loss on divestitures (503) 62
Other adjustments, net 164 (6)
Changes in assets and liabilities    
Premium and trade receivables (1,274) (1,723)
Other assets 152 (124)
Medical claims liabilities 1,976 1,661
Unearned revenue 1,964 (169)
Accounts payable and accrued expenses 686 993
Other long-term liabilities 863 964
Other operating activities, net 1 2
Net cash provided by operating activities 7,837 3,530
Cash flows from investing activities:    
Capital expenditures (771) (662)
Purchases of investments (5,118) (5,253)
Sales and maturities of investments 2,842 4,069
Acquisitions, net of cash acquired (1,457) (534)
Divestiture proceeds, net of divested cash 1,362 (62)
Net cash used in investing activities (3,142) (2,442)
Cash flows from financing activities:    
Proceeds from long-term debt 357 9,247
Payments and repurchases of long-term debt (1,202) (7,411)
Common stock repurchases (1,663) (49)
Payments for debt extinguishment (14) (157)
Debt issuance costs 0 (72)
Other financing activities, net 57 39
Net cash (used in) provided by financing activities (2,465) 1,597
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (37) (8)
Net increase in cash, cash equivalents, and restricted cash and cash equivalents 2,193 2,677
Cash and cash equivalents reclassified from (to) held for sale (192) 0
Cash, cash equivalents, and restricted cash and cash equivalents, beginning of period 13,214 10,957
Cash, cash equivalents, and restricted cash and cash equivalents, end of period 15,215 13,634
Supplemental disclosures of cash flow information:    
Interest paid 462 479
Income taxes paid 448 477
The following table provides a reconciliation of cash, cash equivalents, and restricted cash and cash equivalents reported within the Consolidated Balance Sheets to the totals above:    
Cash and cash equivalents 14,987 13,423
Restricted cash and cash equivalents, included in restricted deposits 228 211
Total cash, cash equivalents, and restricted cash and cash equivalents $ 15,215 $ 13,634
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.22.2.2
Organization and Operations
 9 Months Ended
Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization and Operations Organization and Operations
Basis of Presentation

The accompanying interim financial statements have been prepared under the presumption that users of the interim financial information have either read or have access to the audited financial statements included in the Form 10-K for the fiscal year ended December 31, 2021. The unaudited interim financial statements herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, footnote disclosures that would substantially duplicate the disclosures contained in the December 31, 2021 audited financial statements have been omitted from these interim financial statements, where appropriate. In the opinion of management, these financial statements reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for a fair presentation of the results of the interim periods presented.

Certain 2021 amounts in the consolidated financial statements and notes to the consolidated financial statements have been reclassified to conform to the 2022 presentation. Beginning in 2022, the Company has included a separate line item for depreciation expense on the Consolidated Statement of Operations, which was previously included in selling, general and administrative (SG&A) expenses. Prior period SG&A expense ratios have also been conformed to the current presentation. These reclassifications have no effect on net earnings or stockholders’ equity as previously reported.

On January 4, 2022, the Company acquired all of the issued and outstanding shares of Magellan Health, Inc. (Magellan) (the Magellan Acquisition). The acquisition was accounted for as a business combination. See Note 2. Acquisitions and Divestitures for further details.

Accounting Guidance Not Yet Adopted

The Company has determined that there are no recently issued accounting pronouncements that will have a material impact on its consolidated financial position, results of operations, or cash flows.
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.22.2.2
Acquisitions and Divestitures
 9 Months Ended
Sep. 30, 2022
Business Combination and Asset Acquisition [Abstract]  
Acquisitions and Divestitures Acquisitions and Divestitures
Magellan Acquisition

On January 4, 2022, the Company acquired all of the issued and outstanding shares of Magellan. Total consideration for the acquisition was $2,491 million, consisting of $2,431 million in cash and $60 million related to the fair value of replacement equity awards associated with pre-combination service. The purchase price has been adjusted to reflect the net effective settlement of preexisting relationships between the Company and Magellan of $70 million. The Company recognized $8 million and $100 million of acquisition related expenses related to Magellan for the three and nine months ended September 30, 2022, respectively.

The Magellan Acquisition was accounted for as a business combination using the acquisition method of accounting that requires assets acquired and liabilities assumed to be recognized at fair value as of the acquisition date. The significant areas of the assessment of fair value that remain preliminary include identifiable intangible assets and goodwill, premium and related receivables, medical claims liability, and income taxes, and accordingly, the Company has recorded provisional amounts which are subject to adjustment. Measurement period adjustments will be recorded in the period in which they are determined, as if they had been completed at the acquisition date.
The Company's preliminary allocation of the fair value of assets acquired and liabilities assumed as of the acquisition date of January 4, 2022 is as follows ($ in millions):
Assets acquired and liabilities assumed 
Cash and cash equivalents
$998 
Premium and related receivables
791 
Short-term investments
144 
Other current assets
194 
Long-term investments
43 
Restricted deposits
7 
Property, software and equipment
90 
Intangible assets (a)
751 
Other long-term assets50 
Total assets acquired 3,068 
Medical claims liability247 
Accounts payable and accrued expenses495 
Return of premium payable53 
Unearned revenue8 
Current portion of long-term debt5 
Long-term debt (b)
542 
Deferred tax liabilities (c)
123 
Other long-term liabilities69 
Total liabilities assumed1,542 
Mezzanine equity32 
Total identifiable net assets1,494 
Goodwill (d)
997 
Total assets acquired and liabilities assumed$2,491 

The Company has made the following preliminary fair value adjustments based on information reviewed through September 30, 2022. Significant fair value adjustments are noted as follows:

(a) The identifiable intangible assets acquired are to be measured at fair value as of the completion of the acquisition. The fair value of intangible assets will be determined primarily using variations of the income approach, which is based on the present value of the future after-tax cash flows attributable to each identified intangible asset. Other valuation methods, including the market approach and cost approach, will be considered in estimating the fair value. The identifiable intangible assets include purchased contract rights, trade names, provider contracts, and developed technologies. The Company has estimated the fair value of intangible assets to be $751 million with a weighted average life of 13 years. The Company adjusted its estimate of the identifiable intangible assets during the third quarter, resulting in additional amortization of $15 million.

The fair values and weighted average useful lives for identifiable intangible assets acquired are as follows:
Fair ValueWeighted Average Useful Life (in years)
Purchased contract rights$470 13
Provider contracts100 15
Trade names80 17
Developed technologies101 5
Total intangible assets acquired$751 13
(b) Debt is required to be measured at fair value under the acquisition method of accounting. The fair value of Magellan's Senior Notes and Credit Agreement assumed in the acquisition was $535 million. In January 2022, the Company paid off Magellan's debt acquired in the transaction using Magellan's cash on hand.

(c) The preliminary deferred tax liabilities are presented net of $116 million of deferred tax assets.

(d) Goodwill is estimated at $997 million and primarily relates to synergies expected from the acquisition and the assembled workforce of Magellan. The assignment of goodwill to the Company’s respective segments has not been completed at this time, but the majority of goodwill is expected to be allocated to the Specialty segment. The majority of the goodwill is not deductible for income tax purposes.

PANTHERx Rare Divestiture

On July 14, 2022, the Company completed the previously announced sale of PANTHERx Rare (PANTHERx) for $1,373 million. The Company recognized a gain of $490 million, or $382 million after-tax, which is included in investment and other income on the Consolidated Statements of Operations.

Spanish and Central European Divestiture

On July 25, 2022, as part of the Company’s previously announced review of strategic alternatives for its international portfolio, the Company announced it has signed a definitive agreement to sell its ownership stakes in its Spanish and Central European businesses, including Ribera Salud, Torrejón Salud, and Pro Diagnostics Group.

As of September 30, 2022, the assets and liabilities of the Spanish and Central European businesses were considered held for sale resulting in $666 million of assets held for sale in Other Current Assets and $582 million of liabilities held for sale in Accounts Payable and Accrued Expenses on the Consolidated Balance Sheet. The majority of the held for sale assets were previously reported as cash and cash equivalents, premium and trade receivables, and property, software and equipment. During the third quarter, the Company recorded an impairment charge primarily related to intangible assets and goodwill associated with the pending divestiture of $165 million, or $138 million after-tax.
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.22.2.2
Short-term and Long-term Investments, Restricted Deposits
 9 Months Ended
Sep. 30, 2022
Investments, Debt and Equity Securities [Abstract]  
Short-term and Long-term Investments, Restricted Deposits Short-term and Long-term Investments, Restricted Deposits
Short-term and long-term investments and restricted deposits by investment type consist of the following ($ in millions):
 September 30, 2022December 31, 2021
 Amortized
Cost		Gross
Unrealized
Gains		Gross
Unrealized Losses		Fair
Value		Amortized
Cost		Gross
Unrealized
Gains		Gross
Unrealized Losses		Fair
Value
Debt securities:
U.S. Treasury securities and obligations of U.S. government
corporations and agencies
$666 $— $(18)$648 $642 $— $(2)$640 
Corporate securities9,648 1 (897)8,752 8,145 130 (75)8,200 
Restricted certificates of deposit
4 — — 4 4 — — 4 
Restricted cash equivalents
228 — — 228 96 — — 96 
Short-term time deposits
275 — — 275 109 — — 109 
Municipal securities3,980 — (320)3,660 3,398 85 (15)3,468 
Asset-backed securities1,335 — (68)1,267 1,308 5 (5)1,308 
Residential mortgage-backed securities
1,154 — (135)1,019 850 10 (7)853 
Commercial mortgage-backed securities
970 — (96)874 870 13 (10)873 
Equity securities (1)
6 — — 6 326 — — 326 
Private equity investments
551 — — 551 587 — — 587 
Life insurance contracts
165 — — 165 186 — — 186 
Total$18,982 $1 $(1,534)$17,449 $16,521 $243 $(114)$16,650 
(1) Investments in equity securities as of December 31, 2021 primarily consisted of exchange traded funds in fixed income securities.

The Company's investments are debt securities classified as available-for-sale with the exception of equity securities, certain private equity investments and life insurance contracts. The Company's investment policies are designed to provide liquidity, preserve capital and maximize total return on invested assets with the focus on high credit quality securities. The Company limits the size of investment in any single issuer other than U.S. treasury securities and obligations of U.S. government corporations and agencies. As of September 30, 2022, 98% of the Company's investments in rated securities carry an investment grade rating by nationally recognized statistical rating organizations. At September 30, 2022, the Company held certificates of deposit, equity securities, private equity investments, and life insurance contracts, which did not carry a credit rating. Accrued interest income on available-for-sale debt securities was $119 million and $96 million at September 30, 2022 and December 31, 2021, respectively, and is included in other current assets on the Consolidated Balance Sheets.

The Company's residential mortgage-backed securities are primarily issued by the Federal National Mortgage Association, Government National Mortgage Association, or Federal Home Loan Mortgage Corporation, which carry implicit or explicit guarantees of the U.S. government. The Company's commercial mortgage-backed securities are primarily senior tranches with a weighted average rating of AAA and a weighted average duration of 4 years at September 30, 2022.
The fair value of available-for-sale debt securities with gross unrealized losses by investment type and length of time that individual securities have been in a continuous unrealized loss position were as follows ($ in millions):
 September 30, 2022December 31, 2021
 Less Than 12 Months12 Months or MoreLess Than 12 Months12 Months or More
 Unrealized LossesFair
Value		Unrealized LossesFair
Value		Unrealized LossesFair
Value		Unrealized LossesFair
Value
U.S. Treasury securities and obligations of U.S. government corporations and agencies
$(14)$556 $(4)$67 $(2)$598 $— $3 
Corporate securities(562)6,737 (335)1,975 (66)4,209 (9)209 
Municipal securities(228)2,998 (92)586 (14)1,173 (1)39 
Asset-backed securities(57)1,094 (11)166 (5)770 — 33 
Residential mortgage-backed securities(86)770 (49)244 (7)472 — 15 
Commercial mortgage-backed securities(59)650 (37)218 (8)380 (2)32 
Total$(1,006)$12,805 $(528)$3,256 $(102)$7,602 $(12)$331 

As of September 30, 2022, the gross unrealized losses were generated from 6,688 positions out of a total of 6,847 positions. The change in fair value of available-for-sale debt securities is primarily a result of movement in interest rates subsequent to the purchase of the security.

For each security in an unrealized loss position, the Company assesses whether it intends to sell the security or if it is more likely than not the Company will be required to sell the security before recovery of the amortized cost basis for reasons such as liquidity, contractual, or regulatory purposes. If the security meets this criterion, the decline in fair value is recorded in earnings. The Company does not intend to sell these securities prior to maturity and it is not likely that the Company will be required to sell these securities prior to maturity; therefore, the Company did not record an impairment for these securities.

In addition, the Company monitors available-for-sale debt securities for credit losses. Certain investments have experienced a decline in fair value due to changes in credit quality, market interest rates and/or general economic conditions. The Company recognizes an allowance when evidence demonstrates that the decline in fair value is credit related. Evidence of a credit related loss may include rating agency actions, adverse conditions specifically related to the security, or failure of the issuer of the security to make scheduled payments.

The contractual maturities of short-term and long-term debt securities and restricted deposits are as follows ($ in millions):
 September 30, 2022December 31, 2021
 InvestmentsRestricted DepositsInvestmentsRestricted Deposits
 Amortized
Cost		Fair
Value		Amortized
Cost		Fair
Value		Amortized
Cost		Fair
Value		Amortized
Cost		Fair
Value
One year or less$2,053 $2,029 $521 $518 $1,390 $1,396 $368 $368 
One year through five years7,296 6,752 518 482 6,212 6,294 460 457 
Five years through ten years4,077 3,496 241 205 3,647 3,681 244 243 
Greater than ten years95 85 — — 73 78 — — 
Asset-backed securities3,459 3,160 — — 3,028 3,034 — — 
Total$16,980 $15,522 $1,280 $1,205 $14,350 $14,483 $1,072 $1,068 
 
Actual maturities may differ from contractual maturities due to call or prepayment options. Equity securities, private equity investments and life insurance contracts are excluded from the table above because they do not have a contractual maturity. The Company has an option to redeem at amortized cost substantially all of the securities included in the greater than ten years category listed above.
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.22.2.2
Fair Value Measurements
 9 Months Ended
Sep. 30, 2022
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
Assets and liabilities recorded at fair value in the Consolidated Balance Sheets are categorized based upon observable or unobservable inputs used to estimate fair value. Level inputs are as follows:
Level Input:Input Definition:
Level IInputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.
 
Level IIInputs other than quoted prices included in Level I that are observable for the asset or liability through corroboration with market data at the measurement date.
 
Level IIIUnobservable inputs that reflect management's best estimate of what market participants would use in pricing the asset or liability at the measurement date.

The following table summarizes fair value measurements by level at September 30, 2022, for assets and liabilities measured at fair value on a recurring basis ($ in millions):
 Level ILevel IILevel IIITotal
Assets    
Cash and cash equivalents$14,987 $— $— $14,987 
Investments:    
U.S. Treasury securities and obligations of U.S. government corporations and agencies$313 $— $— $313 
Corporate securities— 8,721 — 8,721 
Municipal securities— 3,053 — 3,053 
Short-term time deposits— 275 — 275 
Asset-backed securities— 1,267 — 1,267 
Residential mortgage-backed securities— 1,019 — 1,019 
Commercial mortgage-backed securities— 874 — 874 
Equity securities4 2 — 6 
Total investments$317 $15,211 $— $15,528 
Restricted deposits:    
Cash and cash equivalents$228 $— $— $228 
Certificates of deposit— 4 — 4 
Corporate securities— 31 — 31 
Municipal securities
— 607 — 607 
U.S. Treasury securities and obligations of U.S. government corporations and agencies
335 — — 335 
Total restricted deposits$563 $642 $— $1,205 
Total assets at fair value$15,867 $15,853 $— $31,720 
The following table summarizes fair value measurements by level at December 31, 2021, for assets and liabilities measured at fair value on a recurring basis ($ in millions):
 Level ILevel IILevel IIITotal
Assets    
Cash and cash equivalents$13,118 $— $— $13,118 
Investments:    
U.S. Treasury securities and obligations of U.S. government corporations and agencies$171 $— $— $171 
Corporate securities— 8,170 — 8,170 
Municipal securities— 2,999 — 2,999 
Short-term time deposits— 109 — 109 
Asset backed securities— 1,308 — 1,308 
Residential mortgage backed securities— 853 — 853 
Commercial mortgage backed securities— 873 — 873 
Equity securities324 2 — 326 
Total investments$495 $14,314 $— $14,809 
Restricted deposits:    
Cash and cash equivalents$96 $— $— $96 
Certificates of deposit— 4 — 4 
Corporate securities— 30 — 30 
Municipal securities
— 469 — 469 
U.S. Treasury securities and obligations of U.S. government corporations and agencies
469 — — 469 
Total restricted deposits$565 $503 $— $1,068 
Other long-term assets:
Interest rate swap agreements$— $15 $— $15 
Total assets at fair value$14,178 $14,832 $— $29,010 
 
The Company utilizes matrix-pricing services to estimate fair value for securities which are not actively traded on the measurement date. The Company designates these securities as Level II fair value measurements. In addition, the aggregate carrying amount of the Company's private equity investments and life insurance contracts, which approximates fair value, was $716 million and $773 million as of September 30, 2022 and December 31, 2021, respectively.
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.22.2.2
Property, Software and Equipment
 9 Months Ended
Sep. 30, 2022
Property, Plant and Equipment [Abstract]  
Property, Software and Equipment Property, Software and Equipment
Property, software and equipment consist of the following ($ in millions):
 September 30, 2022December 31, 2021
Computer software$2,211 $1,825 
Building641 1,116 
Furniture and office equipment407 753 
Leasehold improvements454 732 
Computer hardware648 617 
Land178 248 
Property, software and equipment, at cost4,539 5,291 
Less: accumulated depreciation(2,060)(1,900)
Property, software and equipment, net$2,479 $3,391 
During the second quarter of 2022, in connection with the adoption of a more modern, flexible work environment, the Company undertook a real estate optimization initiative to evaluate future real estate needs and downsize its real estate footprint for owned and leased properties. As a result of this evaluation, during the second quarter of 2022, the Company substantially changed the use or abandoned various properties and assessed for impairment. The Company engaged a third-party real estate specialist to determine the fair value of its owned properties. The valuation primarily considered comparable properties in each market as well as future cash flows.

As a result of the optimization, the Company has recognized impairment charges related to owned real estate of $57 million and $763 million for the three and nine months ended September 30, 2022, respectively. The Company also recognized impairment on fixed assets related to leased real estate of $14 million and $237 million for the three and nine months ended September 30, 2022, respectively. These impairments are primarily related to the Managed Care segment. The remainder of the $1,574 million charge relates to right-of-use (ROU) asset impairments, which is included within Other Long-term assets on the balance sheet, refer to Note 9. Leases.
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.22.2.2
Medical Claims Liability
 9 Months Ended
Sep. 30, 2022
Insurance [Abstract]  
Medical Claims Liability Medical Claims Liability
The following table summarizes the change in medical claims liability ($ in millions):
Nine Months Ended September 30,
20222021
Balance, January 1$14,243 $12,438 
Less: Reinsurance recoverable23 23 
Balance, January 1, net14,220 12,415 
Acquisitions and divestitures 249 — 
Incurred related to:
Current year84,457 74,736 
Prior years(1,196)(1,526)
Total incurred83,261 73,210 
Paid related to:
Current year70,305 62,205 
Prior years10,968 9,344 
Total paid81,273 71,549 
Balance, September 30, net
16,457 14,076 
Plus: Reinsurance recoverable8 23 
Balance, September 30
$16,465 $14,099 

Reinsurance recoverables related to medical claims are included in premium and trade receivables. Changes in estimates of incurred claims for prior years are primarily attributable to reserving under moderately adverse conditions. The impact from COVID-19 on healthcare utilization and medical claims submission patterns continues to provide increased estimation uncertainty on the incurred but not reported liability. Additionally, as a result of minimum health benefits ratio (HBR) and other return of premium programs, the Company recorded $121 million and $438 million as a reduction to premium revenue in the nine months ended September 30, 2022 and 2021, respectively.

Incurred but not reported (IBNR) plus expected development on reported claims as of September 30, 2022 was $11,130 million. Total IBNR plus expected development on reported claims represents estimates for claims incurred but not reported, development on reported claims, and estimates for the costs necessary to process unpaid claims at the end of each period. The Company estimates its liability using actuarial methods that are commonly used by health insurance actuaries and meet Actuarial Standards of Practice. These actuarial methods consider factors such as historical data for payment patterns, cost trends, product mix, seasonality, utilization of healthcare services, and other relevant factors.
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.22.2.2
Affordable Care Act
 9 Months Ended
Sep. 30, 2022
Affordable Care Act [Abstract]  
Affordable Care Act Affordable Care Act
The Affordable Care Act established risk spreading premium stabilization programs as well as a minimum annual medical loss ratio (MLR) and cost sharing reductions.

The Company's net receivables (payables) for each of the programs are as follows ($ in millions):
September 30, 2022December 31, 2021
Risk adjustment receivable$1,068 $522 
Risk adjustment payable(652)(536)
Minimum medical loss ratio(69)(196)
Cost sharing reduction receivable10 69 
Cost sharing reduction payable(81)(42)
In June 2022, CMS announced the final risk adjustment transfers for the 2021 benefit year. As a result of the announcement, the Company increased its risk adjustment net receivables by $403 million from December 31, 2021. After consideration of minimum MLR and other related impacts, the net pre-tax benefit recognized was approximately $368 million in the nine months ended September 30, 2022
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.22.2.2
Debt
 9 Months Ended
Sep. 30, 2022
Debt Disclosure [Abstract]  
Debt Debt
 
Debt consists of the following ($ in millions):
 September 30, 2022December 31, 2021
$2,500 million 4.25% Senior Notes due December 15, 2027
$2,403 $2,484 
$2,300 million 2.45% Senior Notes due July 15, 2028
2,304 2,304 
$3,500 million 4.625% Senior Notes due December 15, 2029
3,324 3,500 
$2,000 million 3.375% Senior Notes due February 15, 2030
2,000 2,000 
$2,200 million 3.00% Senior Notes due October 15, 2030
2,200 2,200 
$2,200 million 2.50% Senior Notes due March 1, 2031
2,200 2,200 
$1,300 million 2.625% Senior Notes due August 1, 2031
1,300 1,300 
Total senior notes15,731 15,988 
Term loan facility2,196 2,195 
Revolving credit agreement120 149 
Construction loan payable181 184 
Finance leases and other258 493 
Debt issuance costs(153)(171)
Total debt18,333 18,838 
Less current portion(249)(267)
 Long-term debt$18,084 $18,571 

Of the Company's total debt, approximately 15% is variable rate debt tied to London Interbank Offered Rate (LIBOR). The debt agreements that may be impacted by the discontinuation of LIBOR include provisions that the Company believes are sufficient to transition from the existing LIBOR rates to the prevailing successor market rates as necessary.

Senior Notes

In connection with the Magellan Acquisition in January 2022, the Company redeemed Magellan’s existing outstanding 4.4% Senior Notes due 2024 and paid off the existing Credit Agreement using Magellan’s cash on hand. The Company recognized an immaterial net pre-tax gain on extinguishment including related fees and expenses and the write-off of the unamortized premium.
During the third quarter of 2022, the Company utilized a portion of the proceeds from the PANTHERx divestiture to repurchase $83 million of its par value Senior Notes due 2027 and $176 million of its par value Senior Notes due 2029 through the Company’s debt repurchase program. The Company recognized a $10 million gain on the redemptions of the notes.

Foreign Currency Swap

In order to manage the foreign exchange risk associated with an intercompany note receivable related to the Circle Health acquisition, the Company entered into a foreign currency swap agreement for a notional amount of $705 million, to purchase £509 million. The swap agreement was formally designated and qualified as a fair value hedge. All gains and losses due to changes in the fair value of the foreign currency swap completely offset changes in the remeasurement of the intercompany note receivable within investment and other income in the Consolidated Statement of Operations, resulting in no net impact to the Consolidated Statement of Operations.

On March 31, 2022, the foreign currency swap settled in connection with its expiration, and the Company received cash proceeds of $35 million. The Company does not hold or issue any derivative instruments for trading or speculative purposes.

Circle Health Debt Refinancing

In May 2022, the Company refinanced certain debt agreements for its Circle Health subsidiary with a new £250 million credit facility maturing in May 2025. The Company recognized a $13 million pre-tax gain on the extinguishment of the existing debt. As of September 30, 2022, £180 million was drawn on the facility, which is included within Finance leases and other in the table above. The new facility is guaranteed by the Company and has similar borrowing rates and covenants to the Company's Revolving Credit Agreement.

Construction Loan

In October 2017, the Company executed a $200 million non-recourse construction loan to fund the expansion of the Company's corporate headquarters. Until final completion of the construction project, which occurred in July 2021, the loan bore interest based on one month LIBOR plus 2.70%, which reduced to LIBOR plus 2.00% at the time construction was completed. The agreement contains financial and non-financial covenants similar to those contained in the Company Credit Facility. The Company guaranteed completion of the construction project associated with the loan. As of September 30, 2022, the Company had $181 million in borrowings outstanding under the loan, which is included in the current portion of long-term debt.

In April 2022, the Company extended the term of the loan for an additional one year. The extension reduced interest on the loan to the Secured Overnight Financing Rate (SOFR) plus 1.85% and matures in April 2023.

Debt Repurchase Program

In June 2022, the Company's Board of Directors authorized a new $1,000 million debt repurchase program in preparation for future debt reductions as part of the Company’s strategic value creation initiatives. During the quarter ended September 30, 2022, the Company repurchased $259 million of its par value senior notes, as described above, for $247 million.

As of September 30, 2022, there was $753 million available under the program. In October 2022, the Company repurchased an additional $58 million of its par value senior notes for $53 million.
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.22.2.2
Leases
 9 Months Ended
Sep. 30, 2022
Leases [Abstract]  
Leases Leases
The following table sets forth the ROU assets and lease liabilities ($ in millions):
 September 30, 2022December 31, 2021
Assets
ROU assets (recorded within other long-term assets)$2,456 $3,566 
Liabilities
Short-term (recorded within accounts payable and accrued expenses)$193 $204 
Long-term (recorded within other long-term liabilities)3,038 3,619 
Total lease liabilities$3,231 $3,823 
As part of the real estate optimization initiative as described in Note 5. Property, Software and Equipment, the Company vacated and abandoned various domestic leased properties. As a result, the Company assessed the ROU assets for impairment. The Company engaged a third-party real estate specialist to determine the recoverability of the leased properties. The valuation primarily considered comparable leased properties in each market and the assessment of potential future rental income that could be generated by the ROU assets.

As a result of the optimization, the Company recognized $53 million and $574 million of ROU asset impairments in the three and nine months ended September 30, 2022, respectively, primarily related to the Managed Care segment. The remainder of the $1,574 million charge was recorded within Property, Software and Equipment, refer to Note 5. Property, Software and Equipment.

As of September 30, 2022, the weighted average remaining lease term for the Company was 20.1 years. The lease liabilities as of September 30, 2022 reflect a weighted average discount rate of 5.6%.
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stockholders' Equity
 9 Months Ended
Sep. 30, 2022
Equity [Abstract]  
Stockholders' Equity Stockholders' Equity
In June 2022, the Company's Board of Directors authorized an additional $3,000 million to the Company’s existing stock repurchase program for its common stock, for a total $4,000 million, in preparation for closing of the Magellan Rx and PANTHERx divestitures as well as planning for the future.

During the third quarter of 2022, the Company entered into an accelerated share repurchase (ASR) agreement with Bank of America to purchase $1,000 million of the Company's common stock in aggregate under the Company’s stock repurchase program. In July 2022, 8.6 million shares were delivered to the Company, representing 80% of the notional amount under the ASR. In October 2022, an additional 3.0 million shares were delivered upon settlement of the ASR based upon the volume-weighted average price (VWAP) over the term of the agreement, less a discount. In total, 11.6 million shares were purchased through the $1,000 million ASR.

The Company also repurchased an additional 2.9 million shares for $240 million during the third quarter. The remaining common stock repurchases relate to the purchase of shares to satisfy tax withholding requirements in connection with employee equity awards.

During the nine months ended September 30, 2022, the Company has repurchased a total of 15.7 million shares of Centene common stock for $1,384 million, exclusive of the $200 million unsettled portion under the ASR. As of September 30, 2022, the Company had a remaining amount of $2,216 million available under the Company’s stock repurchase program.
In October 2022, the Company repurchased an additional 828 thousand shares for $66 million
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.22.2.2
Earnings Per Share
 9 Months Ended
Sep. 30, 2022
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
The following table sets forth the calculation of basic and diluted net earnings per common share ($ in millions, except per share data in dollars and shares in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
 2022202120222021
Earnings attributable to Centene Corporation$738 $584 $1,415 $748 
Shares used in computing per share amounts: 
Weighted average number of common shares outstanding573,961 583,244 580,277 582,636 
Common stock equivalents (as determined by applying the treasury stock method)6,646 7,458 6,807 7,518 
Weighted average number of common shares and potential dilutive common shares outstanding580,607 590,702 587,084 590,154 
  
Net earnings per common share attributable to Centene Corporation:
Basic earnings per common share$1.29 $1.00 $2.44 $1.28 
Diluted earnings per common share$1.27 $0.99 $2.41 $1.27 

The calculation of diluted earnings per common share for the three months ended September 30, 2022 and 2021 excludes 152 thousand shares and 111 thousand shares, respectively, related to anti-dilutive stock options, restricted stock, and restricted stock units.

The calculation of diluted earnings per common share for the nine months ended September 30, 2022 and 2021 excludes the impact of 193 thousand shares and 57 thousand shares, respectively, related to anti-dilutive stock options, restricted stock, and restricted stock units.
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.22.2.2
Segment Information
 9 Months Ended
Sep. 30, 2022
Segment Reporting [Abstract]  
Segment Information Segment Information
Centene operates in two segments: Managed Care and Specialty Services. The Managed Care segment consists of Centene's health plans, including all of the functions needed to operate them. The Specialty Services segment consists of Centene's specialty companies offering auxiliary healthcare services and products. Factors used in determining the reportable business segments include the nature of operating activities, the existence of separate senior management teams, and the type of information presented to the Company's chief operating decision-maker to evaluate all results of operations.

Segment information for the three months ended September 30, 2022, is as follows ($ in millions):
 Managed 
Care		Specialty
Services		EliminationsConsolidated
Total
Total revenues from external customers$33,722 $2,143 $— $35,865 
Total revenues from internal customers2 3,264 (3,266)— 
Total revenues$33,724 $5,407 $(3,266)$35,865 
Earnings from operations$527 $(51)$— $476 

Segment information for the three months ended September 30, 2021, is as follows ($ in millions):
 Managed 
Care		Specialty
Services		EliminationsConsolidated
Total
Total revenues from external customers$30,888 $1,518 $— $32,406 
Total revenues from internal customers1 3,209 (3,210)— 
Total revenues$30,889 $4,727 $(3,210)$32,406 
Earnings from operations$699 $(154)$— $545 
Segment information for the nine months ended September 30, 2022, follows ($ in millions):
 Managed CareSpecialty
Services		EliminationsConsolidated
Total
Total revenues from external customers$101,428 $7,558 $— $108,986 
Total revenues from internal customers6 9,939 (9,945)— 
Total revenues$101,434 $17,497 $(9,945)$108,986 
Earnings from operations$1,634 $(34)$— $1,600 

Segment information for the nine months ended September 30, 2021, follows ($ in millions):
 Managed CareSpecialty
Services		EliminationsConsolidated
Total
Total revenues from external customers$89,078 $4,336 $— $93,414 
Total revenues from internal customers4 9,217 (9,221)— 
Total revenues$89,082 $13,553 $(9,221)$93,414 
Earnings from operations$1,240 $(59)$— $1,181 
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.22.2.2
Contingencies
 9 Months Ended
Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]  
Contingencies Contingencies
Overview

The Company is routinely subjected to legal and regulatory proceedings in the normal course of business. These matters can include, without limitation:

•periodic compliance and other reviews and investigations by various federal and state regulatory agencies with respect to requirements applicable to the Company's business, including, without limitation, those related to payment of out-of-network claims, submissions to CMS for risk adjustment payments, or the False Claims Act, the calculation of minimum MLR and rebates related thereto, submissions to state agencies related to payments or state false claims acts, pre-authorization penalties, timely review of grievances and appeals, timely and accurate payment of claims, and the Health Insurance Portability and Accountability Act of 1996 and other federal and state fraud, waste and abuse laws;

•litigation arising out of general business activities, such as tax matters, disputes related to healthcare benefits coverage or reimbursement, putative securities class actions, and medical malpractice, privacy, real estate, intellectual property and employment-related claims; and

•disputes regarding reinsurance arrangements, claims arising out of the acquisition or divestiture of various assets, class actions, and claims relating to the performance of contractual and non-contractual obligations to providers, members, employer groups and others, including, but not limited to, the alleged failure to properly pay claims and challenges to the manner in which the Company processes claims, claims related to network adequacy and claims alleging that the Company has engaged in unfair business practices.

Among other things, these matters may result in awards of damages, fines or penalties, which could be substantial, and/or could require changes to the Company's business. The Company intends to vigorously defend itself against legal and regulatory proceedings to which it is currently a party; however, these proceedings are subject to many uncertainties. In some of the cases pending against the Company, substantial non-economic or punitive damages are being sought.

The Company records reserves and accrues costs for certain legal proceedings and regulatory matters to the extent that it determines an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. While such reserves and accrued costs reflect the Company's best estimate of the probable loss for such matters, the recorded amounts may differ materially from the actual amount of any such losses. In some cases, no estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made because of the inherently unpredictable nature of legal and regulatory proceedings, which may be exacerbated by various factors, including but not limited to, they may involve indeterminate claims for monetary damages or may involve fines, penalties or punitive damages; present novel legal theories or legal uncertainties; involve disputed facts; represent a shift in regulatory policy; involve a large number of parties, claimants or regulatory bodies; are in the early stages of the proceedings; involve a number of separate proceedings and/or a wide range of potential outcomes; or result in a change of business practices.
As of the date of this report, amounts accrued for legal proceedings and regulatory matters were not material, except for the reserve estimate as described below with respect to claims or potential claims involving services provided by Envolve Pharmacy Solutions, Inc. (Envolve), as the Company's pharmacy benefits manager (PBM) subsidiary. It is possible that in a particular quarter or annual period the Company's financial condition, results of operations, cash flow and/or liquidity could be materially adversely affected by an ultimate unfavorable resolution of or development in legal and/or regulatory proceedings, including as described below. Except for the proceedings discussed below, the Company believes that the ultimate outcome of any of the regulatory and legal proceedings that are currently pending against it should not have a material adverse effect on financial condition, results of operations, cash flow, or liquidity.

California

On October 20, 2015, the Company's California subsidiary, Health Net of California, Inc. (Health Net California), was named as a defendant in a California taxpayer action filed in Los Angeles County Superior Court, captioned as Michael D. Myers v. State Board of Equalization, Dave Jones, Insurance Commissioner of the State of California, Betty T. Yee, Controller of the State of California, et al., Los Angeles Superior Court Case No. BS158655. This action is brought under a California statute that permits an individual taxpayer to sue a governmental agency when the taxpayer believes the agency has failed to enforce governing law. Plaintiff contends that Health Net California, a California licensed Health Care Service Plan (HCSP), is an "insurer" for purposes of taxation despite acknowledging it is not an "insurer" under regulatory law. Under California law, "insurers" must pay a gross premiums tax (GPT), calculated as 2.35% on gross premiums. As a licensed HCSP, Health Net California has paid the California Corporate Franchise Tax (CFT), the tax generally paid by California businesses. Plaintiff contends that Health Net California must pay the GPT rather than the CFT. Plaintiff seeks a writ of mandate directing the California taxing agencies to collect the GPT, and seeks an order requiring Health Net California to pay GPT, interest and penalties for a period dating to eight years prior to the October 2015 filing of the complaint. This lawsuit is being coordinated with similar lawsuits filed against other entities (collectively, Related Actions). In March 2018, the Court overruled the Company's demurrer seeking to dismiss the complaint and denied the Company's motion to strike allegations seeking retroactive relief. In August 2018, the trial court stayed all the Related Actions pending determination of a writ of mandate by the California Court of Appeals in two of the Related Actions. In March 2019, the California Court of Appeals denied the writ of mandate. The defendants in those Related Actions sought review by the California Supreme Court, which declined to review the matter. Upon the return of the matter to the Los Angeles County Superior Court, motions for summary judgment were scheduled. Health Net California's motion for summary judgment was heard by the Court in March 2020. In March 2020, the Court granted Health Net California's motion for summary judgment. In September 2020, the plaintiff appealed the Court's decision. The Company intends to continue its vigorous defense against these claims; however, this matter is subject to many uncertainties, and an adverse outcome in this matter could potentially have a materially adverse impact on the Company's financial position, results of operations and cash flows.

Beginning in April 2021, several lawsuits have been filed against the Company and its subsidiaries, alleging that the defendants failed to prevent Health Net members' personal and health data from being exposed in connection with a data breach involving Accellion's File Transfer Appliance. The Company denies any wrongdoing and is seeking indemnification from Accellion for these claims. In December 2021, the plaintiffs in three of the pending actions filed a motion for preliminary approval of a settlement with the Company and its subsidiaries, which, if approved by the court, should resolve most or all of the pending litigation. In addition, claims related to these lawsuits are anticipated to be covered in part by the Company's insurance carrier. As a result, while these matters are subject to many uncertainties, the Company does not believe that an adverse outcome in these matters is likely to have a materially adverse impact on the Company’s financial position, results of operations and cash flows.
Pharmacy Benefits Management Matters

On March 11, 2021, the State of Ohio filed a civil action against the Company and the Company's subsidiaries, Buckeye Health Plan Community Solutions, Inc. and Envolve, in Franklin County Court of Common Pleas, captioned as Ohio Department of Medicaid, et al. v. Centene Corporation, et al. The complaint alleged breaches of contract with the Ohio Department of Medicaid relating to the provision of PBM services and violations of Ohio law relating to such contracts, including among other things, by (i) seeking payment for services already reimbursed, (ii) not accurately disclosing to the Ohio Department of Medicaid the true cost of the PBM services and (iii) inflating dispensing fees for prescription drugs. The plaintiffs sought an undisclosed sum of money in damages, penalties, and possible termination of the contract with Buckeye Health Plan.

The Company has reached no-fault agreements with the Attorney Generals in 13 states, including Ohio, to resolve claims and/or allegations made by the states related to services provided by Envolve. As a result of the settlement, the Ohio Attorney General’s litigation against the Company was dismissed. Additionally, the Company is in discussions to bring final resolution to similar concerns in other affected states. Consistent with those discussions, the Company recorded a reserve estimate of $1,250 million in the second quarter of 2021 related to this issue, inclusive of the above settlements and rebates that the Company determined in the course of the matter are payable across products. Additional claims, reviews or investigations relating to the Company's PBM business across products may be brought by other states, the federal government or shareholder litigants, and there is no guarantee the Company will have the ability to settle such claims with other states within the reserve estimate the Company has recorded and on other acceptable terms, or at all. This matter is subject to many uncertainties, and an adverse outcome in this matter could have an adverse impact on the Company's financial position, results of operations and cash flows.
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.22.2.2
Organization and Operations (Policies)
 9 Months Ended
Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation
Basis of Presentation

The accompanying interim financial statements have been prepared under the presumption that users of the interim financial information have either read or have access to the audited financial statements included in the Form 10-K for the fiscal year ended December 31, 2021. The unaudited interim financial statements herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, footnote disclosures that would substantially duplicate the disclosures contained in the December 31, 2021 audited financial statements have been omitted from these interim financial statements, where appropriate. In the opinion of management, these financial statements reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for a fair presentation of the results of the interim periods presented.

Certain 2021 amounts in the consolidated financial statements and notes to the consolidated financial statements have been reclassified to conform to the 2022 presentation. Beginning in 2022, the Company has included a separate line item for depreciation expense on the Consolidated Statement of Operations, which was previously included in selling, general and administrative (SG&A) expenses. Prior period SG&A expense ratios have also been conformed to the current presentation. These reclassifications have no effect on net earnings or stockholders’ equity as previously reported.
On January 4, 2022, the Company acquired all of the issued and outstanding shares of Magellan Health, Inc. (Magellan) (the Magellan Acquisition). The acquisition was accounted for as a business combination. See Note 2. Acquisitions and Divestitures for further details.
Accounting Guidance Not Yet Adopted
Accounting Guidance Not Yet Adopted

The Company has determined that there are no recently issued accounting pronouncements that will have a material impact on its consolidated financial position, results of operations, or cash flows.
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.22.2.2
Acquisitions and Divestitures (Tables)
 9 Months Ended
Sep. 30, 2022
Business Combination and Asset Acquisition [Abstract]  
Schedule of Allocation of the Fair Value of Assets Acquired and Liabilities Assumed
The Company's preliminary allocation of the fair value of assets acquired and liabilities assumed as of the acquisition date of January 4, 2022 is as follows ($ in millions):
Assets acquired and liabilities assumed 
Cash and cash equivalents
$998 
Premium and related receivables
791 
Short-term investments
144 
Other current assets
194 
Long-term investments
43 
Restricted deposits
7 
Property, software and equipment
90 
Intangible assets (a)
751 
Other long-term assets50 
Total assets acquired 3,068 
Medical claims liability247 
Accounts payable and accrued expenses495 
Return of premium payable53 
Unearned revenue8 
Current portion of long-term debt5 
Long-term debt (b)
542 
Deferred tax liabilities (c)
123 
Other long-term liabilities69 
Total liabilities assumed1,542 
Mezzanine equity32 
Total identifiable net assets1,494 
Goodwill (d)
997 
Total assets acquired and liabilities assumed$2,491 
Schedule of Preliminary Fair Values and Weighted Average Useful Lives for Identifiable Intangible Assets Acquired
The fair values and weighted average useful lives for identifiable intangible assets acquired are as follows:
Fair ValueWeighted Average Useful Life (in years)
Purchased contract rights$470 13
Provider contracts100 15
Trade names80 17
Developed technologies101 5
Total intangible assets acquired$751 13
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.22.2.2
Short-term and Long-term Investments, Restricted Deposits (Tables)
 9 Months Ended
Sep. 30, 2022
Investments, Debt and Equity Securities [Abstract]  
Short-term and long-term investments and restricted deposits by investment type
Short-term and long-term investments and restricted deposits by investment type consist of the following ($ in millions):
 September 30, 2022December 31, 2021
 Amortized
Cost		Gross
Unrealized
Gains		Gross
Unrealized Losses		Fair
Value		Amortized
Cost		Gross
Unrealized
Gains		Gross
Unrealized Losses		Fair
Value
Debt securities:
U.S. Treasury securities and obligations of U.S. government
corporations and agencies
$666 $— $(18)$648 $642 $— $(2)$640 
Corporate securities9,648 1 (897)8,752 8,145 130 (75)8,200 
Restricted certificates of deposit
4 — — 4 4 — — 4 
Restricted cash equivalents
228 — — 228 96 — — 96 
Short-term time deposits
275 — — 275 109 — — 109 
Municipal securities3,980 — (320)3,660 3,398 85 (15)3,468 
Asset-backed securities1,335 — (68)1,267 1,308 5 (5)1,308 
Residential mortgage-backed securities
1,154 — (135)1,019 850 10 (7)853 
Commercial mortgage-backed securities
970 — (96)874 870 13 (10)873 
Equity securities (1)
6 — — 6 326 — — 326 
Private equity investments
551 — — 551 587 — — 587 
Life insurance contracts
165 — — 165 186 — — 186 
Total$18,982 $1 $(1,534)$17,449 $16,521 $243 $(114)$16,650 
(1) Investments in equity securities as of December 31, 2021 primarily consisted of exchange traded funds in fixed income securities.
Fair value of available-for-sale investments with gross unrealized losses by investment type and length of time
The fair value of available-for-sale debt securities with gross unrealized losses by investment type and length of time that individual securities have been in a continuous unrealized loss position were as follows ($ in millions):
 September 30, 2022December 31, 2021
 Less Than 12 Months12 Months or MoreLess Than 12 Months12 Months or More
 Unrealized LossesFair
Value		Unrealized LossesFair
Value		Unrealized LossesFair
Value		Unrealized LossesFair
Value
U.S. Treasury securities and obligations of U.S. government corporations and agencies
$(14)$556 $(4)$67 $(2)$598 $— $3 
Corporate securities(562)6,737 (335)1,975 (66)4,209 (9)209 
Municipal securities(228)2,998 (92)586 (14)1,173 (1)39 
Asset-backed securities(57)1,094 (11)166 (5)770 — 33 
Residential mortgage-backed securities(86)770 (49)244 (7)472 — 15 
Commercial mortgage-backed securities(59)650 (37)218 (8)380 (2)32 
Total$(1,006)$12,805 $(528)$3,256 $(102)$7,602 $(12)$331 
Contractual maturities of short-term and long-term investments and restricted deposits
The contractual maturities of short-term and long-term debt securities and restricted deposits are as follows ($ in millions):
 September 30, 2022December 31, 2021
 InvestmentsRestricted DepositsInvestmentsRestricted Deposits
 Amortized
Cost		Fair
Value		Amortized
Cost		Fair
Value		Amortized
Cost		Fair
Value		Amortized
Cost		Fair
Value
One year or less$2,053 $2,029 $521 $518 $1,390 $1,396 $368 $368 
One year through five years7,296 6,752 518 482 6,212 6,294 460 457 
Five years through ten years4,077 3,496 241 205 3,647 3,681 244 243 
Greater than ten years95 85 — — 73 78 — — 
Asset-backed securities3,459 3,160 — — 3,028 3,034 — — 
Total$16,980 $15,522 $1,280 $1,205 $14,350 $14,483 $1,072 $1,068 
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.22.2.2
Fair Value Measurements (Tables)
 9 Months Ended
Sep. 30, 2022
Fair Value Disclosures [Abstract]  
Assets and Liabilities, Based Upon Observable or Unobservable Inputs, Level Input Definitions
Assets and liabilities recorded at fair value in the Consolidated Balance Sheets are categorized based upon observable or unobservable inputs used to estimate fair value. Level inputs are as follows:
Level Input:Input Definition:
Level IInputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.
 
Level IIInputs other than quoted prices included in Level I that are observable for the asset or liability through corroboration with market data at the measurement date.
 
Level IIIUnobservable inputs that reflect management's best estimate of what market participants would use in pricing the asset or liability at the measurement date.
Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following table summarizes fair value measurements by level at September 30, 2022, for assets and liabilities measured at fair value on a recurring basis ($ in millions):
 Level ILevel IILevel IIITotal
Assets    
Cash and cash equivalents$14,987 $— $— $14,987 
Investments:    
U.S. Treasury securities and obligations of U.S. government corporations and agencies$313 $— $— $313 
Corporate securities— 8,721 — 8,721 
Municipal securities— 3,053 — 3,053 
Short-term time deposits— 275 — 275 
Asset-backed securities— 1,267 — 1,267 
Residential mortgage-backed securities— 1,019 — 1,019 
Commercial mortgage-backed securities— 874 — 874 
Equity securities4 2 — 6 
Total investments$317 $15,211 $— $15,528 
Restricted deposits:    
Cash and cash equivalents$228 $— $— $228 
Certificates of deposit— 4 — 4 
Corporate securities— 31 — 31 
Municipal securities
— 607 — 607 
U.S. Treasury securities and obligations of U.S. government corporations and agencies
335 — — 335 
Total restricted deposits$563 $642 $— $1,205 
Total assets at fair value$15,867 $15,853 $— $31,720 
The following table summarizes fair value measurements by level at December 31, 2021, for assets and liabilities measured at fair value on a recurring basis ($ in millions):
 Level ILevel IILevel IIITotal
Assets    
Cash and cash equivalents$13,118 $— $— $13,118 
Investments:    
U.S. Treasury securities and obligations of U.S. government corporations and agencies$171 $— $— $171 
Corporate securities— 8,170 — 8,170 
Municipal securities— 2,999 — 2,999 
Short-term time deposits— 109 — 109 
Asset backed securities— 1,308 — 1,308 
Residential mortgage backed securities— 853 — 853 
Commercial mortgage backed securities— 873 — 873 
Equity securities324 2 — 326 
Total investments$495 $14,314 $— $14,809 
Restricted deposits:    
Cash and cash equivalents$96 $— $— $96 
Certificates of deposit— 4 — 4 
Corporate securities— 30 — 30 
Municipal securities
— 469 — 469 
U.S. Treasury securities and obligations of U.S. government corporations and agencies
469 — — 469 
Total restricted deposits$565 $503 $— $1,068 
Other long-term assets:
Interest rate swap agreements$— $15 $— $15 
Total assets at fair value$14,178 $14,832 $— $29,010 
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.22.2.2
Property, Software and Equipment (Tables)
 9 Months Ended
Sep. 30, 2022
Property, Plant and Equipment [Abstract]  
Components of Property, Software and Equipment
Property, software and equipment consist of the following ($ in millions):
 September 30, 2022December 31, 2021
Computer software$2,211 $1,825 
Building641 1,116 
Furniture and office equipment407 753 
Leasehold improvements454 732 
Computer hardware648 617 
Land178 248 
Property, software and equipment, at cost4,539 5,291 
Less: accumulated depreciation(2,060)(1,900)
Property, software and equipment, net$2,479 $3,391 
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.22.2.2
Medical Claims Liability (Tables)
 9 Months Ended
Sep. 30, 2022
Insurance [Abstract]  
Schedule of change in medical claims liability
The following table summarizes the change in medical claims liability ($ in millions):
Nine Months Ended September 30,
20222021
Balance, January 1$14,243 $12,438 
Less: Reinsurance recoverable23 23 
Balance, January 1, net14,220 12,415 
Acquisitions and divestitures 249 — 
Incurred related to:
Current year84,457 74,736 
Prior years(1,196)(1,526)
Total incurred83,261 73,210 
Paid related to:
Current year70,305 62,205 
Prior years10,968 9,344 
Total paid81,273 71,549 
Balance, September 30, net
16,457 14,076 
Plus: Reinsurance recoverable8 23 
Balance, September 30
$16,465 $14,099 
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.22.2.2
Affordable Care Act (Tables)
 9 Months Ended
Sep. 30, 2022
Affordable Care Act [Abstract]  
Schedule of net receivables (payables) related to the Affordable Care Act Programs
The Company's net receivables (payables) for each of the programs are as follows ($ in millions):
September 30, 2022December 31, 2021
Risk adjustment receivable$1,068 $522 
Risk adjustment payable(652)(536)
Minimum medical loss ratio(69)(196)
Cost sharing reduction receivable10 69 
Cost sharing reduction payable(81)(42)
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.22.2.2
Debt (Tables)
 9 Months Ended
Sep. 30, 2022
Debt Disclosure [Abstract]  
Schedule of Debt
Debt consists of the following ($ in millions):
 September 30, 2022December 31, 2021
$2,500 million 4.25% Senior Notes due December 15, 2027
$2,403 $2,484 
$2,300 million 2.45% Senior Notes due July 15, 2028
2,304 2,304 
$3,500 million 4.625% Senior Notes due December 15, 2029
3,324 3,500 
$2,000 million 3.375% Senior Notes due February 15, 2030
2,000 2,000 
$2,200 million 3.00% Senior Notes due October 15, 2030
2,200 2,200 
$2,200 million 2.50% Senior Notes due March 1, 2031
2,200 2,200 
$1,300 million 2.625% Senior Notes due August 1, 2031
1,300 1,300 
Total senior notes15,731 15,988 
Term loan facility2,196 2,195 
Revolving credit agreement120 149 
Construction loan payable181 184 
Finance leases and other258 493 
Debt issuance costs(153)(171)
Total debt18,333 18,838 
Less current portion(249)(267)
 Long-term debt$18,084 $18,571 
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.22.2.2
Leases (Tables)
 9 Months Ended
Sep. 30, 2022
Leases [Abstract]  
ROU Assets and Liabilities
The following table sets forth the ROU assets and lease liabilities ($ in millions):
 September 30, 2022December 31, 2021
Assets
ROU assets (recorded within other long-term assets)$2,456 $3,566 
Liabilities
Short-term (recorded within accounts payable and accrued expenses)$193 $204 
Long-term (recorded within other long-term liabilities)3,038 3,619 
Total lease liabilities$3,231 $3,823 
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.22.2.2
Earnings Per Share (Tables)
 9 Months Ended
Sep. 30, 2022
Earnings Per Share [Abstract]  
Calculation of Basic and Diluted Net Earnings Per Common Share
The following table sets forth the calculation of basic and diluted net earnings per common share ($ in millions, except per share data in dollars and shares in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
 2022202120222021
Earnings attributable to Centene Corporation$738 $584 $1,415 $748 
Shares used in computing per share amounts: 
Weighted average number of common shares outstanding573,961 583,244 580,277 582,636 
Common stock equivalents (as determined by applying the treasury stock method)6,646 7,458 6,807 7,518 
Weighted average number of common shares and potential dilutive common shares outstanding580,607 590,702 587,084 590,154 
  
Net earnings per common share attributable to Centene Corporation:
Basic earnings per common share$1.29 $1.00 $2.44 $1.28 
Diluted earnings per common share$1.27 $0.99 $2.41 $1.27 
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.22.2.2
Segment Information (Tables)
 9 Months Ended
Sep. 30, 2022
Segment Reporting [Abstract]  
Segment Information
Segment information for the three months ended September 30, 2022, is as follows ($ in millions):
 Managed 
Care		Specialty
Services		EliminationsConsolidated
Total
Total revenues from external customers$33,722 $2,143 $— $35,865 
Total revenues from internal customers2 3,264 (3,266)— 
Total revenues$33,724 $5,407 $(3,266)$35,865 
Earnings from operations$527 $(51)$— $476 

Segment information for the three months ended September 30, 2021, is as follows ($ in millions):
 Managed 
Care		Specialty
Services		EliminationsConsolidated
Total
Total revenues from external customers$30,888 $1,518 $— $32,406 
Total revenues from internal customers1 3,209 (3,210)— 
Total revenues$30,889 $4,727 $(3,210)$32,406 
Earnings from operations$699 $(154)$— $545 
Segment information for the nine months ended September 30, 2022, follows ($ in millions):
 Managed CareSpecialty
Services		EliminationsConsolidated
Total
Total revenues from external customers$101,428 $7,558 $— $108,986 
Total revenues from internal customers6 9,939 (9,945)— 
Total revenues$101,434 $17,497 $(9,945)$108,986 
Earnings from operations$1,634 $(34)$— $1,600 

Segment information for the nine months ended September 30, 2021, follows ($ in millions):
 Managed CareSpecialty
Services		EliminationsConsolidated
Total
Total revenues from external customers$89,078 $4,336 $— $93,414 
Total revenues from internal customers4 9,217 (9,221)— 
Total revenues$89,082 $13,553 $(9,221)$93,414 
Earnings from operations$1,240 $(59)$— $1,181 
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.22.2.2
Acquisitions and Divestitures - Narrative (Details) - Magellan Acquisition - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Jan. 04, 2022
Sep. 30, 2022
Sep. 30, 2022
Business Acquisition [Line Items]      
Consideration transferred $ 2,491    
Cash paid 2,431    
Consideration transferred related to fair value of replacement equity awards associated with pre-combination service 60    
Settlement of pre-existing payables and receivables prior to acquisition $ (70)    
Acquisition related expenses   $ 8 $ 100
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.22.2.2
Acquisitions and Divestitures - Schedule of Fair Value of Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Millions
Sep. 30, 2022
Jan. 04, 2022
Dec. 31, 2021
Assets acquired and liabilities assumed      
Goodwill $ 20,040   $ 19,771
Goodwill $ 20,040   $ 19,771
Magellan Acquisition      
Assets acquired and liabilities assumed      
Cash and cash equivalents   $ 998  
Premium and related receivables   791  
Short-term investments   144  
Other current assets   194  
Long-term investments   43  
Restricted deposits   7  
Property, software and equipment   90  
Intangible assets   751  
Other long-term assets   50  
Total assets acquired   3,068  
Medical claims liability   247  
Accounts payable and accrued expenses   495  
Return of premium payable   53  
Unearned revenue   8  
Current portion of long-term debt   5  
Long-term debt   542  
Deferred tax liabilities   123  
Other long-term liabilities   69  
Total liabilities assumed   1,542  
Mezzanine equity   32  
Total identifiable net assets   1,494  
Goodwill   997  
Total assets acquired and liabilities assumed   2,491  
Debt assumed, aggregate principal   535  
Deferred tax assets   116  
Goodwill   $ 997  
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.22.2.2
Acquisitions and Divestitures - Identifiable Intangible Assets (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Jan. 04, 2022
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Acquired Finite-Lived Intangible Assets [Line Items]          
Amortization of acquired intangible assets   $ 211 $ 198 $ 609 $ 581
Magellan Acquisition          
Acquired Finite-Lived Intangible Assets [Line Items]          
Intangible assets $ 751        
Weighted Average Useful Life (in years) 13 years        
Magellan Acquisition | Purchased contract rights          
Acquired Finite-Lived Intangible Assets [Line Items]          
Intangible assets $ 470        
Weighted Average Useful Life (in years) 13 years        
Magellan Acquisition | Provider contracts          
Acquired Finite-Lived Intangible Assets [Line Items]          
Intangible assets $ 100        
Weighted Average Useful Life (in years) 15 years        
Magellan Acquisition | Trade names          
Acquired Finite-Lived Intangible Assets [Line Items]          
Intangible assets $ 80        
Weighted Average Useful Life (in years) 17 years        
Magellan Acquisition | Developed technologies          
Acquired Finite-Lived Intangible Assets [Line Items]          
Intangible assets $ 101        
Weighted Average Useful Life (in years) 5 years        
Magellan Acquisition | Adjustment to intangible assets          
Acquired Finite-Lived Intangible Assets [Line Items]          
Amortization of acquired intangible assets   $ 15      
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.22.2.2
Acquisitions and Divestitures - Divestitures (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Jul. 14, 2022
Sep. 30, 2022
Sep. 30, 2022
Sep. 30, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Gain on disposition of business     $ (503) $ 62
PANTHERx Rare | Disposal Group, Disposed of by Sale, Not Discontinued Operations        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Proceeds from sale of business $ 1,373      
Gain on disposition of business (490)      
Gain on disposition of business, net of tax $ 382      
Spanish and Central European Businesses | Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Assets held for sale   $ 666 666  
Liabilities held for sale   582 $ 582  
Impairment associated with pending divestiture   165    
Impairment associated with pending divestiture, after tax   $ 138    
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.22.2.2
Short-term and Long-term Investments, Restricted Deposits - By Investment Type (Details) - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Debt Securities    
Gross Unrealized Gains $ 1 $ 243
Gross Unrealized Losses (1,534) (114)
Equity securities 6 326
Private equity investments 551 587
Life insurance contracts 165 186
Total, Amortized Cost 18,982 16,521
Total, Fair Value 17,449 16,650
U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Debt Securities    
Amortized Cost 666 642
Gross Unrealized Gains 0 0
Gross Unrealized Losses (18) (2)
Fair Value 648 640
Corporate securities    
Debt Securities    
Amortized Cost 9,648 8,145
Gross Unrealized Gains 1 130
Gross Unrealized Losses (897) (75)
Fair Value 8,752 8,200
Restricted certificates of deposit    
Debt Securities    
Amortized Cost 4 4
Gross Unrealized Gains 0 0
Gross Unrealized Losses 0 0
Fair Value 4 4
Restricted cash equivalents    
Debt Securities    
Amortized Cost 228 96
Gross Unrealized Gains 0 0
Gross Unrealized Losses 0 0
Fair Value 228 96
Short-term time deposits    
Debt Securities    
Amortized Cost 275 109
Gross Unrealized Gains 0 0
Gross Unrealized Losses 0 0
Fair Value 275 109
Municipal securities    
Debt Securities    
Amortized Cost 3,980 3,398
Gross Unrealized Gains 0 85
Gross Unrealized Losses (320) (15)
Fair Value 3,660 3,468
Asset-backed securities    
Debt Securities    
Amortized Cost 1,335 1,308
Gross Unrealized Gains 0 5
Gross Unrealized Losses (68) (5)
Fair Value 1,267 1,308
Residential mortgage-backed securities    
Debt Securities    
Amortized Cost 1,154 850
Gross Unrealized Gains 0 10
Gross Unrealized Losses (135) (7)
Fair Value 1,019 853
Commercial mortgage-backed securities    
Debt Securities    
Amortized Cost 970 870
Gross Unrealized Gains 0 13
Gross Unrealized Losses (96) (10)
Fair Value $ 874 $ 873
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.22.2.2
Short-term and Long-term Investments, Restricted Deposits - Narrative (Details)
$ in Millions
 9 Months Ended
Sep. 30, 2022
USD ($)
position
Dec. 31, 2021
USD ($)
Schedule Of Investments And Restricted Deposits By Type [Line Items]    
Accrued interest income | $ $ 119 $ 96
Positions from which gross unrealized losses were generated 6,688  
Total investment positions 6,847  
Commercial mortgage-backed securities    
Schedule Of Investments And Restricted Deposits By Type [Line Items]    
Investments recorded at fair value that carry rating of AAA Plus, weighted average (in years) 4 years  
Rated Securities | External Credit Rating, Investment Grade | Investment Securities    
Schedule Of Investments And Restricted Deposits By Type [Line Items]    
Percentage of investments in rated securities carry an investment grade rating by nationally recognized statistical rating organizations 98.00%  
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.22.2.2
Short-term and Long-term Investments, Restricted Deposits - Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time (Details) - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Unrealized Losses    
Less Than 12 Months $ (1,006) $ (102)
12 Months or More (528) (12)
Fair Value    
Fair Value, Less Than 12 Months 12,805 7,602
Fair Value, 12 Months or More 3,256 331
U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Unrealized Losses    
Less Than 12 Months (14) (2)
12 Months or More (4) 0
Fair Value    
Fair Value, Less Than 12 Months 556 598
Fair Value, 12 Months or More 67 3
Corporate securities    
Unrealized Losses    
Less Than 12 Months (562) (66)
12 Months or More (335) (9)
Fair Value    
Fair Value, Less Than 12 Months 6,737 4,209
Fair Value, 12 Months or More 1,975 209
Municipal securities    
Unrealized Losses    
Less Than 12 Months (228) (14)
12 Months or More (92) (1)
Fair Value    
Fair Value, Less Than 12 Months 2,998 1,173
Fair Value, 12 Months or More 586 39
Asset-backed securities    
Unrealized Losses    
Less Than 12 Months (57) (5)
12 Months or More (11) 0
Fair Value    
Fair Value, Less Than 12 Months 1,094 770
Fair Value, 12 Months or More 166 33
Residential mortgage-backed securities    
Unrealized Losses    
Less Than 12 Months (86) (7)
12 Months or More (49) 0
Fair Value    
Fair Value, Less Than 12 Months 770 472
Fair Value, 12 Months or More 244 15
Commercial mortgage-backed securities    
Unrealized Losses    
Less Than 12 Months (59) (8)
12 Months or More (37) (2)
Fair Value    
Fair Value, Less Than 12 Months 650 380
Fair Value, 12 Months or More $ 218 $ 32
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.22.2.2
Short-term and Long-term Investments, Restricted Deposits - Contractual Maturities of Short-Term and Long-Term Investments and Restricted Deposits (Details) - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Investments    
Amortized Cost    
One year or less $ 2,053 $ 1,390
One year through five years 7,296 6,212
Five years through ten years 4,077 3,647
Greater than ten years 95 73
Asset-backed securities 3,459 3,028
Amortized Cost 16,980 14,350
Fair Value    
One year or less 2,029 1,396
One year through five years 6,752 6,294
Five years through ten years 3,496 3,681
Greater than ten years 85 78
Asset-backed securities 3,160 3,034
Fair Value 15,522 14,483
Restricted Deposits    
Amortized Cost    
One year or less 521 368
One year through five years 518 460
Five years through ten years 241 244
Greater than ten years 0 0
Asset-backed securities 0 0
Amortized Cost 1,280 1,072
Fair Value    
One year or less 518 368
One year through five years 482 457
Five years through ten years 205 243
Greater than ten years 0 0
Asset-backed securities 0 0
Fair Value $ 1,205 $ 1,068
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.22.2.2
Fair Value Measurements - Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Assets    
Cash and cash equivalents $ 14,987 $ 13,118
Investments:    
Equity securities 6 326
Total assets at fair value 31,720 29,010
U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Investments:    
Fair Value 648 640
Corporate securities    
Investments:    
Fair Value 8,752 8,200
Municipal securities    
Investments:    
Fair Value 3,660 3,468
Short-term time deposits    
Investments:    
Fair Value 275 109
Asset-backed securities    
Investments:    
Fair Value 1,267 1,308
Residential mortgage-backed securities    
Investments:    
Fair Value 1,019 853
Commercial mortgage-backed securities    
Investments:    
Fair Value 874 873
Investments available-for-sale    
Investments:    
Fair Value 15,528 14,809
Investments available-for-sale | U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Investments:    
Fair Value 313 171
Investments available-for-sale | Corporate securities    
Investments:    
Fair Value 8,721 8,170
Investments available-for-sale | Municipal securities    
Investments:    
Fair Value 3,053 2,999
Investments available-for-sale | Short-term time deposits    
Investments:    
Fair Value 275 109
Investments available-for-sale | Asset-backed securities    
Investments:    
Fair Value 1,267 1,308
Investments available-for-sale | Residential mortgage-backed securities    
Investments:    
Fair Value 1,019 853
Investments available-for-sale | Commercial mortgage-backed securities    
Investments:    
Fair Value 874 873
Restricted deposits    
Investments:    
Fair Value 1,205 1,068
Restricted deposits | U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Investments:    
Fair Value 335 469
Restricted deposits | Corporate securities    
Investments:    
Fair Value 31 30
Restricted deposits | Municipal securities    
Investments:    
Fair Value 607 469
Restricted deposits | Cash and cash equivalents    
Investments:    
Fair Value 228 96
Restricted deposits | Certificates of deposit    
Investments:    
Fair Value 4 4
Other long-term assets: | Interest rate swap agreements    
Investments:    
Derivative asset   15
Level I    
Assets    
Cash and cash equivalents 14,987 13,118
Investments:    
Equity securities 4 324
Total assets at fair value 15,867 14,178
Level I | Investments available-for-sale    
Investments:    
Fair Value 317 495
Level I | Investments available-for-sale | U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Investments:    
Fair Value 313 171
Level I | Investments available-for-sale | Corporate securities    
Investments:    
Fair Value 0 0
Level I | Investments available-for-sale | Municipal securities    
Investments:    
Fair Value 0 0
Level I | Investments available-for-sale | Short-term time deposits    
Investments:    
Fair Value 0 0
Level I | Investments available-for-sale | Asset-backed securities    
Investments:    
Fair Value 0 0
Level I | Investments available-for-sale | Residential mortgage-backed securities    
Investments:    
Fair Value 0 0
Level I | Investments available-for-sale | Commercial mortgage-backed securities    
Investments:    
Fair Value 0 0
Level I | Restricted deposits    
Investments:    
Fair Value 563 565
Level I | Restricted deposits | U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Investments:    
Fair Value 335 469
Level I | Restricted deposits | Corporate securities    
Investments:    
Fair Value 0 0
Level I | Restricted deposits | Municipal securities    
Investments:    
Fair Value 0 0
Level I | Restricted deposits | Cash and cash equivalents    
Investments:    
Fair Value 228 96
Level I | Restricted deposits | Certificates of deposit    
Investments:    
Fair Value 0 0
Level I | Other long-term assets: | Interest rate swap agreements    
Investments:    
Derivative asset   0
Level II    
Assets    
Cash and cash equivalents 0 0
Investments:    
Equity securities 2 2
Total assets at fair value 15,853 14,832
Level II | Investments available-for-sale    
Investments:    
Fair Value 15,211 14,314
Level II | Investments available-for-sale | U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Investments:    
Fair Value 0 0
Level II | Investments available-for-sale | Corporate securities    
Investments:    
Fair Value 8,721 8,170
Level II | Investments available-for-sale | Municipal securities    
Investments:    
Fair Value 3,053 2,999
Level II | Investments available-for-sale | Short-term time deposits    
Investments:    
Fair Value 275 109
Level II | Investments available-for-sale | Asset-backed securities    
Investments:    
Fair Value 1,267 1,308
Level II | Investments available-for-sale | Residential mortgage-backed securities    
Investments:    
Fair Value 1,019 853
Level II | Investments available-for-sale | Commercial mortgage-backed securities    
Investments:    
Fair Value 874 873
Level II | Restricted deposits    
Investments:    
Fair Value 642 503
Level II | Restricted deposits | U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Investments:    
Fair Value 0 0
Level II | Restricted deposits | Corporate securities    
Investments:    
Fair Value 31 30
Level II | Restricted deposits | Municipal securities    
Investments:    
Fair Value 607 469
Level II | Restricted deposits | Cash and cash equivalents    
Investments:    
Fair Value 0 0
Level II | Restricted deposits | Certificates of deposit    
Investments:    
Fair Value 4 4
Level II | Other long-term assets: | Interest rate swap agreements    
Investments:    
Derivative asset   15
Level III    
Assets    
Cash and cash equivalents 0 0
Investments:    
Equity securities 0 0
Total assets at fair value 0 0
Level III | Investments available-for-sale    
Investments:    
Fair Value 0 0
Level III | Investments available-for-sale | U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Investments:    
Fair Value 0 0
Level III | Investments available-for-sale | Corporate securities    
Investments:    
Fair Value 0 0
Level III | Investments available-for-sale | Municipal securities    
Investments:    
Fair Value 0 0
Level III | Investments available-for-sale | Short-term time deposits    
Investments:    
Fair Value 0 0
Level III | Investments available-for-sale | Asset-backed securities    
Investments:    
Fair Value 0 0
Level III | Investments available-for-sale | Residential mortgage-backed securities    
Investments:    
Fair Value 0 0
Level III | Investments available-for-sale | Commercial mortgage-backed securities    
Investments:    
Fair Value 0 0
Level III | Restricted deposits    
Investments:    
Fair Value 0 0
Level III | Restricted deposits | U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Investments:    
Fair Value 0 0
Level III | Restricted deposits | Corporate securities    
Investments:    
Fair Value 0 0
Level III | Restricted deposits | Municipal securities    
Investments:    
Fair Value 0 0
Level III | Restricted deposits | Cash and cash equivalents    
Investments:    
Fair Value 0 0
Level III | Restricted deposits | Certificates of deposit    
Investments:    
Fair Value $ 0 0
Level III | Other long-term assets: | Interest rate swap agreements    
Investments:    
Derivative asset   $ 0
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.22.2.2
Fair Value Measurements - Narrative (Details) - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Fair Value Disclosures [Abstract]    
Aggregate carrying amount of life insurance contracts and equity investments, fair value $ 716 $ 773
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.22.2.2
Property, Software and Equipment - Components (Details) - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Property, Plant and Equipment [Line Items]    
Property, software and equipment, at cost $ 4,539 $ 5,291
Less: accumulated depreciation (2,060) (1,900)
Property, software and equipment, net 2,479 3,391
Computer software    
Property, Plant and Equipment [Line Items]    
Property, software and equipment, at cost 2,211 1,825
Building    
Property, Plant and Equipment [Line Items]    
Property, software and equipment, at cost 641 1,116
Furniture and office equipment    
Property, Plant and Equipment [Line Items]    
Property, software and equipment, at cost 407 753
Leasehold improvements    
Property, Plant and Equipment [Line Items]    
Property, software and equipment, at cost 454 732
Computer hardware    
Property, Plant and Equipment [Line Items]    
Property, software and equipment, at cost 648 617
Land    
Property, Plant and Equipment [Line Items]    
Property, software and equipment, at cost $ 178 $ 248
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.22.2.2
Property, Software and Equipment - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2022
Property, Plant and Equipment [Line Items]    
Remaining asset impairment charges   $ 1,574
Real Estate Owned and Related Fixed Assets    
Property, Plant and Equipment [Line Items]    
Tangible asset impairment charges $ 57 763
Leased Real Estate and Fixed Assets    
Property, Plant and Equipment [Line Items]    
Tangible asset impairment charges $ 14 $ 237
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.22.2.2
Medical Claims Liability - Schedule of Change in Medical Claims Liability (Details) - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]    
Balance, January 1 $ 14,243 $ 12,438
Less: Reinsurance recoverable 23 23
Balance, January 1, net 14,220 12,415
Acquisitions and divestitures 249 0
Incurred related to:    
Current year 84,457 74,736
Prior years (1,196) (1,526)
Total incurred 83,261 73,210
Paid related to:    
Current year 70,305 62,205
Prior years 10,968 9,344
Total paid 81,273 71,549
Balance, September 30, net 16,457 14,076
Plus: Reinsurance recoverable 8 23
Balance, September 30 $ 16,465 $ 14,099
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.22.2.2
Medical Claims Liability - Narrative (Details) - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Insurance [Abstract]    
Amounts recorded as an adjustment to premium revenues related to minimum HBR and return of premium programs $ 121 $ 438
Short-duration insurance contracts, Incurred but not reported and expected development on reported claims $ 11,130  
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.22.2.2
Affordable Care Act - Net Receivables (Payables) for Each of the Ongoing Programs (Details) - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Affordable Care Act [Abstract]    
Risk adjustment receivable $ 1,068 $ 522
Risk adjustment payable (652) (536)
Minimum medical loss ratio (69) (196)
Cost sharing reduction receivable 10 69
Cost sharing reduction payable $ (81) $ (42)
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.22.2.2
Affordable Care Act - Additional information (Details) - USD ($)
$ in Millions
 6 Months Ended 9 Months Ended
Jun. 30, 2022
Sep. 30, 2022
Affordable Care Act [Abstract]    
Risk adjustment, increase to net receivables $ 403  
Risk adjustment and reinsurance pre-tax benefit   $ 368
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.22.2.2
Debt - Schedule of Debt (Details) - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Debt Instrument [Line Items]    
Total senior notes $ 15,731,000,000 $ 15,988,000,000
Construction loan payable 181,000,000 184,000,000
Finance leases and other 258,000,000 493,000,000
Debt issuance costs (153,000,000) (171,000,000)
Total debt 18,333,000,000 18,838,000,000
Less current portion (249,000,000) (267,000,000)
 Long-term debt 18,084,000,000 18,571,000,000
Revolving credit agreement    
Debt Instrument [Line Items]    
Credit facility 120,000,000 149,000,000
Term loan facility    
Debt Instrument [Line Items]    
Credit facility 2,196,000,000 2,195,000,000
$2,500 million 4.25% Senior Notes due December 15, 2027 | Senior Notes    
Debt Instrument [Line Items]    
Debt, face amount $ 2,500,000,000  
Interest rate 4.25%  
Senior notes $ 2,403,000,000 2,484,000,000
$2,300 million 2.45% Senior Notes due July 15, 2028 | Senior Notes    
Debt Instrument [Line Items]    
Debt, face amount $ 2,300,000,000  
Interest rate 2.45%  
Senior notes $ 2,304,000,000 2,304,000,000
$3,500 million 4.625% Senior Notes due December 15, 2029 | Senior Notes    
Debt Instrument [Line Items]    
Debt, face amount $ 3,500,000,000  
Interest rate 4.625%  
Senior notes $ 3,324,000,000 3,500,000,000
$2,000 million 3.375% Senior Notes due February 15, 2030 | Senior Notes    
Debt Instrument [Line Items]    
Debt, face amount $ 2,000,000,000  
Interest rate 3.375%  
Senior notes $ 2,000,000,000 2,000,000,000
$2,200 million 3.00% Senior Notes due October 15, 2030 | Senior Notes    
Debt Instrument [Line Items]    
Debt, face amount $ 2,200,000,000  
Interest rate 3.00%  
Senior notes $ 2,200,000,000 2,200,000,000
$2,200 million 2.50% Senior Notes due March 1, 2031 | Senior Notes    
Debt Instrument [Line Items]    
Debt, face amount $ 2,200,000,000  
Interest rate 2.50%  
Senior notes $ 2,200,000,000 2,200,000,000
$1,300 million 2.625% Senior Notes due August 1, 2031 | Senior Notes    
Debt Instrument [Line Items]    
Debt, face amount $ 1,300,000,000  
Interest rate 2.625%  
Senior notes $ 1,300,000,000 $ 1,300,000,000
XML 60 R50.htm IDEA: XBRL DOCUMENT v3.22.2.2
Debt - Narrative (Details)
£ in Millions
 1 Months Ended 3 Months Ended 9 Months Ended
Mar. 31, 2022
USD ($)
Oct. 25, 2022
USD ($)
May 31, 2022
USD ($)
Apr. 30, 2022
Jul. 31, 2021
GBP (£)
Oct. 31, 2017
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2021
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2022
GBP (£)
Sep. 30, 2021
USD ($)
Jun. 30, 2022
USD ($)
May 31, 2022
GBP (£)
Jan. 31, 2022
Dec. 31, 2021
USD ($)
Jul. 31, 2021
USD ($)
Debt Instrument [Line Items]                                
Payments for foreign currency hedge | £         £ 509                      
Debt extinguishment     $ 13,000,000       $ 10,000,000 $ (79,000,000) $ 26,000,000   $ (125,000,000)          
Construction loan payable             181,000,000   181,000,000           $ 184,000,000  
Debt repurchase program, authorized amount                       $ 1,000,000,000        
Debt repurchase program, amount available under the program             753,000,000   753,000,000              
Senior Notes                                
Debt Instrument [Line Items]                                
Debt redemption amount             259,000,000   $ 259,000,000              
Gain on redemption of debt             10,000,000                  
Repurchase of senior debt             $ 247,000,000                  
Senior Notes | Subsequent Event                                
Debt Instrument [Line Items]                                
Debt redemption amount   $ 58,000,000                            
Repurchase of senior debt   $ 53,000,000                            
Senior Notes | $2,500 million 4.25% Senior Notes due December 15, 2027                                
Debt Instrument [Line Items]                                
Interest rate             4.25%   4.25%              
Debt redemption amount             $ 83,000,000   $ 83,000,000              
Debt, face amount             $ 2,500,000,000   $ 2,500,000,000              
Senior Notes | $3,500 million 4.625% Senior Notes due December 15, 2029                                
Debt Instrument [Line Items]                                
Interest rate             4.625%   4.625%              
Debt redemption amount             $ 176,000,000   $ 176,000,000              
Debt, face amount             $ 3,500,000,000   $ 3,500,000,000              
Construction Loan Payable                                
Debt Instrument [Line Items]                                
Debt, face amount           $ 200,000,000                    
Extension term       1 year                        
Foreign Line of Credit                                
Debt Instrument [Line Items]                                
Credit facility, maximum borrowing capacity | £                         £ 250      
Proceeds from credit facility | £                   £ 180            
Magellan Acquisition                                
Debt Instrument [Line Items]                                
Interest rate                           4.40%    
LIBOR | Construction Loan Payable | Maximum                                
Debt Instrument [Line Items]                                
Basis spread on variable rate           2.70%                    
LIBOR | Construction Loan Payable | Minimum                                
Debt Instrument [Line Items]                                
Basis spread on variable rate         2.00%                      
SOFR | Construction Loan Payable                                
Debt Instrument [Line Items]                                
Basis spread on variable rate       1.85%                        
Currency Swap                                
Debt Instrument [Line Items]                                
Derivative agreement                               $ 705,000,000
Proceeds from termination of interest rate swaps $ 35,000,000                              
Debt Total | Credit Availability Concentration Risk | LIBOR                                
Debt Instrument [Line Items]                                
Percentage of investments in rated securities carry an investment grade rating by nationally recognized statistical rating organizations                 15.00% 15.00%            
XML 61 R51.htm IDEA: XBRL DOCUMENT v3.22.2.2
Leases - ROU Assets and Liabilities (Details) - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Assets    
ROU assets (recorded within other long-term assets) $ 2,456 $ 3,566
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] Other long-term assets Other long-term assets
Liabilities    
Short-term (recorded within accounts payable and accrued expenses) $ 193 $ 204
Long-term (recorded within other long-term liabilities) 3,038 3,619
Total lease liabilities $ 3,231 $ 3,823
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Accounts payable and accrued expenses Accounts payable and accrued expenses
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] Other long-term liabilities Other long-term liabilities
XML 62 R52.htm IDEA: XBRL DOCUMENT v3.22.2.2
Leases - Narrative (Details)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2022
USD ($)
Sep. 30, 2022
USD ($)
Leases [Abstract]    
ROU impairment $ 53 $ 574
Remaining asset impairment charges   $ 1,574
Weighted average remaining lease term 20 years 1 month 6 days 20 years 1 month 6 days
Weighted-average discount rate for operating leases 5.60% 5.60%
XML 63 R53.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stockholders' Equity (Details) - USD ($)
shares in Thousands, $ in Millions
 1 Months Ended 3 Months Ended 4 Months Ended 9 Months Ended
Oct. 25, 2022
Jul. 31, 2022
Jun. 30, 2022
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Oct. 25, 2022
Sep. 30, 2022
Equity, Class of Treasury Stock [Line Items]                      
Stock repurchase program, increase to authorized amount     $ 3,000                
Stock repurchase program, authorized amount     $ 4,000   $ 4,000            
Common stock repurchases       $ 1,243 $ 349 $ 71 $ 15 $ 4 $ 29    
Unsettled portion under ASR                     $ 200
Stock repurchase program, remaining available       2,216             2,216
Subsequent Event                      
Equity, Class of Treasury Stock [Line Items]                      
Common stock repurchases (in shares) 828                    
Common stock repurchases $ 66                    
Share Repurchase Agreement                      
Equity, Class of Treasury Stock [Line Items]                      
Common stock repurchases                     $ 1,384
Common Stock                      
Equity, Class of Treasury Stock [Line Items]                      
Common stock repurchases (in shares)                     15,700
Common Stock | Accelerated Share Repurchase Agreement                      
Equity, Class of Treasury Stock [Line Items]                      
Accelerated share repurchases agreement, amount       $ 1,000              
Common stock repurchases (in shares)   8,600                  
Shares repurchased, percentage of notional amount   80.00%                  
Common Stock | Accelerated Share Repurchase Agreement | Subsequent Event                      
Equity, Class of Treasury Stock [Line Items]                      
Common stock repurchases (in shares) 3,000                 11,600  
Common Stock | Share Repurchase Agreement                      
Equity, Class of Treasury Stock [Line Items]                      
Common stock repurchases (in shares)       2,900              
Common stock repurchases       $ 240              
XML 64 R54.htm IDEA: XBRL DOCUMENT v3.22.2.2
Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Earnings attributable to Centene Corporation        
Earnings attributable to Centene Corporation $ 738 $ 584 $ 1,415 $ 748
Shares used in computing per share amounts:        
Weighted average number of common shares outstanding (in shares) 573,961 583,244 580,277 582,636
Common stock equivalents (as determined by applying the treasury stock method) (in shares) 6,646 7,458 6,807 7,518
Weighted average number of common shares and potential dilutive common shares outstanding (in shares) 580,607 590,702 587,084 590,154
Net earnings per common share attributable to Centene Corporation:        
Basic earnings per common share (in dollars per share) $ 1.29 $ 1.00 $ 2.44 $ 1.28
Diluted earnings per common share (in dollars per share) $ 1.27 $ 0.99 $ 2.41 $ 1.27
Anti-dilutive restricted stock and restricted stock units excluded from the calculation of diluted earnings (loss) per common share (in shares) 152 111 193 57
XML 65 R55.htm IDEA: XBRL DOCUMENT v3.22.2.2
Segment Information (Details)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2022
USD ($)
Sep. 30, 2021
USD ($)
Sep. 30, 2022
USD ($)
segment
Sep. 30, 2021
USD ($)
Segment Reporting [Abstract]        
Number of operating segments | segment     2  
Segment Reporting Information [Line Items]        
Total revenues $ 35,865 $ 32,406 $ 108,986 $ 93,414
Earnings from operations 476 545 1,600 1,181
Eliminations        
Segment Reporting Information [Line Items]        
Total revenues (3,266) (3,210) (9,945) (9,221)
Managed  Care        
Segment Reporting Information [Line Items]        
Total revenues 33,724 30,889 101,434 89,082
Earnings from operations 527 699 1,634 1,240
Managed  Care | Operating Segments        
Segment Reporting Information [Line Items]        
Total revenues 33,722 30,888 101,428 89,078
Managed  Care | Eliminations        
Segment Reporting Information [Line Items]        
Total revenues 2 1 6 4
Specialty Services        
Segment Reporting Information [Line Items]        
Total revenues 5,407 4,727 17,497 13,553
Earnings from operations (51) (154) (34) (59)
Specialty Services | Operating Segments        
Segment Reporting Information [Line Items]        
Total revenues 2,143 1,518 7,558 4,336
Specialty Services | Eliminations        
Segment Reporting Information [Line Items]        
Total revenues $ 3,264 $ 3,209 $ 9,939 $ 9,217
XML 66 R56.htm IDEA: XBRL DOCUMENT v3.22.2.2
Contingencies (Details)
$ in Millions
Sep. 30, 2022
state
Dec. 31, 2021
claim
Jun. 30, 2021
USD ($)
Pending Litigation      
Loss Contingencies [Line Items]      
Pending claims | claim   3  
Reserve estimate | $     $ 1,250
Settled Litigation      
Loss Contingencies [Line Items]      
Number of states where no fault agreements were reached with attorney generals | state 13    
XML 67 cnc-20220930_htm.xml IDEA: XBRL DOCUMENT 0001071739 2022-01-01 2022-09-30 0001071739 2022-10-14 0001071739 2022-09-30 0001071739 2021-12-31 0001071739 us-gaap:HealthCarePremiumMember 2022-07-01 2022-09-30 0001071739 us-gaap:HealthCarePremiumMember 2021-07-01 2021-09-30 0001071739 us-gaap:HealthCarePremiumMember 2022-01-01 2022-09-30 0001071739 us-gaap:HealthCarePremiumMember 2021-01-01 2021-09-30 0001071739 us-gaap:ServiceMember 2022-07-01 2022-09-30 0001071739 us-gaap:ServiceMember 2021-07-01 2021-09-30 0001071739 us-gaap:ServiceMember 2022-01-01 2022-09-30 0001071739 us-gaap:ServiceMember 2021-01-01 2021-09-30 0001071739 2022-07-01 2022-09-30 0001071739 2021-07-01 2021-09-30 0001071739 2021-01-01 2021-09-30 0001071739 us-gaap:CommonStockMember 2022-06-30 0001071739 us-gaap:CommonStockMember 2022-03-31 0001071739 us-gaap:CommonStockMember 2021-12-31 0001071739 us-gaap:CommonStockMember 2022-09-30 0001071739 us-gaap:TreasuryStockCommonMember 2022-03-31 0001071739 us-gaap:TreasuryStockCommonMember 2022-06-30 0001071739 us-gaap:TreasuryStockCommonMember 2021-12-31 0001071739 us-gaap:TreasuryStockCommonMember 2022-09-30 0001071739 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001071739 us-gaap:RetainedEarningsMember 2021-12-31 0001071739 us-gaap:NoncontrollingInterestMember 2021-12-31 0001071739 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001071739 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-03-31 0001071739 2022-01-01 2022-03-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001071739 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001071739 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001071739 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-03-31 0001071739 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001071739 us-gaap:RetainedEarningsMember 2022-03-31 0001071739 us-gaap:NoncontrollingInterestMember 2022-03-31 0001071739 2022-03-31 0001071739 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001071739 us-gaap:NoncontrollingInterestMember 2022-04-01 2022-06-30 0001071739 2022-04-01 2022-06-30 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2022-06-30 0001071739 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001071739 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001071739 us-gaap:TreasuryStockCommonMember 2022-04-01 2022-06-30 0001071739 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001071739 us-gaap:RetainedEarningsMember 2022-06-30 0001071739 us-gaap:NoncontrollingInterestMember 2022-06-30 0001071739 2022-06-30 0001071739 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001071739 us-gaap:NoncontrollingInterestMember 2022-07-01 2022-09-30 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 2022-09-30 0001071739 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001071739 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001071739 us-gaap:TreasuryStockCommonMember 2022-07-01 2022-09-30 0001071739 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0001071739 us-gaap:RetainedEarningsMember 2022-09-30 0001071739 us-gaap:NoncontrollingInterestMember 2022-09-30 0001071739 us-gaap:CommonStockMember 2021-06-30 0001071739 us-gaap:CommonStockMember 2020-12-31 0001071739 us-gaap:CommonStockMember 2021-03-31 0001071739 us-gaap:CommonStockMember 2021-09-30 0001071739 us-gaap:TreasuryStockCommonMember 2020-12-31 0001071739 us-gaap:TreasuryStockCommonMember 2021-09-30 0001071739 us-gaap:TreasuryStockCommonMember 2021-06-30 0001071739 us-gaap:TreasuryStockCommonMember 2021-03-31 0001071739 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001071739 us-gaap:RetainedEarningsMember 2020-12-31 0001071739 us-gaap:NoncontrollingInterestMember 2020-12-31 0001071739 2020-12-31 0001071739 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001071739 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-03-31 0001071739 2021-01-01 2021-03-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0001071739 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001071739 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001071739 us-gaap:TreasuryStockCommonMember 2021-01-01 2021-03-31 0001071739 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001071739 us-gaap:RetainedEarningsMember 2021-03-31 0001071739 us-gaap:NoncontrollingInterestMember 2021-03-31 0001071739 2021-03-31 0001071739 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001071739 us-gaap:NoncontrollingInterestMember 2021-04-01 2021-06-30 0001071739 2021-04-01 2021-06-30 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2021-06-30 0001071739 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001071739 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001071739 us-gaap:TreasuryStockCommonMember 2021-04-01 2021-06-30 0001071739 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001071739 us-gaap:RetainedEarningsMember 2021-06-30 0001071739 us-gaap:NoncontrollingInterestMember 2021-06-30 0001071739 2021-06-30 0001071739 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001071739 us-gaap:NoncontrollingInterestMember 2021-07-01 2021-09-30 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0001071739 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001071739 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001071739 us-gaap:TreasuryStockCommonMember 2021-07-01 2021-09-30 0001071739 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0001071739 us-gaap:RetainedEarningsMember 2021-09-30 0001071739 us-gaap:NoncontrollingInterestMember 2021-09-30 0001071739 2021-09-30 0001071739 cnc:MagellanHealthMember 2022-01-04 2022-01-04 0001071739 cnc:MagellanHealthMember 2022-01-04 0001071739 cnc:MagellanHealthMember 2022-07-01 2022-09-30 0001071739 cnc:MagellanHealthMember 2022-01-01 2022-09-30 0001071739 cnc:MagellanHealthMember cnc:MeasurementPeriodAdjustmentToIntangibleAssetsMember 2022-07-01 2022-09-30 0001071739 cnc:MagellanHealthMember us-gaap:ContractualRightsMember 2022-01-04 0001071739 cnc:MagellanHealthMember us-gaap:ContractualRightsMember 2022-01-04 2022-01-04 0001071739 cnc:MagellanHealthMember us-gaap:InsuranceContractsAcquiredInBusinessCombinationMember 2022-01-04 0001071739 cnc:MagellanHealthMember us-gaap:InsuranceContractsAcquiredInBusinessCombinationMember 2022-01-04 2022-01-04 0001071739 cnc:MagellanHealthMember us-gaap:TradeNamesMember 2022-01-04 0001071739 cnc:MagellanHealthMember us-gaap:TradeNamesMember 2022-01-04 2022-01-04 0001071739 cnc:MagellanHealthMember us-gaap:DevelopedTechnologyRightsMember 2022-01-04 0001071739 cnc:MagellanHealthMember us-gaap:DevelopedTechnologyRightsMember 2022-01-04 2022-01-04 0001071739 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember cnc:PANTHERxRareMember 2022-07-14 2022-07-14 0001071739 us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember cnc:SpanishAndCentralEuropeanBusinessesMember 2022-09-30 0001071739 us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember cnc:SpanishAndCentralEuropeanBusinessesMember 2022-07-01 2022-09-30 0001071739 us-gaap:USTreasuryAndGovernmentMember 2022-09-30 0001071739 us-gaap:USTreasuryAndGovernmentMember 2021-12-31 0001071739 us-gaap:CorporateDebtSecuritiesMember 2022-09-30 0001071739 us-gaap:CorporateDebtSecuritiesMember 2021-12-31 0001071739 cnc:RestrictedCertificatesOfDepositMember 2022-09-30 0001071739 cnc:RestrictedCertificatesOfDepositMember 2021-12-31 0001071739 cnc:RestrictedCashEquivalentsMember 2022-09-30 0001071739 cnc:RestrictedCashEquivalentsMember 2021-12-31 0001071739 us-gaap:BankTimeDepositsMember 2022-09-30 0001071739 us-gaap:BankTimeDepositsMember 2021-12-31 0001071739 us-gaap:MunicipalBondsMember 2022-09-30 0001071739 us-gaap:MunicipalBondsMember 2021-12-31 0001071739 us-gaap:AssetBackedSecuritiesMember 2022-09-30 0001071739 us-gaap:AssetBackedSecuritiesMember 2021-12-31 0001071739 us-gaap:ResidentialMortgageBackedSecuritiesMember 2022-09-30 0001071739 us-gaap:ResidentialMortgageBackedSecuritiesMember 2021-12-31 0001071739 us-gaap:CommercialMortgageBackedSecuritiesMember 2022-09-30 0001071739 us-gaap:CommercialMortgageBackedSecuritiesMember 2021-12-31 0001071739 cnc:RatedSecuritiesMember cnc:InvestmentSecuritiesMember us-gaap:ExternalCreditRatingInvestmentGradeMember 2022-01-01 2022-09-30 0001071739 us-gaap:CommercialMortgageBackedSecuritiesMember 2022-01-01 2022-09-30 0001071739 us-gaap:InvestmentsMember 2022-09-30 0001071739 us-gaap:DepositsMember 2022-09-30 0001071739 us-gaap:InvestmentsMember 2021-12-31 0001071739 us-gaap:DepositsMember 2021-12-31 0001071739 us-gaap:FairValueInputsLevel1Member 2022-09-30 0001071739 us-gaap:FairValueInputsLevel2Member 2022-09-30 0001071739 us-gaap:FairValueInputsLevel3Member 2022-09-30 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:USTreasuryAndGovernmentMember 2022-09-30 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:USTreasuryAndGovernmentMember 2022-09-30 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:USTreasuryAndGovernmentMember 2022-09-30 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:USTreasuryAndGovernmentMember 2022-09-30 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:CorporateDebtSecuritiesMember 2022-09-30 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember 2022-09-30 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember 2022-09-30 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:CorporateDebtSecuritiesMember 2022-09-30 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:MunicipalBondsMember 2022-09-30 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:MunicipalBondsMember 2022-09-30 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:MunicipalBondsMember 2022-09-30 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:MunicipalBondsMember 2022-09-30 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:BankTimeDepositsMember 2022-09-30 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:BankTimeDepositsMember 2022-09-30 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:BankTimeDepositsMember 2022-09-30 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:BankTimeDepositsMember 2022-09-30 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:AssetBackedSecuritiesMember 2022-09-30 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:AssetBackedSecuritiesMember 2022-09-30 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember 2022-09-30 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:AssetBackedSecuritiesMember 2022-09-30 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:ResidentialMortgageBackedSecuritiesMember 2022-09-30 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:ResidentialMortgageBackedSecuritiesMember 2022-09-30 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:ResidentialMortgageBackedSecuritiesMember 2022-09-30 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2022-09-30 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:CommercialMortgageBackedSecuritiesMember 2022-09-30 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:CommercialMortgageBackedSecuritiesMember 2022-09-30 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:CommercialMortgageBackedSecuritiesMember 2022-09-30 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:CommercialMortgageBackedSecuritiesMember 2022-09-30 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel1Member 2022-09-30 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel2Member 2022-09-30 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel3Member 2022-09-30 0001071739 us-gaap:AvailableforsaleSecuritiesMember 2022-09-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:CashAndCashEquivalentsMember 2022-09-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:CashAndCashEquivalentsMember 2022-09-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:CashAndCashEquivalentsMember 2022-09-30 0001071739 us-gaap:DepositsMember us-gaap:CashAndCashEquivalentsMember 2022-09-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:CertificatesOfDepositMember 2022-09-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:CertificatesOfDepositMember 2022-09-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:CertificatesOfDepositMember 2022-09-30 0001071739 us-gaap:DepositsMember us-gaap:CertificatesOfDepositMember 2022-09-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:CorporateDebtSecuritiesMember 2022-09-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember 2022-09-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember 2022-09-30 0001071739 us-gaap:DepositsMember us-gaap:CorporateDebtSecuritiesMember 2022-09-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:MunicipalBondsMember 2022-09-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:MunicipalBondsMember 2022-09-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:MunicipalBondsMember 2022-09-30 0001071739 us-gaap:DepositsMember us-gaap:MunicipalBondsMember 2022-09-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:USTreasuryAndGovernmentMember 2022-09-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:USTreasuryAndGovernmentMember 2022-09-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:USTreasuryAndGovernmentMember 2022-09-30 0001071739 us-gaap:DepositsMember us-gaap:USTreasuryAndGovernmentMember 2022-09-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member 2022-09-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member 2022-09-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member 2022-09-30 0001071739 us-gaap:FairValueInputsLevel1Member 2021-12-31 0001071739 us-gaap:FairValueInputsLevel2Member 2021-12-31 0001071739 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:USTreasuryAndGovernmentMember 2021-12-31 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:USTreasuryAndGovernmentMember 2021-12-31 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:USTreasuryAndGovernmentMember 2021-12-31 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:USTreasuryAndGovernmentMember 2021-12-31 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:CorporateDebtSecuritiesMember 2021-12-31 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember 2021-12-31 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember 2021-12-31 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:CorporateDebtSecuritiesMember 2021-12-31 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:MunicipalBondsMember 2021-12-31 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:MunicipalBondsMember 2021-12-31 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:MunicipalBondsMember 2021-12-31 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:MunicipalBondsMember 2021-12-31 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:BankTimeDepositsMember 2021-12-31 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:BankTimeDepositsMember 2021-12-31 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:BankTimeDepositsMember 2021-12-31 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:BankTimeDepositsMember 2021-12-31 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:AssetBackedSecuritiesMember 2021-12-31 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:AssetBackedSecuritiesMember 2021-12-31 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember 2021-12-31 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:AssetBackedSecuritiesMember 2021-12-31 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:ResidentialMortgageBackedSecuritiesMember 2021-12-31 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:ResidentialMortgageBackedSecuritiesMember 2021-12-31 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:ResidentialMortgageBackedSecuritiesMember 2021-12-31 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2021-12-31 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:CommercialMortgageBackedSecuritiesMember 2021-12-31 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:CommercialMortgageBackedSecuritiesMember 2021-12-31 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:CommercialMortgageBackedSecuritiesMember 2021-12-31 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:CommercialMortgageBackedSecuritiesMember 2021-12-31 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001071739 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001071739 us-gaap:AvailableforsaleSecuritiesMember 2021-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:CashAndCashEquivalentsMember 2021-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:CashAndCashEquivalentsMember 2021-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:CashAndCashEquivalentsMember 2021-12-31 0001071739 us-gaap:DepositsMember us-gaap:CashAndCashEquivalentsMember 2021-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:CertificatesOfDepositMember 2021-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:CertificatesOfDepositMember 2021-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:CertificatesOfDepositMember 2021-12-31 0001071739 us-gaap:DepositsMember us-gaap:CertificatesOfDepositMember 2021-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:CorporateDebtSecuritiesMember 2021-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember 2021-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember 2021-12-31 0001071739 us-gaap:DepositsMember us-gaap:CorporateDebtSecuritiesMember 2021-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:MunicipalBondsMember 2021-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:MunicipalBondsMember 2021-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:MunicipalBondsMember 2021-12-31 0001071739 us-gaap:DepositsMember us-gaap:MunicipalBondsMember 2021-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:USTreasuryAndGovernmentMember 2021-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:USTreasuryAndGovernmentMember 2021-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:USTreasuryAndGovernmentMember 2021-12-31 0001071739 us-gaap:DepositsMember us-gaap:USTreasuryAndGovernmentMember 2021-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001071739 us-gaap:OtherNoncurrentAssetsMember us-gaap:FairValueInputsLevel1Member us-gaap:InterestRateSwapMember 2021-12-31 0001071739 us-gaap:OtherNoncurrentAssetsMember us-gaap:FairValueInputsLevel2Member us-gaap:InterestRateSwapMember 2021-12-31 0001071739 us-gaap:OtherNoncurrentAssetsMember us-gaap:FairValueInputsLevel3Member us-gaap:InterestRateSwapMember 2021-12-31 0001071739 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateSwapMember 2021-12-31 0001071739 cnc:ComputerSoftwareMember 2022-09-30 0001071739 cnc:ComputerSoftwareMember 2021-12-31 0001071739 us-gaap:BuildingMember 2022-09-30 0001071739 us-gaap:BuildingMember 2021-12-31 0001071739 cnc:FurnitureAndOfficeEquipmentMember 2022-09-30 0001071739 cnc:FurnitureAndOfficeEquipmentMember 2021-12-31 0001071739 us-gaap:LeaseholdImprovementsMember 2022-09-30 0001071739 us-gaap:LeaseholdImprovementsMember 2021-12-31 0001071739 us-gaap:ComputerEquipmentMember 2022-09-30 0001071739 us-gaap:ComputerEquipmentMember 2021-12-31 0001071739 us-gaap:LandMember 2022-09-30 0001071739 us-gaap:LandMember 2021-12-31 0001071739 cnc:RealEstateOwnedAndRelatedFixedAssetsMember 2022-07-01 2022-09-30 0001071739 cnc:RealEstateOwnedAndRelatedFixedAssetsMember 2022-01-01 2022-09-30 0001071739 cnc:FixedAssetsLeasedRealEstateMember 2022-07-01 2022-09-30 0001071739 cnc:FixedAssetsLeasedRealEstateMember 2022-01-01 2022-09-30 0001071739 2022-01-01 2022-06-30 0001071739 cnc:FourPointTwoFivePercentSeniorNotesDueInTwentyTwentySevenMember us-gaap:SeniorNotesMember 2022-09-30 0001071739 cnc:FourPointTwoFivePercentSeniorNotesDueInTwentyTwentySevenMember us-gaap:SeniorNotesMember 2021-12-31 0001071739 cnc:A2300Million245SeniorNotsDueJuly2028Member us-gaap:SeniorNotesMember 2022-09-30 0001071739 cnc:A2300Million245SeniorNotsDueJuly2028Member us-gaap:SeniorNotesMember 2021-12-31 0001071739 cnc:A3500Million4625SeniorNotesDueDecember2029Member us-gaap:SeniorNotesMember 2022-09-30 0001071739 cnc:A3500Million4625SeniorNotesDueDecember2029Member us-gaap:SeniorNotesMember 2021-12-31 0001071739 cnc:A2200Million375SeniorNotesDueFebruary2030Member us-gaap:SeniorNotesMember 2022-09-30 0001071739 cnc:A2200Million375SeniorNotesDueFebruary2030Member us-gaap:SeniorNotesMember 2021-12-31 0001071739 cnc:A2200Million300SeniorNotesDueOctober2030Member us-gaap:SeniorNotesMember 2022-09-30 0001071739 cnc:A2200Million300SeniorNotesDueOctober2030Member us-gaap:SeniorNotesMember 2021-12-31 0001071739 cnc:A2200Million250SeniorNotesDueMarch2031Member us-gaap:SeniorNotesMember 2022-09-30 0001071739 cnc:A2200Million250SeniorNotesDueMarch2031Member us-gaap:SeniorNotesMember 2021-12-31 0001071739 cnc:A1300Million2625SeniorNotesDueAugust2031Member us-gaap:SeniorNotesMember 2022-09-30 0001071739 cnc:A1300Million2625SeniorNotesDueAugust2031Member us-gaap:SeniorNotesMember 2021-12-31 0001071739 cnc:TermLoanCreditAgreementMember 2022-09-30 0001071739 cnc:TermLoanCreditAgreementMember 2021-12-31 0001071739 us-gaap:RevolvingCreditFacilityMember 2022-09-30 0001071739 us-gaap:RevolvingCreditFacilityMember 2021-12-31 0001071739 cnc:DebtTotalMember us-gaap:CreditAvailabilityConcentrationRiskMember us-gaap:LondonInterbankOfferedRateLIBORMember 2022-01-01 2022-09-30 0001071739 cnc:MagellanHealthMember 2022-01-31 0001071739 us-gaap:SeniorNotesMember 2022-07-01 2022-09-30 0001071739 us-gaap:CurrencySwapMember 2021-07-31 0001071739 2021-07-01 2021-07-31 0001071739 us-gaap:CurrencySwapMember 2022-03-31 2022-03-31 0001071739 us-gaap:ForeignLineOfCreditMember 2022-05-31 0001071739 2022-05-01 2022-05-31 0001071739 us-gaap:ForeignLineOfCreditMember 2022-01-01 2022-09-30 0001071739 us-gaap:ConstructionLoanPayableMember 2017-10-31 0001071739 srt:MaximumMember us-gaap:ConstructionLoanPayableMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-10-01 2017-10-31 0001071739 srt:MinimumMember us-gaap:ConstructionLoanPayableMember us-gaap:LondonInterbankOfferedRateLIBORMember 2021-07-01 2021-07-31 0001071739 us-gaap:ConstructionLoanPayableMember 2022-04-01 2022-04-30 0001071739 us-gaap:ConstructionLoanPayableMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2022-04-01 2022-04-30 0001071739 us-gaap:SeniorNotesMember 2022-09-30 0001071739 us-gaap:SeniorNotesMember us-gaap:SubsequentEventMember 2022-10-25 0001071739 us-gaap:SeniorNotesMember us-gaap:SubsequentEventMember 2022-10-01 2022-10-25 0001071739 2022-06-01 2022-06-30 0001071739 cnc:AcceleratedShareRepurchaseAgreementMember us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001071739 cnc:AcceleratedShareRepurchaseAgreementMember us-gaap:CommonStockMember 2022-07-01 2022-07-31 0001071739 cnc:AcceleratedShareRepurchaseAgreementMember us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2022-10-01 2022-10-25 0001071739 cnc:AcceleratedShareRepurchaseAgreementMember us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2022-07-01 2022-10-25 0001071739 cnc:ShareRepurchaseAgreementMember us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001071739 us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001071739 cnc:ShareRepurchaseAgreementMember 2022-01-01 2022-09-30 0001071739 us-gaap:SubsequentEventMember 2022-10-01 2022-10-25 0001071739 us-gaap:OperatingSegmentsMember cnc:ManagedCareMember 2022-07-01 2022-09-30 0001071739 us-gaap:OperatingSegmentsMember cnc:SpecialtyServicesMember 2022-07-01 2022-09-30 0001071739 us-gaap:IntersegmentEliminationMember cnc:ManagedCareMember 2022-07-01 2022-09-30 0001071739 us-gaap:IntersegmentEliminationMember cnc:SpecialtyServicesMember 2022-07-01 2022-09-30 0001071739 us-gaap:IntersegmentEliminationMember 2022-07-01 2022-09-30 0001071739 cnc:ManagedCareMember 2022-07-01 2022-09-30 0001071739 cnc:SpecialtyServicesMember 2022-07-01 2022-09-30 0001071739 us-gaap:OperatingSegmentsMember cnc:ManagedCareMember 2021-07-01 2021-09-30 0001071739 us-gaap:OperatingSegmentsMember cnc:SpecialtyServicesMember 2021-07-01 2021-09-30 0001071739 us-gaap:IntersegmentEliminationMember cnc:ManagedCareMember 2021-07-01 2021-09-30 0001071739 us-gaap:IntersegmentEliminationMember cnc:SpecialtyServicesMember 2021-07-01 2021-09-30 0001071739 us-gaap:IntersegmentEliminationMember 2021-07-01 2021-09-30 0001071739 cnc:ManagedCareMember 2021-07-01 2021-09-30 0001071739 cnc:SpecialtyServicesMember 2021-07-01 2021-09-30 0001071739 us-gaap:OperatingSegmentsMember cnc:ManagedCareMember 2022-01-01 2022-09-30 0001071739 us-gaap:OperatingSegmentsMember cnc:SpecialtyServicesMember 2022-01-01 2022-09-30 0001071739 us-gaap:IntersegmentEliminationMember cnc:ManagedCareMember 2022-01-01 2022-09-30 0001071739 us-gaap:IntersegmentEliminationMember cnc:SpecialtyServicesMember 2022-01-01 2022-09-30 0001071739 us-gaap:IntersegmentEliminationMember 2022-01-01 2022-09-30 0001071739 cnc:ManagedCareMember 2022-01-01 2022-09-30 0001071739 cnc:SpecialtyServicesMember 2022-01-01 2022-09-30 0001071739 us-gaap:OperatingSegmentsMember cnc:ManagedCareMember 2021-01-01 2021-09-30 0001071739 us-gaap:OperatingSegmentsMember cnc:SpecialtyServicesMember 2021-01-01 2021-09-30 0001071739 us-gaap:IntersegmentEliminationMember cnc:ManagedCareMember 2021-01-01 2021-09-30 0001071739 us-gaap:IntersegmentEliminationMember cnc:SpecialtyServicesMember 2021-01-01 2021-09-30 0001071739 us-gaap:IntersegmentEliminationMember 2021-01-01 2021-09-30 0001071739 cnc:ManagedCareMember 2021-01-01 2021-09-30 0001071739 cnc:SpecialtyServicesMember 2021-01-01 2021-09-30 0001071739 us-gaap:PendingLitigationMember 2021-12-31 0001071739 us-gaap:SettledLitigationMember 2022-09-30 0001071739 us-gaap:PendingLitigationMember 2021-06-30 shares iso4217:USD iso4217:USD shares pure cnc:position iso4217:GBP cnc:segment cnc:claim cnc:state 0001071739 --12-31 2022 Q3 false http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent http://fasb.org/us-gaap/2022#AccountsPayableAndAccruedLiabilitiesCurrent http://fasb.org/us-gaap/2022#AccountsPayableAndAccruedLiabilitiesCurrent http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent 10-Q true 2022-09-30 false 001-31826 CENTENE CORPORATION DE 42-1406317 7700 Forsyth Boulevard St. Louis, MO 63105 314 725-4477 Common Stock $0.001 Par Value CNC NYSE Yes Yes Large Accelerated Filer false false false 566259693 14987000000 13118000000 13770000000 12238000000 2191000000 1539000000 2327000000 1602000000 33275000000 28497000000 14053000000 14043000000 1205000000 1068000000 2479000000 3391000000 20040000000 19771000000 7523000000 7824000000 2597000000 3781000000 81172000000 78375000000 16465000000 14243000000 9995000000 8493000000 2205000000 2328000000 2416000000 434000000 249000000 267000000 31330000000 25765000000 18084000000 18571000000 480000000 1407000000 5678000000 5610000000 55572000000 51353000000 66000000 82000000 0.001 0.001 10000000 10000000 0 0 0 0 0 0 0.001 0.001 800000000 800000000 606931000 570091000 602704000 582479000 1000000 1000000 19774000000 19672000000 -1394000000 77000000 9554000000 8139000000 36840000 20225000 2557000000 1094000000 25378000000 26795000000 156000000 145000000 25534000000 26940000000 81172000000 78375000000 31848000000 28876000000 95247000000 83436000000 1878000000 1638000000 6679000000 4054000000 33726000000 30514000000 101926000000 87490000000 2139000000 1892000000 7060000000 5924000000 35865000000 32406000000 108986000000 93414000000 28111000000 25430000000 83261000000 73210000000 1571000000 1355000000 5658000000 3510000000 2846000000 2537000000 8391000000 6910000000 150000000 147000000 470000000 414000000 211000000 198000000 609000000 581000000 2211000000 1965000000 7258000000 6129000000 289000000 229000000 1739000000 229000000 0 0 0 1250000000 35389000000 31861000000 107386000000 92233000000 476000000 545000000 1600000000 1181000000 692000000 424000000 786000000 566000000 10000000 -79000000 26000000 -125000000 169000000 170000000 491000000 503000000 1009000000 720000000 1921000000 1119000000 269000000 139000000 500000000 376000000 740000000 581000000 1421000000 743000000 2000000 -3000000 6000000 -5000000 738000000 584000000 1415000000 748000000 1.29 1.00 2.44 1.28 1.27 0.99 2.41 1.27 573961000 583244000 580277000 582636000 580607000 590702000 587084000 590154000 740000000 581000000 1421000000 743000000 -3000000 -1000000 -12000000 16000000 -383000000 -47000000 -1267000000 -125000000 -101000000 -17000000 -216000000 -20000000 -481000000 -63000000 -1471000000 -161000000 259000000 518000000 -50000000 582000000 2000000 -3000000 6000000 -5000000 257000000 521000000 -56000000 587000000 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 602704000 1000000 19672000000 77000000 8139000000 20225000 -1094000000 145000000 26940000000 849000000 -1000000 848000000 -171000000 -562000000 -562000000 3221000 28000000 28000000 60000000 60000000 846000 71000000 71000000 70000000 70000000 605925000 1000000 19830000000 -485000000 8988000000 21071000 -1165000000 144000000 27313000000 -172000000 -3000000 -175000000 -106000000 -428000000 -428000000 519000 10000000 10000000 4249000 349000000 349000000 59000000 59000000 606444000 1000000 19899000000 -913000000 8816000000 25320000 -1514000000 141000000 26430000000 738000000 -2000000 736000000 -120000000 -481000000 -481000000 487000 24000000 24000000 200000000 11520000 1043000000 1243000000 51000000 51000000 17000000 17000000 606931000 1000000 19774000000 -1394000000 9554000000 36840000 -2557000000 156000000 25534000000 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 598249000 1000000 19459000000 337000000 6792000000 16770000 -816000000 112000000 25885000000 699000000 -5000000 694000000 -49000000 -161000000 -161000000 1675000 9000000 9000000 316000 19000000 156000 10000000 29000000 51000000 51000000 9000000 9000000 599608000 1000000 19500000000 176000000 7491000000 16926000 -826000000 116000000 26458000000 -535000000 -3000000 -538000000 19000000 63000000 63000000 390000 9000000 9000000 10000 60000 4000000 4000000 36000000 36000000 21000000 21000000 599988000 1000000 19545000000 239000000 6956000000 16986000 -830000000 134000000 26045000000 584000000 -8000000 576000000 -15000000 -63000000 -63000000 720000 9000000 9000000 222000 15000000 15000000 40000000 40000000 5000000 5000000 10000000 10000000 3000000 3000000 600708000 1000000 19594000000 176000000 7540000000 17208000 -845000000 124000000 26590000000 1421000000 743000000 1178000000 1098000000 180000000 127000000 1739000000 229000000 26000000 -125000000 2000000 309000000 -682000000 -143000000 503000000 -62000000 -164000000 6000000 1274000000 1723000000 -152000000 124000000 1976000000 1661000000 1964000000 -169000000 686000000 993000000 863000000 964000000 1000000 2000000 7837000000 3530000000 771000000 662000000 5118000000 5253000000 2842000000 4069000000 1457000000 534000000 1362000000 -62000000 -3142000000 -2442000000 357000000 9247000000 1202000000 7411000000 1663000000 49000000 14000000 157000000 0 72000000 57000000 39000000 -2465000000 1597000000 -37000000 -8000000 2193000000 2677000000 192000000 0 13214000000 10957000000 15215000000 13634000000 462000000 479000000 448000000 477000000 14987000000 13423000000 228000000 211000000 15215000000 13634000000 Organization and Operations <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim financial statements have been prepared under the presumption that users of the interim financial information have either read or have access to the audited financial statements included in the Form 10-K for the fiscal year ended December 31, 2021. The unaudited interim financial statements herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, footnote disclosures that would substantially duplicate the disclosures contained in the December 31, 2021 audited financial statements have been omitted from these interim financial statements, where appropriate. In the opinion of management, these financial statements reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for a fair presentation of the results of the interim periods presented.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain 2021 amounts in the consolidated financial statements and notes to the consolidated financial statements have been reclassified to conform to the 2022 presentation. Beginning in 2022, the Company has included a separate line item for depreciation expense on the Consolidated Statement of Operations, which was previously included in selling, general and administrative (SG&amp;A) expenses. Prior period SG&amp;A expense ratios have also been conformed to the current presentation. These reclassifications have no effect on net earnings or stockholders’ equity as previously reported.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2022, the Company acquired all of the issued and outstanding shares of Magellan Health, Inc. (Magellan) (the Magellan Acquisition). The acquisition was accounted for as a business combination. See Note 2. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further details. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Guidance Not Yet Adopted</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined that there are no recently issued accounting pronouncements that will have a material impact on its consolidated financial position, results of operations, or cash flows.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim financial statements have been prepared under the presumption that users of the interim financial information have either read or have access to the audited financial statements included in the Form 10-K for the fiscal year ended December 31, 2021. The unaudited interim financial statements herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, footnote disclosures that would substantially duplicate the disclosures contained in the December 31, 2021 audited financial statements have been omitted from these interim financial statements, where appropriate. In the opinion of management, these financial statements reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for a fair presentation of the results of the interim periods presented.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain 2021 amounts in the consolidated financial statements and notes to the consolidated financial statements have been reclassified to conform to the 2022 presentation. Beginning in 2022, the Company has included a separate line item for depreciation expense on the Consolidated Statement of Operations, which was previously included in selling, general and administrative (SG&amp;A) expenses. Prior period SG&amp;A expense ratios have also been conformed to the current presentation. These reclassifications have no effect on net earnings or stockholders’ equity as previously reported.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2022, the Company acquired all of the issued and outstanding shares of Magellan Health, Inc. (Magellan) (the Magellan Acquisition). The acquisition was accounted for as a business combination. See Note 2. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures</span> for further details. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Guidance Not Yet Adopted</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined that there are no recently issued accounting pronouncements that will have a material impact on its consolidated financial position, results of operations, or cash flows.</span></div> Acquisitions and Divestitures<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Magellan Acquisition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2022, the Company acquired all of the issued and outstanding shares of Magellan. Total consideration for the acquisition was $2,491 million, consisting of $2,431 million in cash and $60 million related to the fair value of replacement equity awards associated with pre-combination service. The purchase price has been adjusted to reflect the net effective settlement of preexisting relationships between the Company and Magellan of $70 million. The Company recognized $8 million and $100 million of acquisition related expenses related to Magellan for the three and nine months ended September 30, 2022, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Magellan Acquisition was accounted for as a business combination using the acquisition method of accounting that requires assets acquired and liabilities assumed to be recognized at fair value as of the acquisition date. The significant areas of the assessment of fair value that remain preliminary include identifiable intangible assets and goodwill, premium and related receivables, medical claims liability, and income taxes, and accordingly, the Company has recorded provisional amounts which are subject to adjustment. Measurement period adjustments will be recorded in the period in which they are determined, as if they had been completed at the acquisition date.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's preliminary allocation of the fair value of assets acquired and liabilities assumed as of the acquisition date of January 4, 2022 is as follows ($ in millions):</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:59.941%"><tr><td style="width:1.0%"/><td style="width:74.753%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.507%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.340%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets acquired and liabilities assumed</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium and related receivables</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">791 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted deposits</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, software and equipment</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">751 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,068 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical claims liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return of premium payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (b)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mezzanine equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable net assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,494 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(d) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired and liabilities assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,491 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has made the following preliminary fair value adjustments based on information reviewed through September 30, 2022. Significant fair value adjustments are noted as follows:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-27pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The identifiable intangible assets acquired are to be measured at fair value as of the completion of the acquisition. The fair value of intangible assets will be determined primarily using variations of the income approach, which is based on the present value of the future after-tax cash flows attributable to each identified intangible asset. Other valuation methods, including the market approach and cost approach, will be considered in estimating the fair value. The identifiable intangible assets include purchased contract rights, trade names, provider contracts, and developed technologies. The Company has estimated the fair value of intangible assets to be $751 million with a weighted average life of 13 years. The Company adjusted its estimate of the identifiable intangible assets during the third quarter, resulting in additional amortization of $15 million.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values and weighted average useful lives for identifiable intangible assets acquired are as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.385%"><tr><td style="width:1.0%"/><td style="width:45.124%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.273%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.209%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.273%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.421%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Useful Life (in years)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased contract rights</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technologies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">751 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Debt is required to be measured at fair value under the acquisition method of accounting. The fair value of Magellan's Senior Notes and Credit Agreement assumed in the acquisition was $535 million. In January 2022, the Company paid off Magellan's debt acquired in the transaction using Magellan's cash on hand.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-27pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The preliminary deferred tax liabilities are presented net of $116 million of deferred tax assets.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-27pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(d) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is estimated at $997 million and primarily relates to synergies expected from the acquisition and the assembled workforce of Magellan. The assignment of goodwill to the Company’s respective segments has not been completed at this time, but the majority of goodwill is expected to be allocated to the Specialty segment. The majority of the goodwill is not deductible for income tax purposes.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-27pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PANTHERx Rare Divestiture</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-27pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 14, 2022, the Company completed the previously announced sale of PANTHERx Rare (PANTHERx) for $1,373 million. The Company recognized a gain of $490 million, or $382 million after-tax, which is included in investment and other income on the Consolidated Statements of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Spanish and Central European Divestiture</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 25, 2022, as part of the Company’s previously announced review of strategic alternatives for its international portfolio, the Company announced it has signed a definitive agreement to sell its ownership stakes in its Spanish and Central European businesses, including Ribera Salud, Torrejón Salud, and Pro Diagnostics Group. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, the assets and liabilities of the Spanish and Central European businesses were considered held for sale resulting in $666 million of assets held for sale in Other Current Assets and $582 million of liabilities held for sale in Accounts Payable and Accrued Expenses on the Consolidated Balance Sheet. The majority of the held for sale assets were previously reported as cash and cash equivalents, premium and trade receivables, and property, software and equipment. During the third quarter, the Company recorded an impairment charge primarily related to intangible assets and goodwill associated with the pending divestiture of $165 million, or $138 million after-tax.</span></div> 2491000000 2431000000 60000000 70000000 8000000 100000000 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's preliminary allocation of the fair value of assets acquired and liabilities assumed as of the acquisition date of January 4, 2022 is as follows ($ in millions):</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:59.941%"><tr><td style="width:1.0%"/><td style="width:74.753%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.507%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.340%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets acquired and liabilities assumed</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium and related receivables</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">791 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted deposits</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, software and equipment</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">751 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,068 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical claims liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return of premium payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (b)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mezzanine equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable net assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,494 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(d) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired and liabilities assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,491 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 998000000 791000000 144000000 194000000 43000000 7000000 90000000 751000000 50000000 3068000000 247000000 495000000 53000000 8000000 5000000 542000000 123000000 69000000 1542000000 32000000 1494000000 997000000 2491000000 751000000 P13Y 15000000 <div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values and weighted average useful lives for identifiable intangible assets acquired are as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.385%"><tr><td style="width:1.0%"/><td style="width:45.124%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.273%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.209%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.273%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.421%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Useful Life (in years)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased contract rights</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technologies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">751 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div> 470000000 P13Y 100000000 P15Y 80000000 P17Y 101000000 P5Y 751000000 P13Y 535000000 116000000 997000000 1373000000 490000000 382000000 666000000 582000000 165000000 138000000 Short-term and Long-term Investments, Restricted Deposits<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term and long-term investments and restricted deposits by investment type consist of the following ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:22.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.381%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government </span><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">corporations and agencies</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">666 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">648 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">642 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">640 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,648 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(897)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,752 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,145 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,200 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted certificates of deposit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash equivalents</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">228 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">228 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">275 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">275 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,980 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(320)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,660 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,398 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,468 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,335 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,267 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,308 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,308 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,154 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(135)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,019 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">850 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">853 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">970 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">874 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">870 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">873 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">326 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">326 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private equity investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">551 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">551 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">587 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">587 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life insurance contracts</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">186 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">186 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,982 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,534)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,449 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,521 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,650 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="48" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:10.8pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investments in equity securities as of December 31, 2021 primarily consisted of exchange traded funds in fixed income securities.</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's investments are debt securities classified as available-for-sale with the exception of equity securities, certain private equity investments and life insurance contracts. The Company's investment policies are designed to provide liquidity, preserve capital and maximize total return on invested assets with the focus on high credit quality securities. The Company limits the size of investment in any single issuer other than U.S. treasury securities and obligations of U.S. government corporations and agencies. As of September 30, 2022, 98% of the Company's investments in rated securities carry an investment grade rating by nationally recognized statistical rating organizations. At September 30, 2022, the Company held certificates of deposit, equity securities, private equity investments, and life insurance contracts, which did not carry a credit rating. Accrued interest income on available-for-sale debt securities was $119 million and $96 million at September 30, 2022 and December 31, 2021, respectively, and is included in other current assets on the Consolidated Balance Sheets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's residential mortgage-backed securities are primarily issued by the Federal National Mortgage Association, Government National Mortgage Association, or Federal Home Loan Mortgage Corporation, which carry implicit or explicit guarantees of the U.S. government. The Company's commercial mortgage-backed securities are primarily senior tranches with a weighted average rating of AAA and a weighted average duration of 4 years at September 30, 2022.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of available-for-sale debt securities with gross unrealized losses by investment type and length of time that individual securities have been in a continuous unrealized loss position were as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.514%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12 Months or More</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12 Months or More</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(562)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,737 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,975 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,209 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(228)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,998 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,173 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,094 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,006)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,805 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(528)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,256 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,602 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, the gross unrealized losses were generated from 6,688 positions out of a total of 6,847 positions. The change in fair value of available-for-sale debt securities is primarily a result of movement in interest rates subsequent to the purchase of the security.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each security in an unrealized loss position, the Company assesses whether it intends to sell the security or if it is more likely than not the Company will be required to sell the security before recovery of the amortized cost basis for reasons such as liquidity, contractual, or regulatory purposes. If the security meets this criterion, the decline in fair value is recorded in earnings. The Company does not intend to sell these securities prior to maturity and it is not likely that the Company will be required to sell these securities prior to maturity; therefore, the Company did not record an impairment for these securities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company monitors available-for-sale debt securities for credit losses. Certain investments have experienced a decline in fair value due to changes in credit quality, market interest rates and/or general economic conditions. The Company recognizes an allowance when evidence demonstrates that the decline in fair value is credit related. Evidence of a credit related loss may include rating agency actions, adverse conditions specifically related to the security, or failure of the issuer of the security to make scheduled payments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contractual maturities of short-term and long-term debt securities and restricted deposits are as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.514%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Deposits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Deposits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year or less</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,053 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,029 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,390 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,396 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,296 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,752 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,212 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,294 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,077 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,496 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,647 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,681 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,459 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,160 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,028 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,034 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,980 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,522 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,280 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,205 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,350 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,483 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,072 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,068 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual maturities may differ from contractual maturities due to call or prepayment options. Equity securities, private equity investments and life insurance contracts are excluded from the table above because they do not have a contractual maturity. The Company has an option to redeem at amortized cost substantially all of the securities included in the greater than ten years category listed above.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term and long-term investments and restricted deposits by investment type consist of the following ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:22.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.381%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government </span><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">corporations and agencies</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">666 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">648 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">642 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">640 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,648 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(897)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,752 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,145 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,200 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted certificates of deposit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash equivalents</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">228 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">228 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">275 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">275 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,980 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(320)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,660 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,398 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,468 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,335 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,267 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,308 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,308 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,154 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(135)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,019 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">850 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">853 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">970 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">874 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">870 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">873 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">326 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">326 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private equity investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">551 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">551 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">587 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">587 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life insurance contracts</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">186 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">186 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,982 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,534)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,449 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,521 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,650 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="48" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:10.8pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investments in equity securities as of December 31, 2021 primarily consisted of exchange traded funds in fixed income securities.</span></div></td></tr></table></div> 666000000 0 18000000 648000000 642000000 0 2000000 640000000 9648000000 1000000 897000000 8752000000 8145000000 130000000 75000000 8200000000 4000000 0 0 4000000 4000000 0 0 4000000 228000000 0 0 228000000 96000000 0 0 96000000 275000000 0 0 275000000 109000000 0 0 109000000 3980000000 0 320000000 3660000000 3398000000 85000000 15000000 3468000000 1335000000 0 68000000 1267000000 1308000000 5000000 5000000 1308000000 1154000000 0 135000000 1019000000 850000000 10000000 7000000 853000000 970000000 0 96000000 874000000 870000000 13000000 10000000 873000000 6000000 6000000 326000000 326000000 551000000 551000000 587000000 587000000 165000000 165000000 186000000 186000000 18982000000 1000000 1534000000 17449000000 16521000000 243000000 114000000 16650000000 0.98 119000000 96000000 P4Y <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of available-for-sale debt securities with gross unrealized losses by investment type and length of time that individual securities have been in a continuous unrealized loss position were as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.514%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12 Months or More</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12 Months or More</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(562)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,737 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,975 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,209 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(228)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,998 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,173 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,094 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,006)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,805 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(528)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,256 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,602 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 14000000 556000000 4000000 67000000 2000000 598000000 0 3000000 562000000 6737000000 335000000 1975000000 66000000 4209000000 9000000 209000000 228000000 2998000000 92000000 586000000 14000000 1173000000 1000000 39000000 57000000 1094000000 11000000 166000000 5000000 770000000 0 33000000 86000000 770000000 49000000 244000000 7000000 472000000 0 15000000 59000000 650000000 37000000 218000000 8000000 380000000 2000000 32000000 1006000000 12805000000 528000000 3256000000 102000000 7602000000 12000000 331000000 6688 6847 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contractual maturities of short-term and long-term debt securities and restricted deposits are as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.514%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Deposits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Deposits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year or less</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,053 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,029 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,390 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,396 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,296 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,752 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,212 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,294 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,077 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,496 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,647 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,681 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,459 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,160 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,028 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,034 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,980 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,522 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,280 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,205 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,350 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,483 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,072 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,068 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div> 2053000000 2029000000 521000000 518000000 1390000000 1396000000 368000000 368000000 7296000000 6752000000 518000000 482000000 6212000000 6294000000 460000000 457000000 4077000000 3496000000 241000000 205000000 3647000000 3681000000 244000000 243000000 95000000 85000000 0 0 73000000 78000000 0 0 3459000000 3160000000 0 0 3028000000 3034000000 0 0 16980000000 15522000000 1280000000 1205000000 14350000000 14483000000 1072000000 1068000000 Fair Value Measurements <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities recorded at fair value in the Consolidated Balance Sheets are categorized based upon observable or unobservable inputs used to estimate fair value. Level inputs are as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:86.016%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level Input:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Input Definition:</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inputs other than quoted prices included in Level I that are observable for the asset or liability through corroboration with market data at the measurement date.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level III</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unobservable inputs that reflect management's best estimate of what market participants would use in pricing the asset or liability at the measurement date.</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes fair value measurements by level at September 30, 2022, for assets and liabilities measured at fair value on a recurring basis ($ in millions): </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:53.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level III</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,987 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,987 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,721 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,721 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,053 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,053 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,267 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,267 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">874 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">874 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,211 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,528 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted deposits:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restricted deposits</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,205 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,867 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,853 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,720 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes fair value measurements by level at December 31, 2021, for assets and liabilities measured at fair value on a recurring basis ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:53.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level III</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,118 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,118 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,170 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,170 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,999 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,999 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,308 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,308 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,314 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,809 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted deposits:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restricted deposits</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,068 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,178 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,832 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,010 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes matrix-pricing services to estimate fair value for securities which are not actively traded on the measurement date. The Company designates these securities as Level II fair value measurements. In addition, the aggregate carrying amount of the Company's private equity investments and life insurance contracts, which approximates fair value, was $716 million and $773 million as of September 30, 2022 and December 31, 2021, respectively.</span></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities recorded at fair value in the Consolidated Balance Sheets are categorized based upon observable or unobservable inputs used to estimate fair value. Level inputs are as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:86.016%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level Input:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Input Definition:</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inputs other than quoted prices included in Level I that are observable for the asset or liability through corroboration with market data at the measurement date.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level III</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unobservable inputs that reflect management's best estimate of what market participants would use in pricing the asset or liability at the measurement date.</span></td></tr></table></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes fair value measurements by level at September 30, 2022, for assets and liabilities measured at fair value on a recurring basis ($ in millions): </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:53.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level III</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,987 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,987 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,721 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,721 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,053 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,053 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,267 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,267 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">874 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">874 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,211 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,528 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted deposits:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restricted deposits</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,205 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,867 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,853 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,720 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes fair value measurements by level at December 31, 2021, for assets and liabilities measured at fair value on a recurring basis ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:53.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level III</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,118 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,118 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,170 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,170 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,999 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,999 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,308 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,308 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,314 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,809 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted deposits:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restricted deposits</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,068 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,178 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,832 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,010 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 14987000000 0 0 14987000000 313000000 0 0 313000000 0 8721000000 0 8721000000 0 3053000000 0 3053000000 0 275000000 0 275000000 0 1267000000 0 1267000000 0 1019000000 0 1019000000 0 874000000 0 874000000 4000000 2000000 0 6000000 317000000 15211000000 0 15528000000 228000000 0 0 228000000 0 4000000 0 4000000 0 31000000 0 31000000 0 607000000 0 607000000 335000000 0 0 335000000 563000000 642000000 0 1205000000 15867000000 15853000000 0 31720000000 13118000000 0 0 13118000000 171000000 0 0 171000000 0 8170000000 0 8170000000 0 2999000000 0 2999000000 0 109000000 0 109000000 0 1308000000 0 1308000000 0 853000000 0 853000000 0 873000000 0 873000000 324000000 2000000 0 326000000 495000000 14314000000 0 14809000000 96000000 0 0 96000000 0 4000000 0 4000000 0 30000000 0 30000000 0 469000000 0 469000000 469000000 0 0 469000000 565000000 503000000 0 1068000000 0 15000000 0 15000000 14178000000 14832000000 0 29010000000 716000000 773000000 Property, Software and Equipment<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, software and equipment consist of the following ($ in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.906%"><tr><td style="width:1.0%"/><td style="width:41.735%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.015%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.019%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.731%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer software</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,211 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,825 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,116 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and office equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">732 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, software and equipment, at cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,539 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,291 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,060)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,900)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, software and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,479 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,391 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2022, in connection with the adoption of a more modern, flexible work environment, the Company undertook a real estate optimization initiative to evaluate future real estate needs and downsize its real estate footprint for owned and leased properties. As a result of this evaluation, during the second quarter of 2022, the Company substantially changed the use or abandoned various properties and assessed for impairment. The Company engaged a third-party real estate specialist to determine the fair value of its owned properties. The valuation primarily considered comparable properties in each market as well as future cash flows. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the optimization, the Company has recognized impairment charges related to owned real estate of $57 million and $763 million for the three and nine months ended September 30, 2022, respectively. The Company also recognized impairment on fixed assets related to leased real estate of $14 million and $237 million for the three and nine months ended September 30, 2022, respectively. These impairments are primarily related to the Managed Care segment. The remainder of the $1,574 million charge relates to right-of-use (ROU) asset impairments, which is included within Other Long-term assets on the balance sheet, refer to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 9.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Leases.</span></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, software and equipment consist of the following ($ in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.906%"><tr><td style="width:1.0%"/><td style="width:41.735%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.015%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.019%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.731%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer software</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,211 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,825 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,116 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and office equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">732 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, software and equipment, at cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,539 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,291 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,060)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,900)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, software and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,479 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,391 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div> 2211000000 1825000000 641000000 1116000000 407000000 753000000 454000000 732000000 648000000 617000000 178000000 248000000 4539000000 5291000000 2060000000 1900000000 2479000000 3391000000 57000000 763000000 14000000 237000000 1574000000 Medical Claims Liability<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the change in medical claims liability ($ in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.496%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, January 1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,243 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,438 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, January 1, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,220 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,415 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions and divestitures </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,457 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,736 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,196)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,526)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,261 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,210 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,305 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,205 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,968 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,344 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,273 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,549 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, September 30, net</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,457 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,076 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: Reinsurance recoverable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,465 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,099 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reinsurance recoverables related to medical claims are included in premium and trade receivables. Changes in estimates of incurred claims for prior years are primarily attributable to reserving under moderately adverse conditions. The impact from COVID-19 on healthcare utilization and medical claims submission patterns continues to provide increased estimation uncertainty on the incurred but not reported liability. Additionally, as a result of minimum health benefits ratio (HBR) and other return of premium programs, the Company recorded $121 million and $438 million as a reduction to premium revenue in the nine months ended September 30, 2022 and 2021, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incurred but not reported (IBNR) plus expected development on reported claims as of September 30, 2022 was $11,130 million. Total IBNR plus expected development on reported claims represents estimates for claims incurred but not reported, development on reported claims, and estimates for the costs necessary to process unpaid claims at the end of each period. The Company estimates its liability using actuarial methods that are commonly used by health insurance actuaries and meet Actuarial Standards of Practice. These actuarial methods consider factors such as historical data for payment patterns, cost trends, product mix, seasonality, utilization of healthcare services, and other relevant factors.</span></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the change in medical claims liability ($ in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.496%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, January 1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,243 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,438 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, January 1, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,220 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,415 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions and divestitures </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,457 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,736 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,196)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,526)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,261 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,210 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,305 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,205 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,968 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,344 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,273 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,549 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, September 30, net</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,457 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,076 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: Reinsurance recoverable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,465 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,099 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 14243000000 12438000000 23000000 23000000 14220000000 12415000000 249000000 0 84457000000 74736000000 -1196000000 -1526000000 83261000000 73210000000 70305000000 62205000000 10968000000 9344000000 81273000000 71549000000 16457000000 14076000000 8000000 23000000 16465000000 14099000000 -121000000 -438000000 11130000000 Affordable Care Act <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Affordable Care Act established risk spreading premium stabilization programs as well as a minimum annual medical loss ratio (MLR) and cost sharing reductions. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's net receivables (payables) for each of the programs are as follows ($ in millions):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk adjustment receivable</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,068 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk adjustment payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(652)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(536)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minimum medical loss ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(196)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost sharing reduction receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost sharing reduction payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>In June 2022, CMS announced the final risk adjustment transfers for the 2021 benefit year. As a result of the announcement, the Company increased its risk adjustment net receivables by $403 million from December 31, 2021. After consideration of minimum MLR and other related impacts, the net pre-tax benefit recognized was approximately $368 million in the nine months ended September 30, 2022 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's net receivables (payables) for each of the programs are as follows ($ in millions):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk adjustment receivable</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,068 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk adjustment payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(652)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(536)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minimum medical loss ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(196)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost sharing reduction receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost sharing reduction payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1068000000 522000000 652000000 536000000 69000000 196000000 10000000 69000000 81000000 42000000 403000000 -368000000 Debt <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt consists of the following ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.496%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,500 million 4.25% Senior Notes due December 15, 2027</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,484 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,300 million 2.45% Senior Notes due July 15, 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,304 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,304 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,500 million 4.625% Senior Notes due December 15, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,324 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,000 million 3.375% Senior Notes due February 15, 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,200 million 3.00% Senior Notes due October 15, 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,200 million 2.50% Senior Notes due March 1, 2031</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,300 million 2.625% Senior Notes due August 1, 2031</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total senior notes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,731 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,988 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan facility</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,196 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,195 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving credit agreement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction loan payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,333 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,838 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(249)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(267)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,084 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,571 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of the Company's total debt, approximately 15% is variable rate debt tied to London Interbank Offered Rate (LIBOR). The debt agreements that may be impacted by the discontinuation of LIBOR include provisions that the Company believes are sufficient to transition from the existing LIBOR rates to the prevailing successor market rates as necessary.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Notes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Magellan Acquisition in January 2022, the Company redeemed Magellan’s existing outstanding 4.4% Senior Notes due 2024 and paid off the existing Credit Agreement using Magellan’s cash on hand. The Company recognized an immaterial net pre-tax gain on extinguishment including related fees and expenses and the write-off of the unamortized premium.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2022, the Company utilized a portion of the proceeds from the PANTHERx divestiture to repurchase $83 million of its par value Senior Notes due 2027 and $176 million of its par value Senior Notes due 2029 through the Company’s debt repurchase program. The Company recognized a $10 million gain on the redemptions of the notes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Swap</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to manage the foreign exchange risk associated with an intercompany note receivable related to the Circle Health acquisition, the Company entered into a foreign currency swap agreement for a notional amount of $705 million, to purchase £509 million. The swap agreement was formally designated and qualified as a fair value hedge. All gains and losses due to changes in the fair value of the foreign currency swap completely offset changes in the remeasurement of the intercompany note receivable within investment and other income in the Consolidated Statement of Operations, resulting in no net impact to the Consolidated Statement of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 31, 2022, the foreign currency swap settled in connection with its expiration, and the Company received cash proceeds of $35 million. The Company does not hold or issue any derivative instruments for trading or speculative purposes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Circle Health Debt Refinancing</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the Company refinanced certain debt agreements for its Circle Health subsidiary with a new £250 million credit facility maturing in May 2025. The Company recognized a $13 million pre-tax gain on the extinguishment of the existing debt. As of September 30, 2022, £180 million was drawn on the facility, which is included within Finance leases and other in the table above. The new facility is guaranteed by the Company and has similar borrowing rates and covenants to the Company's Revolving Credit Agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Construction Loan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2017, the Company executed a $200 million non-recourse construction loan to fund the expansion of the Company's corporate headquarters. Until final completion of the construction project, which occurred in July 2021, the loan bore interest based on one month LIBOR plus 2.70%, which reduced to LIBOR plus 2.00% at the time construction was completed. The agreement contains financial and non-financial covenants similar to those contained in the Company Credit Facility. The Company guaranteed completion of the construction project associated with the loan. As of September 30, 2022, the Company had $181 million in borrowings outstanding under the loan, which is included in the current portion of long-term debt.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, the Company extended the term of the loan for an additional one year. The extension reduced interest on the loan to the Secured Overnight Financing Rate (SOFR) plus 1.85% and matures in April 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Repurchase Program</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company's Board of Directors authorized a new $1,000 million debt repurchase program in preparation for future debt reductions as part of the Company’s strategic value creation initiatives. During the quarter ended September 30, 2022, the Company repurchased $259 million of its par value senior notes, as described above, for $247 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, there was $753 million available under the program. In October 2022, the Company repurchased an additional $58 million of its par value senior notes for $53 million.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt consists of the following ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.496%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,500 million 4.25% Senior Notes due December 15, 2027</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,484 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,300 million 2.45% Senior Notes due July 15, 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,304 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,304 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,500 million 4.625% Senior Notes due December 15, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,324 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,000 million 3.375% Senior Notes due February 15, 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,200 million 3.00% Senior Notes due October 15, 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,200 million 2.50% Senior Notes due March 1, 2031</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,300 million 2.625% Senior Notes due August 1, 2031</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total senior notes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,731 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,988 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan facility</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,196 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,195 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving credit agreement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction loan payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,333 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,838 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(249)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(267)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,084 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,571 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 2500000000 0.0425 2403000000 2484000000 2300000000 0.0245 2304000000 2304000000 3500000000 0.04625 3324000000 3500000000 2000000000 0.03375 2000000000 2000000000 2200000000 0.0300 2200000000 2200000000 2200000000 0.0250 2200000000 2200000000 1300000000 0.02625 1300000000 1300000000 15731000000 15988000000 2196000000 2195000000 120000000 149000000 181000000 184000000 258000000 493000000 153000000 171000000 18333000000 18838000000 249000000 267000000 18084000000 18571000000 0.15 0.044 83000000 176000000 10000000 705000000 509000000 35000000 250000000 13000000 180000000 200000000 0.0270 0.0200 181000000 P1Y 0.0185 1000000000 259000000 247000000 753000000 58000000 53000000 Leases<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the ROU assets and lease liabilities ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets (recorded within other long-term assets)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkMzZmZTdiZGI2NDRmNDVhNDYxN2E2MzgzNDExZjc1L3NlYzo5ZDM2ZmU3YmRiNjQ0ZjQ1YTQ2MTdhNjM4MzQxMWY3NV83Ni9mcmFnOjIxMzc4NTc5NWM3ZjRkMzZhYWM2OWYzMjM0NGQxMWFjL3RhYmxlOjI1MDkzYmEyZDZiNDQyMTg4ZDM1YmRiM2JjYTJiYmU3L3RhYmxlcmFuZ2U6MjUwOTNiYTJkNmI0NDIxODhkMzViZGIzYmNhMmJiZTdfMy0xLTEtMS0yNjI0OTk_090ace32-1814-4d3e-8b46-1af8a14cbf9a">2,456</span> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkMzZmZTdiZGI2NDRmNDVhNDYxN2E2MzgzNDExZjc1L3NlYzo5ZDM2ZmU3YmRiNjQ0ZjQ1YTQ2MTdhNjM4MzQxMWY3NV83Ni9mcmFnOjIxMzc4NTc5NWM3ZjRkMzZhYWM2OWYzMjM0NGQxMWFjL3RhYmxlOjI1MDkzYmEyZDZiNDQyMTg4ZDM1YmRiM2JjYTJiYmU3L3RhYmxlcmFuZ2U6MjUwOTNiYTJkNmI0NDIxODhkMzViZGIzYmNhMmJiZTdfMy0zLTEtMS0yNjI0OTk_09850097-b1a4-46b8-8ff1-e74ab6c9467e">3,566</span> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term (recorded within accounts payable and accrued expenses)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkMzZmZTdiZGI2NDRmNDVhNDYxN2E2MzgzNDExZjc1L3NlYzo5ZDM2ZmU3YmRiNjQ0ZjQ1YTQ2MTdhNjM4MzQxMWY3NV83Ni9mcmFnOjIxMzc4NTc5NWM3ZjRkMzZhYWM2OWYzMjM0NGQxMWFjL3RhYmxlOjI1MDkzYmEyZDZiNDQyMTg4ZDM1YmRiM2JjYTJiYmU3L3RhYmxlcmFuZ2U6MjUwOTNiYTJkNmI0NDIxODhkMzViZGIzYmNhMmJiZTdfNi0xLTEtMS0yNjI0OTk_fd4ef84c-50d9-4508-9bd0-e14cb3de6e6d">193</span> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkMzZmZTdiZGI2NDRmNDVhNDYxN2E2MzgzNDExZjc1L3NlYzo5ZDM2ZmU3YmRiNjQ0ZjQ1YTQ2MTdhNjM4MzQxMWY3NV83Ni9mcmFnOjIxMzc4NTc5NWM3ZjRkMzZhYWM2OWYzMjM0NGQxMWFjL3RhYmxlOjI1MDkzYmEyZDZiNDQyMTg4ZDM1YmRiM2JjYTJiYmU3L3RhYmxlcmFuZ2U6MjUwOTNiYTJkNmI0NDIxODhkMzViZGIzYmNhMmJiZTdfNi0zLTEtMS0yNjI0OTk_2259aa95-b754-486b-ba2e-43ef097c4fb9">204</span> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term (recorded within other long-term liabilities)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkMzZmZTdiZGI2NDRmNDVhNDYxN2E2MzgzNDExZjc1L3NlYzo5ZDM2ZmU3YmRiNjQ0ZjQ1YTQ2MTdhNjM4MzQxMWY3NV83Ni9mcmFnOjIxMzc4NTc5NWM3ZjRkMzZhYWM2OWYzMjM0NGQxMWFjL3RhYmxlOjI1MDkzYmEyZDZiNDQyMTg4ZDM1YmRiM2JjYTJiYmU3L3RhYmxlcmFuZ2U6MjUwOTNiYTJkNmI0NDIxODhkMzViZGIzYmNhMmJiZTdfNy0xLTEtMS0yNjI0OTk_efa748ff-56d3-47ce-9a98-0d832eb9ecc3">3,038</span> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkMzZmZTdiZGI2NDRmNDVhNDYxN2E2MzgzNDExZjc1L3NlYzo5ZDM2ZmU3YmRiNjQ0ZjQ1YTQ2MTdhNjM4MzQxMWY3NV83Ni9mcmFnOjIxMzc4NTc5NWM3ZjRkMzZhYWM2OWYzMjM0NGQxMWFjL3RhYmxlOjI1MDkzYmEyZDZiNDQyMTg4ZDM1YmRiM2JjYTJiYmU3L3RhYmxlcmFuZ2U6MjUwOTNiYTJkNmI0NDIxODhkMzViZGIzYmNhMmJiZTdfNy0zLTEtMS0yNjI0OTk_7c1d80b4-d7c7-4b07-8771-41746a6b553e">3,619</span> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,231 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,823 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the real estate optimization initiative as described in Note 5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Property, Software and Equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company vacated and abandoned various domestic leased properties. As a result, the Company assessed the ROU assets for impairment. The Company engaged a third-party real estate specialist to determine the recoverability of the leased properties. The valuation primarily considered comparable leased properties in each market and the assessment of potential future rental income that could be generated by the ROU assets. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the optimization, the Company recognized $53 million and $574 million of ROU asset impairments in the three and nine months ended September 30, 2022, respectively, primarily related to the Managed Care segment. The remainder of the $1,574 million charge was recorded within Property, Software and Equipment, refer to Note 5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Property, Software and Equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, the weighted average remaining lease term for the Company was 20.1 years. The lease liabilities as of September 30, 2022 reflect a weighted average discount rate of 5.6%.</span></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the ROU assets and lease liabilities ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets (recorded within other long-term assets)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkMzZmZTdiZGI2NDRmNDVhNDYxN2E2MzgzNDExZjc1L3NlYzo5ZDM2ZmU3YmRiNjQ0ZjQ1YTQ2MTdhNjM4MzQxMWY3NV83Ni9mcmFnOjIxMzc4NTc5NWM3ZjRkMzZhYWM2OWYzMjM0NGQxMWFjL3RhYmxlOjI1MDkzYmEyZDZiNDQyMTg4ZDM1YmRiM2JjYTJiYmU3L3RhYmxlcmFuZ2U6MjUwOTNiYTJkNmI0NDIxODhkMzViZGIzYmNhMmJiZTdfMy0xLTEtMS0yNjI0OTk_090ace32-1814-4d3e-8b46-1af8a14cbf9a">2,456</span> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkMzZmZTdiZGI2NDRmNDVhNDYxN2E2MzgzNDExZjc1L3NlYzo5ZDM2ZmU3YmRiNjQ0ZjQ1YTQ2MTdhNjM4MzQxMWY3NV83Ni9mcmFnOjIxMzc4NTc5NWM3ZjRkMzZhYWM2OWYzMjM0NGQxMWFjL3RhYmxlOjI1MDkzYmEyZDZiNDQyMTg4ZDM1YmRiM2JjYTJiYmU3L3RhYmxlcmFuZ2U6MjUwOTNiYTJkNmI0NDIxODhkMzViZGIzYmNhMmJiZTdfMy0zLTEtMS0yNjI0OTk_09850097-b1a4-46b8-8ff1-e74ab6c9467e">3,566</span> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term (recorded within accounts payable and accrued expenses)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkMzZmZTdiZGI2NDRmNDVhNDYxN2E2MzgzNDExZjc1L3NlYzo5ZDM2ZmU3YmRiNjQ0ZjQ1YTQ2MTdhNjM4MzQxMWY3NV83Ni9mcmFnOjIxMzc4NTc5NWM3ZjRkMzZhYWM2OWYzMjM0NGQxMWFjL3RhYmxlOjI1MDkzYmEyZDZiNDQyMTg4ZDM1YmRiM2JjYTJiYmU3L3RhYmxlcmFuZ2U6MjUwOTNiYTJkNmI0NDIxODhkMzViZGIzYmNhMmJiZTdfNi0xLTEtMS0yNjI0OTk_fd4ef84c-50d9-4508-9bd0-e14cb3de6e6d">193</span> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkMzZmZTdiZGI2NDRmNDVhNDYxN2E2MzgzNDExZjc1L3NlYzo5ZDM2ZmU3YmRiNjQ0ZjQ1YTQ2MTdhNjM4MzQxMWY3NV83Ni9mcmFnOjIxMzc4NTc5NWM3ZjRkMzZhYWM2OWYzMjM0NGQxMWFjL3RhYmxlOjI1MDkzYmEyZDZiNDQyMTg4ZDM1YmRiM2JjYTJiYmU3L3RhYmxlcmFuZ2U6MjUwOTNiYTJkNmI0NDIxODhkMzViZGIzYmNhMmJiZTdfNi0zLTEtMS0yNjI0OTk_2259aa95-b754-486b-ba2e-43ef097c4fb9">204</span> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term (recorded within other long-term liabilities)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkMzZmZTdiZGI2NDRmNDVhNDYxN2E2MzgzNDExZjc1L3NlYzo5ZDM2ZmU3YmRiNjQ0ZjQ1YTQ2MTdhNjM4MzQxMWY3NV83Ni9mcmFnOjIxMzc4NTc5NWM3ZjRkMzZhYWM2OWYzMjM0NGQxMWFjL3RhYmxlOjI1MDkzYmEyZDZiNDQyMTg4ZDM1YmRiM2JjYTJiYmU3L3RhYmxlcmFuZ2U6MjUwOTNiYTJkNmI0NDIxODhkMzViZGIzYmNhMmJiZTdfNy0xLTEtMS0yNjI0OTk_efa748ff-56d3-47ce-9a98-0d832eb9ecc3">3,038</span> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkMzZmZTdiZGI2NDRmNDVhNDYxN2E2MzgzNDExZjc1L3NlYzo5ZDM2ZmU3YmRiNjQ0ZjQ1YTQ2MTdhNjM4MzQxMWY3NV83Ni9mcmFnOjIxMzc4NTc5NWM3ZjRkMzZhYWM2OWYzMjM0NGQxMWFjL3RhYmxlOjI1MDkzYmEyZDZiNDQyMTg4ZDM1YmRiM2JjYTJiYmU3L3RhYmxlcmFuZ2U6MjUwOTNiYTJkNmI0NDIxODhkMzViZGIzYmNhMmJiZTdfNy0zLTEtMS0yNjI0OTk_7c1d80b4-d7c7-4b07-8771-41746a6b553e">3,619</span> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,231 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,823 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 2456000000 3566000000 193000000 204000000 3038000000 3619000000 3231000000 3823000000 53000000 574000000 1574000000 P20Y1M6D 0.056 Stockholders' Equity <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company's Board of Directors authorized an additional $3,000 million to the Company’s existing stock repurchase program for its common stock, for a total $4,000 million, in preparation for closing of the Magellan Rx and PANTHERx divestitures as well as planning for the future. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2022, the Company entered into an accelerated share repurchase (ASR) agreement with Bank of America to purchase $1,000 million of the Company's common stock in aggregate under the Company’s stock repurchase program. In July 2022, 8.6 million shares were delivered to the Company, representing 80% of the notional amount under the ASR. In October 2022, an additional 3.0 million shares were delivered upon settlement of the ASR based upon the volume-weighted average price (VWAP) over the term of the agreement, less a discount. In total, 11.6 million shares were purchased through the $1,000 million ASR. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also repurchased an additional 2.9 million shares for $240 million during the third quarter. The remaining common stock repurchases relate to the purchase of shares to satisfy tax withholding requirements in connection with employee equity awards.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2022, the Company has repurchased a total of 15.7 million shares of Centene common stock for $1,384 million, exclusive of the $200 million unsettled portion under the ASR. As of September 30, 2022, the Company had a remaining amount of $2,216 million available under the Company’s stock repurchase program.</span></div>In October 2022, the Company repurchased an additional 828 thousand shares for $66 million 3000000000 4000000000 1000000000 8600000 0.80 3000000 11600000 1000000000 2900000 240000000 15700000 1384000000 200000000 2216000000 828000 66000000 Earnings Per Share <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the calculation of basic and diluted net earnings per common share ($ in millions, except per share data in dollars and shares in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.671%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings attributable to Centene Corporation</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,415 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in computing per share amounts:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573,961 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583,244 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580,277 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582,636 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock equivalents (as determined by applying the treasury stock method)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,646 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,458 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,807 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,518 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares and potential dilutive common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580,607 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590,702 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587,084 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590,154 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings per common share attributable to Centene Corporation:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per common share</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.29 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.44 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.28 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.27 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.99 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.41 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.27 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of diluted earnings per common share for the three months ended September 30, 2022 and 2021 excludes 152 thousand shares and 111 thousand shares, respectively, related to anti-dilutive stock options, restricted stock, and restricted stock units.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of diluted earnings per common share for the nine months ended September 30, 2022 and 2021 excludes the impact of 193 thousand shares and 57 thousand shares, respectively, related to anti-dilutive stock options, restricted stock, and restricted stock units.</span></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the calculation of basic and diluted net earnings per common share ($ in millions, except per share data in dollars and shares in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.671%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings attributable to Centene Corporation</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,415 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in computing per share amounts:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573,961 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583,244 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580,277 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582,636 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock equivalents (as determined by applying the treasury stock method)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,646 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,458 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,807 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,518 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares and potential dilutive common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580,607 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590,702 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587,084 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590,154 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings per common share attributable to Centene Corporation:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per common share</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.29 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.44 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.28 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.27 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.99 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.41 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.27 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div> 738000000 584000000 1415000000 748000000 573961000 583244000 580277000 582636000 6646000 7458000 6807000 7518000 580607000 590702000 587084000 590154000 1.29 1.00 2.44 1.28 1.27 0.99 2.41 1.27 152000 111000 193000 57000 Segment Information <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Centene operates in two segments: Managed Care and Specialty Services. The Managed Care segment consists of Centene's health plans, including all of the functions needed to operate them. The Specialty Services segment consists of Centene's specialty companies offering auxiliary healthcare services and products. Factors used in determining the reportable business segments include the nature of operating activities, the existence of separate senior management teams, and the type of information presented to the Company's chief operating decision-maker to evaluate all results of operations.</span></div><div style="text-align:justify;text-indent:13.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the three months ended September 30, 2022, is as follows ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"/><td style="width:45.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.723%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Managed <br/>Care</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated<br/>Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from external customers</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,722 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,143 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,865 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from internal customers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,264 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,266)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,724 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,407 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,266)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,865 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the three months ended September 30, 2021, is as follows ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"/><td style="width:45.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.723%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Managed <br/>Care</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated<br/>Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from external customers</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,888 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,518 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,406 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from internal customers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,209 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,210)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,889 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,727 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,210)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,406 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(154)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the nine months ended September 30, 2022, follows ($ in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"/><td style="width:45.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.723%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Managed Care</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Specialty<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from external customers</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,428 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,558 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,986 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from internal customers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,939 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,945)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,434 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,497 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,945)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,986 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,634 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,600 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the nine months ended September 30, 2021, follows ($ in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"/><td style="width:45.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.723%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Managed Care</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Specialty<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from external customers</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,078 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,336 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,414 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from internal customers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,217 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,221)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,082 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,553 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,221)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,414 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,240 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 2 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the three months ended September 30, 2022, is as follows ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"/><td style="width:45.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.723%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Managed <br/>Care</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated<br/>Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from external customers</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,722 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,143 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,865 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from internal customers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,264 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,266)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,724 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,407 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,266)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,865 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the three months ended September 30, 2021, is as follows ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"/><td style="width:45.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.723%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Managed <br/>Care</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated<br/>Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from external customers</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,888 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,518 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,406 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from internal customers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,209 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,210)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,889 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,727 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,210)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,406 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(154)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the nine months ended September 30, 2022, follows ($ in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"/><td style="width:45.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.723%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Managed Care</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Specialty<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from external customers</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,428 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,558 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,986 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from internal customers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,939 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,945)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,434 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,497 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,945)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,986 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,634 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,600 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the nine months ended September 30, 2021, follows ($ in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"/><td style="width:45.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.723%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Managed Care</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Specialty<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from external customers</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,078 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,336 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,414 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from internal customers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,217 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,221)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,082 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,553 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,221)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,414 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,240 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 33722000000 2143000000 35865000000 2000000 3264000000 -3266000000 33724000000 5407000000 -3266000000 35865000000 527000000 -51000000 476000000 30888000000 1518000000 32406000000 1000000 3209000000 -3210000000 30889000000 4727000000 -3210000000 32406000000 699000000 -154000000 545000000 101428000000 7558000000 108986000000 6000000 9939000000 -9945000000 101434000000 17497000000 -9945000000 108986000000 1634000000 -34000000 1600000000 89078000000 4336000000 93414000000 4000000 9217000000 -9221000000 89082000000 13553000000 -9221000000 93414000000 1240000000 -59000000 1181000000 Contingencies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is routinely subjected to legal and regulatory proceedings in the normal course of business. These matters can include, without limitation:</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">periodic compliance and other reviews and investigations by various federal and state regulatory agencies with respect to requirements applicable to the Company's business, including, without limitation, those related to payment of out-of-network claims, submissions to CMS for risk adjustment payments, or the False Claims Act, the calculation of minimum MLR and rebates related thereto, submissions to state agencies related to payments or state false claims acts, pre-authorization penalties, timely review of grievances and appeals, timely and accurate payment of claims, and the Health Insurance Portability and Accountability Act of 1996 and other federal and state fraud, waste and abuse laws;</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">litigation arising out of general business activities, such as tax matters, disputes related to healthcare benefits coverage or reimbursement, putative securities class actions, and medical malpractice, privacy, real estate, intellectual property and employment-related claims; and</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disputes regarding reinsurance arrangements, claims arising out of the acquisition or divestiture of various assets, class actions, and claims relating to the performance of contractual and non-contractual obligations to providers, members, employer groups and others, including, but not limited to, the alleged failure to properly pay claims and challenges to the manner in which the Company processes claims, claims related to network adequacy and claims alleging that the Company has engaged in unfair business practices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among other things, these matters may result in awards of damages, fines or penalties, which could be substantial, and/or could require changes to the Company's business. The Company intends to vigorously defend itself against legal and regulatory proceedings to which it is currently a party; however, these proceedings are subject to many uncertainties. In some of the cases pending against the Company, substantial non-economic or punitive damages are being sought. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records reserves and accrues costs for certain legal proceedings and regulatory matters to the extent that it determines an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. While such reserves and accrued costs reflect the Company's best estimate of the probable loss for such matters, the recorded amounts may differ materially from the actual amount of any such losses. In some cases, no estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made because of the inherently unpredictable nature of legal and regulatory proceedings, which may be exacerbated by various factors, including but not limited to, they may involve indeterminate claims for monetary damages or may involve fines, penalties or punitive damages; present novel legal theories or legal uncertainties; involve disputed facts; represent a shift in regulatory policy; involve a large number of parties, claimants or regulatory bodies; are in the early stages of the proceedings; involve a number of separate proceedings and/or a wide range of potential outcomes; or result in a change of business practices. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the date of this report, amounts accrued for legal proceedings and regulatory matters were not material, except for the reserve estimate as described below with respect to claims or potential claims involving services provided by Envolve Pharmacy Solutions, Inc. (Envolve), as the Company's pharmacy benefits manager (PBM) subsidiary. It is possible that in a particular quarter or annual period the Company's financial condition, results of operations, cash flow and/or liquidity could be materially adversely affected by an ultimate unfavorable resolution of or development in legal and/or regulatory proceedings, including as described below. Except for the proceedings discussed below, the Company believes that the ultimate outcome of any of the regulatory and legal proceedings that are currently pending against it should not have a material adverse effect on financial condition, results of operations, cash flow, or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">California</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 20, 2015, the Company's California subsidiary, Health Net of California, Inc. (Health Net California), was named as a defendant in a California taxpayer action filed in Los Angeles County Superior Court, captioned as Michael D. Myers v. State Board of Equalization, Dave Jones, Insurance Commissioner of the State of California, Betty T. Yee, Controller of the State of California, et al., Los Angeles Superior Court Case No. BS158655. This action is brought under a California statute that permits an individual taxpayer to sue a governmental agency when the taxpayer believes the agency has failed to enforce governing law. Plaintiff contends that Health Net California, a California licensed Health Care Service Plan (HCSP), is an "insurer" for purposes of taxation despite acknowledging it is not an "insurer" under regulatory law. Under California law, "insurers" must pay a gross premiums tax (GPT), calculated as 2.35% on gross premiums. As a licensed HCSP, Health Net California has paid the California Corporate Franchise Tax (CFT), the tax generally paid by California businesses. Plaintiff contends that Health Net California must pay the GPT rather than the CFT. Plaintiff seeks a writ of mandate directing the California taxing agencies to collect the GPT, and seeks an order requiring Health Net California to pay GPT, interest and penalties for a period dating to eight years prior to the October 2015 filing of the complaint. This lawsuit is being coordinated with similar lawsuits filed against other entities (collectively, Related Actions). In March 2018, the Court overruled the Company's demurrer seeking to dismiss the complaint and denied the Company's motion to strike allegations seeking retroactive relief. In August 2018, the trial court stayed all the Related Actions pending determination of a writ of mandate by the California Court of Appeals in two of the Related Actions. In March 2019, the California Court of Appeals denied the writ of mandate. The defendants in those Related Actions sought review by the California Supreme Court, which declined to review the matter. Upon the return of the matter to the Los Angeles County Superior Court, motions for summary judgment were scheduled. Health Net California's motion for summary judgment was heard by the Court in March 2020. In March 2020, the Court granted Health Net California's motion for summary judgment. In September 2020, the plaintiff appealed the Court's decision. The Company intends to continue its vigorous defense against these claims; however, this matter is subject to many uncertainties, and an adverse outcome in this matter could potentially have a materially adverse impact on the Company's financial position, results of operations and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in April 2021, several lawsuits have been filed against the Company and its subsidiaries, alleging that the defendants failed to prevent Health Net members' personal and health data from being exposed in connection with a data breach involving Accellion's File Transfer Appliance. The Company denies any wrongdoing and is seeking indemnification from Accellion for these claims. In December 2021, the plaintiffs in three of the pending actions filed a motion for preliminary approval of a settlement with the Company and its subsidiaries, which, if approved by the court, should resolve most or all of the pending litigation. In addition, claims related to these lawsuits are anticipated to be covered in part by the Company's insurance carrier. As a result, while these matters are subject to many uncertainties, the Company does not believe that an adverse outcome in these matters is likely to have a materially adverse impact on the Company’s financial position, results of operations and cash flows.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pharmacy Benefits Management Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 11, 2021, the State of Ohio filed a civil action against the Company and the Company's subsidiaries, Buckeye Health Plan Community Solutions, Inc. and Envolve, in Franklin County Court of Common Pleas, captioned as Ohio Department of Medicaid, et al. v. Centene Corporation, et al. The complaint alleged breaches of contract with the Ohio Department of Medicaid relating to the provision of PBM services and violations of Ohio law relating to such contracts, including among other things, by (i) seeking payment for services already reimbursed, (ii) not accurately disclosing to the Ohio Department of Medicaid the true cost of the PBM services and (iii) inflating dispensing fees for prescription drugs. The plaintiffs sought an undisclosed sum of money in damages, penalties, and possible termination of the contract with Buckeye Health Plan. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has reached no-fault agreements with the Attorney Generals in 13 states, including Ohio, to resolve claims and/or allegations made by the states related to services provided by Envolve. As a result of the settlement, the Ohio Attorney General’s litigation against the Company was dismissed. Additionally, the Company is in discussions to bring final resolution to similar concerns in other affected states. Consistent with those discussions, the Company recorded a reserve estimate of $1,250 million in the second quarter of 2021 related to this issue, inclusive of the above settlements and rebates that the Company determined in the course of the matter are payable across products. Additional claims, reviews or investigations relating to the Company's PBM business across products may be brought by other states, the federal government or shareholder litigants, and there is no guarantee the Company will have the ability to settle such claims with other states within the reserve estimate the Company has recorded and on other acceptable terms, or at all. This matter is subject to many uncertainties, and an adverse outcome in this matter could have an adverse impact on the Company's financial position, results of operations and cash flows.</span></div> 3 13 1250000000 EXCEL 68 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�_B,,R"AM6MMUY:V9U<+T6O>=WBG035-PV3 M+QODXKCR(N\D^%8?*FT$P7K9L0/>H_ZKNY.T"D:4LFZP5;5H0>)^Y=U&BTUB M]*W"WS4>U=D<3"0[(1[-XL]RY86&$'(LM$%@-#SA%CDW0$3CQX#IC2Z-X?G\ MA/Z[C9UBV3&%6\&_UZ6N5M[,@Q+WK.?ZFSC^@4,\J<$K!%?V"T>GFTT]*'JE M13,8$X.F;MW(GH<\G!G,PC<,XL$@MKR=(\OR$]-LO93B"-)H$YJ9V%"M-9&K M6W,H]UK2;DUV>OV9R;9N#PKN4,)]Q23"QP>VXZANEH$F!T8M* :PC0.+WP"; MPQ?1ZDK!Y[;$\K5]0,1&=O&)W2:^"GB/W02FH0]Q&,=7\*9CM%.+-WU_M/_< M[I265!S_7HK7P267X*H2]X'1W MR0MH4QF@4"L22EV!INWB-<_=R+,<>+;$$T\\.^)9.)[*E=L'J%LJ;D4C=+."ADHBO:A"H@C0V.P(S9?25 M0KZV;\K,?**SV9AAIK6L=[W+@1:PQ58CX6V%[(1T\7^ ?#JC;SI+Z!OY290: M63)SAZ*@5^24:%,*NEZ;G/X,E#6B;[5:P'?;2TB1/:&DU@AM;RE2=L]3IX"Z MK-(4O,%)\ZD_SR)R/?7C)*$Q].,\IS'VLVEV*@[J*,4CX(^^?F*<(E#PD2GJ M8QHEM1?RN7L!UG7\Q9XW':^F7J]Z^3)8-D@9+V\@\[,D@]Q/TAG-9V%.\S2: MO9^[.<9.4 9US;BK%>K/UP*D@#+RD\Y#/P]C6N=^2'DVZRA-['5XN\S><7J+ MX8Z]#4)'.HGG=@A#&N))DCCA;+R5_V.=TQ!.YG-G'9V$E_I%<-;6&Y0'^W@I MPJ0J<1U^E([OXZU[%GZJN\?U"Y.'NE7 <4^FX21//9#NP7(++3K[2.R$IB?' M3BMZXU$:!=K?"SJJ86$B@, +T* M 9 >&PO=V]R:W-H965T #[3W.G<17U+,NR@MJ4JB8:5M/@DEY<<7??7_A8PLX_6\?.\8R%P:NE?Q4+NUF M&N0!6<)*;*6]5[MWT,63.KZ%DL;_DEU[EQ4!66R-554'1@^JLFY'\=3EX0"0 MQS\!L [ O-^M(>_E7\**V42K'='N-K*YB0_5H]&YLG:B/%B-IR7B[.P!UIAB M2][7K< N4Z,/8B[!G$TBBQ;_.*9O'; 5]Y[RL?8C\ES2D7!TE.N[AG+@]$ MQQFQ&\ _#4"J5D9P,A(4P4(U!]TK$9+2$&$0)+&J#1F]1BY\GE(BE3F[(+>B MQI)&: .+4DC[C=S($I^OMV7(-?XH62Z%Q3L?E!42"_P1ZBT@IU85@2<+NL;M MM@1 &_*:)$DX9@PG+*0\P?'-JYQ1]M8=I6&>I2>IROH_5(PD(3JH /*]H )^F?IKH>'_S3^-:\\!ITF!]&!T2@8>;1H^29"G@0Q[^K _TC.N1%&(]S_RJ3 M)#N*JDA"3OE+5>"H J-CEU'&Z( *SF+N/GTT0>635@0/Z4T.:L!X[+]%Q7,- M:$[)J?]5T4%+@:ZN?>-DR$)M:]MV%_UNWYM=MBW)C^MM8W?'3#?:7H-T%/%\I9?<+9Z#O6&?? 5!+ P04 M" #-J%A5HWGX8V(# #K"P &0 'AL+W=O[!*DIF[9IG:I6W2ZF73APDE@U-K5-TO[[ M'0.AH25HJ7(#V/A].>>QL<]X+=6]7@(8\IAPH2?.TICTW'5UM(2$ZE.9@L W MV\:W>.)X-B#@$!GK0/&V@DO@W!IA& ^EIU-]T@JWGS?N7_+< M,9<9U7 I^6\6F^7$&3DDACG-N+F1ZZ]0YM.W?I'D.K^2=3G6O8-1BG_9H;E3%= M%C'Y.V+JDBLIS%*3SR*&N$$?MNO/6O0N\JD@^1M(4[_5\#L5I\3K?22^Y_M- M^;3+;R$])5UOISQ\L[R63;>:\F[NU]WA-\TT]FA=F[P_/["/?#.0Z+\-(4X+ MRUZSI=V;SG5*(Y@XN/EH4"MP@@_O.@/O4Q.N0YJ%!S*KH>Q5*'MM[L$EKF\6 M@_U#D*%15.@Y*-6X:*>%U2"WLKOQ*O![9YVQN]I&T_J]?=$C MH7I)4LH:4132?@U%]R6*5O]]41S(K(9B4*$8O&V5X+G)J<&[D61.F2(KRC,@ MO MJ ^\%\Q;$]F7^8',:LR'%?-A*W.L5PPO^"%."PD>&9YK8H&+\HG..!3'G8(( MV*IHIXI)9>>"/F^,31R'KW[DD^%+D*W1[0OR0&8UD*,*Y*@5Y/8AL5FN\(A5 MIX:FHWW:ZK;O03%Z17I4YQR^'M'QGN>BR-C=*H\24(N\S-0DDIDP1:54]5:5 M[$5>P+G/PXLR^(JJ!<-*B<,)$3D10& "S)@ &0 'AL M+W=O(:'K&$XC5)SLN(BK5HMA/TT0 #?*B*)P2QYE/ M(\KBR7J5OWR9#%<"U0FD41%8\?(.3'BPF>/+UQP_8'J=^8KE<)W<,M MR*_)M5!+TRHE8!'$*>,Q$K"[F%SB]UN7Z(+\&]\8'-/&:Z2'NK#Y^BG]8SYX-9@[FL*&A_^R0!XN M)N<3%,".9J&\X<<_H1S03.?Y/$SSO^A8?M>9(#]+)8_*8K4&$8N+__2A!-$H MP-XS!:0L("\M<,L"]Z4%7EG@Y62*H>0G_R%C*]#9($8T#M%6;(95,9@)2] [=JATMR$) ?(<^4B;0 M-QIF^=)EFH),41X@(,B+OS!ZQT*5IFK5YUFDWG^]!4E9F+Y1:5]OM^CUJS?H M%6(QNF)AJ-NNIE(-1*_.U"]7^D.QTN29E;Z%Y RYSEM$'$(&RC?F\K]H?(8< M[]GRK;E\"[[JCO-RW"Z?*OK5)B#5)B!YGOO<)BA TB;(L &2%B"',!7!WG"P MGC+>IPGUX6*BYH04Q#U,UK__AN?.'T/0;(9M+86U@+H54->4OO[$>7!4.]<0 ML:)RGE?J.?%^K69(SUE-[YLHC/EC4?1;XN5B@:N6K3%ZU1B]_SU&[T5C-.:/ M'6._I6&,LVJ,,^,8K]2!)PQIC!J3U-!XC2EC?P4VP[:6PEKTYA6]^:FFE;E- MH#;#MI;"6D 7%="%<7?\ MM=2P1>:\(G-N)',M(&)9E,,1$%()^K\/"M!="(-\C(%C^11ALP:?Q1)W^%AJ MV.*SK/@LC7QN#US(=Q)$I+Q'ZU7TW&YCS!F+9=G#@CVO@\52PQ86[-3RZ1C! M_"T/()3F"J& Z!D)AK&88\9R*=-:8)9=,+9:MLDTM!P;R7SA\?Y%>XPY9S0: MW$/CN5TRECJVR=2VC(WNN+Y1- 3S]1P30,*5%@QSL>K&95IKBNEB.87RXMIY ML5EZKP5/0,C'MRCE.WFD O+I6!^F$KWS##*RZ;F;,JW):.ET(5GJV(942S,V M6_/G6-)XS]1!R339V#3C39G6VG-FW8.3K99M++5G8[-H%]-P6$TY!C967;M, M:[*9]?:84S@TKB4:&Y5R_0^7-"R!5"X]2,:J-)=I33*N,^\ZGZV>;3:U#V.S M$%]!P'Q%QP\IB]+JY.)Q$(]5(2[3FGB(UYN03Z'$N'9B;);B2]_GF3IHHX0^ MTGS&4=,Q]7V1J2,7/"00I\-J;,X=C:HOQ]YRUD5U"CO&M1YCLQ_?@,Q$K"\J M)N691,EL$(]51\9]29[UA.<4DDQJ229F2?X: Q5Q?DIU#W$V",4<,?I*8%^0 MNU./K89M)K4>$[,>;\I3AD2=6.G;!VK7J0]? =P-ZHXYZ3$ZAR:369&+6Y"WL0.C+89(^-"^'#=*QJL>D MK\>8=*<:6RW;=&H_)F8_[HK@KP!9-672-^7YLLOG%*),:E$F9E$N;/"E-V>L MNC+INS(>^'6=PI9);;2T3CZ M/KQ<=D\=;+5LTZA]F)A]>/"D<]1]8:N.3/J.3+S>!79;/=NW?&M+=LV6O%6* M\X3D+:+[O8 ]E:#.*%CLLX0.WPVVJLUN7YMG;M<);;5L8ZK%V36+<\M_GI^" MS"FCP?15&>-Y%\PI9-FM9=DUR[+QH0&KFERFS8TSD*V6!8UIXP$A_3C7%15[ M%JC'D*KG MU-;_ 5!+ P04 " #-J%A5@ZN\3<(% !*- &0 'AL+W=O,1=M<)=$E::<=]N-'R8IDQC)KS6>Y22R9YSD27XHG>D..GH7\K):,:?0U MB5-UU5IJO;ILM]5LR1*JSL6*I>:;N9 )U>90+MIJ)1F-\J D;@>>UV\GE*>M M\2@_=R_'(['6,4_9O41JG214?KMFL7B^:OFMEQ,?^6*ILQ/M\6A%%^R!Z^0W;V[FB2HV%?$G'NGE56O8 M0A&;TW6L/XKG7UAQ0[V,-Q.QRG^BYZ*MUT*SM=(B*8+-%20\W?ZF7XN.V GP MNP<"@B(@>!W0.Q#0*0(ZQV;H%@'=8S/TBH#>L1GZ14 _[_MM9^4]'5)-QR,I MGI',6AM:]B&7*X\V'S+VNN>*:R0C2-4&B$5IKKM60* M?4 W$4LUGW/Z%#-TDVJ:+GCV<:(4TPJ=A4Q3'JOWINGC0XC.WKU'[Q!/T1V/ MXXPY:FMSE5FN]JRXHNGVBH(#5]1!=R+52X5P&K&H)AZ[XR\<\6W3.V47!2]= M=!TX@;_2]!QYW9]0X 5!W?VXPQ_8ZAQUO(/AX?'A?EUOG):=_.?L5E]VRN'6 MR7D=UW"3+$*$IURS#[=FM$4UX^J/6Q.(;C1+U)\U5WV]S=*MSY+-QI=J16?L MJF6F6\7DAK7&/_[@][V?Z_2#A(60, P)(T P2_=NJ7O711]/$B$U_YOFU43, M34$IQ@&OI*>Y]'5J.]E-U=["^CDLJ[N;<>";H;W9%7&_C7\QM-O@_39][\)N M0_;;](95+JLG>V5/]IP]>6?J?1S3%.W,W'5]YJ0T[3-(6 @)PY P @2S=.V7 MNO;?9&;L0^H."0LA81@21H!@ENZ#4O>!\WF^.68"'.S-(X/>JSEKZDS35"M( M&(:$$2"8I=6PU&KHU.I3_IYB'LO)ADDS#Z-'Q>;K&-WR.4-GYJ_>;XQ*];Y. M03?8[VQ#ZYY!9V1372%A&!)&@&"6KA>EKA>-:RKZ!]VOY6QIWEHC-#-O%-*\ M!".9#8#:1]29H>F\"PD+(6$8$D: 8);FOE>]^7IO4G&+-$#2@])"4!H&I1$H MFBW_CO'AGUYX"\9NY>T.O%>5UYVHL620- Q*(U T6[*@DBSXO^KO=\BN NP. M;2PO) V#T@@4S9:W\H9\IP5QL Q+L>$1DV45KG]202TA4%H(2L.@- )%LS6O M?"&_^S9%&-0C J6%H#0,2B-0-%O^RLSRW6[6<46XMV_'>7M%&-2C J5A4!J! MHMF253Z5[[1#3BK";K+?*2@M!*5A4!J!HMEB5WZ6/WR;Z@MI!4U!:2$H#8/2"!3-EK^RO7RW M[W5<];W8J[[#O>(+:EB!TC HC4#1[)4(E6<5.$V14XKO=\C^X'#Q=84 MAD%I!(IFRUMY4H';DSI0?$.V8;%8&=DUFRU3$8L%KZ_#;G[3B1B4%H+2,"B- M0-%LW2MC*PC>I X'D';0%)06@M(P*(U T6SY*^,K3;/5Z=G_J7H5]S'ON79+NMI<)O=]G<4;G@ MJ4(QFYM4WOG 3%%RNW%E>Z#%*M]H\22T%DG^<&PO=V]R:W-H965T MMX=A M#[1$VT0I426I. 'VXT=2BFPY-A>C?.F++5+W'EZ>0UZ*Y&A#V5>^1DB IYP4 M?.RLA2BO7)>G:Y1#?DY+5,@W2\IR*&21K5Q>,@0S[903-_"\R,TA+IS)2-?= ML\F(5H+@ MTSP*L\A^QYA@C=C!W?>:EXP*NU4!7N9%3"%9HC\:6\9[+DMB@9 MSE'!,2T 0\NQ,_6O$C]4#MKB3XPV?.<9J*XL*/VJ"K?9V/%41(B@5"@(*/\> MT34B1"').+XUH$[;IG+_8-/8>@Y(*RYHWCC+"')$?Y(LO\QB\?_8$(4P M")D%1L#?*G(._$$/!%X0'.J/V7V.RG/0]XZZQ]_GGKS=W3>0T6]'1U_C]8_@ MW18IS1&8"RB0S ZB!V:0P"*553J+J0$SS3(]?""1@X6GA'(]5A;/JEA2+NL_ M,EJ5O @7]_DA& 6]D:_^= ]V=UN(/#X:JD M>L5+F**Q([,F1^P1.9.??_(C[Y=#2MH$BVV")9; .IH/6LT')O3)1[FZ )G" M,ZV>EA;0)5A47!KR0U-\9@0\516;8'$-%FDPM68^3LY"KS]R'W?9?FT4!:U) MA\.PY3 T:VK <#>C#RZ] M/;:-K9[*MDVPQ!)8A^W+ENW+[V&[!PJ9TV2%@$^'F+]\-<[[%\$>\<8 3B7> M)EAB":Q#O.]M=UF>D?IY"0O,UWK%N)8K"9/+0E(QN=^'!9@U LAEX_6GP@TB MV=F2LK,Z%3$KWP[F:$]=2*RBQ5;1$EMH7=UW=M?^C_4%T<1K2WF;:+%5M,06 M6E?Y8*M\8)SQ4SF?!0=K.7V!G+[Z2^*@($:8DP4)7N]EHJB;I./&*#09);;B MZM*W/7CPC7O8'>PJ'58X$&;9>><'^ABQNCR&24V(JKR^%V(^^; M=_*W>0DQ4VD'0,YIBF42RL &BS4H4:'32+8]WCM(K-6=?8.V2ZP?A?O$VFPR ML87656![#.";SP%.4Z 'X%(@=NS[R]S6R6*$![8M%_MB6-W*VT*KQ7!W#KUS MQ%;ZMH&#E%:%J(][V]KV1F.JS_'WZF-UTZ$/T[4BI>":J"]_YG\!U!+ P04 M" #-J%A5NTV&F4X' #C, &0 'AL+W=O=-FEML+$)V;61MO:VF[1)U;KM7E/BI&B ,W#2]?[Z M,R2-,?Z1K! >/WP?&S\?_.!=/+#J1WU/*0>_BKRL+R?WG&_>3*=U>D^+ MI#YG&UJ**RM6%0D7I]5Z6F\JFBS;1D4^14$038LD*R>+B_:WFVIQP;8\STIZ M4X%Z6Q1)]?B.YNSA<@(G3S]\R=;WO/EANKC8)&MZ2_FWS4TESJ9'+\NLH&6= ML1)4='4Y>0O?7$5ATZ"U^)[1A[IS#)I0[AC[T9Q\7%Y.@D81S6G*&Q>)^+.C M5S3/&T]"Q\^#T\GQGDW#[O&3]_=M\"*8NZ2F5RS_.UOR^\M)/ %+NDJV.?_" M'OZBAX!(XR]E>=W^"QX.ML$$I-N:L^+06"@HLG+_-_EUZ(A. X@M#="A 7IN M@_#0H.VYZ5Y9&]9UPI/%1<4>0-58"V_-0=LW;6L1358VPWC+*W$U$^WXXO:> M5?R,TZH 2;D$GUBYWI]]+'>TYF+ >/T:?!&'599RN@37=,/JC-?@#+Q[[%B! MKX\;"EY>4YYD>?U*7/YV>PU>OG@%7H"L!)^S/!?#5E],N5#=W'N:'A2^VRM$ M-H5TBKXX=AHX=AEI_H=7?'0>W--U6 M&<^H,9Z] VQVT,S+-_4F2>GE1$R\FE8[.EG\_AN,@C],T7ERIL0:'F,-7=X7 M'RI6U^!;*?)#GOTC!O^#R O&D/=^HM9/DSEV"]'7NVX/\O P M>9_$N7E(]HY(Y^YGD(2XI]%D!;%9)#F*)$Z1?_[<9OP1U,XGAF@WCGK2=(L0 M169ET5%9Y%1V4V6[A%- ]PHS.>%-$B-- "'],3;8Q#.SR-E1Y,PI\E.VHD): MO:V2,J4@926O1.HW2IQIMX<1Z4DTV,26?HR/$F.GQ*^,)_EK\+80F;1]#*]8 MS4WZ8L.]YS'J*318101!L\;Y4>/\.1K?)UD%OB?YEIKTS?4[SS">]_09K**( M!&9],) <"IP*OYW?GH.O8BJ+H>Y.EQ9+["[/UDG#_1JP%6AMUVQ'J[)%3\JJ M#:L.UQM[\0)2II:YYM8Q-#W[\J;V6H?><"R-#AY\Q>O)FQJOA"]T\FYQ>I(= M'"BY-.IG4Y,11I9'6-(2^L+EP5'W_D%?HLM$%2AY";T!$YI8&/@+F;C>#)YPG;VK0$K]P-CK!. D^ M.%Y/WM1X)&1U"WBB$FEF=08ARZ.3X@Q1@XW==H, DMTP1) MD",WR QE66BJS3OODL]ZMOHV2_R\[_8]V))$I1.'J5[83QX'@]>5/C ME61&;C*?3CM(9VU_^>HT485)&B,WC9^?<) .W?X[C=-$%2BIC-Q4'I)N]/6I MIM!EHBJ4"$7N)>R)3*.O2+5Q=9FHHB3GD)MSW1R3U/=M$6"7Y+;5O]O;X,GF MR9L:NX0HFH].+DX,#X[7DS>UB">)'+J)?#JYA#IB$>J_TAB,YI;222@Q'+HQ M/*#$J,.V/WN=)JI ">/0#>,!^2745Y6:0I>)JK!3I'4O.]WY)=37D8:AU8VL M0RN9%KJ9UOFTP+."/KV[F+O.Z6KH?//E30U<,C,D8_-+Z*3NX'@]>5/CE0@. MW0A^1G[1L8IF_=*LP0@&<\M3*.D;NND[(,'HF-6FK\M$%2A)'+I)/"3!Z(M* M3:'+1%4H>1FZ%YTG$HR^BC2,K6&I:1M;+,&&W6#[O"VS--LD^8F*C-O-T-GF MRYL:M"0F'EWRQ5Y+OKZ\J?%* ..Q)5^L0S6'3Q%WLM_OKRIL8K48S'%G^QX>ML M&/9I9[0*;(^AY##V5?S%.FZUJ:*;6*8PD3PFWDJ_Q%#4C?K+$I.13:3D)QE3 M^"7Z$A*BJ%^2-EE9!YA(U)&3A=]L24N>B3>:YE%<)VOZO+3C=CQT&OKRIG:# M1"H97?PE7HN_OKRI\4I D['%7Z(3%T+2KQ,:K&+;Q@S2V;_DJP),3E> #2;0 MIE#BF7@K 1-]C7D&M?QMLK+L8R(2IF1,&9@8-B8%L+_WQF 5$\LN.B*Q1]S8 MNV)%0:OT/V0=KU5A7][47I!T):.KPL1K5=B7-W7SGX1U-+8J'!D*OK/^C#88 MQ3/+E(XDI"-?9>'H=%G88 (MDR:2K(Z\U84C?>5Y-N]O23(9V5)C)%$:C:D- M1_JFW'C6IXK1J-]]T\X.]&;[_^>D6HL! SE=B5;!^4S$5>UWU.]/.-NTF]+O M&.>L: _O:;*D56,@KJ\8XT\GS3[WX_]K6/P+4$L#!!0 ( ,VH6%64U0[\ M( 0 )D. 9 >&PO=V]R:W-H965T&'*VE>M09HH&G(A=Z[&7&+"]]7\<9%DR?RB4*^K*0JF"& MNBKU]5(A2YQ1D?M1$/3]@G'A349N[$Y-1K(T.1=XIT"71<'4Y@ISN1Y[H;<= MN.=I9NR /QDM68IS-%^7=XIZ?H.2\ *%YE* PL78FX:7LS"R!F[&'QS7NM4& M2^5!RD?;N4G&7F ]PAQC8R$8_:UPAGENDT\LS1NF:&349*KD'9V81F&TX;9TUL MN+#;.#>*OG*R,Y-Y)I4Y,:@*8"*!SU*D5>]&K% ;VC"CC^&>FHK'!A.XQJ74 MW&@X@=^84LSN GRX1L-XKC_"$7 !MSS/:8_TR#?DHEW(CVMWKBIWHE?<&<*M M%";3\$DDF.S:^T2MX1=M^5U%G8!S7)Y"+SB&*(@B^#J_A@]''\%1( _W.#CK MQKO&F/!"AQ=N\3K\[#7[T'.XO=?\I/A,RASA]T5;>IC2INQ3_VH#7S9+A+\^ M$Q#<&"STW_ODKE8]V[^JS1&7>LEB''N4!#2J%7J3'W\(^\%/^Z0Y$-B.0&>- M0&==Z)-I'*N2%.""CB<)0HU8%@C_P=$^WA58WX'95+::A.%PY*_:=+Z=,^PW M4W:=8K$M5BYRT'^_W!X 6+3H_>N2G]AF^_D^\7:5A..[$]KTU@[0W]_K=T!F<7 M+^AT+OA..A<-G8M..C-9%*AB3IP*2HLIU;&3!Q8_TIYIC$M%U' OLT[8MT;9 M@4FU=.UN%M9J19&?4O&DBKE!IO3'?Y3 MJ=/PG2J%P?.U(NAT[-[F-)@W44-Y^M,396Y!L353F' #]TZUJUKJ*A=\E^.IE#R72@=!V18J>18JZ2RPE:%+%!@Z% M%6_)1&'D*FDK5]=AR$2[1J7ND-6A^; !P6S%8GF^<1&="E>DM:%A;7A,!W8; MQBIE])&]6N!JU^TQ:DI<<#I\6;&[&;Y50;]U^:?JE;HW$3&7I3#5.Z 9;=Y= M4_?:\)^G5X^V6Z923I>7'!=D&IQ>4*U6U3NHZABY=$^)!VGH8>*:&;T=4=D) M]'TAI=EV[ +-:W3R/U!+ P04 " #-J%A5 E]_2&H& !+*0 &0 'AL M+W=OZ+A?9B"Y/MP#U^=<.YP_4O:= M[P@1X$>6YOQBLA-B_VXVX^L=R6)^1OV/*<'D28Y^3:K439)1G*>T!PP\G Q>0_?7?J+8D 9\2TAC[QQ# HJ*TJ_ M%R>?-Q<3K\B(I&0M"HA8_CN22Y*F!9+,X]\*=%)?LQC8//Z)_K$D+\FL8DXN M:?I/LA&[B\E\ C;D(3ZDXH8^_DTJ0D&!MZ8I+_^"QRK6FX#U@0N:58-E!EF2 MG_['/ZH;T1@ _9X!J!J A@[ U0!<$CUE5M*ZBD6\/&?T$; B6J(5!^6]*4=+ M-DE>/,9;P>2WB1PGEK<[RL14$):!.-^ +S3?GLX^YT?"A7Q@@K\%-_*0)6M! M-N"*["E/! =3\#%.&/@6IP<"Z -X?XR3-%ZE9"KO[_0V3DD30](2._")4<[! M?2X++DW^(\7U."<#N:4].V9!\*T=)\#M9.N#U%1'R&OR-O/;][15X M_>H-> 62'%PG:2IK@I_/A+PE!;'9NJ+_X40?]=$G^S. O;< >0@9AE_:AU^1 MM1P.R^&P/7PF'T3]-%#]-%")AWOPM#MC8G2"\,T0Q;1_Q_?QFEQ,Y+SFA!W) M9/GG'S#T_C+Q(<0 2N:2YV1KXGD+ $*53IN)Q" M*5+GLV.3B#$*U4&M!/TZ0=^:8)T6H$P>,6)*[P01-"\@(K'7'%O4= M6[QFP4;C E\NSA5&Z\I:=GJ, MUY.<\G%H-W*[.$.G%NX*K4U5F3BTN_@O"'2%V+SC@:9ZIJ#%O.?!*$>'=DL? MK=!0M^XPZJ:JQ^">1)6[0ZNK+B\KE24-=3;FY]3I7:&U22NOA^'+119:&X;1 MC!VAM1FKA@':.X:A,T;O :9!B+IU:(@*PYY*5*T"M/<*PZ;)7+\TQMV>RQ2U MZ,E/&3.T._,S6NO4DUVAM5>'RI21W91_06N1[KUAA+L*9HCRD=?S:)#R:&3W MZ-%JBW0OAHNH6T:&J/YD&VMOJU$NKP]YLD[V"#O8 M<;!V *,9.T)K,U8= +)W $/GC6')CK1UO2FJT?ZV4U3>C^S>/VRJ! 8M[3J" M*:AGZ8B42R.[2]L%%SFU9U=H;:K*GM'P!?W0PM%-&"T66N'H41!&/5TC4EZ- M[%X]7G!U1P[FW5;<$(3[Y%;9-K)ZY?*]5!LQ7<7K[U)[GE%GI0SUX";NR2VRW:+K?8J3>[0FM35=Z,AZ_.AU:-[L#06W3W> Q14=3W M9)1/8[M/CU9;K-LQ#+5?,O0@W&,,6'DVMF^CWQ">;$@N$MG>9I2);;PEP\37 M#CRZP'Z'GV/EYSAR(+[6GF T8T=H;<:J(\#VCF#H-#*LS+4^P!04]52FZ@.P MO0\8-G$6AGW<13<]/:AGBOO*K7V[6]O%UW=JTZ[0VE253?O#%^L#J\;7W;@I MJQ4M/. M.[J\?H>W^XW?TOV72Z]O[0]&,W:$UF:LV@/?WAX,G42&-7K0U3934,^/(;YJ M"GQ[4S!LWN@_E$^U_4-34-\45V;MV\WZ&>UUZM*NT-I4E4O[P]?M0\M&-^,P MT+37L'*?]YFBLFS?;MGCM?>$UWP[!T'M'1D]"'=K:-9XTZUXS? Z9MLDYR E M#W*0=Q9)INSTYM[I1-!]^?+;B@I!L_)P1^(-846 _/Z!4O'SI'B?KGY_&PO=V]R:W-H965TX_/!7,.T.F!LF>^(42 7UF:\YFU$6)[9=L\ MWI ,\TNZ);E\LJ(LPT(VV=KF6T;PLDS*4ALY3F!G.,FM^;2\=\_F4[H3:9*3 M>P;X+LLP^_V)I/0PLZ#U3[=X31Z)^+Z]9[)EURC+)",Y3V@. M&%G-K&MXM7#+A#+B1T(.O'4-BE*>*'TN&E^6,\LI&)&4Q** P/)G3Q8D30LD MR>/?"M2JWUDDMJ]?T&_+XF4Q3YB3!4U_)DNQF5F1!99DA7>I>*"'OTE5D%_@ MQ33EY5]PJ&(="\0[+FA6)4L&69(??_&OJB-:"= ;2$!5 CHUP:T2W++0([.R MK!LL\'S*Z &P(EJB%1=EWY39LIHD+X;Q43#Y-)%Y8OZXH4Q<",(R@/,E^(?F MZV/K2[XG7,@!$_PC>)"7+(D%68(;LJ4\$1Q<@ 7-!9/CL,,IN,-BQQ*1$ [H M"AQ1OW50O_50RRFH[G14XGD# M>*U>T-5B3"[F]17?XIC,+#EQ.6%[8LW__ ,&SE^ZRLX$UJG3K>MT2W1WH,[K M3'X&R7]R4"UVI[CE+/1-8IU2O+M4S#NG7G(#?!#- &4@)UX[K$2$H$0IY MW<^1X[M3>]\N0@V"[L2I@SKD_)JE%-+S+2N^: 4#8]&X)33;Y4CYJM Z MTA3ZJ,]5$X4FW@#7QO&@T65&2U@%UYV BMCJHH((#I!M/ N:3>MT&:N V@2B MOHYI8L(!D8"-C[2/DF M-6&>%PVX 6S<"IKM2K/*UK(THHQ6M3.A=6MN+!!&;UQ[0J.)CB[W3&C=Q_@VJ0E!K]%X@:.T5&#QLKX15:ARF,>DPU05XP8/RH<4-D M=L.Q HXTSNCU.U4;-* YJ+6+-/OBZ?*-5+/KZZ(QI$NP,4-D-L,1XHU4AU,8 MFD*Z#!L'1&8'?%TED.IJ$"FK4%V4$PYLAU#C?LA_PRH4&:US]$'!F="ZI38& MBLP&>HJ (=4?-;*@V_ -"5ACH5'?[G5!_L#.%#7&A\R;O]$" MIN[ND--?V^F"O(%U"6I,"YE-:X2 J:ZD3$%32/?XJK$MUVQ;(P3,5=VHS] 8 MTF78V)7[BET9%:)*[IPFJ8.KBW*4*6.W#IF+$_X[S-9)SN5D7BV/'=^HD+0K+S<$+PDK B0SU>4BI=&<91=_^MB_C]02P,$% @ MS:A85;JTL0M-$@ ,\D !D !X;"]W;W)K&UL MS5UM;]Q&#OXK@J\XM, EUHS>*C@OK2Q37%(\5GI$3EZ]NRQZ[]L;YIFB/Z\76^V;T]NAN'NS>GI M=G73W-;;U]U=LQG_;YI<^VM[?WM;]7S\TZ^[Q[8DX>?K%I_;Z9MC]XO3\[*Z^;CXW MPV]WO_3C3Z?/7B[;VV:S;;M-U#=7;T^^%V_>29GMCMB;_-XVCUOP[VB7RT77 M?=G]\.'R[4F\"ZE9-ZMAYZ,>__?0O&O6ZYVK,9 _CEY/GA?='0C__>3]QWWV M8S87];9YUZW_TUX.-V]/RI/HLKFJ[]?#I^[QI^:8T3[ 5;?>[O\;/1YMXY-H M=;\=NMOCP6,$M^WF\/_ZS^.9 >(=.( >3Q SCT@.1Z0[!,]1+9/ZWT]U.=G M??<8]3OKT=ON'_MSLS]ZS*;=[.KX>>C'O[;C<FG4T@BCZ?KMMQM_5F\OHY[:^:-?MT#;;IP,NHWJ M?G9EBSXUJ_N^;S?7T0_UMMU&W[YOAKI=;[\;U_SM\_OHVV^^B[Z)VDWTL5VO MQTIOSTZ',=%=N*>K8U(_')*2$TE];NY>1TG\CTC&4CH.?X+_>%" M/_QT/+W/YU@^GV.Y]Y=,^#N<)%<:A^-2]W&[C_";[5V]:MZ>C)_1;=,_-"?G M?_^;R.-_NI)BS]_5VYL]"E:[?S1_W+TXT0PORK[$$PU_1=O=AVW\F7=D>7&3@%.=&$6R+1.;N$N3/D>5H9+]V0[V. MZN.%8XBN=M>'A]WUP15B;@<@"AD;8=I6LHI%[ ZT> ZT0 /][?7GU]&O_?Y2 M!L_D'N?=Q;J]KG=WHFW4745[V^ONH>DW.W!%JZZ_Z_KCWW?VXSUQLYHH QJ& M+^B8G&EGK'P^8V70IZOD3)3)F99H]9QHA4)#W=-<:5;VQRHM#<2Z;";P*F)U M+X_QJ_ 1=0WQN-" P(@ATQ\.YDF7RIB>KF(1 [^($\(X'0U25 M128-Z+FL1MH_ 3[% 1. 3[>;]I5>S=>VPGPH6Z\Z\'D34]:T0D1QB<$*Z'@ M\J8GJRB%P#D% 3X'5\AS\T[MLDKS"58G%*<0.*GX?-/UPZNAZ6^C87S,'!_D M[KIMZZ:?N"OOFC!YTQ-7'$4480!D)1=!6'RIC_7*L(AXR#T25:BP>5-3U81 M#8G>VPGT'0_6@"5S\Z'6997$$Y<_"1H,."WXU&S;R[$*[7CWO1VOA-?CX\8\ M..*.O2NT1 ]"*@HBDS XLE(/+F]ZLHIZ2/1N3\$Q=5SG1&7"T;8JLV0"C8HG M2)PGO.MN;YM^]0(PHGZ]Z\/D33\+BI+(/ R,K#2$RYN>K*(A$N^5$& L',\E MJ8E%E]$4%A5ED#AE %6(ZH>Z7=<7Z^;55=>_VM9K=["L70HN;WKZBIC(*@R$ MK&R$RYO>@E9L),';'S@(CP=K5\0LDV9CQF66EE,4,5'L(<'9 P[$Z+_15VLW MXH'ZUIS+FWY:%?-)\-D*!?"$E=]P>=.3!4,6O,5" #QQ],H3$]ZVD2C$!+@5 M%TEP+D*">VYG$E_'NUQ+]$L2Q8.2+ R;K'2'RYN>K*(["=Z!(;!I3VC*0@H3 MG XK44QT)A-%3A*QB1Q9ETZ;2M951/$(%6L)<59"XE.G]XFOI;W 'N)ADNJ*%,:-ME)68D, MES<]645DTI#)3FK/;.S>IL-HLK>9*M*1XJ2#Q*='\Q-?RKMB2S1@4K"5)' O M">]FDB6X3*JX3!HR^TGMJ8ZC^>FRFFQ^IHIYI#CS( 'Z\NXHOK)W"9?HT:2* M!J5AHZ*4E=UP>=.35>PF#1D5I:XID-4==5A-=D=31452G(K,>%9Z8?L47]B[ M@$LTVM.1 M@1VL..5P8.]KMDGQZ+S+O$1W)E,<*0L;1F6L1(?+FYZL(CI9R# JL^=,26)! MVC9*\XE'J4R1D@PG)6Y$S^V-XLZ]:[1$0R93+"@+&TQEK%R&RYN^X5UQF3QD M,)7;$Z?$[(RZ;";ZHKEB'3G..MQPG-L,Q9W[5HC+FWXJ%,_)P\9(.2O!X?*F M)ZL(3AXR1LKM"5$>FX_R#J/)ZV.NR$B.DY&)ZZ//NT7X"MZ%6J+IDBL&E(<- MD')6BL+E34\6O!84,D#*':_X6+-[AU$U];:28A,YSB8F0-GT0WO5KL;;]IYJ M'O_D#)VUK\+E33\;BL+D85.CG)6D<'G3DU4D)0^9&N7V/,A\*$=-])?2%)DH M<#+Q[^&FZ:-UM[D^S(0.;]*]&3'Y83/^8JQ.=""3C_7=^(#3-X?W=ET9X"MY MOWFV1 ^E4&RF")L6%:Q\AEWG?].-=>*'H1A'6$2E8.R)9]39XX>AYF,5P]$[D MU!U-<8H";XOXO1%>.&8W66D-&UUFJ2BF<*,X08%S@N,E:W^[]=U:C+OVQM02 M38U2\9 R;$!3LI(++F]ZLHIO23"!*3#**TF[J"E(@(E3@3FPO%K M=L[QD+TKOT2SI%04I0R;!I6L/(7+FYZLXBEER#2HM.<\]@9CA]'D!N-2,8L2 M9Q8>,)_;3L=7]"[<$LV34K&9,HS-E*QLALN;GJQB,V7(?*>T.8KY$CIJH@<% MI$]P$N.!T+D==GQ%[Z(MT4LI%6\JPP8^)2LWXO*FJ\,H;E2%#'PJ>YAC(A0U MT8-2'*;".8P'0GVV'..K^A:.RYM^CA2=JL+F0!4KM>'RIB>KJ$T5,@>J[!&/ MA5+,1 ]*49 *IR >*/78>(POZEVW)=HLE2)#5=A8J&)E-ES>]&05LZE"QD*5 M/?&Q0(J9Z$$I!E+A#,0#I"_??(S'X%W&)>9&E:)'5=C]&2!.ER0 M/)P]%+(PBYD8XG!0'0YG)5X/42_<@TS$X*\MMXBX7 S4Y>) >;F85U^.RYV1 ML 0)!TG,Q?8) M=?RKMD2/1T"U71$V 1/,.KL+">U"I=V0*=C3T2@U0&V,P !G(61Q*8C.UJ;% MU_&OV!(-'@$U>478]$HPJ_$N(\<+]7AQ#5P2HO9TRH8H9F,$!J@,(9Y+7D5] M]LX0B_F7;8D>CX#RO2)L?B6817N74>V%LKVX5"Z)4WM"96]W=EE-[7<64&67 MD-DEH3I_[S.QE'_=EFCL""CT*\+&6()9WW<1@5\!%'X%KJI+*L[3LRSAE'%'-+&H=_FXW!EG"3 C&3;0$KP"P&SNC(0!X\%E=V?MC"9\^"<] M>PXF@+ZO( 1^CP!W[HXFCO7/8)%.#Y ,%A*?:4WOD!:\JL!L[HQ4 =?!M7C] M=DD_.<,OL+-'7 )(^@H9V(7!-8']"[-(%P9(!0M"*WC6+NDG)QHULPJ"V1CQ M >Z!Z^=Z[I-^\F9LE+9D[9QV:9E,!0ST> 4AR/MT!7O19FG"N3>\N-P99P,0 MEB1PDL0KS,OFSD@8< ]<#I>BCHGKC2(IS%??G79I(B9>.Q )_,:B61.E_Z_= MTT30_C!8I"4#M(%%$CBUXA7]97-G) RX#"ZU2^+>GD=9=W34Q@@,, ]"H]<' M[[.[^OB:_M5;I#,#Q()%$DA[>%6 V=P9"0/:@VOODG!UJ.#9TLU.LTGM9@&4 M>P4AW>L#VOG?0%R9WP+'6!::> HBE<8F,V=D3 @4[@<+P7:U/%&EJWH M[#*;EG060,Q7$&J^/J#U^NXZ?%W_.B[2K@'BPB(-'%#Q2@:SN3,2AE\8&32@ M2NWAD^-+[!Q6T]]B!T1^!:'RZP-;G^^\PY?U+^(B+1R@."S2P'$5KW PFSLC M84"*<+E>$K7V(,JA_^PTFQ2 %D#L5Q!JOSZX??F&;"(*_ZHN,LP"2L0B#1QF M\2H*L[G3$P::P@+7\26_P=;QW4^V++3+;%(76@ 18$&H /L]GKUT@S8>A'=- MN=P99PU0K2QPPL4K3LSFSD@84"9<$I@$L3V,LM6BW5:3& ;TAM 3!AB>NTL; M]^A?GT7:/QG\ENRPU[,$K[(PFSLC8<"&<#U?$I#V="I/K9&)PRJ+)P$)F LA M!HP#\JLV=O%(_>N^2.,(J!F++.R=+L&K6,SFSD@8\"5<)Y@$.OUB%VZC!P;T MA04A,$R"?'8W%U_(NV1<[HPS SA5'CATXY4Q9G-G) SH4!XT=,OM89HE-NTT MFD0I("Z$[C")TMGM6WPA_Z(MTA0"NL 6/V=P9"0.>@\L, MDV"U)U_6;1^U,0(#?(30)Z:!ZK%3&U_+OVJ+]'J 3+(H D=BO.K';.Z,A '5 MP36'*9@6#OU!$Z:HC1$8H"2$6#& *>=6;5Y]8S9WQFD"]*@('(7Q2B*SN3,2 M!JP'ER.>MU6;5R#YR=T<&6L!A(\%H7S\!''W9FW\8/\<%FGX .ED06@G(YNU M>663V=P9J0*R0R@G^U$]ASZR1050&R-.P%&*P%X,KL'L7YA%>C% AED0.LSS M-FL7,UHRJ(T>'U!'%K@BL>]F[7+&>U2HC1$HH V$M/'SI>MEN[1Q[]ZXXG)G MG Y 5LK <1*ONC&;.R-A0#MP36&*-I:T#"!N8P0&Z $A1CP?F%^UBX]'[5__ M15HQ0%E9E('C*EZA9#9W1L* O>#RQ"3@9[QPA=H8@0&N0>@:>P%^=D $BE= F!4BE=.FX5+\HHNL[G3$P:BRQ)7.:90+N@Y&FYC M! ;8#"&.3*-\;LN66,F[9ESNC%,#^)0(FZE)7MEE-G=&PH )X3K')$CIF1IN M8P0&& LACTR#=&Z?EEC)OV9+M( D$&B6(FP.)GDUE]G<&0D#@H2+'),@I>=@ MN(T1&" RA#;RC"NISZX<8CG_PBW1^9% GUF*L F8Y!5=9G-G) Q(#JYR3"*5 MGH#A-GI@0!Q9$N+(,Y Z?PC\XQG,K9DR\)1)$E(8H,<&ULK51-3]PP$/TKHQ155*(X'[!4-!L)=H7: Q5B!3U4 M/7BSDZR%8P?;V85_W[$3HD5:: ^])!Y[WO.\9X_SK38/=HWHX*F1RDZCM7/M M.6.V7&/#[;%N4=%*I4W#'86F9K8UR% M&+!=TW#S?(E2;Z=1$KU,W(IZ[?P$*_*6U[A =]?>&(K8R+(2#2HKM *#U32Z M2,YGF<\/"?<"MW9G#%[)4NL''WQ?3:/8%X022^<9./TV.$,I/1&5\3AP1N.6 M'K@[?F&_"MI)RY);G&GY4ZS<>AI]B6"%%>^DN]7;;SCH.?5\I98V?&$[Y,81 ME)UUNAG 5$$C5/_G3X,/.X#DY U .@#2?P5D R XQ_K*@JPY=[S(C=Z"\=G$ MY@?!FX F-4+Y4UPX0ZN"<*ZXXL+ /9<=PC5RVQFD(W(6/L,/;@SW'L/A'!T7 MTGZBV;O%' X//L$!" 770DHZ"YLS1Z5X0E8.VU[VVZ9O;+O ]ABR^ C2.$WW MP&?OP^=8$CP)\.0UG)$!HPOIZ$(:^+*_NS 7MI3:&V'AU\72.D,W[?<^A3WE MR7Y*WWWGMN4E3B-J+XMF@U'Q\4,RB;_NT_N?R%ZIST;UV7OLQ45=&ZRY0RCI MS)^%JH$WNE,.= 525$AG389P55*&5L$1"URM !\[X9YI>8/6A8MS!)7WJ6U>PE\8XWO:/$'4$L#!!0 ( ,VH M6%5D>R6]#@0 ,86 9 >&PO=V]R:W-H965T0\1 M/RXM;+U<^,)V>V4NV*M%2G>P ?4U70M]9I:82'GCT%PO5?FG-+!3"EF:1^L*/'Z$8R#-X 8]D_A<=BUK'0D$F M%8^+9LT@9LGID_XHA*@UX,F%!E(TD/_;X!8-N7+VB5D^UB-5=+40_(B$J=9H MYB#7)N_6T[#$W,:-$OI;IOO4:BVT(X3Z>8,V?*N.5 "B28C^^)ZQ5-\MA=ZC M!QZG/-''$KU]!$59)-_IRU\WC^CMFW?H#6()^LRB2-\5N;"5)F6@[: @<'\B M0"X0V$!ZBUSG!A&'D([VA_[V1PAT.\[;<;/=UE*4>I!2#Y+CN?^IQSJB>ORF M&'\_Z7+T24$L_^D:]80]Z<8V3^2=3&D 2TL_(&484"+E67"B?H:0YMEI'#:N*Y\X5]J$_7+O+(')=% M#=:3DO6DE_432'FG5X8@B[.(*@CU ZW%"1@U2T87U1.>5V/QGCA3YXQK1Q6> M.TXW6:\DZ[U2X@0ZY?5:;,C$/Y>W7>2ZE^2=EHRGO8S-0I I$"7A+G:]$-<^ M @.!-:;URVG]$5<"?T@9!@)KR# K99B-MQ+,VE8E&)]9M5V$9\3KMNJ\9#WO M97V?L2ADR:Z+5&_GM;=F(+#&D-BI?KR=$3U:@ ^DQ%!H32EJ.0:/Y],"N^[! MZ>3U.MH/&C*'0FN-700.[ M8UJX-\9<+<5 :$TIJO2"^^/+ZRS<#BD3QS^W<+O(]]P+#JZ"#.Y/,D^@WZ/V M/ H1BU/!#V#(=K\*] )=?;L&0FN.7:4A/!W3N8,&I:'0FE)440GW1I!7.M=O M.]>;G#NW7>2[Y()SJVR#^\--F6CW5(27$FT_QM5W:B"TYL15+L+S,4T[:'8: M"JWYHE^%)]*;2%YGV@*[F1AF9Z;M*L)^MVE)E71(?])YTBP[*?6V7;W[,!!: M<\C:-LRH^S##;L2,D9!(E9#(B'LQI+W/@OV63]M%I&;F$V^[MLEH=G@_4[%C MB401;'67<^MKFXO3INGI1/$TWW=\YDKQ.#_< PU!F +]_99S]7)BMC++K>O5 MOU!+ P04 " #-J%A5=G/]M! # "5"P &0 'AL+W=ODW"RX2K/12+&V9"L!1!DJH[3I.WTXP858PS/8F(ACRE:*$P40@ MN4H2+)[.@?+-R.I8VXTI6<;*;-C!,,5+F(&Z2R="K^R2)2(),$DX0P(6(^NL M)5#RR3BP4P0*OJ)KRS6MR^>_ MX95TO+(^7L;GO5J?"<6Z'-7B_+S1X>A:02)_U7F? M!+$&*WC_KM-W/M4);XFL8D.WM*';Q!Y,P5Q)A"T1EE)?;B1),1&9!V&,Q1)J M6Z^18W<^\IKB:QB0[^TH?^&3=YOTX:6R"HV^*4-?F,W?,-L2>84 M]NIQ_X^V[/EE4^::\I#>3HC?]^H;]Z1,]:0QU1O0?YVF4Y_[UQ3MM8YM)-VW M5"V15?0/2OV#-^S809LVM$16L:'C/(\/3OL]6W!6[M+NBZ:MB7$]_T77VCN# M3P+Z.#,/2A3R%5/Y#%3NEC/G639IV<_A^Q'Y#)@O M%$^S,6K.E1[*LL=8S\T@3(!^O^!<;1?F@'(2#WX#4$L#!!0 ( ,VH6%4> MZ3O_,P0 (@/ 9 >&PO=V]R:W-H965TD[.3?CY04V98H MI07R8I'TW?&[X_$^WO3 Q3>Y!5#H*6.YG#E;I797KBN3+61$7O(=Y/J?-1<9 M47HJ-J[<"2!IJ90QU_>\R,T(S9WYM%Q;BOF4%XK1')8"R2++B'B^ <8/,P<[ M+POW=+-59L&=3W=D P^@'G=+H6=N8R6E&>22\AP)6,^<:WRUP&.C4$K\1>$@ M3\;(N++B_)N9?$EGCF<0 8-$&1-$?_:P ,:,)8WC>VW4:?8TBJ?C%^N?2^>U M,RLB8<'9WS15VYDS=E *:U(P=<\/OT/MT,C82SB3Y2\ZU+*>@Y)"*I[5RAI! M1O/J2Y[J0)PH:#MV!;]6\-L*88]"4"L$I:,5LM*M6Z+(?"KX 0DCK:V901F; M4EM[0W-SC ]*Z'^IUE/S.TAI0AA:,$(SB;Y2LJ*,JF?T$3WHE$D+!HBOT6)+ M\@T@FJ->A?>WH AE\H-6?7RX1>_??4#O2@W*F#XQ.765!FRV=9,:W$T%SN\! M-T%W/%=;B3[E*:3G^JYVM/'6?_'VQA\T^ "[2Q1X%\CW?-^"9_'CZG@ 3M $ M/RCM!3WVCL'3]Q$]YCM"TY? DKP97J?_Z430=T>A3T_Z_DI _]QSQI!.Y ,1 MZ;^VR%8[A_:=37&XDCN2P,S1MU^"V(,S__47''F_V<+R1L;.@A0V00J'K,]O M""-Y A?H#Y(7NM(@;'.WLA&5-DSIVL]QZ(?!U-V?^F&1TD+C1NH,X*@!.!H$ M^!6DO$+W0'-9" -5E[>$[T&0%0,;ULK&^_Y$DA!*3ZH!E1^JOXE0W<^"WOX!L9.W-XTC@\&3R6 MA7%7EY]G(,+FZ*03X7$8CN+6.72EXC .(OM98._(8-X@N*6@NGH::':*\3K; M?L1X$K7 6<5&?A^Z$W[%@^C^Y$JS):TSQ@H0=Z,7^!%N ^R*Q8&/>U(9^T> M_F R+PWIO)+(M8DWRN2WLG;N\)%T\2!=O9K,M?I9H+W &[7/HRL6Z2K94P#Q MD>[P,-^]ELYAM^YZDVC<1M<5FP1AV /N2'5XF.NJ;#;O%"NV+FV-L1^WRO MB:KMJR:*[\K.:<65[L/*X5:WRB",@/Y_S;EZF9@-FN9[_C]02P,$% @ MS:A851BZK:/D @ '0< !D !X;"]W;W)K&UL MK55M3]LP$/XK5H8FD("D2.]]YN%'ZWA0 ECP(+LTH**PM+\+09 4(:DY5"1)WEDH+ M:G&J5Z$I-=#<@P0/XR@Z"P5E,DB'?NU&IT-56V_PE<'&[(R) M4[)0ZMY-KO-1$#F'@$-F'0/%WQJFP+DC0C=^-9Q!>Z0#[HZW[)^\=M2RH :F MBG]CN2U&P7E ;H!<0.(GP/ZKP"2!I!XH;5G7M8EM30=:K4AVEDCFQOXV'@TJF'297%N M->XRQ-ET!CG+*"=33IDPY#.C"\:9?20GY O5FKH@D\-+L)1QDB0Z)G$4QQW^3/\>WMOC3M+&-?%\R2M\U])4FLH,R/?QPEB-U_5' M5Y1JEGXWBROA"U/2#$8!UJ@!O88@??NF=Q9]Z)+XG\B>".ZW@OO[V-.Q4)6T M!BL[4QI32J@A%,LT_XF7&,O>$JL(GBM8)=!H#;("9\VI16/[X7EITT_.6YLGJ@>MZL%> MU?-":7N25ZY0L"FQ-NL9WFZ7='-,KF56:8TB%Y4E4EE45B+*A0AEPD.)'0TG M.<:$J]*'RG?(QBCSE=FE>?!2&ULK55=;]HP%/TK5UDUM=)H M/B"A[2 2A4W;0S<$ZO8P[<$D%^+5B3/;0/OO9SLAHI"B==I+XH][CL^QKZ\' M6RX>9(:HX#%GA1PZF5+EC>O*),.8J%GEESD1.FN6+FR%$A2"\J9&WA> MY.:$%DX\L&-3$0_X6C%:X%2 7.?L/83&KZ$,VF_L*UC/0>2M50\K\%:04Z+ZD\>ZWW8 _B]%P!!#0C^%M"M M 5UKM%)F;4V((O% \"T($ZW93,/NC45K-[0PISA70L]2C5/Q:*DS(24+AC F M F&4*.C %YT^,TR0;LR,A/,I>;*M"]#A\($D&? EJ SA:['BM%C!5/"5(+F. MG: BE.G0#MS/)W!^=@%G0 NXHXSIDY,#5VGA9GDWJ47>5B*#%T3.L;R$KO<. M B\(6N#CT_ ))AKN6[C_'.[J[6KV+&CV++!\W5?LV8_10BJAD_)GF[V*K]?. M9R[JC2Q)@D-'WT2)8H-._/:-'WGOV\S^)[)GUKN-]>XI]GA&Y0.0])=.3'V5 ME;['NR1ILUUQ19;+E)--['O1U<#=[-LY#@K-(6]:5/8:E;U7J2RK[&V36!&% M>ZMWHC XD-@2%':C=HUAHS$\J?&.%C1?YY!C2A/"@'$I01!=V]IDABTRKP]4 MML3XUR^HC!J5T4F58RX5R(P(<\4%INNJ^)X^]NA(B.\=:#T.V;/S3&F_4=K_ M%Z4GCKY_E'B=*_] 9TM,[S YW;WJ:UZ^.R)6M)# <*E1WF5?VQ35:U)U%"]M M05YPI&ULK57O;],P$/U7 M3F%"0]J6+&F['Z21N@X$2).F58,/B ]N\Y.&CJ150SQ);&= M>^_NG>V7=*/T@UDB6GBLA#3C8&EM?1F&)E]BQ3T\OIT,7[@,\<-V9G#$[)7*D'-_E8 MC(/(%80"<^L8&+W6.$4A'!&5\:/E#+J4#K@[WK*_]]I)RYP9G"KQA1=V.0[. M RBP9"MA[]3F [9Z?(&Y$L8_8=/$GET$D*^,554+I@HJ+ILW>VS[L ,@GGY MW +BOP4D+2#Q0IO*O*QK9EF6:K4![:*)S0U\;SR:U'#I=G%F-7WEA+/9I*23 M4+"Y0)@RC3#)+1S#I"BXZS(3P&5S5%S/#Z_1,B[,&PJYGUW#X<$;.* (N.%" M4(!)0TLU.>8P;_-?-?GC9_*/X$9)NS3P3A98]."G^_$7>_ A]:)K2+QMR%6\ ME_#32IY $AU!',5Q7SW[X3.LGX,_*2?I]B?Q?,D+]N?K9&ZLI@OPK:_?#=^@ MG\^9PJ6I68[C@&Z]0;W&('O]ZG04O>T3^Y_(GD@?=-('^]BS.VX>@!7?Z1*0 M;=@C.F@Y&95!L HD&9S&'/G:]:;WX#7L(\_NS&R=#:(D#=>[^O96\(_ZAIV^ MX4OT 9,%2>+2K#23.0*E/+;L$>8HL>2V3^+>!"_=Z^$?_4I&YUV_&HGACM-4 MJ!?>@ WD:B5M8SK=:N?Q$V]MX>_PY@=QP_2"Q(+ DJ#1R1GEUXWI-A.K:N]; MW$)>C^?-DO4$L#!!0 ( ,VH6%6Y3AK"D 8 M !\M 9 >&PO=V]R:W-H965TY!EQA8JB2Y%)PVP#S]24DQ3HN@;DX?8 MLL\Y/']>#G^B-7U@_&NQIE2 [UF:%U>]M1";MX-!$:]I%A5]MJ&Y_.:.\2P2 M\I*O!L6&TVA9.F7I 7!<)!%2=Z;3INSA MJ@=[3Q]\3E9KH3X8S*:;:$7G5'S9?.+R:K"+LDPRFA<)RP&G=U>]=_#M=1@H MA]+BKX0^%'OO@9*R8.RKNKA=7O4"E1%-:2Q4B$B^W--KFJ8JDLSC6QVTMVM3 M.>Z_?XK^H10OQ2RB@EZS].]D*=97O7$/+.E=M$W%9_;P"ZT%A2I>S-*B_ \> M*ML1ZH%X6PB6U]T1>PYPV.& :@=TK .N'7 IM,JLE'43B6@V MY>P!<&4MHZDW9=^4WE)-DJMAG LNOTVDGYC=T(4 ;\!<3H_E-J6 W8'RHYB /]\E ;@5M"L^-]V4\_P&'PLTVJIV"&<+P3CEW19W\R$:6@H'G".,B9 MH(5-;A5C6,90J_]^!L,1AD'Y-QW<[ZNQV4[&XX:MD2S9)4N;Z#%:I-26FV+XIFBM?[-W3NDK/K:K3OHCA)$_%HU8O:$P\%UBEJ,VTM2#-3 MO>'" SNN6D?EYN5,UAGDY,'Q%,V4K+=M2/S.3"<&G"S>4S13O&8 Z(: 8V:F M9?.'DZ%]:EIM0^?3-1)HJQ")]%/X(YA4<_J[@$"RW5-X% MQ#1;4 Y@6 +X"/QG&%DE.AL^>4@]13.[2;,''/F=STZ6.5F\IVBF>,TTT TU M2OQK-9TIB#*V[=A8QZV[ %3/T?:,=K9WKAZ-/=#)/;/;7)(-+03@D;#>2-3^ M$.Z)"?H!06%3R-F Y;J#U>B#W.@S/W 35[L;8T(".Q37MD:5(>Z;(J1!!3E9 M0%49O%=E4)_8JLROV_3QJ<*,CZ@P[D9/OB=_#IQ!>\<1GL\C_!Y(/,>)!-*$ MA-R$=%2%0>US!H0[*HR[O7/U:/Q![F.+@Q6F]F]6&$2:%<;=T+E"-,H@-\H< MK#"A;4SL=X'(PC%M6S-1S3'H ,?@!L<,CP*9R3%EQBO(^(IF]I,&&>079)!7 MD/$5S12O009Y !G4!AG:KVAF/VF0Z>P9IG\&4\@RT\TSDH%IYIVYJ):I[!!\]ED%%G@L!29OZ(!=,T MR59GQ%,\5KFL$>: 9;CF50UX1^#IK!FF;PA313 M^ZL?78PJTY3Q'"A#-,J0RU"&6 YEND:$6 YEVK9FHAIER$&40<:A3&@K,;]% M/%Z#\KD+#(^H+^Y&3UUBOJ*97:0IAOBE&.*58GQ%,\5KBB$>*(98**9S-C\' MQ9"]1TDNI!C2<2C39!AW.^?JT Q#+F,88F&8SB&Q,,RA J,9AAQ@&-@X];6? MR;S;KK9R5$XH,5X1QEG18XLKF16IGDF"GG[^>2+\BF>3IH!FR7^.Y4_ MRQ>/1?-2;O+\]^8+>_[Y9-2LD5S*6=402?W7@_PFE\M&JM?CCQUZ\ERS&?CR M\9-N;%Y\_6)NDE)^RY?_D\ZKN\\G%R=B+F^3];+ZGO^TY.X%31MOEB_+S?_% MS]VRHQ,Q6Y=5OMH-KM=@E6;;OY-?NS?BQ0!5?6. NAN@'CI@O!LPWA^@O#%@ MLALPV1N@3-X8,-T-F!ZZ2F>[ 6>'#CC?#3@_=,#%;L#%H0,N=P,N#QV@C)ZV MW.C@(<\;^^"MK3QM;N7@[:T\;7#EX"VN/&URY>!MKCQM=.7@K:X\;7;EX.VN M/&UX9;/E3[>_5YM?2BVIDNNK(O\IBF;YVFL>;'ZS-^/KW\4T:T+H1U74WTWK M<=6U)F\J\7<1)$61-'$@?M-DE:3+\F_B/_]#.1O_0Z29\-/ELDZ,\NJTJDLV M T]G._[;EE??X!7AYUEU5PH]F\MYSWAK>/SXO?'.\/C+@?&G]5OU_'ZI3^_7 M5W40])/BHQ@K'X0Z4E7QSQ^:^.TO?^M[7X:9<%9]%.KT749[;VT>#UD9?5CY ME;%?. ]V5K*><#K\@:9G[(^_85 M#3#VX8PRP#C,VKC',.^\SQ[SROSW-GUVT"L+CO@Q?N>%A>^L49*UOY\]PZ/A MX9J...A]+:SLJJ6-<[@I7X7Z]>0-B57)7_ MU[.67[?:I%]K]F\_E??)3'X^J7=@2UD\R)/KYIT?_:,OT4A,(S&=Q P2,TG, M(C&;Q!P2K#=_ZAEI M5N]6%X7,9H_B3LX74ORYV\_MB\]!_=CX)#&-Q'02,[:8LOT7K#D$\G ]'5U> MG3Z\C$6RHD5B-HDY).:2F$=B/HD%)!:26$1B,81U8G'Z'(O3P5C<[$7*7U6: M+=9I>==$9%_Z#2+'IA^):5OL[$7$*./1YK]NSNAD58/$3!*S>MZ/4=_[8;]> M\._GEWU+.J^75,_Z%G3)%^+UK)^B3OOJ^F3=@,1"$HM(+(:P3NB3ODT50V4[$7;^'&'G[^\W%?)^7I/^2/$?CQ;\9C9L\%,E#DBZ;O3VQ MSN:R$-7=\S)]63E8[-BL)#&-Q'02,TC,)#'KXM6.V/FT=[YNDV6=@\NZ9%F/ MQ'P2"T@L)+&(Q&((Z^3@Y7,.7@[FX ^9I7DA@KR2?5?+?!T)1&3WG8W,5*'@%RXZ#$A/5 M-%334I^ MV\7QY@''8>CHZ"0U#=5T5#-0S40U:Z>]G-2JT]XSN#9:V-EI9^\7=M'"'JKY MJ!:@6HAJ$:K%E-8-/;4-/74P],PDS<2FZ^TY]_);,:^CL#?X!K&C@X_4-%33 M4W$3;=U!-0S4=U0Q4,U'-0C4;U1Q4_+1?_G5Z!UG8/KNFA=#]5\5 M0+42U"-5B2NM&GMI& MWG#+31-Y'\1M76 H[=!.&U334$U'-0/53%2S=EJWTZ__D[5LM+)S1&47K>RA MFH]J :J%J!:A6DQIW<1K.VG4X4Z:_1,OX[T3+V<'G7FY[,U)M.\&U314TU'- M0#43U2Q4LU'-0347U3Q4\U$M0+40U2)4BRFMF[5M:T[]D#SSLN.H "4U#=5T M5#-0S40U"]5L5'-0S44U#]5\5 M0+42U"-5B2NL&:-N7HP[?P^7],R]H(PZJ M::BFHYJ!:B:J63M-4?=.@9R]/O6"-MD<7-=%ZWJHYJ-:@&HAJD6H%E-:-^G: M!AJ5:J 9AHZ.//2^,:BFHYJ!:B:J66K/K4'.>^]$9:.%G<,+NVAA#]5\5 M0 M+42U"-5B2NN&7ML>H[Y_JYGWS[Z@;3&HIJ&:CFH&JIFH9JFOFY/&;YY]01MC MCJCLHI4]5/-1+4"U$-4B5(LIK9MX;=N+.MSVTKD_H-?<'S!Z^_Z P];1R8=V MLJ":CFH&JIFH9J&:C6H.JKFHYJ&:CVH!JH6H%J%:3&G=]&P[652VDT5%.UE0 M34,U'=4,5#-1S4(U&]4<5'-1S4,U']4"5 M1+4*UF-(Z 3IN.UG&PYTL!TVX MAXUC4Q/5-%3348@VNZ":_LY;I8A'F12]T8?VM:": MA6HVJCFHYJ*:AVH^J@6H%J):A&HQI77346W3<;@_QL@+F2XRL9EHY[?B6R'G M:?]>(]HD@VH:JNFH9J":B6H6JMFHYJ":BVH>JOFH%J!:B&H1JL64UHW.MM%F M/$8/5H[1[AE4TU!-1S4#U4Q4LU#-1C4'U5Q4\U#-1[4 U4)4BU MIK1N@+;= M,_7#P7/EFWW-YFAENDRKQP]BE?Q*5^N5N,F+&DNSA9@E=?WZ>^)/T10>][V, MK\-EC@Y64M-034U8*'O*=[![M#M&:$ M:C&E=0.S[989#W?+1$4^DW)>BMLB7XE9-SZ'(Q)MHT$U#=5T5#-0S40U"]5L M5'-0S=UIG>!0+O:"PT-K^J@6H%J(:A&JQ936C!L6W7&Y^S13+1K!]4T5--1S4 U$]4L5+-1S4$U%]4\5/-1+4"U$-4B5(LI MK1N@;>?/>+CSY]V/LA@>?W1BHMT^J*:CFH%J)JI9J&:CFH-J+JIYJ.:C6H!J MX4Y[]7GOD^[1BPBM&E-:-PO;/I[QX&7NUY[]-?PN_A1O=D/6W_.W)WMZDQ)M MZT$U#=5T5#-0S40U"]5L5'-0S44U#]5\5 M0+42U"-5B2NODZ:1MZYF,T,GY M!.WP034-U714,U#-1#4+U6Q4YL M^9J4:2G*VD[FHMX7?4B*=+,?^M9D?=@[.D'1GB!4TU'-0#5SI^U/GIK[ G<: M)-&J-JHYJ.:BFH=J/JH%J!:B6H1J,:5ULU%MLW&X!>B@R7J:O359']:/3DJT M+PC5=%0S4,U$-0O5;%1S4,U%-0_5?%0+4"U$M0C58DKKYFG;%S1A^X(F:%\0 MJFFHIJ.:@6HFJEFH9J.:@VHNJGFHYJ-:@&HAJD6H%E-:-T#;OJ#Z(3M9'_2. M3E!2TU!-1S5CIRFCO>EU=W9MHD4M5+-1S4$U%]4\5/-1+4"U$-4B5(LIK1N- M;0?09+@#Z$=H#$[5>],1[?U!-0W5=%0S4,U$-0O5;%1S4,U%-0_5?%0+4"U$ MM0C58DKKAFC;(S0Y8R?H:*\0JFFHIJ.:@6HFJEFH9J.:@VHNJGFHYJ-:@&HA MJD6H%E-:-T#;7J')\&U]CI^@H\U"J*:AFK[3]L]8*Q=[MQ@TT+(FJEFH9J.: M@VHNJGFHYJ-:@&HAJD6H%E-:-QS;/J#).W< 6A>%S&:/XL?/Y+XW#-$^(%33 M4$U'-0/53%2S4,U&-0?57%3S4,U'M0#50E2+4"VFM&YBMMU"$_:N/Q.T/0C5 M-%334_E]YE2R;2XRVGR[\Y2%)E\G-]A.&O^79K-ZU++8I^CTM M?Z\7W+0/]68GVAB$:AJJZ:AFH)J):A:JV:CFH)J+:AZJ^:@6H%J(:A&JQ936 MS=>V,6C*-@9-T<8@5--034U -5"5(M0+::T M;H"VC4'UP\$9O2R:_<]D(;=3^(=Z M\D:5D_WDSDYZ*4LW615JDLQ2PIBD>1 M9"\6%(LBF6\N4VIN+G3S*+8'!)+E\E$4[[WE'^>1MGC]MRUY?W=>Q[2?%(LU*L92W]2J, M/IY/3T21+NZ>OZCR^_J']43&ULK5;;;MLX$/T50ELL$B");K;B9&T!J;-%%TC;(&[: MAV(?:'EL$:5(+4G'R=_OD%(4.V:<7OQBB=2!0SI1K&DG]E,U..@D% 9C"G2VYNY.H]M(+ZEJ^0 M7+M?LFIMHX 42VUDU8+1@XJ)YDGOVT"L =+!"X"D!20_"DA;0.J$-IXY69?4 MT'RHY(HH:XUL]L7%QJ%1#1/V&B=&X5>&.)-? <9 DV-R\^F67&@-1A,J9N2* MT2GCS##\>' )AC*N#]'L=G))#MX$"?*!<8YWH8>A05 M.'8"]0E)HR.21$GB@8]WPR^A0'CLX/$F/,0 =%%(NB@DCB]]@:\1[I/1X'I^ MG*VQS2&9.\2VB+L\Z?6S87BWKG/;*.UG3T8; M_OOO M,Z'W1+:A,^MT9CL#."FE,DWLMA*:%H5<"DSUFCY0>]FVI>&F6J(-W.-_(#8] M;WYG6ZD;GZ7/TGO;)HEZ_NP^[<2<[A1SU>7!J\7)G^[7JZ YJ+]>?%$Z>";! M8Y3%9WX-@T[#8*>&S])@K7%;G>M.^GP<;#>()(V?^>@Q&B2IW\>SSL>SG^LB MC]7R<$3&2Z6P=>RIB^SVX^)'$M17<7NGW0AC'#V-#=$O!_*C%,5>8_F:+R]7 MB'>TV!-;$[EP;?:R@^\'JA9,:*R#.=)')Z=89*J9)9N%D;4;QZ;2X'#G7DN< MOT%9 _P^E](\+NR$UTWT^?]02P,$% @ S:A85?\4OXW/ @ 3@@ !D M !X;"]W;W)K&ULK59M;],P$/XKIS"A36)-FO0% M1AMIZYA 8C"M&ON ^. FU\9:$@?;;;=_S]EY60M9&&)?&K_<\_B>._NNDZV0 M=RI!U'"?I;F:.HG6Q8GKJBC!C*F>*#"GG:60&=,TE2M7%1)9;$%9ZOJ>-W(S MQG,GG-BU*QE.Q%JG/,ZV3JO'4@QB5;I_I: M;#]BI6=H^"*1*OL+V])VZ#L0K946604F#S*>EU]V7\5A!^ /G@#X%*J.X !X#I<\32G@:N)J.L^@W*CB/BNY_2>X [@4N4X4?,ACC%OP MLV[\NPZ\2SH;L7XM]LSO))QCT8/ >P.^Y_MP,S^'PX.C-K_^FV;/O:#)16!Y M@^Y MVD&C=M#%'EY_O0&>%8Q+*@JZ36J)'UF\J4:;P<:9=:FK)O6]^ !F530A\P\5AA!S![:0C1[ :(]Y>-&^?A9 MRH]KY3%7D5A3/JG@(5 G!&J*IOC5L6C-<'E(O[^3%:_G#4>_W:[(]25!O=Z8KH\LNU&ULM=U;[LQ\\+]GY]UK7CPV8.Y=Q-V'?E_>HMT==F;]LB"/;@;/[V-G@Q6/J!1 M[LTC/RG^)4_;92?C'IEODC0*RN)L#0(OW/[O?B__$'L%F=-<()<%\F'!\(6" M05DP:%LP+ N&;5=I5!:,VHXP+@O&;0LF9<&D;<&T+)BV+3@K"\[:%E#I>Q6V]M^KRY:;&]^]L=J]@K%3=U9Q=Q]$3B?/G,RW\H=NVB/ML9O3!/ MX5T:9[_ULKIT=I=&\Z^KR%^P./F%J-\V7OJ#O%=8ZGI^\H'\2K[<*>3]NP\D M6;DQ2X@7DL^K:).XX2(Y(>_RVS>>[V>!2B[Z:;9".=N?EX-_W XNOS X)3=1 MF*X2HH8+MFBH5\7U@]?J;7']\+5Z1UQ_)JCO9QMBMS7DYZWQ41:"O\_34R*/ M3H@LR7+#^ER+RZV-?TH&],5RY;7R,"N77BQ7Q>5W;"TLU_[?Z+JX_,:-A8_= M:+_RM*'<;+_R3>56^Y5O*K?_WV[C'+WAN+UXL'M.&13>X 5O^RQR0JY]-TE( M]$ ^9_.#9!/_(,6S#?G+R0J(F;(@^;OI26.K#YOU?%IRGJS=.;OL9?..A,6/ MK#?[^2X2Z]0Y&^G1%D M$^SU)IZOLODM63KJ+8^X9:SS9%4I=DX7$%"2FCFNAH?)PP(=&JR\T&)X=!*N^S(3RBQ@- M8XWX1SVUXEP?_T2)BQ-_>P(L([BXG7. M3;A@,;FZNVW:9858UUT6B2E(3$5B&A+3D9B!Q$PD9B$Q&XDYD_J3P]X,@,O@ M=)?!Z9$3M)CE;XQXX9*XCZ[GN_<^:TJED.^:2B2F(#%UBXWV__0R'1\<2) C MZDC,0&(F$K.0F(W$G%WLUWH5$?+>"\LN@0^-$::U8_]4GO*SO6OQV)V3 MB=14J*9!-1VJ&5#-A&H65+.AFH/2^&3*53)EV&N5);5_WCL>'X91.%SG,"(U M%:II4$V':@94,Z&:!=5LJ.:@-#Z,50\,%;Y)/[O+CX3DMGH1Z&H9,Q:\<'XJ MQCK/;Z%-+U!-A6H:5-.AF@'53*AF034;JCDHC0]NU?Y"AV][J@KM>H%J"E13 MH9H&U72H9D U$ZI94,V&:@Y*XZ-<-FF*PVAC!*$--%!-@6HJ5-.@F@[5 M#*AF0C4+JME0S4%I?%2K+B(Z>=M),+2Q"*HI4$V%:AI4TZ&: =5,J&9!-1NJ M.2B-CW+5C$3%W4A'OU\#[4*":@I44Z&:!M5TJ&9 -1.J65#-AFH.K?E M\5&N6IUD<:O3_O&XF"ES\V?W^8!\(OBTI7B$SFF&MD=!-;74N!<-:Q^FU*!C MZE#-@&HF5+.@F@W5')3&I[1J>Y*/:WMZ[017S':.IEP[19B.#W=_!3JF"M4T MJ*9#-0.JF5#-@FHV5'-0&A_-J@E*;M$$E>R%9P=-=\GRR7$8Y1]2 M=7W1(13:&U5J>1/U+JC2Z?0PI]">)ZBF034=JAE0S81J%E2SH9J#TOB<5CU/ MLK 1X[C7H;(%VWST3CQTY_A"^Z&@F@K5-*BF0S4#JIE0S8)J-E1S4!H?\ZH? M2AZ][4M3T!XIJ*9 -16J:5!-AVH&5#.AF@75;*CFH#0^RE4OE7S<]Q*]>M([ MKIVFUK_Y[EH\>.=H0GNGH)H&U72H9D U$ZI94,UNV"LIK;UZXJ &Y3-7-47) MXN]6.I@E=WN'5FQW/G9".Z*@F@K5-*BF0S4#JIE0S8)J-E1S4!J?XZHC2IZ^ M[308VAD%U12HID(U#:KI4,V :B94LZ":#=4%A&J%#ZE#-@&HF5+.@F@W5')2V36-_[XI/ 8N7Q77,$C+/ MWT/=7JAE=^_N6FE7Q16C#N[_2,\5VG"_2L^M[970*GY[8;8;-UYZ84)\]I - M)9U.LD-+O+W6V?9&&JV+ZTW=1VD:!<6/*^8N6)POD/W^(8K2YQOY +LKSLW^ M U!+ P04 " #-J%A56JYE*I8$ "&$@ &0 'AL+W=O\DZ271&I#3GJHVU]O/#C@! MU6#6-DG[[V\,A";$I=4N7Q(P,\]XGAG/V)X=&'\6"2$2O60T%W,CD;*X-4T1 M)23#8L0*DL.7+>,9EO#*=Z8H.,%QI911T[&LP,QPFAN+637VR!:O]X2RP]RPC>/ MW272#5@+F8%WI$UD4_%(XH^!] MUH+?*%2NF[7O%7$AEG@QX^R N)(&-/50L5]I U]IKA)E+3E\34%/+E:8YVF^ M$^B1<+1.,"?H.B02IU36I%%].!OY-6"EP M'L/@E7I_2"F%-! S4\(6<^+GI@N4P$6N4QB37Z8;_^M$?? M!&Y:@IPC0?=.+^":%"/D6E^08SF.9C[+SZO;.G=^S?KJIZV?D>&VV>)6>.Y' MV8*EY.FFE'A#"9(,+4DN24[0DO&"<:QJ@"[V-;JG1U('Q/ MC,7OO]F!]8>.^"'!PB'!5@.!G87(:T/D]:'_.FZ+HN2J4@L:I$$/"><-B,H+S, M-A \Z/0[?Z,)66_1/,W+L3@.[D[@:L8GK>-W< MU8E9SGC!LZVT#;_6F_ST6:=03/)7$,:,4<_'6 [7YW!B:G/;LD3/M MI',C==;9.ZFL 7)&W2J[TIM[IQC8)P<:NY>/4*UKJ :#,&+KIMA=X!HI:S2= M=DFYE )2["XI'U@\)\5Y(\7I)>4.:M[7MN)!&L*"CA1+=;-0E?%BL%2G/$1> M(EK"40IM.4TT;#TXKF^T[7:HU0O9% M^FF$IFZ7Z$LAOTNS>7*NS@C?51<: KR"[6-]:&I'VTN3N^JJH#-^;]\N;&PO=V]R:W-H965T!IDM./#)6'+(O9MVN:%H]7,SQ[.G&;;'>\ M.F$LYOMX2^\H_[3_R,21T5'624;S,BERQ.CF:O8.7T:66074BC\3^E@>O495 M*O=%\:4Z^+"^FIG5'=&4KGB%B,6_![JD:5J1Q'W\TT)GW36KP./73_3W=?(B MF?NXI,LB_2M9\]W5S)^A-=W$AY3?%H^_T#8AI^*MBK2L_Z+'1FO;,[0ZE+S( MVF!Q!UF2-__CK^U ' 40,A% V@#RW "K#;"D #&4Z@"[#;"?>P6G#:A3-YK< MZX$+8QXOYJQX1*Q2"UKUHA[].EJ,5Y)7$^6.,_%N(N+XXHYN1=DY^I WDZXJ MWNN0\CA)RS?H%4IR=).DJ3A=S@TN+EB%&:L6?MW R03<0C=%SGZ"SQ8\_8-?\654(2%@("8N 8(.2V%U);!U]\=LANZ<, M%1LD/C%87!>EG3[)/XH>)R*1Y<' MFA^H\K.JB7>/)ICE^*XSG&1+A8K8ICM4A6,5-OW EV316!98-K8[U2!3K\O4 MTV8:Q2P7$[!$&U9D3PU@XO/9&RTJVY-N>Z02UT:>N+$A8" F+@&"#$@1="8(SMKX LD"0L! 2%@'!!@7" M9O\0;[ZP^;6 X\7YUB*NW O4,BRM]% E"P*Y:T1*&2$3+0$?>1:L3?4Z3L$;KU;(\8LM-0B$S?3^0F\18ADUL6[;<)<8Z/S!],M$E>H^$]2;I ME.,R=2[DT*UCYB*QJC<(._=Q:Q7:CJ M$0#U**"T$)060=&&->I]"G;/V2VU+NCD,D'20E!:!$4;EJDW65COLI[1+<=^ MI^J61.X:"IGHEK[<-Q3N271+XLN=8ZP3W=+S)UI'[[.PWF@I6\?WW)>>>?)L M!/5?H+0(BC:L3F_!\#D]& 8U8:"T$)060=&&OR[T/HR\U(>1L262&X9"@J5F MH9#(7STI)!/?.Y'>=Q&][[K;TU42I_R;>))@#\EJ(D50WP5*"T%I$11M6([> M=Y%S^BX"ZKM :2$H+8*B#;E%"APIX=>')[ M4,@LQ[$F6D1ON@B@J">"Y060=&&->H]%SFGYR*@G@N4%H+2(BC:L$R]YR(O]5QD['X( MMBVY9RB\E(-EQZ50>8XC^RV%RK8L=Z)K]':+Z.V6LFM\SV[IF2=/1%"[!4J+ MH&C#ZO1VBYS3;A%0NP5*"T%I$11MN"^IMUO62^U6"QC^G._*7V@K5:;\S:Y" M%026I(I4*H(]J5\81SOV,LJV]5;)$JV*0\Z;G5G=V6X[YKMZ$Z)T_AI?+K'B M?(@OHV:S98]O]G[>Q&R;Y"5*Z499'5+WQ!<4YB45GR)"5I83]^1[)KDB[Q&O!+(EDZGZ7/DGP\ MW$KUJ#, 0YYR+O3(RXPIKGQ?IQGD5%_* @2V+*7*J<&J6OFZ4$ 7+BCG?A0$ M/3^G3'CCH;LV5>.A7!O.!$P5T>L\I^KY&KC[EPSU:9L1?\\;"@*YB! M>2BF"FM^35FP'(1F4A %RY'W*;Q*!K:_Z_"=P5;OE(F=R5S*1UNY68R\P X( M.*3&$BC^;6 "G%L0#N-WQ?3J6]K W?(+_;.;.\YE3C5,)/_!%B8;>0./+&!) MU]S-VCG"G(!8HCMPRPU;4KN%#EAH9=DM?Z8*F,/)PSVI0&_#&[]^% MO>#C(5MMPI*68'ONXMI=[.CQ$7>W4FNRO_)^WF(?R4XOLO&D1NKVAR9^CF^2ZD7.JOQ+6=3#[7MF,XZ&_V972TNWVI'1K*=U& M*?L]&HKO48K^ (W'!;_ M.:\:&:OW?7;/J_Z;8IL$Y:T!-L3.:A%#AH7X;=U/@=%Y+), M"3399J" "$E&PO<>VS>) MZ:#4*TZOYI1J;YES40[]N=;%QR HIW.:D_)$%E08)),J)]ITU2PH"T5)6@(I MYT&WTXF#G##ACP9BD5_DNO2FOJ1#/XQ/?<_*C65*A_[-T?N? M"ZG/WWGV?/#AX*!S/4'TI-/!A0'$Q..GB3^FC4GWMJ7; M/O_NJ^\@'S;,0XR6N',>MG-BY%X',;S%QNFA>RI_WR.KWP"MY0_J.AL-,BDV MY1;Y-F#RDIQZMX0/_3'A;*(8L#*2,[ZRX2X$II)+Y6E3Y\9(")'RSL*A[<$M M4.OD3$A5Y;89[-])??D.L.Z!0<9Y8[#KV\!H4!"MJ1(7IE-=7 4?0%[=OEX5 MQN%,D578/?,WA.IDDDRD2JEJTH3^.C0:<)J!'<5F@6[ ME?KSP@Q'5'VH%'JI:,:657^9-08P]1!7)T7!5Y\XFXF%H0-8\;RX5 MNS/9H%2F)D"5[]U2I=FT'?FE2'%-EWI=3LL,]]S=0\__=IYG5%!%>-NTJ?VW M/,LO=ASU7LMR]539->ST6+_TW[K)LWTP&>^#R;VHR?X^F$SVP&3OU9Z:SS$9 MODF30;T5:NVWMG9;3=2#7>W0_PZ[9[Y)ZDT6C&LFZMZ"<2SF1@##\F .,(YE87G^I_'TT?%8#//6=R)] ME--'.9;E0L;5!\OCYB3F<(\T2:(HCK$9'8^=#L;8O,4Q?-UJF#=@8'D@T_/F M&E]MO$(>KP-L31^K$&RD>"5B(\7G&A#WO $C2=RKC>4!!K8*6.U ?G<>J"DW M)XI@53%OV!V,(TF"(5"+[AJ-8V1V8OBXUP>[2Z(H2=P(8&X'480A<#?B".8 M/&!(%%7OP9WW4;!^3P6;WS]'?P!02P,$% @ S:A859>*NQS $P( M L !?3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:(7->=I3W;+T]!;X"O.DQQ0FE( M2S,.\,W2?S+W\PPU1>5*(Y5;&GC3Y?YVX$G1H2)8%II%R=.B':5_'C"5;/K[(/E>2 M/[\H_;15ZHE]+8O*3+R#MFX,0 MMBR&P6@T'I9<5MZ7S^>VUGKH[B@K,BM5!85UP:,4+^;?^GJ7/4LCM[*0]MO$ M:WX7PF.EK&0I7T4^\48>,P?UZD-K8YHFF? ^.S@(/;O9-5-[*P0L^Y%;]K=3K*:E\W M WC<XR]M[LP#E1$I?2ZC0=WF#1XB2K-)D>3>?;A9S]MMT.5W-%BR]72PV MJ0,8((#!Q0#9U9H[D"$"&?Y R'0#F_O%"@"3&Y:L%P\.9(1 1A>#G"7W:P":37D#. >E&"OM20L7T1]A[_ 1+61Z4-H. MP&QE@[A4U;[=NZMJ6!<350VQ:VZXU.R1%R?![@4W$,'ZA$X4,='XQ*:!M 8Z MG_WV"TO5SKYP+9IH+J #'.%4%Q-3C4_LFGN1UWD1FQ5H83K-.!\3NSJTWMB$[?Q-P0$+L!M7\WFI@V F)MO&?_MW"Z MF)A/ F*?]"0!YS_\9Y<1\TI [)4Z&^B%PI02$"NE30OZL$),)R&Q3KYW<"\B M)I>06"X],NYEQ,P27M0L Q<3G3G2BB9DEI!ZIH)B=:&)R"8GE@F/&+B:FFY!Z!(-BCMV):TP_ M$;%^WLLA!ZRI<3$Q!467F> "S!77VEVKB# +19>S<@'+(7F74S,0A&QA1#,NG.ZF)B%(F(+]0T<@!"N]B R(5U,S$+1 M!<8W S;-\T;SG2<=LU#T(X8X;3_,3\"J=JP=]L-L7I+U MDOV9KY.XQYB 8F(!O0W+!NPA^8--C1&V3>7>'B,7$Q-03"R@?S#_(Y28?6)B M^_1--?=38O*)B>73-^#M8\3,$Q.;IW?$VP>)KN=3+^B[$]']>)AOXL8WP_,W M.;G8R4KD*VC:0#D(+5MK5F_:Y<,HKA<$=J>BF$%94BT5S\^?^)P_3_KR-U!+ M P04 " #-J%A5##^0_.4! !_(0 &@ 'AL+U]R96QS+W=O )/[F/!00D5#B]B %28/D<269Q#)[HE" M$8Y%08/F5-;8\O7?^)-E>_Z2=FW9=H>\V?9YOIS[]96*W6FV7Z:E; M?NS3H?PR.'QVPWO>I%2:R6L[K%-9-.&XN^[.X;*1F_/D9O+\MFB&YS=I0NT@ MA2"M'V009/6#'(*\?E"$H%@_: 9!L_I!MQ!T6S_H#H+NZ@?=0]!]_2"9HHQ3 M@J01U@1:"W(M!%X+@BT$8@N2+01F"Z(M!&H+LBT$;@O"+01R"](M!'8+XBT$ M>BOJK01Z*^JM!'KKZ&&;0&]%O95 ;T6]E4!O1;V50&]%O95 ;T6]E4!O1;V5 M0&]%O95 ;T.]C4!O0[V-0&]#O8U ;QN]+"'0VU!O(]#;4&\CT-M0;R/0VU!O M(]#;4&\CT-M0;R/0VU%O)]#;46\GT-M1;R?0VU%O)]#;1R^["?1VU-L)]';4 MVPGT=M3;"?1VU-L)]';4VPGTCJAW)- [HMZ10.^(>D<"O2/J'0GTCJAW)- [ MCCY6$N@=4>_XGWKG7!E&ULS=K);L(P% 707T'95L1X"!T$;-IN6Q;] 3=Y0$026[:A\/=UPB"UHJB( M2KT;(F+[W1=;.IMD]+:UY'N;NFK\.%F$8!\8\_F":NU38ZF)(S/C:AWB7S=G M5N=+/2=Q/;K'&B MK:W*7(Z)N?*@GI3[<*+ MKN,LMJF8#]N*?'J^Q(D>S6Q6YE28?%7'):FWCG3A%T2AKM)=T9OSR2'N,.U^ M^=7Y79ES@7'FU!GKXXDYNCSN<"3MZKZ-A-9=KM_CKV=\K']A'P*D#PG2AP+I(P/I8PC2QRU('W<@?=R#],$' M*(V@B,I12.4HIG(45#F*JAR%58[B*D>!E:/(*E!D%2BR"A19!8JL D56@2*K M0)%5H,@J4&05*+)*%%DEBJP215:)(JM$D56BR"I19)4HLDH4626*K I%5H4B MJT*15:'(JE!D52BR*A19%8JL"D56A2)KAB)KAB)KAB)KAB)KAB)KAB)K]I^R MOANS_.LW^>TUK779'/)9][G$Y!-02P$"% ,4 " #-J%A5!T%-8H$ "Q M $ @ $ 9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0 M ( ,VH6%5WP"^B[@ "L" 1 " :\ !D;V-0&UL4$L! A0#% @ S:A8 M50)"#SW+!0 OQX !@ ("!#0@ 'AL+W=O 8 M " @0X. !X;"]W;W)K&PO=V]R:W-H M965T&UL4$L! A0#% @ S:A858*5FXDH" 5RT !@ M ("!N1@ 'AL+W=O&PO=V]R:W-H965T&UL M4$L! A0#% @ S:A85>V<('O+ P S!, !@ ("!MS@ M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ S:A8 M5:. Q9-*"@ EQL !D ("!$$L 'AL+W=OP* ".'@ &0 M @(&150 >&PO=V]R:W-H965T&UL4$L! A0#% @ S:A85:NMY+KZ! IPL M !D ("!)F< 'AL+W=OK#F\% !D# &0 @(%7; M>&PO=V]R:W-H965T&UL4$L! A0#% @ S:A85>^TU7&,"0 XQ< !D M ("!%74 'AL+W=O&PO=V]R:W-H965T M@0 + * 9 M " @7V# !X;"]W;W)K&UL4$L! A0# M% @ S:A85=Z&PO=V]R:W-H965T&UL4$L! A0#% @ S:A85?D*]]_.!0 P1( !D M ("!$[, 'AL+W=O&PO M=V]R:W-H965T&UL4$L! A0#% @ S:A859P9GMB\ @ ) 8 !D ("! ML+\ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ S:A853*&PO=V]R:W-H965T&UL4$L! A0#% @ S:A85;M-AIE.!P XS !D M ("!BN4 'AL+W=O&PO=V]R M:W-H965T&UL M4$L! A0#% @ S:A8522+#JW8! QA@ !D ("!!_@ M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ MS:A8561[);T.! QA8 !D ("!+!(! 'AL+W=O!P &0 @($] M(0$ >&PO=V]R:W-H965TEP( 4' 9 " @4 D 0!X;"]W;W)K&UL4$L! A0#% @ S:A85;E.&L*0!@ 'RT !D M ("!#B&PO=V]R:W-H M965T&UL4$L! M A0#% @ S:A85?\4OXW/ @ 3@@ !D ("!&4(! 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ S:A8 M52A#=D''!0 X"H !D ("!G5(! 'AL+W=O&PO=V]R:W-H965T7!E&UL4$L%!@ ! - $ =Q$ /5H 0 $! end XML 69 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 70 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 71 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 361 315 1 false 77 0 false 9 false false R1.htm 0001001 - Document - Cover Sheet http://www.centene.com/role/Cover Cover Cover 1 false false R2.htm 1001002 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 1002003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 1003004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 1004005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS) Sheet http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS) Statements 5 false false R6.htm 1005006 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Sheet http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Statements 6 false false R7.htm 1006007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) Sheet http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) Statements 7 false false R8.htm 1007008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 8 false false R9.htm 2101101 - Disclosure - Organization and Operations Sheet http://www.centene.com/role/OrganizationandOperations Organization and Operations Notes 9 false false R10.htm 2103102 - Disclosure - Acquisitions and Divestitures Sheet http://www.centene.com/role/AcquisitionsandDivestitures Acquisitions and Divestitures Notes 10 false false R11.htm 2109103 - Disclosure - Short-term and Long-term Investments, Restricted Deposits Sheet http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDeposits Short-term and Long-term Investments, Restricted Deposits Notes 11 false false R12.htm 2115104 - Disclosure - Fair Value Measurements Sheet http://www.centene.com/role/FairValueMeasurements Fair Value Measurements Notes 12 false false R13.htm 2119105 - Disclosure - Property, Software and Equipment Sheet http://www.centene.com/role/PropertySoftwareandEquipment Property, Software and Equipment Notes 13 false false R14.htm 2123106 - Disclosure - Medical Claims Liability Sheet http://www.centene.com/role/MedicalClaimsLiability Medical Claims Liability Notes 14 false false R15.htm 2127107 - Disclosure - Affordable Care Act Sheet http://www.centene.com/role/AffordableCareAct Affordable Care Act Notes 15 false false R16.htm 2131108 - Disclosure - Debt Sheet http://www.centene.com/role/Debt Debt Notes 16 false false R17.htm 2135109 - Disclosure - Leases Sheet http://www.centene.com/role/Leases Leases Notes 17 false false R18.htm 2139110 - Disclosure - Stockholders' Equity Sheet http://www.centene.com/role/StockholdersEquity Stockholders' Equity Notes 18 false false R19.htm 2141111 - Disclosure - Earnings Per Share Sheet http://www.centene.com/role/EarningsPerShare Earnings Per Share Notes 19 false false R20.htm 2144112 - Disclosure - Segment Information Sheet http://www.centene.com/role/SegmentInformation Segment Information Notes 20 false false R21.htm 2147113 - Disclosure - Contingencies Sheet http://www.centene.com/role/Contingencies Contingencies Notes 21 false false R22.htm 2202201 - Disclosure - Organization and Operations (Policies) Sheet http://www.centene.com/role/OrganizationandOperationsPolicies Organization and Operations (Policies) Policies 22 false false R23.htm 2304301 - Disclosure - Acquisitions and Divestitures (Tables) Sheet http://www.centene.com/role/AcquisitionsandDivestituresTables Acquisitions and Divestitures (Tables) Tables http://www.centene.com/role/AcquisitionsandDivestitures 23 false false R24.htm 2310302 - Disclosure - Short-term and Long-term Investments, Restricted Deposits (Tables) Sheet http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsTables Short-term and Long-term Investments, Restricted Deposits (Tables) Tables http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDeposits 24 false false R25.htm 2316303 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.centene.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.centene.com/role/FairValueMeasurements 25 false false R26.htm 2320304 - Disclosure - Property, Software and Equipment (Tables) Sheet http://www.centene.com/role/PropertySoftwareandEquipmentTables Property, Software and Equipment (Tables) Tables http://www.centene.com/role/PropertySoftwareandEquipment 26 false false R27.htm 2324305 - Disclosure - Medical Claims Liability (Tables) Sheet http://www.centene.com/role/MedicalClaimsLiabilityTables Medical Claims Liability (Tables) Tables http://www.centene.com/role/MedicalClaimsLiability 27 false false R28.htm 2328306 - Disclosure - Affordable Care Act (Tables) Sheet http://www.centene.com/role/AffordableCareActTables Affordable Care Act (Tables) Tables http://www.centene.com/role/AffordableCareAct 28 false false R29.htm 2332307 - Disclosure - Debt (Tables) Sheet http://www.centene.com/role/DebtTables Debt (Tables) Tables http://www.centene.com/role/Debt 29 false false R30.htm 2336308 - Disclosure - Leases (Tables) Sheet http://www.centene.com/role/LeasesTables Leases (Tables) Tables http://www.centene.com/role/Leases 30 false false R31.htm 2342309 - Disclosure - Earnings Per Share (Tables) Sheet http://www.centene.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.centene.com/role/EarningsPerShare 31 false false R32.htm 2345310 - Disclosure - Segment Information (Tables) Sheet http://www.centene.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.centene.com/role/SegmentInformation 32 false false R33.htm 2405401 - Disclosure - Acquisitions and Divestitures - Narrative (Details) Sheet http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails Acquisitions and Divestitures - Narrative (Details) Details 33 false false R34.htm 2406402 - Disclosure - Acquisitions and Divestitures - Schedule of Fair Value of Assets Acquired and Liabilities Assumed (Details) Sheet http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails Acquisitions and Divestitures - Schedule of Fair Value of Assets Acquired and Liabilities Assumed (Details) Details 34 false false R35.htm 2407403 - Disclosure - Acquisitions and Divestitures - Identifiable Intangible Assets (Details) Sheet http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails Acquisitions and Divestitures - Identifiable Intangible Assets (Details) Details 35 false false R36.htm 2408404 - Disclosure - Acquisitions and Divestitures - Divestitures (Details) Sheet http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails Acquisitions and Divestitures - Divestitures (Details) Details 36 false false R37.htm 2411405 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - By Investment Type (Details) Sheet http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails Short-term and Long-term Investments, Restricted Deposits - By Investment Type (Details) Details 37 false false R38.htm 2412406 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Narrative (Details) Sheet http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails Short-term and Long-term Investments, Restricted Deposits - Narrative (Details) Details http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsTables 38 false false R39.htm 2413407 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time (Details) Sheet http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails Short-term and Long-term Investments, Restricted Deposits - Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time (Details) Details 39 false false R40.htm 2414408 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Contractual Maturities of Short-Term and Long-Term Investments and Restricted Deposits (Details) Sheet http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails Short-term and Long-term Investments, Restricted Deposits - Contractual Maturities of Short-Term and Long-Term Investments and Restricted Deposits (Details) Details 40 false false R41.htm 2417409 - Disclosure - Fair Value Measurements - Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Sheet http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails Fair Value Measurements - Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Details 41 false false R42.htm 2418410 - Disclosure - Fair Value Measurements - Narrative (Details) Sheet http://www.centene.com/role/FairValueMeasurementsNarrativeDetails Fair Value Measurements - Narrative (Details) Details 42 false false R43.htm 2421411 - Disclosure - Property, Software and Equipment - Components (Details) Sheet http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails Property, Software and Equipment - Components (Details) Details 43 false false R44.htm 2422412 - Disclosure - Property, Software and Equipment - Narrative (Details) Sheet http://www.centene.com/role/PropertySoftwareandEquipmentNarrativeDetails Property, Software and Equipment - Narrative (Details) Details 44 false false R45.htm 2425413 - Disclosure - Medical Claims Liability - Schedule of Change in Medical Claims Liability (Details) Sheet http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails Medical Claims Liability - Schedule of Change in Medical Claims Liability (Details) Details 45 false false R46.htm 2426414 - Disclosure - Medical Claims Liability - Narrative (Details) Sheet http://www.centene.com/role/MedicalClaimsLiabilityNarrativeDetails Medical Claims Liability - Narrative (Details) Details 46 false false R47.htm 2429415 - Disclosure - Affordable Care Act - Net Receivables (Payables) for Each of the Ongoing Programs (Details) Sheet http://www.centene.com/role/AffordableCareActNetReceivablesPayablesforEachoftheOngoingProgramsDetails Affordable Care Act - Net Receivables (Payables) for Each of the Ongoing Programs (Details) Details 47 false false R48.htm 2430416 - Disclosure - Affordable Care Act - Additional information (Details) Sheet http://www.centene.com/role/AffordableCareActAdditionalinformationDetails Affordable Care Act - Additional information (Details) Details 48 false false R49.htm 2433417 - Disclosure - Debt - Schedule of Debt (Details) Sheet http://www.centene.com/role/DebtScheduleofDebtDetails Debt - Schedule of Debt (Details) Details 49 false false R50.htm 2434418 - Disclosure - Debt - Narrative (Details) Sheet http://www.centene.com/role/DebtNarrativeDetails Debt - Narrative (Details) Details 50 false false R51.htm 2437419 - Disclosure - Leases - ROU Assets and Liabilities (Details) Sheet http://www.centene.com/role/LeasesROUAssetsandLiabilitiesDetails Leases - ROU Assets and Liabilities (Details) Details 51 false false R52.htm 2438420 - Disclosure - Leases - Narrative (Details) Sheet http://www.centene.com/role/LeasesNarrativeDetails Leases - Narrative (Details) Details 52 false false R53.htm 2440421 - Disclosure - Stockholders' Equity (Details) Sheet http://www.centene.com/role/StockholdersEquityDetails Stockholders' Equity (Details) Details http://www.centene.com/role/StockholdersEquity 53 false false R54.htm 2443422 - Disclosure - Earnings Per Share (Details) Sheet http://www.centene.com/role/EarningsPerShareDetails Earnings Per Share (Details) Details http://www.centene.com/role/EarningsPerShareTables 54 false false R55.htm 2446423 - Disclosure - Segment Information (Details) Sheet http://www.centene.com/role/SegmentInformationDetails Segment Information (Details) Details http://www.centene.com/role/SegmentInformationTables 55 false false R56.htm 2448424 - Disclosure - Contingencies (Details) Sheet http://www.centene.com/role/ContingenciesDetails Contingencies (Details) Details http://www.centene.com/role/Contingencies 56 false false All Reports Book All Reports cnc-20220930.htm a2022093010-qexhibit311.htm a2022093010-qexhibit312.htm a2022093010-qexhibit321.htm a2022093010-qexhibit322.htm cnc-20220930.xsd cnc-20220930_cal.xml cnc-20220930_def.xml cnc-20220930_lab.xml cnc-20220930_pre.xml http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 73 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "cnc-20220930.htm": { "axisCustom": 0, "axisStandard": 25, "contextCount": 361, "dts": { "calculationLink": { "local": [ "cnc-20220930_cal.xml" ] }, "definitionLink": { "local": [ "cnc-20220930_def.xml" ] }, "inline": { "local": [ "cnc-20220930.htm" ] }, "labelLink": { "local": [ "cnc-20220930_lab.xml" ] }, "presentationLink": { "local": [ "cnc-20220930_pre.xml" ] }, "schema": { "local": [ "cnc-20220930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 514, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 6, "http://xbrl.sec.gov/dei/2022": 5, "total": 11 }, "keyCustom": 40, "keyStandard": 275, "memberCustom": 25, "memberStandard": 51, "nsprefix": "cnc", "nsuri": "http://www.centene.com/20220930", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover", "role": "http://www.centene.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2103102 - Disclosure - Acquisitions and Divestitures", "role": "http://www.centene.com/role/AcquisitionsandDivestitures", "shortName": "Acquisitions and Divestitures", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2109103 - Disclosure - Short-term and Long-term Investments, Restricted Deposits", "role": "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDeposits", "shortName": "Short-term and Long-term Investments, Restricted Deposits", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2115104 - Disclosure - Fair Value Measurements", "role": "http://www.centene.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2119105 - Disclosure - Property, Software and Equipment", "role": "http://www.centene.com/role/PropertySoftwareandEquipment", "shortName": "Property, Software and Equipment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InsuranceDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2123106 - Disclosure - Medical Claims Liability", "role": "http://www.centene.com/role/MedicalClaimsLiability", "shortName": "Medical Claims Liability", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InsuranceDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "cnc:AffordableCareActDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2127107 - Disclosure - Affordable Care Act", "role": "http://www.centene.com/role/AffordableCareAct", "shortName": "Affordable Care Act", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "cnc:AffordableCareActDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2131108 - Disclosure - Debt", "role": "http://www.centene.com/role/Debt", "shortName": "Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2135109 - Disclosure - Leases", "role": "http://www.centene.com/role/Leases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2139110 - Disclosure - Stockholders' Equity", "role": "http://www.centene.com/role/StockholdersEquity", "shortName": "Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2141111 - Disclosure - Earnings Per Share", "role": "http://www.centene.com/role/EarningsPerShare", "shortName": "Earnings Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "if5924c29f510442295a58d6064878d29_I20220930", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1001002 - Statement - CONSOLIDATED BALANCE SHEETS", "role": "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "shortName": "CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i8c7e93af4d5a417d9b174671956ebe09_I20211231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2144112 - Disclosure - Segment Information", "role": "http://www.centene.com/role/SegmentInformation", "shortName": "Segment Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2147113 - Disclosure - Contingencies", "role": "http://www.centene.com/role/Contingencies", "shortName": "Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2202201 - Disclosure - Organization and Operations (Policies)", "role": "http://www.centene.com/role/OrganizationandOperationsPolicies", "shortName": "Organization and Operations (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2304301 - Disclosure - Acquisitions and Divestitures (Tables)", "role": "http://www.centene.com/role/AcquisitionsandDivestituresTables", "shortName": "Acquisitions and Divestitures (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "cnc:ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2310302 - Disclosure - Short-term and Long-term Investments, Restricted Deposits (Tables)", "role": "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsTables", "shortName": "Short-term and Long-term Investments, Restricted Deposits (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "cnc:ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "cnc:FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2316303 - Disclosure - Fair Value Measurements (Tables)", "role": "http://www.centene.com/role/FairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "cnc:FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2320304 - Disclosure - Property, Software and Equipment (Tables)", "role": "http://www.centene.com/role/PropertySoftwareandEquipmentTables", "shortName": "Property, Software and Equipment (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2324305 - Disclosure - Medical Claims Liability (Tables)", "role": "http://www.centene.com/role/MedicalClaimsLiabilityTables", "shortName": "Medical Claims Liability (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "cnc:ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2328306 - Disclosure - Affordable Care Act (Tables)", "role": "http://www.centene.com/role/AffordableCareActTables", "shortName": "Affordable Care Act (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "cnc:ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2332307 - Disclosure - Debt (Tables)", "role": "http://www.centene.com/role/DebtTables", "shortName": "Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "if5924c29f510442295a58d6064878d29_I20220930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)", "role": "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "if5924c29f510442295a58d6064878d29_I20220930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2336308 - Disclosure - Leases (Tables)", "role": "http://www.centene.com/role/LeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2342309 - Disclosure - Earnings Per Share (Tables)", "role": "http://www.centene.com/role/EarningsPerShareTables", "shortName": "Earnings Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2345310 - Disclosure - Segment Information (Tables)", "role": "http://www.centene.com/role/SegmentInformationTables", "shortName": "Segment Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "ia3423be8fe5745c99192368044596375_D20220104-20220104", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405401 - Disclosure - Acquisitions and Divestitures - Narrative (Details)", "role": "http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails", "shortName": "Acquisitions and Divestitures - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "ia3423be8fe5745c99192368044596375_D20220104-20220104", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "if5924c29f510442295a58d6064878d29_I20220930", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2406402 - Disclosure - Acquisitions and Divestitures - Schedule of Fair Value of Assets Acquired and Liabilities Assumed (Details)", "role": "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails", "shortName": "Acquisitions and Divestitures - Schedule of Fair Value of Assets Acquired and Liabilities Assumed (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i3706afdbc7d9404b8d19ffc760a2fe00_I20220104", "decimals": "-6", "lang": "en-US", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "ia0cf2922cf044f03971fd21ea4f3cdf0_D20220701-20220930", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407403 - Disclosure - Acquisitions and Divestitures - Identifiable Intangible Assets (Details)", "role": "http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails", "shortName": "Acquisitions and Divestitures - Identifiable Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "ia3423be8fe5745c99192368044596375_D20220104-20220104", "decimals": null, "lang": "en-US", "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:GainLossOnSaleOfBusiness", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408404 - Disclosure - Acquisitions and Divestitures - Divestitures (Details)", "role": "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails", "shortName": "Acquisitions and Divestitures - Divestitures (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "ia39e5727a20c47369c144c0c14e6de60_D20220714-20220714", "decimals": "-6", "lang": "en-US", "name": "us-gaap:ProceedsFromDivestitureOfBusinesses", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "cnc:ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "if5924c29f510442295a58d6064878d29_I20220930", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411405 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - By Investment Type (Details)", "role": "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "shortName": "Short-term and Long-term Investments, Restricted Deposits - By Investment Type (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "cnc:ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "if5924c29f510442295a58d6064878d29_I20220930", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "if5924c29f510442295a58d6064878d29_I20220930", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2412406 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Narrative (Details)", "role": "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails", "shortName": "Short-term and Long-term Investments, Restricted Deposits - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "if5924c29f510442295a58d6064878d29_I20220930", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "if5924c29f510442295a58d6064878d29_I20220930", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2413407 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time (Details)", "role": "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails", "shortName": "Short-term and Long-term Investments, Restricted Deposits - Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "if5924c29f510442295a58d6064878d29_I20220930", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "ia0cf2922cf044f03971fd21ea4f3cdf0_D20220701-20220930", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS", "role": "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "ia0cf2922cf044f03971fd21ea4f3cdf0_D20220701-20220930", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i8f41ab96f78046f78bd4e830f152ff8e_I20220930", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2414408 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Contractual Maturities of Short-Term and Long-Term Investments and Restricted Deposits (Details)", "role": "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails", "shortName": "Short-term and Long-term Investments, Restricted Deposits - Contractual Maturities of Short-Term and Long-Term Investments and Restricted Deposits (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i8f41ab96f78046f78bd4e830f152ff8e_I20220930", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "if5924c29f510442295a58d6064878d29_I20220930", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2417409 - Disclosure - Fair Value Measurements - Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)", "role": "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "shortName": "Fair Value Measurements - Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "if5924c29f510442295a58d6064878d29_I20220930", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "if5924c29f510442295a58d6064878d29_I20220930", "decimals": "-6", "first": true, "lang": "en-US", "name": "cnc:LifeInsuranceContractsAndEquityInvestmentsFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2418410 - Disclosure - Fair Value Measurements - Narrative (Details)", "role": "http://www.centene.com/role/FairValueMeasurementsNarrativeDetails", "shortName": "Fair Value Measurements - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "if5924c29f510442295a58d6064878d29_I20220930", "decimals": "-6", "first": true, "lang": "en-US", "name": "cnc:LifeInsuranceContractsAndEquityInvestmentsFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "if5924c29f510442295a58d6064878d29_I20220930", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2421411 - Disclosure - Property, Software and Equipment - Components (Details)", "role": "http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails", "shortName": "Property, Software and Equipment - Components (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "if5924c29f510442295a58d6064878d29_I20220930", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OtherAssetImpairmentCharges", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2422412 - Disclosure - Property, Software and Equipment - Narrative (Details)", "role": "http://www.centene.com/role/PropertySoftwareandEquipmentNarrativeDetails", "shortName": "Property, Software and Equipment - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "ie44bfd2ea9104cd7b9003eb271d981be_D20220701-20220930", "decimals": "-6", "lang": "en-US", "name": "us-gaap:TangibleAssetImpairmentCharges", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i8c7e93af4d5a417d9b174671956ebe09_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2425413 - Disclosure - Medical Claims Liability - Schedule of Change in Medical Claims Liability (Details)", "role": "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails", "shortName": "Medical Claims Liability - Schedule of Change in Medical Claims Liability (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "ia8e4d31e7e9d4c19abe8a3defa3e541f_I20201231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": "-6", "first": true, "lang": "en-US", "name": "cnc:AmountsRecordedAsAnAdjustmentToPremiumRevenuesRelatedToMinimumHBRAndReturnOfPremiumPrograms", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2426414 - Disclosure - Medical Claims Liability - Narrative (Details)", "role": "http://www.centene.com/role/MedicalClaimsLiabilityNarrativeDetails", "shortName": "Medical Claims Liability - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": "-6", "first": true, "lang": "en-US", "name": "cnc:AmountsRecordedAsAnAdjustmentToPremiumRevenuesRelatedToMinimumHBRAndReturnOfPremiumPrograms", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "cnc:ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "if5924c29f510442295a58d6064878d29_I20220930", "decimals": "-6", "first": true, "lang": "en-US", "name": "cnc:AffordableCareActRiskAdjustmentReceivable", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2429415 - Disclosure - Affordable Care Act - Net Receivables (Payables) for Each of the Ongoing Programs (Details)", "role": "http://www.centene.com/role/AffordableCareActNetReceivablesPayablesforEachoftheOngoingProgramsDetails", "shortName": "Affordable Care Act - Net Receivables (Payables) for Each of the Ongoing Programs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "cnc:ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "if5924c29f510442295a58d6064878d29_I20220930", "decimals": "-6", "first": true, "lang": "en-US", "name": "cnc:AffordableCareActRiskAdjustmentReceivable", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i04ec4fe0ef0145de9ca36d004d31377b_D20220101-20220630", "decimals": "-6", "first": true, "lang": "en-US", "name": "cnc:AffordableCareActRiskAdjustmentNetReceivableIncreaseDecrease", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2430416 - Disclosure - Affordable Care Act - Additional information (Details)", "role": "http://www.centene.com/role/AffordableCareActAdditionalinformationDetails", "shortName": "Affordable Care Act - Additional information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i04ec4fe0ef0145de9ca36d004d31377b_D20220101-20220630", "decimals": "-6", "first": true, "lang": "en-US", "name": "cnc:AffordableCareActRiskAdjustmentNetReceivableIncreaseDecrease", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "if5924c29f510442295a58d6064878d29_I20220930", "decimals": "-6", "first": true, "lang": "en-US", "name": "cnc:SeniorNotesTotal", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2433417 - Disclosure - Debt - Schedule of Debt (Details)", "role": "http://www.centene.com/role/DebtScheduleofDebtDetails", "shortName": "Debt - Schedule of Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "if5924c29f510442295a58d6064878d29_I20220930", "decimals": "-6", "first": true, "lang": "en-US", "name": "cnc:SeniorNotesTotal", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "ia0cf2922cf044f03971fd21ea4f3cdf0_D20220701-20220930", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS)", "role": "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS", "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "ia0cf2922cf044f03971fd21ea4f3cdf0_D20220701-20220930", "decimals": "-6", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i5196a50785c048c99d027f5eeaec53c6_D20210701-20210731", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:PaymentsForHedgeInvestingActivities", "reportCount": 1, "unique": true, "unitRef": "gbp", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2434418 - Disclosure - Debt - Narrative (Details)", "role": "http://www.centene.com/role/DebtNarrativeDetails", "shortName": "Debt - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i5196a50785c048c99d027f5eeaec53c6_D20210701-20210731", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:PaymentsForHedgeInvestingActivities", "reportCount": 1, "unique": true, "unitRef": "gbp", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "if5924c29f510442295a58d6064878d29_I20220930", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2437419 - Disclosure - Leases - ROU Assets and Liabilities (Details)", "role": "http://www.centene.com/role/LeasesROUAssetsandLiabilitiesDetails", "shortName": "Leases - ROU Assets and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "if5924c29f510442295a58d6064878d29_I20220930", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "ia0cf2922cf044f03971fd21ea4f3cdf0_D20220701-20220930", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseImpairmentLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2438420 - Disclosure - Leases - Narrative (Details)", "role": "http://www.centene.com/role/LeasesNarrativeDetails", "shortName": "Leases - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "ia0cf2922cf044f03971fd21ea4f3cdf0_D20220701-20220930", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseImpairmentLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "ia00327c84185488b979dc2deeb0290b2_D20220601-20220630", "decimals": "-6", "first": true, "lang": "en-US", "name": "cnc:StockRepurchaseProgramIncreaseAuthorizedAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2440421 - Disclosure - Stockholders' Equity (Details)", "role": "http://www.centene.com/role/StockholdersEquityDetails", "shortName": "Stockholders' Equity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "ia00327c84185488b979dc2deeb0290b2_D20220601-20220630", "decimals": "-6", "first": true, "lang": "en-US", "name": "cnc:StockRepurchaseProgramIncreaseAuthorizedAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "ia0cf2922cf044f03971fd21ea4f3cdf0_D20220701-20220930", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2443422 - Disclosure - Earnings Per Share (Details)", "role": "http://www.centene.com/role/EarningsPerShareDetails", "shortName": "Earnings Per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "ia0cf2922cf044f03971fd21ea4f3cdf0_D20220701-20220930", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2446423 - Disclosure - Segment Information (Details)", "role": "http://www.centene.com/role/SegmentInformationDetails", "shortName": "Segment Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i684cabb902b6415cac379cb9f383586d_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyPendingClaimsNumber", "reportCount": 1, "unique": true, "unitRef": "claim", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2448424 - Disclosure - Contingencies (Details)", "role": "http://www.centene.com/role/ContingenciesDetails", "shortName": "Contingencies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i684cabb902b6415cac379cb9f383586d_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyPendingClaimsNumber", "reportCount": 1, "unique": true, "unitRef": "claim", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "ic508fff3ef474ff59df1f01afc30d047_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005006 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY", "role": "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i355a4aa55532471ba79760aaeacb98a1_D20210101-20210331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "if5924c29f510442295a58d6064878d29_I20220930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)", "role": "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical", "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "ia0cf2922cf044f03971fd21ea4f3cdf0_D20220701-20220930", "decimals": "-6", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1007008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "role": "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": "-6", "lang": "en-US", "name": "us-gaap:DepreciationAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2101101 - Disclosure - Organization and Operations", "role": "http://www.centene.com/role/OrganizationandOperations", "shortName": "Organization and Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20220930.htm", "contextRef": "i9075817452e94e4ab525d3ae2e8de910_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 77, "tag": { "cnc_A1300Million2625SeniorNotesDueAugust2031Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "$1,300 Million 2.625% Senior Notes due August 2031", "label": "$1,300 Million 2.625% Senior Notes due August 2031 [Member]", "terseLabel": "$1,300 million 2.625% Senior Notes due August 1, 2031" } } }, "localname": "A1300Million2625SeniorNotesDueAugust2031Member", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "cnc_A2200Million250SeniorNotesDueMarch2031Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "$2,200 Million 2.50% Senior Notes due March 2031", "label": "$2,200 Million 2.50% Senior Notes due March 2031 [Member]", "terseLabel": "$2,200 million 2.50% Senior Notes due March 1, 2031" } } }, "localname": "A2200Million250SeniorNotesDueMarch2031Member", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "cnc_A2200Million300SeniorNotesDueOctober2030Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "$2,200 Million 3.00% Senior Notes Due October 2030", "label": "$2,200 Million 3.00% Senior Notes Due October 2030 [Member]", "terseLabel": "$2,200 million 3.00% Senior Notes due October 15, 2030" } } }, "localname": "A2200Million300SeniorNotesDueOctober2030Member", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "cnc_A2200Million375SeniorNotesDueFebruary2030Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "$2,200 Million 3.75% Senior Notes Due February 2030", "label": "$2,200 Million 3.75% Senior Notes Due February 2030 [Member]", "terseLabel": "$2,000 million 3.375% Senior Notes due February 15, 2030" } } }, "localname": "A2200Million375SeniorNotesDueFebruary2030Member", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "cnc_A2300Million245SeniorNotsDueJuly2028Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "$2,300 Million 2.45% Senior Nots due July 2028", "label": "$2,300 Million 2.45% Senior Nots due July 2028 [Member]", "terseLabel": "$2,300 million 2.45% Senior Notes due July 15, 2028" } } }, "localname": "A2300Million245SeniorNotsDueJuly2028Member", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "cnc_A3500Million4625SeniorNotesDueDecember2029Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "$3,500 Million 4.625% Senior Notes due December 2029", "label": "$3,500 Million 4.625% Senior Notes due December 2029 [Member]", "terseLabel": "$3,500 million 4.625% Senior Notes due December 15, 2029" } } }, "localname": "A3500Million4625SeniorNotesDueDecember2029Member", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails", "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "cnc_AcceleratedShareRepurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accelerated Share Repurchase Agreement", "label": "Accelerated Share Repurchase Agreement [Member]", "terseLabel": "Accelerated Share Repurchase Agreement" } } }, "localname": "AcceleratedShareRepurchaseAgreementMember", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "cnc_AcceleratedShareRepurchaseProgramUnsettledAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accelerated Share Repurchase Program, Unsettled Amount", "label": "Accelerated Share Repurchase Program, Unsettled Amount", "terseLabel": "Unsettled portion under ASR" } } }, "localname": "AcceleratedShareRepurchaseProgramUnsettledAmount", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "cnc_AcceleratedShareRepurchasesAgreementAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accelerated Share Repurchases Agreement, Amount", "label": "Accelerated Share Repurchases Agreement, Amount", "terseLabel": "Accelerated share repurchases agreement, amount" } } }, "localname": "AcceleratedShareRepurchasesAgreementAmount", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "cnc_AffordableCareActAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Affordable Care Act [Abstract]", "label": "Affordable Care Act [Abstract]", "terseLabel": "Affordable Care Act [Abstract]" } } }, "localname": "AffordableCareActAbstract", "nsuri": "http://www.centene.com/20220930", "xbrltype": "stringItemType" }, "cnc_AffordableCareActCostSharingReductionReceivable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Affordable Care Act, Cost Sharing Reduction Receivable", "label": "Affordable Care Act, Cost Sharing Reduction Receivable", "terseLabel": "Cost sharing reduction receivable" } } }, "localname": "AffordableCareActCostSharingReductionReceivable", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/AffordableCareActNetReceivablesPayablesforEachoftheOngoingProgramsDetails" ], "xbrltype": "monetaryItemType" }, "cnc_AffordableCareActCostSharingReductionsPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Affordable Care Act Cost Sharing Reductions, Payable", "label": "Affordable Care Act Cost Sharing Reductions, Payable", "negatedLabel": "Cost sharing reduction payable" } } }, "localname": "AffordableCareActCostSharingReductionsPayable", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/AffordableCareActNetReceivablesPayablesforEachoftheOngoingProgramsDetails" ], "xbrltype": "monetaryItemType" }, "cnc_AffordableCareActDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Affordable Care Act Disclosure [Text Block]", "label": "Affordable Care Act Disclosure [Text Block]", "terseLabel": "Affordable Care Act" } } }, "localname": "AffordableCareActDisclosureTextBlock", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/AffordableCareAct" ], "xbrltype": "textBlockItemType" }, "cnc_AffordableCareActMinimumMedicalLossRatio": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Affordable Care Act, Minimum Medical Loss Ratio", "label": "Affordable Care Act Minimum Medical Loss Ratio", "negatedTerseLabel": "Minimum medical loss ratio" } } }, "localname": "AffordableCareActMinimumMedicalLossRatio", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/AffordableCareActNetReceivablesPayablesforEachoftheOngoingProgramsDetails" ], "xbrltype": "monetaryItemType" }, "cnc_AffordableCareActReinsurancePayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Affordable Care Act Reinsurance, Payable", "label": "Affordable Care Act Reinsurance Payable", "negatedLabel": "Risk adjustment payable" } } }, "localname": "AffordableCareActReinsurancePayable", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/AffordableCareActNetReceivablesPayablesforEachoftheOngoingProgramsDetails" ], "xbrltype": "monetaryItemType" }, "cnc_AffordableCareActRiskAdjustmentAndReinsurancePreTaxExpenseBenefit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Affordable Care Act, Risk Adjustment And Reinsurance, Pre-Tax Expense (Benefit)", "label": "Affordable Care Act, Risk Adjustment And Reinsurance, Pre-Tax Expense (Benefit)", "negatedTerseLabel": "Risk adjustment and reinsurance pre-tax benefit" } } }, "localname": "AffordableCareActRiskAdjustmentAndReinsurancePreTaxExpenseBenefit", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/AffordableCareActAdditionalinformationDetails" ], "xbrltype": "monetaryItemType" }, "cnc_AffordableCareActRiskAdjustmentNetReceivableIncreaseDecrease": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Affordable Care Act, Risk Adjustment, Net Receivable Increase (Decrease)", "label": "Affordable Care Act, Risk Adjustment, Net Receivable Increase (Decrease)", "terseLabel": "Risk adjustment, increase to net receivables" } } }, "localname": "AffordableCareActRiskAdjustmentNetReceivableIncreaseDecrease", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/AffordableCareActAdditionalinformationDetails" ], "xbrltype": "monetaryItemType" }, "cnc_AffordableCareActRiskAdjustmentReceivable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Affordable Care Act, Risk Adjustment Receivable", "label": "Affordable Care Act, Risk Adjustment Receivable", "terseLabel": "Risk adjustment receivable" } } }, "localname": "AffordableCareActRiskAdjustmentReceivable", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/AffordableCareActNetReceivablesPayablesforEachoftheOngoingProgramsDetails" ], "xbrltype": "monetaryItemType" }, "cnc_AmountsRecordedAsAnAdjustmentToPremiumRevenuesRelatedToMinimumHBRAndReturnOfPremiumPrograms": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amounts Recorded As An Adjustment To Premium Revenues Related To Minimum HBR and Return Of Premium Programs", "label": "Amounts Recorded As An Adjustment to Premium Revenues Related to Minimum HBR and Return of Premium Programs", "negatedTerseLabel": "Amounts recorded as an adjustment to premium revenues related to minimum HBR and return of premium programs" } } }, "localname": "AmountsRecordedAsAnAdjustmentToPremiumRevenuesRelatedToMinimumHBRAndReturnOfPremiumPrograms", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedDeposits": { "auth_ref": [], "calculation": { "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Restricted Deposits", "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Restricted Deposits", "terseLabel": "Restricted deposits" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedDeposits", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReturnOfPremiumPayable": { "auth_ref": [], "calculation": { "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 6.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Return Of Premium Payable", "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Return Of Premium Payable", "terseLabel": "Return of premium payable" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReturnOfPremiumPayable", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsLongtermInvestments": { "auth_ref": [], "calculation": { "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 9.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Long-term Investments", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Long-term Investments", "terseLabel": "Long-term investments" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsLongtermInvestments", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsShorttermInvestments": { "auth_ref": [], "calculation": { "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 8.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Short-term Investments", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Short-term Investments", "terseLabel": "Short-term investments" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsShorttermInvestments", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsLiability": { "auth_ref": [], "calculation": { "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 5.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Medical Claims Liability", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Medical Claims Liability", "terseLabel": "Medical claims liability" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsLiability", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLongtermDebtPrincipal": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Long-term Debt, Principal", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Long-term Debt, Principal", "terseLabel": "Debt assumed, aggregate principal" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLongtermDebtPrincipal", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "cnc_ComputerSoftwareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Computer Software", "label": "Computer Software [Member]", "terseLabel": "Computer software" } } }, "localname": "ComputerSoftwareMember", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails" ], "xbrltype": "domainItemType" }, "cnc_DebtInstrumentExtensionTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Extension Term", "label": "Debt Instrument, Extension Term", "terseLabel": "Extension term" } } }, "localname": "DebtInstrumentExtensionTerm", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "durationItemType" }, "cnc_DebtRepurchaseProgramAuthorizedAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt Repurchase Program, Authorized Amount", "label": "Debt Repurchase Program, Authorized Amount", "terseLabel": "Debt repurchase program, authorized amount" } } }, "localname": "DebtRepurchaseProgramAuthorizedAmount", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "cnc_DebtRepurchaseProgramRemainingAmountAuthorizedToBeRepurchasedAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt Repurchase Program, Remaining Amount Authorized to be Repurchased, Amount", "label": "Debt Repurchase Program, Remaining Amount Authorized to be Repurchased, Amount", "terseLabel": "Debt repurchase program, amount available under the program" } } }, "localname": "DebtRepurchaseProgramRemainingAmountAuthorizedToBeRepurchasedAmount", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "cnc_DebtSecuritiesAvailableForSaleNumberOfPositions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Securities, Available -for-Sale, Number of Positions", "label": "Debt Securities, Available -for-Sale, Number of Positions", "terseLabel": "Total investment positions" } } }, "localname": "DebtSecuritiesAvailableForSaleNumberOfPositions", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "integerItemType" }, "cnc_DebtTotalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Total", "label": "Debt Total [Member]", "terseLabel": "Debt Total" } } }, "localname": "DebtTotalMember", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "cnc_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDownNetOfTax": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down, Net of Tax", "label": "Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down, Net of Tax", "terseLabel": "Impairment associated with pending divestiture, after tax" } } }, "localname": "DisposalGroupNotDiscontinuedOperationLossGainOnWriteDownNetOfTax", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails" ], "xbrltype": "monetaryItemType" }, "cnc_FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair Value, Assets and Liabilities, Based Upon Observable or Unobservable Inputs, Level Input Definitions", "label": "Fair Value, Assets and Liabilities, Based Upon Observable or Unobservable Inputs, Input Definitions [Table Text Block]", "terseLabel": "Assets and Liabilities, Based Upon Observable or Unobservable Inputs, Level Input Definitions" } } }, "localname": "FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "cnc_FinanceLeaseLiabilityAndOther": { "auth_ref": [], "calculation": { "http://www.centene.com/role/DebtScheduleofDebtDetails": { "order": 2.0, "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Finance Lease Liability And Other", "label": "Finance Lease Liability And Other", "terseLabel": "Finance leases and other" } } }, "localname": "FinanceLeaseLiabilityAndOther", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "cnc_FixedAssetsLeasedRealEstateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fixed Assets, Leased Real Estate", "label": "Fixed Assets, Leased Real Estate [Member]", "terseLabel": "Leased Real Estate and Fixed Assets" } } }, "localname": "FixedAssetsLeasedRealEstateMember", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/PropertySoftwareandEquipmentNarrativeDetails" ], "xbrltype": "domainItemType" }, "cnc_FourPointTwoFivePercentSeniorNotesDueInTwentyTwentySevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Four Point Two Five Percent Senior Notes, Due In Twenty Twenty Seven [Member]", "label": "Four Point Two Five Percent Senior Notes, Due In Twenty Twenty Seven [Member]", "terseLabel": "$2,500 million 4.25% Senior Notes due December 15, 2027" } } }, "localname": "FourPointTwoFivePercentSeniorNotesDueInTwentyTwentySevenMember", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails", "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "cnc_FurnitureAndOfficeEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Furniture and Office Equipment", "label": "Furniture and Office Equipment [Member]", "terseLabel": "Furniture and office equipment" } } }, "localname": "FurnitureAndOfficeEquipmentMember", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails" ], "xbrltype": "domainItemType" }, "cnc_GainLossOnDispositionOfBusinessNetOfTax": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gain (Loss) on Disposition of Business, Net of Tax", "label": "Gain (Loss) on Disposition of Business, Net of Tax", "terseLabel": "Gain on disposition of business, net of tax" } } }, "localname": "GainLossOnDispositionOfBusinessNetOfTax", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails" ], "xbrltype": "monetaryItemType" }, "cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion": { "auth_ref": [], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gain (Loss) on Extinguishment of Debt , Including Cash Portion", "label": "Gain (Loss) on Extinguishment of Debt , Including Cash Portion", "terseLabel": "Debt extinguishment" } } }, "localname": "GainLossOnExtinguishmentOfDebtIncludingCashPortion", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "cnc_InvestmentSecuritiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment Securities", "label": "Investment Securities [Member]", "terseLabel": "Investment Securities" } } }, "localname": "InvestmentSecuritiesMember", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "domainItemType" }, "cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost": { "auth_ref": [], "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investments, Debt Securities, Equity Method Investments And Other, Amortized Cost", "label": "Investments, Debt Securities, Equity Method Investments And Other, Amortized Cost", "totalLabel": "Total, Amortized Cost" } } }, "localname": "InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "xbrltype": "monetaryItemType" }, "cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue": { "auth_ref": [], "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": { "order": 3.0, "parentTag": "cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investments, Debt Securities, Equity Securities And Other, Fair Value", "label": "Investments, Debt Securities, Equity Securities And Other, Fair Value", "totalLabel": "Total, Fair Value" } } }, "localname": "InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "xbrltype": "monetaryItemType" }, "cnc_InvestmentsRecordedAtFairValueThatCarryRatingOfAAAPlusWeightedAverageDuration": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investments Recorded At Fair Value That Carry Rating Of A AA Plus, Weighted Average, Duration", "label": "Investments Recorded At Fair Value That Carry Rating Of A AA Plus, Weighted Average, Duration", "terseLabel": "Investments recorded at fair value that carry rating of AAA Plus, weighted average (in years)" } } }, "localname": "InvestmentsRecordedAtFairValueThatCarryRatingOfAAAPlusWeightedAverageDuration", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "durationItemType" }, "cnc_LifeInsuranceContractsAndEquityInvestmentsFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Life Insurance Contracts And Equity Investments, Fair Value", "label": "Life Insurance Contracts And Equity Investments, Fair Value", "terseLabel": "Aggregate carrying amount of life insurance contracts and equity investments, fair value" } } }, "localname": "LifeInsuranceContractsAndEquityInvestmentsFairValue", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "cnc_MagellanHealthMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Magellan Health", "label": "Magellan Health [Member]", "terseLabel": "Magellan Acquisition" } } }, "localname": "MagellanHealthMember", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails", "http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails", "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "cnc_ManagedCareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ManagedCareMember", "label": "Managed Care [Member]", "verboseLabel": "Managed\u00a0 Care" } } }, "localname": "ManagedCareMember", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "cnc_MeasurementPeriodAdjustmentToIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement Period Adjustment To Intangible Assets", "label": "Measurement Period Adjustment To Intangible Assets [Member]", "terseLabel": "Adjustment to intangible assets" } } }, "localname": "MeasurementPeriodAdjustmentToIntangibleAssetsMember", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "cnc_NumberOfStatesNoFaultAgreementsWithAttorneyGenerals": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of States, No Fault Agreements with Attorney Generals", "label": "Number of States, No Fault Agreements with Attorney Generals", "terseLabel": "Number of states where no fault agreements were reached with attorney generals" } } }, "localname": "NumberOfStatesNoFaultAgreementsWithAttorneyGenerals", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/ContingenciesDetails" ], "xbrltype": "integerItemType" }, "cnc_PANTHERxRareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PANTHERx Rare", "label": "PANTHERx Rare [Member]", "terseLabel": "PANTHERx Rare" } } }, "localname": "PANTHERxRareMember", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails" ], "xbrltype": "domainItemType" }, "cnc_PremiumTaxExpense": { "auth_ref": [], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 6.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Premium tax expense, similar assessments and provider pass through payments.", "label": "Premium Tax Expense", "terseLabel": "Premium tax expense" } } }, "localname": "PremiumTaxExpense", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "cnc_PremiumTaxRevenue": { "auth_ref": [], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Premium tax revenue, similar assessments and provider pass through payments.", "label": "Premium Tax Revenue", "terseLabel": "Premium tax" } } }, "localname": "PremiumTaxRevenue", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "cnc_RatedSecuritiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rated Securities [Member]", "label": "Rated Securities [Member]", "terseLabel": "Rated Securities" } } }, "localname": "RatedSecuritiesMember", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "domainItemType" }, "cnc_RealEstateOwnedAndRelatedFixedAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Real Estate Owned and Related Fixed Assets", "label": "Real Estate Owned and Related Fixed Assets [Member]", "terseLabel": "Real Estate Owned and Related Fixed Assets" } } }, "localname": "RealEstateOwnedAndRelatedFixedAssetsMember", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/PropertySoftwareandEquipmentNarrativeDetails" ], "xbrltype": "domainItemType" }, "cnc_RestrictedCashEquivalentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted Cash Equivalents [Member]", "label": "Restricted Cash Equivalents [Member]", "terseLabel": "Restricted cash equivalents" } } }, "localname": "RestrictedCashEquivalentsMember", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "xbrltype": "domainItemType" }, "cnc_RestrictedCertificatesOfDepositMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted certificates of deposit [member]", "label": "Restricted Certificates Of Deposit [Member]", "terseLabel": "Restricted certificates of deposit" } } }, "localname": "RestrictedCertificatesOfDepositMember", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "xbrltype": "domainItemType" }, "cnc_ReturnofPremiumPayable": { "auth_ref": [], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Return of Premium Payable", "label": "Return of Premium Payable", "terseLabel": "Return of premium payable" } } }, "localname": "ReturnofPremiumPayable", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "cnc_ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Receivables (Payables) Related to the Affordable Care Act Programs", "label": "Schedule Of Receivables (Payables) Related To The Affordable Care Act Programs [Table Text Block]", "terseLabel": "Schedule of net receivables (payables) related to the Affordable Care Act Programs" } } }, "localname": "ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/AffordableCareActTables" ], "xbrltype": "textBlockItemType" }, "cnc_SeniorNotesTotal": { "auth_ref": [], "calculation": { "http://www.centene.com/role/DebtScheduleofDebtDetails": { "order": 3.0, "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Senior Notes, Total", "label": "Senior Notes, Total", "totalLabel": "Total senior notes" } } }, "localname": "SeniorNotesTotal", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "cnc_ShareRepurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Repurchase Agreement", "label": "Share Repurchase Agreement [Member]", "terseLabel": "Share Repurchase Agreement" } } }, "localname": "ShareRepurchaseAgreementMember", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "cnc_SharesIssuedValueAcquisitionsShareBasedPaymentArrangementAfterForfeiture": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Shares Issued, Value, Acquisitions, Share-based Payment Arrangement, after Forfeiture", "label": "Shares Issued, Value, Acquisitions, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Fair value of unvested equity awards in connection with acquisition" } } }, "localname": "SharesIssuedValueAcquisitionsShareBasedPaymentArrangementAfterForfeiture", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "cnc_ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Short-term and long-term investments and restricted deposits by investment type", "label": "Short Term And Long Term Investments And Restricted Deposits By Investment Type [Table Text Block]", "terseLabel": "Short-term and long-term investments and restricted deposits by investment type" } } }, "localname": "ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsTables" ], "xbrltype": "textBlockItemType" }, "cnc_SpanishAndCentralEuropeanBusinessesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Spanish and Central European Businesses", "label": "Spanish and Central European Businesses [Member]", "terseLabel": "Spanish and Central European Businesses" } } }, "localname": "SpanishAndCentralEuropeanBusinessesMember", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails" ], "xbrltype": "domainItemType" }, "cnc_SpecialtyServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SpecialtyServicesMember", "label": "Specialty Services [Member]", "terseLabel": "Specialty Services" } } }, "localname": "SpecialtyServicesMember", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "cnc_StockRepurchaseProgramIncreaseAuthorizedAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock Repurchase Program, Increase, Authorized Amount", "label": "Stock Repurchase Program, Increase, Authorized Amount", "terseLabel": "Stock repurchase program, increase to authorized amount" } } }, "localname": "StockRepurchaseProgramIncreaseAuthorizedAmount", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "cnc_TermLoanCreditAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term Loan Credit Agreement [Member]", "label": "Term Loan Credit Agreement [Member]", "terseLabel": "Term loan facility" } } }, "localname": "TermLoanCreditAgreementMember", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "cnc_TreasuryStockValueAcquiredPercentageOfNotionalAmountOfProgram": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Treasury Stock, Value Acquired, Percentage Of Notional Amount Of Program", "label": "Treasury Stock, Value Acquired, Percentage Of Notional Amount Of Program", "terseLabel": "Shares repurchased, percentage of notional amount" } } }, "localname": "TreasuryStockValueAcquiredPercentageOfNotionalAmountOfProgram", "nsuri": "http://www.centene.com/20220930", "presentation": [ "http://www.centene.com/role/StockholdersEquityDetails" ], "xbrltype": "percentItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r653" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r654" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r651" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r651" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r651" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r663" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r651" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r651" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r651" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r651" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r650" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r652" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r129", "r174", "r187", "r188", "r189", "r190", "r192", "r194", "r198", "r304", "r305", "r306", "r307", "r308", "r309", "r311", "r312", "r314", "r316", "r317" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r129", "r174", "r187", "r188", "r189", "r190", "r192", "r194", "r198", "r304", "r305", "r306", "r307", "r308", "r309", "r311", "r312", "r314", "r316", "r317" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r293", "r295", "r296", "r297", "r322", "r361", "r402", "r404", "r526", "r527", "r528", "r529", "r530", "r531", "r550", "r627", "r629", "r648", "r649" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r293", "r295", "r296", "r297", "r322", "r361", "r402", "r404", "r526", "r527", "r528", "r529", "r530", "r531", "r550", "r627", "r629", "r648", "r649" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r200", "r295", "r296", "r389", "r391", "r552", "r626", "r628" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r200", "r295", "r296", "r389", "r391", "r552", "r626", "r628" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r285", "r293", "r295", "r296", "r297", "r322", "r361", "r392", "r402", "r404", "r408", "r409", "r410", "r526", "r527", "r528", "r529", "r530", "r531", "r550", "r627", "r629", "r648", "r649" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r285", "r293", "r295", "r296", "r297", "r322", "r361", "r392", "r402", "r404", "r408", "r409", "r410", "r526", "r527", "r528", "r529", "r530", "r531", "r550", "r627", "r629", "r648", "r649" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r47" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts Payable and Accrued Liabilities, Current", "terseLabel": "Accounts payable and accrued expenses" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r27", "r276" ], "calculation": { "http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedTerseLabel": "Less: accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r40", "r65", "r67", "r68", "r600", "r634", "r635" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive earnings" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r64", "r68", "r77", "r78", "r79", "r131", "r132", "r133", "r459", "r515", "r630", "r631" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Earnings (Loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Acquired Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r264" ], "lang": { "en-us": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life", "terseLabel": "Weighted Average Useful Life (in years)" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r38" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid in Capital, Common Stock", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r131", "r132", "r133", "r411", "r412", "r413", "r478" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r405", "r414", "r415" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "verboseLabel": "Stock compensation expense" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net earnings to net cash provided by operating activities" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r117", "r262", "r269" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 4.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization of acquired intangible assets" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r156" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "verboseLabel": "Anti-dilutive restricted stock and restricted stock units excluded from the calculation of diluted earnings (loss) per common share (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AssetBackedSecuritiesMember": { "auth_ref": [ "r218", "r393" ], "lang": { "en-us": { "role": { "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.", "label": "Asset-Backed Securities [Member]", "terseLabel": "Asset-backed securities" } } }, "localname": "AssetBackedSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AssetImpairmentCharges": { "auth_ref": [ "r117", "r272" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 7.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "Asset Impairment Charges", "terseLabel": "Impairment" } } }, "localname": "AssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r30", "r126", "r182", "r189", "r196", "r233", "r304", "r305", "r306", "r308", "r309", "r310", "r311", "r313", "r315", "r317", "r318", "r453", "r461", "r490", "r516", "r518", "r559", "r598" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS", "verboseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.centene.com/role/LeasesROUAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r21", "r45", "r126", "r233", "r304", "r305", "r306", "r308", "r309", "r310", "r311", "r313", "r315", "r317", "r318", "r453", "r461", "r490", "r516", "r518" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r481" ], "calculation": { "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "totalLabel": "Total assets at fair value" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Fair Value Disclosure [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": { "auth_ref": [ "r2", "r3", "r12", "r14", "r17", "r280" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Assets", "terseLabel": "Assets held for sale" } } }, "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": { "auth_ref": [ "r208" ], "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": { "order": 1.0, "parentTag": "cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax", "terseLabel": "Gross Unrealized Gains" } } }, "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": { "auth_ref": [ "r209" ], "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": { "order": 2.0, "parentTag": "cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax", "negatedLabel": "Gross Unrealized Losses" } } }, "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Available-for-Sale [Abstract]", "terseLabel": "Investments:" } } }, "localname": "AvailableForSaleSecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract]", "terseLabel": "Unrealized Losses" } } }, "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost": { "auth_ref": [ "r215" ], "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "order": 3.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10", "terseLabel": "Five years through ten years" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": { "auth_ref": [ "r210", "r215", "r585" ], "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "order": 3.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10", "terseLabel": "Five years through ten years" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": { "auth_ref": [ "r214" ], "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "order": 2.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five", "terseLabel": "One year through five years" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": { "auth_ref": [ "r210", "r214", "r584" ], "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "order": 2.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five", "terseLabel": "One year through five years" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost": { "auth_ref": [ "r216" ], "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "order": 4.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10", "terseLabel": "Greater than ten years" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue": { "auth_ref": [ "r210", "r216", "r586" ], "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "order": 4.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10", "terseLabel": "Greater than ten years" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Available-for-Sale, Amortized Cost, Fiscal Year Maturity [Abstract]", "terseLabel": "Amortized Cost" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]", "terseLabel": "Fair Value" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": { "auth_ref": [ "r213" ], "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "order": 1.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One", "terseLabel": "One year or less" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": { "auth_ref": [ "r210", "r213", "r583" ], "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "order": 1.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One", "terseLabel": "One year or less" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost": { "auth_ref": [ "r217" ], "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "order": 5.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.", "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost", "terseLabel": "Asset-backed securities" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": { "auth_ref": [ "r217", "r587" ], "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "order": 5.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.", "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value", "terseLabel": "Asset-backed securities" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableforsaleSecuritiesMember": { "auth_ref": [ "r225" ], "lang": { "en-us": { "role": { "documentation": "Investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Available-for-Sale Securities [Member]", "terseLabel": "Investments available-for-sale" } } }, "localname": "AvailableforsaleSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BankTimeDepositsMember": { "auth_ref": [ "r577" ], "lang": { "en-us": { "role": { "documentation": "Certificates of deposit (CD) or savings accounts with a fixed term or understanding the customer can only withdraw by giving advanced notice with a bank or other financial institution. A CD is a short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest.", "label": "Bank Time Deposits [Member]", "terseLabel": "Short-term time deposits", "verboseLabel": "Short-term time deposits" } } }, "localname": "BankTimeDepositsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/OrganizationandOperationsPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r130" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "verboseLabel": "Organization and Operations" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/OrganizationandOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_BuildingMember": { "auth_ref": [ "r275" ], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.", "label": "Building [Member]", "terseLabel": "Building" } } }, "localname": "BuildingMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r401", "r403", "r436" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails", "http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails", "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r401", "r403", "r430", "r431", "r436" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails", "http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails", "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails", "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "auth_ref": [ "r427" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.", "label": "Business Combination, Acquisition Related Costs", "terseLabel": "Acquisition related expenses" } } }, "localname": "BusinessCombinationAcquisitionRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r440", "r441", "r442" ], "calculation": { "http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "totalLabel": "Consideration transferred" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferredOther1": { "auth_ref": [ "r444" ], "calculation": { "http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash.", "label": "Business Combination, Consideration Transferred, Other", "terseLabel": "Consideration transferred related to fair value of replacement equity awards associated with pre-combination service" } } }, "localname": "BusinessCombinationConsiderationTransferredOther1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "auth_ref": [ "r433" ], "calculation": { "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets", "totalLabel": "Total assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r433" ], "calculation": { "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents", "terseLabel": "Cash and cash equivalents" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": { "auth_ref": [ "r433" ], "calculation": { "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other", "terseLabel": "Other current assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "auth_ref": [ "r433" ], "calculation": { "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables", "terseLabel": "Premium and related receivables" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "auth_ref": [ "r433" ], "calculation": { "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 7.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable", "terseLabel": "Accounts payable and accrued expenses" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": { "auth_ref": [ "r433" ], "calculation": { "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 8.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue", "terseLabel": "Unearned revenue" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt": { "auth_ref": [ "r433" ], "calculation": { "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-Term Debt", "terseLabel": "Current portion of long-term debt" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": { "auth_ref": [ "r433" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets", "terseLabel": "Deferred tax assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "auth_ref": [ "r433" ], "calculation": { "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities", "terseLabel": "Deferred tax liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": { "auth_ref": [ "r432", "r433" ], "calculation": { "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 6.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles", "terseLabel": "Intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails", "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "auth_ref": [ "r433" ], "calculation": { "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities", "totalLabel": "Total liabilities assumed" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "auth_ref": [ "r432", "r433" ], "calculation": { "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net", "totalLabel": "Total identifiable net assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net [Abstract]", "terseLabel": "Assets acquired and liabilities assumed" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets": { "auth_ref": [ "r433" ], "calculation": { "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 7.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets", "terseLabel": "Other long-term assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt": { "auth_ref": [ "r433" ], "calculation": { "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-Term Debt", "terseLabel": "Long-term debt" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": { "auth_ref": [ "r433" ], "calculation": { "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other", "terseLabel": "Other long-term liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r432", "r433" ], "calculation": { "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 5.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment", "terseLabel": "Property, software and equipment" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": { "auth_ref": [ "r433" ], "calculation": { "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net", "totalLabel": "Total assets acquired and liabilities assumed" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts": { "auth_ref": [ "r428" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "For transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination, such as related to pre-existing relationships with the acquiree, this element represents the disclosure of the amount of acquisition related costs.", "label": "Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Costs", "negatedTerseLabel": "Settlement of pre-existing payables and receivables prior to acquisition" } } }, "localname": "BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain": { "auth_ref": [ "r429" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.", "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain", "negatedLabel": "(Gain) on acquisition" } } }, "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r19", "r23", "r119" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "periodEndLabel": "Cash and cash equivalents", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "auth_ref": [], "calculation": { "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": { "order": 1.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents [Member]", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r111", "r119", "r121" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash, cash equivalents, and restricted cash and cash equivalents, end of period", "periodStartLabel": "Cash, cash equivalents, and restricted cash and cash equivalents, beginning of period", "totalLabel": "Total cash, cash equivalents, and restricted cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]", "terseLabel": "The following table provides a reconciliation of cash, cash equivalents, and restricted cash and cash equivalents reported within the Consolidated Balance Sheets to the totals above:" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations": { "auth_ref": [ "r111", "r119", "r121" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; attributable to disposal group, including, but not limited to, discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations", "negatedTerseLabel": "Cash and cash equivalents reclassified from (to) held for sale" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r111", "r491" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase in cash, cash equivalents, and restricted cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CertificatesOfDepositMember": { "auth_ref": [ "r590" ], "lang": { "en-us": { "role": { "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured.", "label": "Certificates of Deposit [Member]", "terseLabel": "Certificates of deposit" } } }, "localname": "CertificatesOfDepositMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r35", "r36", "r37", "r123", "r126", "r146", "r150", "r151", "r153", "r155", "r163", "r164", "r165", "r233", "r304", "r309", "r310", "r311", "r317", "r318", "r359", "r360", "r363", "r367", "r374", "r490", "r655" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfTreasuryStockTable": { "auth_ref": [ "r381", "r382", "r383", "r384" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.", "label": "Class of Treasury Stock [Table]", "terseLabel": "Class of Treasury Stock [Table]" } } }, "localname": "ClassOfTreasuryStockTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommercialMortgageBackedSecuritiesMember": { "auth_ref": [ "r217", "r393" ], "lang": { "en-us": { "role": { "documentation": "Securities collateralized by commercial real estate mortgage loans.", "label": "Commercial Mortgage-Backed Securities [Member]", "terseLabel": "Commercial mortgage-backed securities", "verboseLabel": "Commercial mortgage-backed securities" } } }, "localname": "CommercialMortgageBackedSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r53", "r568", "r605" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r288", "r289", "r290", "r298", "r644" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/Contingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r131", "r132", "r478" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical", "http://www.centene.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r37" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in dollars per share)", "verboseLabel": "Par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r37" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r37" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r37", "r374" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "periodEndLabel": "Balance (in shares)", "periodStartLabel": "Balance (in shares)", "terseLabel": "Common stock, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r37", "r518" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.001 par value; authorized 800,000 shares; 606,931 issued and 570,091 outstanding at September\u00a030, 2022, and 602,704 issued and 582,479 outstanding at December\u00a031, 2021" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r73", "r75", "r76", "r88", "r574", "r613" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive earnings (loss) attributable to Centene Corporation" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r73", "r75", "r87", "r450", "r451", "r465", "r573", "r612" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "negatedTerseLabel": "Comprehensive (earnings) loss attributable to noncontrolling interests" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r73", "r75", "r86", "r449", "r465", "r572", "r611" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Comprehensive earnings (loss)" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComputerEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.", "label": "Computer Equipment [Member]", "terseLabel": "Computer hardware" } } }, "localname": "ComputerEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r167", "r168", "r203", "r488", "r489", "r643" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r167", "r168", "r203", "r488", "r489", "r638", "r643" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r167", "r168", "r203", "r488", "r489", "r638", "r643" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r167", "r168", "r203", "r488", "r489" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Percentage of investments in rated securities carry an investment grade rating by nationally recognized statistical rating organizations" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r167", "r168", "r203", "r488", "r489", "r643" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConstructionLoanPayableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A real estate loan to finance building costs. The funds are disbursed as needed or in accordance with a prearranged plan; generally, a portion of the funds is disbursed at inception and the remainder as construction progresses. The money is repaid on completion of the project (generally one to seven years), usually from the proceeds of a mortgage loan.", "label": "Construction Loan Payable [Member]", "terseLabel": "Construction Loan Payable" } } }, "localname": "ConstructionLoanPayableMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r386", "r387", "r390" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract with Customer, Liability, Current", "terseLabel": "Unearned revenue" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractualRightsMember": { "auth_ref": [ "r438" ], "lang": { "en-us": { "role": { "documentation": "Rights that arise from a contractual arrangement with a third party (not including franchise rights and license agreements).", "label": "Contractual Rights [Member]", "terseLabel": "Purchased contract rights" } } }, "localname": "ContractualRightsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CorporateDebtSecuritiesMember": { "auth_ref": [ "r393", "r400", "r636" ], "lang": { "en-us": { "role": { "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.", "label": "Corporate Debt Securities [Member]", "terseLabel": "Corporate securities" } } }, "localname": "CorporateDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r92", "r552" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of services" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r90" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Costs and Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CreditAvailabilityConcentrationRiskMember": { "auth_ref": [ "r166" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that borrowing or credit line availability under commitments from one or more lenders is to a selected benchmark, such as total debt, segment debt. Risk is the materially adverse effects that funds which may be needed for operations or for a specific purpose will not be available on terms that are acceptable to an entity, if at all.", "label": "Credit Availability Concentration Risk [Member]", "terseLabel": "Credit Availability Concentration Risk" } } }, "localname": "CreditAvailabilityConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CurrencySwapMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.", "label": "Currency Swap [Member]", "verboseLabel": "Currency Swap" } } }, "localname": "CurrencySwapMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtAndCapitalLeaseObligations": { "auth_ref": [ "r566", "r607" ], "calculation": { "http://www.centene.com/role/DebtScheduleofDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.centene.com/role/DebtScheduleofDebtDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term and long-term debt and lease obligation.", "label": "Debt and Lease Obligation", "totalLabel": "Total debt" } } }, "localname": "DebtAndCapitalLeaseObligations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r122", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r336", "r343", "r344", "r346", "r353" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "verboseLabel": "Debt" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/Debt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r31", "r33", "r34", "r125", "r129", "r319", "r320", "r321", "r322", "r323", "r324", "r326", "r332", "r333", "r334", "r335", "r337", "r338", "r339", "r340", "r341", "r342", "r347", "r348", "r349", "r350", "r504", "r560", "r561", "r596" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails", "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Basis spread on variable rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r319", "r347", "r348", "r502", "r504", "r505" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Debt, face amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails", "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r50", "r320" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails", "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails", "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r51", "r125", "r129", "r319", "r320", "r321", "r322", "r323", "r324", "r326", "r332", "r333", "r334", "r335", "r337", "r338", "r339", "r340", "r341", "r342", "r347", "r348", "r349", "r350", "r504" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails", "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRepurchasedFaceAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of the original debt instrument that was repurchased.", "label": "Debt Instrument, Repurchased Face Amount", "terseLabel": "Debt redemption amount" } } }, "localname": "DebtInstrumentRepurchasedFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r51", "r125", "r129", "r319", "r320", "r321", "r322", "r323", "r324", "r326", "r332", "r333", "r334", "r335", "r337", "r338", "r339", "r340", "r341", "r342", "r345", "r347", "r348", "r349", "r350", "r375", "r376", "r377", "r378", "r501", "r502", "r504", "r505", "r591" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails", "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss": { "auth_ref": [ "r212", "r241", "r242", "r243" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of accrued interest on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss", "terseLabel": "Accrued interest income" } } }, "localname": "DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss": { "auth_ref": [ "r241" ], "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": { "order": 4.0, "parentTag": "cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost", "weight": 1.0 }, "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost excluding accrued interest, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss", "totalLabel": "Amortized Cost" } } }, "localname": "DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": { "auth_ref": [ "r223", "r246", "r249" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer", "terseLabel": "Fair Value, 12 Months or More" } } }, "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": { "auth_ref": [ "r223", "r246" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss", "negatedLabel": "12 Months or More" } } }, "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": { "auth_ref": [ "r223", "r246", "r249" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months", "terseLabel": "Fair Value, Less Than 12 Months" } } }, "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": { "auth_ref": [ "r223", "r246" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss", "negatedLabel": "Less Than 12 Months" } } }, "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest": { "auth_ref": [ "r241" ], "calculation": { "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": { "order": 4.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 }, "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": { "order": 3.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": 1.0 }, "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-Sale, Excluding Accrued Interest", "terseLabel": "Fair Value", "totalLabel": "Fair Value" } } }, "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleTable": { "auth_ref": [ "r228" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-Sale [Table]", "terseLabel": "Debt Securities, Available-for-sale [Table]" } } }, "localname": "DebtSecuritiesAvailableForSaleTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": { "auth_ref": [ "r220", "r245", "r249" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]", "terseLabel": "Fair value of available-for-sale investments with gross unrealized losses by investment type and length of time" } } }, "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": { "auth_ref": [ "r221", "r244" ], "lang": { "en-us": { "role": { "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions", "terseLabel": "Positions from which gross unrealized losses were generated" } } }, "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Available-for-Sale, Amortized Cost [Abstract]", "terseLabel": "Debt Securities" } } }, "localname": "DebtSecuritiesAvailableforsaleAmortizedCostAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r117", "r127", "r419", "r423", "r424", "r425" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r416", "r417" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "terseLabel": "Deferred tax liability" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepositsMember": { "auth_ref": [ "r578" ], "lang": { "en-us": { "role": { "documentation": "Amounts held on account by the entity representing a liability to the depositor. Deposits may take various forms (for example, demand deposits, saving deposits, Negotiable Order of Withdrawal (NOW) and time deposits) and may be categorized in multiple ways (such as, foreign and domestic, interest and noninterest bearing).", "label": "Deposits [Member]", "terseLabel": "Restricted Deposits", "verboseLabel": "Restricted deposits" } } }, "localname": "DepositsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r117", "r274" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 5.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation expense" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r117", "r274" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation, Depletion and Amortization, Nonproduction", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssets": { "auth_ref": [ "r58", "r59", "r60", "r487" ], "calculation": { "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": { "order": 3.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset", "terseLabel": "Derivative asset" } } }, "localname": "DerivativeAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r60", "r468", "r469", "r470", "r472" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r466", "r467" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Derivative, Notional Amount", "terseLabel": "Derivative agreement" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DevelopedTechnologyRightsMember": { "auth_ref": [ "r439" ], "lang": { "en-us": { "role": { "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.", "label": "Developed Technology Rights [Member]", "terseLabel": "Developed technologies" } } }, "localname": "DevelopedTechnologyRightsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupClassificationAxis": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Information by disposal group classification.", "label": "Disposal Group Classification [Axis]", "terseLabel": "Disposal Group Classification [Axis]" } } }, "localname": "DisposalGroupClassificationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupClassificationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.", "label": "Disposal Group Classification [Domain]", "terseLabel": "Disposal Group Classification [Domain]" } } }, "localname": "DisposalGroupClassificationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": { "auth_ref": [ "r273", "r282" ], "lang": { "en-us": { "role": { "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.", "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]", "terseLabel": "Disposal Group, Disposed of by Sale, Not Discontinued Operations" } } }, "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember": { "auth_ref": [ "r271", "r273", "r282" ], "lang": { "en-us": { "role": { "documentation": "Disposal group that either has been sold or is classified as held-for-sale. Excludes disposals classified as discontinued operations.", "label": "Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations [Member]", "terseLabel": "Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations" } } }, "localname": "DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown": { "auth_ref": [ "r117", "r273", "r279" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.", "label": "Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down", "terseLabel": "Impairment associated with pending divestiture" } } }, "localname": "DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": { "auth_ref": [ "r401", "r403" ], "lang": { "en-us": { "role": { "documentation": "Name of disposal group.", "label": "Disposal Group Name [Domain]", "terseLabel": "Disposal Group Name [Domain]" } } }, "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r89", "r136", "r137", "r138", "r139", "r140", "r144", "r146", "r153", "r154", "r155", "r159", "r160", "r479", "r480", "r575", "r614" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic earnings per common share (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/EarningsPerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic [Abstract]", "verboseLabel": "Net earnings per common share attributable to Centene Corporation:" } } }, "localname": "EarningsPerShareBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/EarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic, Other Disclosure [Abstract]", "terseLabel": "Shares used in computing per share amounts:", "verboseLabel": "Weighted average number of common shares outstanding:" } } }, "localname": "EarningsPerShareBasicOtherDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/EarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r89", "r136", "r137", "r138", "r139", "r140", "r146", "r153", "r154", "r155", "r159", "r160", "r479", "r480", "r575", "r614" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted earnings per common share (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/EarningsPerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r156", "r157", "r158", "r161" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "verboseLabel": "Earnings Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/EarningsPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r491" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "terseLabel": "Effect of exchange rate changes on cash, cash equivalents, and restricted cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]", "terseLabel": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityClassOfTreasuryStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Equity, Class of Treasury Stock [Line Items]", "terseLabel": "Equity, Class of Treasury Stock [Line Items]" } } }, "localname": "EquityClassOfTreasuryStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r77", "r78", "r79", "r131", "r132", "r133", "r135", "r141", "r143", "r162", "r235", "r374", "r379", "r411", "r412", "r413", "r420", "r421", "r478", "r492", "r493", "r494", "r495", "r496", "r498", "r515", "r630", "r631", "r632" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r24", "r183", "r232" ], "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": { "order": 3.0, "parentTag": "cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Method Investments", "terseLabel": "Private equity investments" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesFvNi": { "auth_ref": [ "r20", "r32", "r486" ], "calculation": { "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": { "order": 2.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 }, "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": { "order": 2.0, "parentTag": "cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.", "label": "Equity Securities, FV-NI, Current", "terseLabel": "Equity securities" } } }, "localname": "EquitySecuritiesFvNi", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ExternalCreditRatingByGroupingAxis": { "auth_ref": [ "r205", "r240", "r302", "r474" ], "lang": { "en-us": { "role": { "documentation": "Information by external rating classified as investment grade or non investment grade.", "label": "External Credit Rating by Grouping [Axis]", "terseLabel": "External Credit Rating by Grouping [Axis]" } } }, "localname": "ExternalCreditRatingByGroupingAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ExternalCreditRatingByGroupingDomain": { "auth_ref": [ "r301", "r473" ], "lang": { "en-us": { "role": { "documentation": "External credit rating classified as investment grade or non-investment grade.", "label": "External Credit Rating by Grouping [Domain]", "terseLabel": "External Credit Rating by Grouping [Domain]" } } }, "localname": "ExternalCreditRatingByGroupingDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ExternalCreditRatingInvestmentGradeMember": { "auth_ref": [ "r301", "r473" ], "lang": { "en-us": { "role": { "documentation": "External credit-rating that could be used to describe the current status of the payment and performance risk of credit derivatives and guarantee obligations that connote investment grade.", "label": "External Credit Rating, Investment Grade [Member]", "terseLabel": "External Credit Rating, Investment Grade" } } }, "localname": "ExternalCreditRatingInvestmentGradeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r481", "r482", "r485" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "auth_ref": [ "r483" ], "lang": { "en-us": { "role": { "documentation": "Class of asset.", "label": "Asset Class [Domain]", "terseLabel": "Asset Class [Domain]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueByAssetClassAxis": { "auth_ref": [ "r481", "r485" ], "lang": { "en-us": { "role": { "documentation": "Information by class of asset.", "label": "Asset Class [Axis]", "terseLabel": "Asset Class [Axis]" } } }, "localname": "FairValueByAssetClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r334", "r347", "r348", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r482", "r523", "r524", "r525" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]", "terseLabel": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r484" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r334", "r393", "r394", "r399", "r400", "r482", "r523" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level I" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r334", "r347", "r348", "r393", "r394", "r399", "r400", "r482", "r524" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level II" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r334", "r347", "r348", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r482", "r525" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level III" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r334", "r347", "r348", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r523", "r524", "r525" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r218", "r219", "r229", "r230", "r231", "r236", "r237", "r238", "r239", "r240", "r245", "r247", "r248", "r249", "r345", "r372", "r476", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r655", "r656", "r657", "r658", "r659", "r660", "r661" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]", "terseLabel": "Schedule Of Investments And Restricted Deposits By Type [Axis]", "verboseLabel": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable": { "auth_ref": [ "r263" ], "lang": { "en-us": { "role": { "documentation": "A table containing detailed characteristics of finite-lived intangible assets acquired during a business combination. Finite-lived intangible assets are assets that have no physical form, but have expected future economic benefit, and are expected to be used over a defined period. Acquired finite-lived intangible assets are disclosed by major class (assets that can be grouped together because they are similar, either by their nature or by their use in operations of the Entity) and in total. Additionally, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period are also disclosed.", "label": "Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]", "terseLabel": "Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]" } } }, "localname": "FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r263", "r265", "r268", "r270", "r553", "r554" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r263", "r267" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignLineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars, outside the reporting entity's home country.", "label": "Foreign Line of Credit [Member]", "terseLabel": "Foreign Line of Credit" } } }, "localname": "ForeignLineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnRepurchaseOfDebtInstrument": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from the difference between the repurchase price of a debt instrument initially issued by the entity and the net carrying amount of the debt at the time of its repurchase.", "label": "Gain (Loss) on Repurchase of Debt Instrument", "terseLabel": "Gain on redemption of debt" } } }, "localname": "GainLossOnRepurchaseOfDebtInstrument", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfBusiness": { "auth_ref": [ "r117", "r460" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.", "label": "Gain (Loss) on Disposition of Business", "negatedLabel": "(Gain) loss on divestitures", "negatedTerseLabel": "Gain on disposition of business" } } }, "localname": "GainLossOnSaleOfBusiness", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r117", "r351", "r352" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain (Loss) on Extinguishment of Debt", "negatedLabel": "(Gain) loss on debt extinguishment" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r28", "r250", "r251", "r258", "r260", "r518", "r558" ], "calculation": { "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 }, "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "netLabel": "Goodwill", "terseLabel": "Goodwill", "verboseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_HealthCarePremiumMember": { "auth_ref": [ "r391" ], "lang": { "en-us": { "role": { "documentation": "Money received from insurance for service provided for maintenance, diagnosis and treatment of physical and mental health.", "label": "Health Care, Premium [Member]", "terseLabel": "Premium" } } }, "localname": "HealthCarePremiumMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "domainItemType" }, "us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Held-to-Maturity, Unrealized Loss Position, Fair Value [Abstract]", "terseLabel": "Fair Value" } } }, "localname": "HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeLossFromContinuingOperations": { "auth_ref": [ "r91", "r118", "r136", "r137", "r138", "r139", "r152", "r155", "r448" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.", "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent", "verboseLabel": "Earnings attributable to Centene Corporation" } } }, "localname": "IncomeLossFromContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/EarningsPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r83", "r182", "r188", "r192", "r195", "r198", "r555", "r569", "r579", "r615" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Earnings before income tax" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": { "auth_ref": [ "r401", "r403" ], "lang": { "en-us": { "role": { "documentation": "Information by name of disposal group.", "label": "Disposal Group Name [Axis]", "terseLabel": "Disposal Group Name [Axis]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]", "verboseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": { "auth_ref": [ "r3", "r6", "r7", "r8", "r9", "r10", "r11", "r13", "r15", "r16", "r17", "r282", "r283" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations [Table]", "verboseLabel": "Disposal Groups, Including Discontinued Operations [Table]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r128", "r142", "r143", "r180", "r418", "r422", "r426", "r616" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Income tax expense" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r120" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Income taxes paid" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r116" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "verboseLabel": "Accounts payable and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r116", "r551" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Contract with Customer, Liability", "terseLabel": "Unearned revenue" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities": { "auth_ref": [ "r116" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) in health care insurance liability balances during the period.", "label": "Increase (Decrease) in Health Care Insurance Liabilities", "terseLabel": "Medical claims liabilities" } } }, "localname": "IncreaseDecreaseInHealthCareInsuranceLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": { "auth_ref": [], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.", "label": "Increase (Decrease) in Other Noncurrent Liabilities", "terseLabel": "Other long-term liabilities" } } }, "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r116" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other assets" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract]", "terseLabel": "Changes in assets and liabilities" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPremiumsReceivable": { "auth_ref": [ "r116" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The change in the premium receivable balance on the balance sheet.", "label": "Increase (Decrease) in Premiums Receivable", "negatedLabel": "Premium and trade receivables" } } }, "localname": "IncreaseDecreaseInPremiumsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r147", "r148", "r149", "r155", "r406" ], "calculation": { "http://www.centene.com/role/EarningsPerShareDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "verboseLabel": "Common stock equivalents (as determined by applying the treasury stock method) (in shares)" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_InsuranceAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Insurance [Abstract]", "terseLabel": "Insurance [Abstract]" } } }, "localname": "InsuranceAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InsuranceContractsAcquiredInBusinessCombinationMember": { "auth_ref": [ "r593", "r637" ], "lang": { "en-us": { "role": { "documentation": "Written contracts detailing the terms and conditions of insurance acquired in a business combination.", "label": "Insurance Contracts Acquired in Business Combination [Member]", "terseLabel": "Provider contracts" } } }, "localname": "InsuranceContractsAcquiredInBusinessCombinationMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InsuranceDisclosureTextBlock": { "auth_ref": [ "r639" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the types of coverages and products sold, and the assets, obligations, recorded liabilities, revenues and expenses arising therefrom, and the amounts of and methodologies and assumptions used in determining the amounts of such items.", "label": "Insurance Disclosure [Text Block]", "terseLabel": "Medical Claims Liability" } } }, "localname": "InsuranceDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiability" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r261", "r266" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r81", "r176", "r500", "r503", "r576" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r108", "r112", "r120" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Interest paid" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateSwapMember": { "auth_ref": [ "r471" ], "lang": { "en-us": { "role": { "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.", "label": "Interest Rate Swap [Member]", "terseLabel": "Interest rate swap agreements" } } }, "localname": "InterestRateSwapMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IntersegmentEliminationMember": { "auth_ref": [ "r174", "r187", "r188", "r189", "r190", "r192", "r194", "r198" ], "lang": { "en-us": { "role": { "documentation": "Eliminating entries used in operating segment consolidation.", "label": "Intersegment Eliminations [Member]", "terseLabel": "Eliminations" } } }, "localname": "IntersegmentEliminationMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentIncomeNonoperating": { "auth_ref": [ "r94" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income from investments (for example, dividends) not considered a component of the entity's core operations.", "label": "Investment Income, Nonoperating", "terseLabel": "Investment and other income" } } }, "localname": "InvestmentIncomeNonoperating", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.", "label": "Investments Classified by Contractual Maturity Date [Table Text Block]", "terseLabel": "Contractual maturities of short-term and long-term investments and restricted deposits" } } }, "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments, Debt and Equity Securities [Abstract]", "terseLabel": "Investments, Debt and Equity Securities [Abstract]" } } }, "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": { "auth_ref": [ "r228", "r556", "r588", "r640", "r662" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for investments in certain debt and equity securities.", "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]", "verboseLabel": "Short-term and Long-term Investments, Restricted Deposits" } } }, "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDeposits" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets held for their financial return, rather than for the entity's operations.", "label": "Investments [Member]", "terseLabel": "Investments" } } }, "localname": "InvestmentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LandMember": { "auth_ref": [ "r391" ], "lang": { "en-us": { "role": { "documentation": "Part of earth's surface not covered by water.", "label": "Land [Member]", "terseLabel": "Land" } } }, "localname": "LandMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r512" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "ROU Assets and Liabilities" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r275" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]", "terseLabel": "Leasehold improvements" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]", "terseLabel": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r48", "r126", "r190", "r233", "r304", "r305", "r306", "r309", "r310", "r311", "r313", "r315", "r317", "r318", "r454", "r461", "r462", "r490", "r516", "r517" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "terseLabel": "Liabilities" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/LeasesROUAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r43", "r126", "r233", "r490", "r518", "r563", "r603" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities, redeemable noncontrolling interests and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r22", "r49", "r126", "r233", "r304", "r305", "r306", "r309", "r310", "r311", "r313", "r315", "r317", "r318", "r454", "r461", "r462", "r490", "r516", "r517", "r518" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": { "auth_ref": [ "r2", "r3", "r12", "r14", "r17", "r280" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Liabilities", "terseLabel": "Liabilities held for sale" } } }, "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense": { "auth_ref": [ "r619", "r622" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": { "order": 1.0, "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.", "label": "Liability for Claims and Claims Adjustment Expense", "periodEndLabel": "Balance, September 30", "periodStartLabel": "Balance, January 1", "terseLabel": "Medical claims liability" } } }, "localname": "LiabilityForClaimsAndClaimsAdjustmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the cost of settling unpaid claims after deduction of reinsurance recoveries related to the acquisition of a business. Includes, but is not limited to, claims which have been incurred but not reported.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions", "terseLabel": "Acquisitions and divestitures" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]", "terseLabel": "Paid related to:" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1": { "auth_ref": [ "r621" ], "calculation": { "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": { "order": 1.0, "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year", "terseLabel": "Current year" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1": { "auth_ref": [ "r621" ], "calculation": { "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": { "order": 2.0, "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years", "terseLabel": "Prior years" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1": { "auth_ref": [ "r620" ], "calculation": { "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims", "totalLabel": "Total incurred" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]", "terseLabel": "Incurred related to:" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet": { "auth_ref": [ "r594", "r619", "r622" ], "calculation": { "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Net", "periodEndLabel": "Balance, September 30, net", "periodStartLabel": "Balance, January 1, net" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]", "terseLabel": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LifeInsuranceCorporateOrBankOwnedAmount": { "auth_ref": [ "r25", "r234" ], "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": { "order": 4.0, "parentTag": "cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the amount that could be realized under a life insurance contract or contracts owned by the Entity as of the date of the statement of financial position. Such Entity-owned life insurance policies are commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).", "label": "Life Insurance, Corporate or Bank Owned, Amount", "terseLabel": "Life insurance contracts" } } }, "localname": "LifeInsuranceCorporateOrBankOwnedAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r34", "r561", "r596" ], "calculation": { "http://www.centene.com/role/DebtScheduleofDebtDetails": { "order": 1.0, "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-Term Line of Credit", "terseLabel": "Credit facility" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r46" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Credit facility, maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LitigationReserve": { "auth_ref": [ "r53", "r291" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.", "label": "Estimated Litigation Liability", "terseLabel": "Reserve estimate" } } }, "localname": "LitigationReserve", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LitigationSettlementExpense": { "auth_ref": [], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 8.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.", "label": "Litigation Settlement, Expense", "terseLabel": "Legal settlement" } } }, "localname": "LitigationSettlementExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LitigationStatusAxis": { "auth_ref": [ "r291" ], "lang": { "en-us": { "role": { "documentation": "Information by status of pending, threatened, or settled litigation.", "label": "Litigation Status [Axis]", "terseLabel": "Litigation Status [Axis]" } } }, "localname": "LitigationStatusAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LitigationStatusDomain": { "auth_ref": [ "r291" ], "lang": { "en-us": { "role": { "documentation": "Status of pending, threatened, or settled litigation.", "label": "Litigation Status [Domain]", "terseLabel": "Litigation Status [Domain]" } } }, "localname": "LitigationStatusDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ContingenciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LoansPayable": { "auth_ref": [ "r34", "r561", "r595" ], "calculation": { "http://www.centene.com/role/DebtScheduleofDebtDetails": { "order": 4.0, "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).", "label": "Loans Payable", "terseLabel": "Construction loan payable" } } }, "localname": "LoansPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails", "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LondonInterbankOfferedRateLIBORMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.", "label": "London Interbank Offered Rate (LIBOR) [Member]", "terseLabel": "LIBOR" } } }, "localname": "LondonInterbankOfferedRateLIBORMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r47" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://www.centene.com/role/DebtScheduleofDebtDetails_1": { "order": 1.0, "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-Term Debt, Current Maturities", "negatedLabel": "Less current portion", "terseLabel": "Current portion of long-term debt" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r34" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://www.centene.com/role/DebtScheduleofDebtDetails_1": { "order": 2.0, "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.", "label": "Long-Term Debt, Excluding Current Maturities", "terseLabel": "Long-term debt", "verboseLabel": "Long-term debt" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermInvestments": { "auth_ref": [ "r25" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).", "label": "Long-Term Investments", "verboseLabel": "Long-term investments" } } }, "localname": "LongTermInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-Term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails", "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r51", "r303" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-Term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails", "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]", "terseLabel": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r291", "r292", "r293", "r294", "r295", "r299", "r300" ], "lang": { "en-us": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]", "terseLabel": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyPendingClaimsNumber": { "auth_ref": [ "r292", "r294" ], "lang": { "en-us": { "role": { "documentation": "Number of pending claims pertaining to a loss contingency.", "label": "Loss Contingency, Pending Claims, Number", "terseLabel": "Pending claims" } } }, "localname": "LossContingencyPendingClaimsNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ContingenciesDetails" ], "xbrltype": "integerItemType" }, "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": { "auth_ref": [ "r18", "r445" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.", "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]", "terseLabel": "Acquisitions and Divestitures" } } }, "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestitures" ], "xbrltype": "textBlockItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r57", "r126", "r233", "r304", "r309", "r310", "r311", "r317", "r318", "r490", "r562", "r602" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "verboseLabel": "Nonredeemable noncontrolling interest" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_MunicipalBondsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long-term debt securities issued by state, city or local governments or the agencies operated by state, city or local governments.", "label": "Municipal Bonds [Member]", "terseLabel": "Municipal securities" } } }, "localname": "MunicipalBondsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r111" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash (used in) provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r111" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r111", "r114", "r118" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r17", "r71", "r74", "r79", "r84", "r118", "r126", "r134", "r136", "r137", "r138", "r139", "r142", "r143", "r152", "r182", "r188", "r192", "r195", "r198", "r233", "r304", "r305", "r306", "r309", "r310", "r311", "r313", "r315", "r317", "r318", "r480", "r490", "r570", "r609" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net earnings attributable to Centene Corporation" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Attributable to Parent [Abstract]", "terseLabel": "Net earnings per common share attributable to Centene Corporation:", "verboseLabel": "Earnings attributable to Centene Corporation" } } }, "localname": "NetIncomeLossAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/EarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r71", "r74", "r79", "r142", "r143", "r456", "r464" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "negatedTerseLabel": "(Earnings) loss attributable to noncontrolling interests" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest": { "auth_ref": [ "r356", "r456", "r457" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.", "label": "Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest", "terseLabel": "Net earnings (loss)" } } }, "localname": "NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Accounting Guidance Not Yet Adopted" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/OrganizationandOperationsPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation": { "auth_ref": [ "r380", "r458" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of the reduction or elimination during the period of a noncontrolling interest resulting from the parent's loss of control and deconsolidation of the entity in which one or more outside parties had a noncontrolling interest.", "label": "Noncontrolling Interest, Decrease from Deconsolidation", "negatedTerseLabel": "Divestiture of noncontrolling interest" } } }, "localname": "NoncontrollingInterestDecreaseFromDeconsolidation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination": { "auth_ref": [ "r380", "r434", "r458" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in noncontrolling interest from a business combination.", "label": "Noncontrolling Interest, Increase from Business Combination", "terseLabel": "Acquisition resulting in noncontrolling interest" } } }, "localname": "NoncontrollingInterestIncreaseFromBusinessCombination", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest": { "auth_ref": [ "r380", "r452", "r458" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.", "label": "Noncontrolling Interest, Increase from Sale of Parent Equity Interest", "terseLabel": "Reclassification to non-redeemable noncontrolling interest" } } }, "localname": "NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance": { "auth_ref": [ "r380", "r452", "r458" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders.", "label": "Noncontrolling Interest, Increase from Subsidiary Equity Issuance", "terseLabel": "Contribution from noncontrolling interest" } } }, "localname": "NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r131", "r132", "r133", "r379", "r446" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Non-redeemable Non- controlling Interest" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other income (expense):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [ "r170" ], "lang": { "en-us": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number of Operating Segments", "terseLabel": "Number of operating segments" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r182", "r188", "r192", "r195", "r198" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Earnings from operations", "verboseLabel": "Earnings from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseImpairmentLoss": { "auth_ref": [ "r506" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from impairment of right-of-use asset from operating lease.", "label": "Operating Lease, Impairment Loss", "terseLabel": "ROU impairment" } } }, "localname": "OperatingLeaseImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/LeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r508" ], "calculation": { "http://www.centene.com/role/LeasesROUAssetsandLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "totalLabel": "Total lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/LeasesROUAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r508" ], "calculation": { "http://www.centene.com/role/LeasesROUAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Short-term (recorded within accounts payable and accrued expenses)" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/LeasesROUAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r509" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.", "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]" } } }, "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/LeasesROUAssetsandLiabilitiesDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r508" ], "calculation": { "http://www.centene.com/role/LeasesROUAssetsandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Long-term (recorded within other long-term liabilities)" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/LeasesROUAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r509" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability.", "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]" } } }, "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/LeasesROUAssetsandLiabilitiesDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r507" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "ROU assets (recorded within other long-term assets)" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/LeasesROUAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r509" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset.", "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]" } } }, "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/LeasesROUAssetsandLiabilitiesDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r511", "r513" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted-average discount rate for operating leases" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/LeasesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r510", "r513" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "verboseLabel": "Weighted average remaining lease term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/LeasesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r187", "r188", "r189", "r190", "r192", "r198" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating Segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherAssetImpairmentCharges": { "auth_ref": [ "r117", "r278" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.", "label": "Other Asset Impairment Charges", "terseLabel": "Remaining asset impairment charges" } } }, "localname": "OtherAssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/LeasesNarrativeDetails", "http://www.centene.com/role/PropertySoftwareandEquipmentNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r44", "r518" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "verboseLabel": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r29" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other long-term assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r61" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "verboseLabel": "Foreign currency translation adjustments" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r72", "r75", "r77", "r78", "r80", "r85", "r374", "r492", "r497", "r498", "r571", "r610" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Other comprehensive earnings (loss) , net of tax", "totalLabel": "Other comprehensive earnings (loss)" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax": { "auth_ref": [ "r65", "r69", "r70", "r227" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.", "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax", "negatedTerseLabel": "Reclassification adjustment, net of tax" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": { "auth_ref": [ "r62", "r65" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.", "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax", "terseLabel": "Change in unrealized gain (loss) on investments, net of tax" } } }, "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax": { "auth_ref": [ "r63", "r66" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.", "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax", "terseLabel": "Other comprehensive earnings (loss), tax (benefit) expense" } } }, "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r52" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other long-term liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashIncomeExpense": { "auth_ref": [ "r118" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.", "label": "Other Noncash Income (Expense)", "negatedLabel": "Other adjustments, net" } } }, "localname": "OtherNoncashIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncurrentAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent assets.", "label": "Other Noncurrent Assets [Member]", "terseLabel": "Other long-term assets:" } } }, "localname": "OtherNoncurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherOperatingActivitiesCashFlowStatement": { "auth_ref": [], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).", "label": "Other Operating Activities, Cash Flow Statement", "terseLabel": "Other operating activities, net" } } }, "localname": "OtherOperatingActivitiesCashFlowStatement", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherRestrictedAssetsNoncurrent": { "auth_ref": [ "r641", "r642" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets that are pledged or subject to withdrawal restrictions, classified as other.", "label": "Other Restricted Assets, Noncurrent", "terseLabel": "Restricted deposits" } } }, "localname": "OtherRestrictedAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForHedgeInvestingActivities": { "auth_ref": [ "r99", "r115" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.", "label": "Payments for Hedge, Investing Activities", "terseLabel": "Payments for foreign currency hedge" } } }, "localname": "PaymentsForHedgeInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForLossesAndLossAdjustmentExpense": { "auth_ref": [ "r113", "r621" ], "calculation": { "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid", "totalLabel": "Total paid" } } }, "localname": "PaymentsForLossesAndLossAdjustmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r103" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Common stock repurchases" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtExtinguishmentCosts": { "auth_ref": [ "r106" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.", "label": "Payment for Debt Extinguishment or Debt Prepayment Cost", "negatedLabel": "Payments for debt extinguishment" } } }, "localname": "PaymentsOfDebtExtinguishmentCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r105" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Payments of Debt Issuance Costs", "negatedLabel": "Debt issuance costs" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r97", "r443" ], "calculation": { "http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "terseLabel": "Cash paid" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r97" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedLabel": "Acquisitions, net of cash acquired" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireInvestments": { "auth_ref": [ "r99" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.", "label": "Payments to Acquire Investments", "negatedLabel": "Purchases of investments" } } }, "localname": "PaymentsToAcquireInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r98" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Capital expenditures" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PendingLitigationMember": { "auth_ref": [ "r291" ], "lang": { "en-us": { "role": { "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.", "label": "Pending Litigation [Member]", "terseLabel": "Pending Litigation" } } }, "localname": "PendingLitigationMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ContingenciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare": { "auth_ref": [ "r617" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.", "label": "Policyholder Benefits and Claims Incurred, Net, Health", "terseLabel": "Medical costs" } } }, "localname": "PolicyholderBenefitsAndClaimsIncurredHealthCare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r36", "r359" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r36" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r36", "r359" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued (in shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r36" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding (in shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r36", "r518" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at September\u00a030, 2022 and December\u00a031, 2021" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PremiumsAndOtherReceivablesNet": { "auth_ref": [ "r608" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date, net of allowance for doubtful accounts, of all premiums and other types of receivables due from other persons or entities.", "label": "Premiums and Other Receivables, Net", "terseLabel": "Premium and trade receivables" } } }, "localname": "PremiumsAndOtherReceivablesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities": { "auth_ref": [ "r101", "r110" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow provided by derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.", "label": "Proceeds from Derivative Instrument, Financing Activities", "terseLabel": "Proceeds from termination of interest rate swaps" } } }, "localname": "ProceedsFromDerivativeInstrumentFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromDivestitureOfBusinesses": { "auth_ref": [ "r95" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.", "label": "Proceeds from Divestiture of Businesses", "terseLabel": "Proceeds from sale of business" } } }, "localname": "ProceedsFromDivestitureOfBusinesses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested": { "auth_ref": [ "r95" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the cash inflow during the period from the sale of a component of the entity.", "label": "Proceeds from Divestiture of Businesses, Net of Cash Divested", "terseLabel": "Divestiture proceeds, net of divested cash" } } }, "localname": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r100" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds from Issuance of Long-Term Debt", "terseLabel": "Proceeds from long-term debt" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLongTermLinesOfCredit": { "auth_ref": [ "r100" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.", "label": "Proceeds from Long-Term Lines of Credit", "terseLabel": "Proceeds from credit facility" } } }, "localname": "ProceedsFromLongTermLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "auth_ref": [ "r102", "r107" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.", "label": "Proceeds from (Payments for) Other Financing Activities", "terseLabel": "Other financing activities, net" } } }, "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments": { "auth_ref": [ "r96" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.", "label": "Proceeds from Sale, Maturity and Collection of Investments", "terseLabel": "Sales and maturities of investments" } } }, "localname": "ProceedsFromSaleMaturityAndCollectionsOfInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r17", "r71", "r74", "r79", "r109", "r126", "r134", "r142", "r143", "r182", "r188", "r192", "r195", "r198", "r233", "r304", "r305", "r306", "r309", "r310", "r311", "r313", "r315", "r317", "r318", "r449", "r455", "r457", "r464", "r465", "r480", "r490", "r579" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net earnings", "totalLabel": "Net earnings", "verboseLabel": "Net earnings" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r277" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails", "http://www.centene.com/role/PropertySoftwareandEquipmentNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r284", "r645", "r646", "r647" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "Property, Software and Equipment" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/PropertySoftwareandEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r26", "r275" ], "calculation": { "http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Property, software and equipment, at cost" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails", "http://www.centene.com/role/PropertySoftwareandEquipmentNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r277", "r518", "r589", "r604" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property, software and equipment, net", "totalLabel": "Property, software and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r277" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Components of Property, Software and Equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/PropertySoftwareandEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r275" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Long-Lived Tangible Asset [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails", "http://www.centene.com/role/PropertySoftwareandEquipmentNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": { "auth_ref": [ "r354", "r355", "r357", "r358" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.", "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount", "terseLabel": "Redeemable noncontrolling interests" } } }, "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments": { "auth_ref": [ "r592", "r618", "r619", "r622" ], "calculation": { "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": { "order": 2.0, "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer.", "label": "Reinsurance Recoverable for Unpaid Claims and Claims Adjustments", "periodEndLabel": "Plus: Reinsurance recoverable", "periodStartLabel": "Less: Reinsurance recoverable" } } }, "localname": "ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r104" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Repayments of Long-Term Debt", "negatedLabel": "Payments and repurchases of long-term debt" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfSeniorDebt": { "auth_ref": [ "r104" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.", "label": "Repayments of Senior Debt", "terseLabel": "Repurchase of senior debt" } } }, "localname": "RepaymentsOfSeniorDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResidentialMortgageBackedSecuritiesMember": { "auth_ref": [ "r207", "r393" ], "lang": { "en-us": { "role": { "documentation": "Securities collateralized by residential real estate mortgage loans.", "label": "Residential Mortgage-Backed Securities [Member]", "terseLabel": "Residential mortgage-backed securities" } } }, "localname": "ResidentialMortgageBackedSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedCashAndCashEquivalents": { "auth_ref": [ "r23", "r119", "r121", "r557", "r599" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Restricted Cash and Cash Equivalents", "periodEndLabel": "Restricted cash and cash equivalents, included in restricted deposits" } } }, "localname": "RestrictedCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r39", "r379", "r518", "r601", "r633", "r635" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r131", "r132", "r133", "r135", "r141", "r143", "r235", "r411", "r412", "r413", "r420", "r421", "r478", "r630", "r632" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r173", "r174", "r187", "r193", "r194", "r200", "r201", "r203", "r388", "r389", "r552" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Premium and service revenues" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r82", "r126", "r173", "r174", "r187", "r193", "r194", "r200", "r201", "r203", "r233", "r304", "r305", "r306", "r309", "r310", "r311", "r313", "r315", "r317", "r318", "r490", "r579" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Total revenues", "totalLabel": "Total revenues" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]", "terseLabel": "Revenues:" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving credit agreement" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock": { "auth_ref": [ "r263" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the characteristics, including initial carrying value, residual amount, weighted average useful life, of finite-lived intangible assets acquired during the period by major class. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.", "label": "Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]", "terseLabel": "Schedule of Preliminary Fair Values and Weighted Average Useful Lives for Identifiable Intangible Assets Acquired" } } }, "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Securities, Available-for-Sale [Line Items]", "terseLabel": "Debt Securities, Available-for-sale [Line Items]", "verboseLabel": "Schedule Of Investments And Restricted Deposits By Type [Line Items]" } } }, "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": { "auth_ref": [ "r211", "r217", "r222", "r223", "r224", "r226", "r581", "r582" ], "lang": { "en-us": { "role": { "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.", "label": "Schedule of Available-for-Sale Securities [Table]", "terseLabel": "Schedule of Available-for-Sale Securities [Table]", "verboseLabel": "Schedule Of Investments And Restricted Deposits By Type [Table]" } } }, "localname": "ScheduleOfAvailableForSaleSecuritiesTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r430", "r431", "r436" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails", "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "Schedule of Debt [Table Text Block]", "terseLabel": "Schedule of Debt" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r155" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Calculation of Basic and Diluted Net Earnings Per Common Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r481", "r482" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense": { "auth_ref": [ "r623" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.", "label": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]", "terseLabel": "Schedule of change in medical claims liability" } } }, "localname": "ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r277" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails", "http://www.centene.com/role/PropertySoftwareandEquipmentNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r435" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "terseLabel": "Schedule of Allocation of the Fair Value of Assets Acquired and Liabilities Assumed" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r182", "r185", "r191", "r259" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r182", "r185", "r191", "r259" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Segment Information" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": { "auth_ref": [ "r475" ], "lang": { "en-us": { "role": { "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg.", "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]", "terseLabel": "SOFR" } } }, "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r169", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r187", "r188", "r189", "r190", "r192", "r193", "r194", "r195", "r196", "r198", "r203", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r286", "r287", "r626" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r169", "r171", "r172", "r182", "r186", "r192", "r196", "r197", "r198", "r199", "r200", "r202", "r203", "r204" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "verboseLabel": "Segment Information" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/SegmentInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "verboseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r93" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 3.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_SeniorNotes": { "auth_ref": [ "r567", "r606" ], "calculation": { "http://www.centene.com/role/DebtScheduleofDebtDetails": { "order": 1.0, "parentTag": "cnc_SeniorNotesTotal", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.", "label": "Senior Notes", "terseLabel": "Senior notes" } } }, "localname": "SeniorNotes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SeniorNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.", "label": "Senior Notes [Member]", "terseLabel": "Senior Notes" } } }, "localname": "SeniorNotesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails", "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ServiceMember": { "auth_ref": [ "r391" ], "lang": { "en-us": { "role": { "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.", "label": "Service [Member]", "terseLabel": "Service" } } }, "localname": "ServiceMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "domainItemType" }, "us-gaap_SettledLitigationMember": { "auth_ref": [ "r291" ], "lang": { "en-us": { "role": { "documentation": "Agreement reached between parties in a litigation that occurs without judicial intervention, supervision or approval.", "label": "Settled Litigation [Member]", "terseLabel": "Settled Litigation" } } }, "localname": "SettledLitigationMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ContingenciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r116" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "verboseLabel": "Stock compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareRepurchaseProgramAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by share repurchase program.", "label": "Share Repurchase Program [Axis]", "terseLabel": "Share Repurchase Program [Axis]" } } }, "localname": "ShareRepurchaseProgramAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareRepurchaseProgramDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the share repurchase program.", "label": "Share Repurchase Program [Domain]", "terseLabel": "Share Repurchase Program [Domain]" } } }, "localname": "ShareRepurchaseProgramDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShortTermInvestments": { "auth_ref": [ "r44", "r564", "r565", "r597" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.", "label": "Short-Term Investments", "terseLabel": "Short-term investments" } } }, "localname": "ShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet": { "auth_ref": [ "r624", "r625" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Undiscounted amount, after reinsurance, of incurred-but-not-reported (IBNR) liabilities plus expected development on reported claims, for claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.", "label": "Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net", "terseLabel": "Short-duration insurance contracts, Incurred but not reported and expected development on reported claims" } } }, "localname": "ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r5", "r169", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r187", "r188", "r189", "r190", "r192", "r193", "r194", "r195", "r196", "r198", "r203", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r281", "r286", "r287", "r626" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r35", "r36", "r37", "r123", "r126", "r146", "r150", "r151", "r153", "r155", "r163", "r164", "r165", "r233", "r304", "r309", "r310", "r311", "r317", "r318", "r359", "r360", "r363", "r367", "r374", "r490", "r655" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r56", "r77", "r78", "r79", "r131", "r132", "r133", "r135", "r141", "r143", "r162", "r235", "r374", "r379", "r411", "r412", "r413", "r420", "r421", "r478", "r492", "r493", "r494", "r495", "r496", "r498", "r515", "r630", "r631", "r632" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]", "terseLabel": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r131", "r132", "r133", "r162", "r552" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r36", "r37", "r374", "r379" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Common stock issued for employee benefit plans (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r36", "r37", "r379", "r407" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Common stock issued for employee benefit plans" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stock repurchase plan authorized.", "label": "Stock Repurchase Program, Authorized Amount", "terseLabel": "Stock repurchase program, authorized amount" } } }, "localname": "StockRepurchaseProgramAuthorizedAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount remaining of a stock repurchase plan authorized.", "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount", "terseLabel": "Stock repurchase program, remaining available" } } }, "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r37", "r41", "r42", "r126", "r206", "r233", "r490", "r518" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total Centene stockholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r0", "r1", "r78", "r126", "r131", "r132", "r133", "r135", "r141", "r233", "r235", "r379", "r411", "r412", "r413", "r420", "r421", "r446", "r447", "r463", "r478", "r490", "r492", "r493", "r498", "r515", "r631", "r632" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total stockholders\u2019 equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]", "terseLabel": "Stockholders' equity", "verboseLabel": "Stockholders\u2019 equity:" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r124", "r360", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r373", "r379", "r385", "r477" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Stockholders' Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r499", "r519" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails", "http://www.centene.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r499", "r519" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails", "http://www.centene.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r499", "r519" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails", "http://www.centene.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental disclosures of cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense": { "auth_ref": [ "r620" ], "calculation": { "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": { "order": 1.0, "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.", "label": "Current Year Claims and Claims Adjustment Expense", "terseLabel": "Current year" } } }, "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense": { "auth_ref": [ "r620" ], "calculation": { "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": { "order": 2.0, "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.", "label": "Prior Year Claims and Claims Adjustment Expense", "terseLabel": "Prior years" } } }, "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TangibleAssetImpairmentCharges": { "auth_ref": [ "r4", "r278" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.", "label": "Tangible Asset Impairment Charges", "terseLabel": "Tangible asset impairment charges" } } }, "localname": "TangibleAssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/PropertySoftwareandEquipmentNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests": { "auth_ref": [ "r54", "r126", "r233", "r490" ], "calculation": { "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests", "terseLabel": "Mezzanine equity" } } }, "localname": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TradeNamesMember": { "auth_ref": [ "r437" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trade Names [Member]", "terseLabel": "Trade names" } } }, "localname": "TradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r218", "r219", "r229", "r230", "r231", "r345", "r372", "r476", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r655", "r656", "r657", "r658", "r659", "r660", "r661" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]", "terseLabel": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockCommonMember": { "auth_ref": [ "r381" ], "lang": { "en-us": { "role": { "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common [Member]", "terseLabel": "Treasury Stock" } } }, "localname": "TreasuryStockCommonMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockCommonShares": { "auth_ref": [ "r381" ], "lang": { "en-us": { "role": { "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common, Shares", "periodEndLabel": "Treasury stock (in shares)", "periodStartLabel": "Treasury stock (in shares)" } } }, "localname": "TreasuryStockCommonShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockShares": { "auth_ref": [ "r55", "r381" ], "lang": { "en-us": { "role": { "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.", "label": "Treasury Stock, Shares", "verboseLabel": "Treasury stock (in shares)" } } }, "localname": "TreasuryStockShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockSharesAcquired": { "auth_ref": [ "r37", "r374", "r379" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.", "label": "Treasury Stock, Shares, Acquired", "negatedLabel": "Common stock repurchases (in shares)", "terseLabel": "Common stock repurchases (in shares)" } } }, "localname": "TreasuryStockSharesAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.centene.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r55", "r381", "r384" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedLabel": "Treasury stock, at cost (36,840 and 20,225 shares, respectively)" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "auth_ref": [ "r374", "r379", "r381" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.", "label": "Treasury Stock, Value, Acquired, Cost Method", "negatedLabel": "Common stock repurchases", "terseLabel": "Common stock repurchases" } } }, "localname": "TreasuryStockValueAcquiredCostMethod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.centene.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_USTreasuryAndGovernmentMember": { "auth_ref": [ "r393", "r580", "r636" ], "lang": { "en-us": { "role": { "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac).", "label": "US Treasury and Government [Member]", "terseLabel": "U.S. Treasury securities and obligations of U.S. government corporations and agencies" } } }, "localname": "USTreasuryAndGovernmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnamortizedDebtIssuanceExpense": { "auth_ref": [], "calculation": { "http://www.centene.com/role/DebtScheduleofDebtDetails": { "order": 5.0, "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.", "label": "Unamortized Debt Issuance Expense", "negatedTerseLabel": "Debt issuance costs" } } }, "localname": "UnamortizedDebtIssuanceExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r145", "r155" ], "calculation": { "http://www.centene.com/role/EarningsPerShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted (in shares)", "totalLabel": "Weighted average number of common shares and potential dilutive common shares outstanding (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r144", "r155" ], "calculation": { "http://www.centene.com/role/EarningsPerShareDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic (in shares)", "verboseLabel": "Weighted average number of common shares outstanding (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 9 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3505-108585" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3581-108585" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r130": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" }, "r161": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r18": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/subtopic&trid=2122178" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599" }, "r204": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org/topic&trid=2134510" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953659-111524" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL6283291-111563" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL121698322-111563" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27337-111563" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27340-111563" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "8B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL6284393-111563" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)-(d)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563" }, "r228": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "https://asc.fasb.org/topic&trid=2196928" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "325", "URI": "https://asc.fasb.org/extlink&oid=6384206&loc=d3e41899-111602" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(10))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL120267853-210455" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "3B", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL120267856-210455" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(3)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922890-210455" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(12))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2599-110228" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230" }, "r284": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org/topic&trid=2155823" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r298": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629" }, "r353": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(12)(c)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(16)(c)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(3)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "14", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "15", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656" }, "r385": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(2)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479" }, "r445": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "https://asc.fasb.org/topic&trid=2303972" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613673-111683" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569655-111683" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5708775-113959" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5708775-113959" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123399704&loc=SL77918431-209957" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r514": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/subtopic&trid=77888251" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.27(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953" }, "r556": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "940", "URI": "https://asc.fasb.org/subtopic&trid=2176304" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(4))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.13,16)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.16)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(24))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(25))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Subparagraph": "b.", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123398031&loc=d3e60009-112784" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123398031&loc=d3e60009-112784" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(b)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(a)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(b)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(c)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(d)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803" }, "r588": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "942", "URI": "https://asc.fasb.org/subtopic&trid=2209399" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "405", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=99397103&loc=d3e6824-158387" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=122135039&loc=d3e569990-122904" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(13)(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16)(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(1)(g))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.16(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.16)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.5)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(20))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(21))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.5)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=99404803&loc=d3e21412-158489" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(cc)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671317-158438" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671321-158438" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "805", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=99383031&loc=d3e30256-158563" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r639": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "944", "URI": "https://asc.fasb.org/topic&trid=2303980" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580" }, "r640": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "946", "URI": "https://asc.fasb.org/subtopic&trid=2324412" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=127002003&loc=SL6242269-115581" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580" }, "r650": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r651": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r652": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r653": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r654": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r655": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r656": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)" }, "r657": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)" }, "r658": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)" }, "r659": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580" }, "r660": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)" }, "r661": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)" }, "r662": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1403" }, "r663": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "17A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(22))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(23))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.13)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" } }, "version": "2.1" } ZIP 74 0001071739-22-000361-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001071739-22-000361-xbrl.zip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�+RY8@0]PY M/OBA(.,Y'"'_FR1IEHZ/IU;"9[8&V0Z>V\'S\V'KXY(H:>'62 MM', I6RRS!;I&+A"RA==9MS+H(FW6YF1-#!?5/S.0?CM7'EVY7\&J'>3__N7 M_PD&3@+NM2:FB8M_7.',3#9**XD-.5<8:,>9,]G3=N083"Y9BK*P+/BB-S*%S7QOR?QGZ!%ANP>'Q!8AMJ@C(-A*)QCLJ2H8PX"P"\L^T4%DTU_'D_Z MG^=9;Y6AQW8./>-#FZD3I'_C\:@"%0'DO_JUES%!8_VEA;K<(P:^N\(UI%ST M6@JF5*5 (7+F-4AFI/'.)F^U=0O+3BQ*.ZTB5NT\]TE!P]3)4X.&1X&&"7ID M#0HMA&-%>60@@V4A.F0^\QP5/4C+Y<*R%8MZ:A4+GMRY[:@9TZ-6P/NV+>K% M(GCCOH.MVM5# V;17D*4OFC! :3T&K5+AAMPUB4Y+H5W+SZF5NUJJIBY.4FG M=-$E\%18J4A)F!F8(W[,LHBH%6U\*VNK!3.-#,Y6"^])HH,-1GH?I"T&T&=B M4"D2QPI88@3OQH4R&SK, 3I,,"H7?,I6$3K8Z!CX6@PO&L^$D4DYESSBN!$+ MMW=.WYRS8GAS?$C7.VI=$.:;2;7ZZ0\#B?$*P@0F<.DR"W9$F'(A([/&)V"V MQM*S=*+ZGV8H*J%)\8PRGB;%#R7%$\0&8I)%<!N$!/$$_:0MZT1-T?TZ@:Q+2DX;ABIY>ZA_5]N.G*_%!Q>R-SM[.54EZL31U+8P4&NM5-Z1XG>[NYW#@9YKWNT M-VKS<3C -+I0[GX:76>I\VH;][?H@O3)V@&$Q)7^Z)>S\BNGER51IDN=92R, M;D-_[^& 9MW!P\-!-QR-GDL=TR#3A#_1PR9,H@W1V>O33[IT_6BB20QSA:[)1!?Z_S:OVO-RM,^ Z!VG;&WN%VK/<[.B3H^3HJNC2: MSJ69#X_"7GT(#R8'\X L'N_A'-B49U,.A_ZJ;1\@PR#FER)U,>@V>D MC8?=_MO#[7R^!C2SSG[_D*9UT!_49>^=PN!2YV4:3P-[O>/%#M+*U-D? M]0[K*NYU][M[M/CC271"WL^E>TB/K]ZS\[?__>7MWT MZ4.C$6\-<&^X.!K/JSZMT?[Q:"<,ZN/][T>MG1?WXXN7>P03A\.W)R-Z2>K@ M7 ]L]/\]GL?;_"G7A_!VO&LW^JOC=:'YD_IX.YKV>CGY\+]/YORDU4J^-9_>WU]NK77W96]][1^-[(5;D*F_)M M+6FEUS?>T;4WC][U3:;K)9II^D;6VF69@,ZUM?71.8TY6LN @,1"@&9I8&&0.-F'.6,AR MNZI?^_EF&F-@.AIOHQ'PCN%L,'YT5=E4/-LG?4>J8?]P>]C)^Q70OHUGJC@T MVIIU#RU66#W(=,U/I$:6.C=7WO.B]-]\5^W\[YG>OLF@C\M7\V?VS3(=#32@_MGY1)? MT:WJ((:G2_#+T>%:GVX]GM*;L']B=)R9(4\]K&%*HOWF\^K61](.('A$IL!Y M!K9$TA/T)P@K9,#Z'B<](1:%FBS5=S M)6*EDS%N=PY(=/MI:2PM&Q>XU_EM*H\[XX&=VG5IJT.+=42,F-9G+Q]N]Q/1 MSFVZ>B6OL;]'4->KGZQS/#[EA.<$_^3+>7A";O-AY^79]?X\I!=QD$;2_._1 M4XGY?'S#?,6]27*'W4J_"[W7'U2&3%,CB=_N#NGO$7=.>(ACLG,9V@:^/; !:[\5O.&XO?T*Z MS\F8EBX=5M"V.^'LHRN.$7HDN3XI4[(-*1B AK!"(M&.05"%*L_6KXP175P M LD@QTE4!_UQ+ZT7(\N+=- _/W?3X?:I)^;"%T^L8W[^%0QD"!\=?O\K%\88 MZ1GDP2-I'@&7GL:%G]N#T]$Y_Q>+CPCV_F1*8/N[2& MUYC^3S5O*;>9O[O&],>>B%3)YVCKO1B9KO53-!J5[C#V^H3A>8/N\4NO'WG5./EYP\[OQ.96#W>_+HK5^D^JRNO MMS]L[,H/*[V]U:^[7^AUL4848H)JK/RRM[I'9.+K[SOK&YN?UW[;_+SZ_G5O M?>/#[OK[S:_K&Z_I]7=\\_WKLO;UU\\?I7):9V\)$IPC2I$B_5;-""$=I\7& M$O+"F3LFO:QT316-PH2$BLAD5C)83OPR>)-#+)C< FG;B =UL.=SM#XG-8/;IG]EW]Q#D9.'5>5<;Q.?=Z8\/P MU"6&^[2XO3,?'HG0F5ML]5\G;K$1 QEN$ZNAFYQ9E,-I&7_WAQ)_1EJEHUY> M+V_/G:W_QN/1OV>."UKI"3@Y=5B,H/OY(LI+_9&L$*<5**:T%80HR)ES7#)3 MK,>,0N5L+B/$S K4B?GP_ZH]K)6.W1#<=OG[.])3YF?"?Q6"=W/GE[:?36I0.H\7M& M+7$GOOLV7_K^>S^ZK#!+ .I6E_WQ>UI]_Z9W&JRYUF5_$O-V@_JG/XB"&YLG MCW0*?G4(W*3/\!IQ^4]V-58(6L:+(4:+(;Y9C&OND7D("WE;*0B>'0]LY8[NZ"LMNKJSSL^=S@G<7#B:;\O53N)9(JS)WWL? M5MX=TSV(D[W=)LZFU]]_V-W<^]!=^[JK-W>V1(T_F8AG^;I%X_MK=VWC=YK/ MJE[[[==Z7_V!QOQA[XU:W^AUUU?>,!#3+D/#-03K @ M\\B I']%*"!&;7GXC:NU74LFIAOT][/8OF<2H??\XNQ@7CBOVJH M M#TEH@GI'09V@!RI <6QT*V(POP6P'YT8G#R)U?&#J"471DS\H/CH2=NF#PV3ZC/X\_QXWA[ M^C2:"_-6"'26 GP!@2( #R9*9AQ/C- H,^31LB1 "TUT@7M9N]S,4'&>YE"8 MAT.')K?3E-O)HP?/A=;&,R^\8F E,8=L!(NR>$UR&U"8*VG^\RFJ-4/LX2Z' M#\_#;'DP[C!LWLU;(- 5 1>)5(,1UC SZAML1"3F8#ES/FMOC;.^J-H<9C9, ME^9HF M'0Y/8Z4GL!&<(RFK%,;(H4B;.D#4++BOB#*ID$#J"CPO+<)=SPVD[ M&WYAS(N=5ZM_UER9?JU/DT9I M :6[C[UQ"LZ%^(C# 0VUY,%Y_G,5W].2,Z.J/4N=E]^6IZF?.KUVO4_VD'^_<44&;\W/]0=[ +R?5]7X93[!MWVML7[VZ]3&8E$SMUN-Y M"0RT52PD#ZQ6T7.A8$Y2+RRK*Z*+S[;O#':]O;!&17*/[[HK-KW_M?-CY]0N-=V]MXP^@ M49$H_/%Y_8^/M#Y*9*F8X*F6?(F9!9D\"V2E6R>MU1HO)S#+:'G@F$-)&8+F MCBL'J%P,5@>3T^7LR[K@/TG(OI(2_?P^WXXK9C2&I#B7$$ :&V@2WMH<>= > MBWRDUGRC;7W)/7>/><9GI93.).?6J/-+;98> M*_?7^R7+[:U2?^62M]=+>[UI-JW7]Y+Z>[N$XI\.=JJIO_/@@+_Z>&/NTW); MDO+4DI3GL7G+]_+F;G"^(KGR0GBGB@>?91 N*14=\0;KP*JKSU?>K+V^BA6_ MV1^2UJL&YFN,>5QV=4X,R=LQBK'K=F]M=XWN2^/Z\N&W=YI8P_'JRMKVYOM? M^=IO=+^5/XX_[-32C.?NWE/7[:;\0ZY]_6MW<^?U+AFK8FWES>=5^7J;QLD_ MK) QNO+[WJ@T8S4^_^2?+[EN/Z7?_H+TO[_W/LC>I[!ST*5U@/65S:^;[^N\ M-WDUAMV?K\8>5W6I,8[8/(P-H( M*9*IB'%A62YJ_OVZC9WO[C5ZU"2*#[/=WE0HRL/#MWB8_SRL'IQ_YT$%*-PZ M/QY@LFVRA]YDZJ-,5F,LP(Q1CD')A;EL,L/:YQB(3TM9W7M+5=P5M85'FW&T M%YM2FR+>3)9L<)P44PG,!$EZJ=1HIN"!Q9)5'/EEDJAZZ:HS@2DW/)ZE&(,& M:@W4SD M5F=^Y-9)D)!0>U &4BGT&BKD]F=1%@W4[A?4)H(L.(\&A75,DZHA MLATUPY0%T]K0IHX!C!B#FH.Y +6'SOF8"VL:;3"DG&1.$<$6X:SSSG)-=(/L MK!*;-3T[,MK]F:'3_UJ#IC8W5K^LK_RR]Z$V6'C_U\[FQAI=^^7QYL:[KVL[ M=$V:_V:UIIT/:% #*U8I$G#DS$L;F4#4W*HBA7)5P-7TK.E[VF[-FI[13:8^ MNJ*TYR$3U"%M,@6.M(@FC%7:>'0%.5K:9$MP+6OZ]Z/>\:DE[7[2W?G99\/< M3M@:XWHH09LP([F(R='#89"4K64V,O,F6&9 %)I.MA&RS!P'2^%C#U(-UL5E*CRNW$Y92$3*4%!43,I'93%[_WO4WYAJ_^]N9X[>L?8DV0/533#XHLACEZ MXK7C(S T!EDN&K0S60CT"\MJFJ>+][3=FCTTHYM,?=2IQCA#9-87(*,[2-(5 M4%B2&A+6+5!$/5TTMSM>]' ;Z1JX>2M@FC2'NCL/*JC*$V=1:1 MA2@-*PFQ.)\,8*FHK.2TW- S=(+6Y/94;E7D(9$![#0 A&B=-IB-TPF\S];J M9A0]KMQ.&$6^N!PY1^:XU[5K=BTNK@JSP6F>!9$M+K['IAY/;MLAT16R1\37 M.A]J'48..F175-'**E44:IYD,XIF1A+77OTT&FYG[;??:9UZW?7WK_BAINZ(VL@@(0C'K%$$S5X9HE@Q, M@BG"MELSBF9TDZF/ MSKGH@ZIE*;5@X%$SE["PK$KB-F?:?ZH:15?LL2MLHO5XV#\_)[J32?0L_,VW MD[=&K1Y*UB;/B4IV&4MB1(,- ^,]\^ M4:MH:MF80 _K>YCC-S6*JZ* MFUB,0@C.!:5=C"8&2)A#_FDQUR:W]RNW$R91!!6L+)9I47O+:6N85[$V@=1: M.DD\2^O9D]MV3G35&6W20 +G,40.W'/T'J*###%;*UUJ)M'L2.)/\SP.=C[L M_-+=E+^*S9UXO+GWCJ[Q=F_]_;LOFQN[_,/[=U_I_R]K.[V]U1H\)XKR +'V MMELSB69TDRFRNTE'F(3,<%/([A;5 M[BZ965VT%C):D51-)M+7,HE6<1"W.Z/"2TJT(Z+[P/;&JQY*T"9K4FCO1-*2 ML%C4^!LPS!FHO?DB]T6Z*+F9$J]J1T2S*[?!QJ2"],;8#%;:D"0Z+X"CT4'G MU.RAQY7;"7O(@ XI!\^BK\E$M<$% M2:K60(94ELRL^@W+8CHBMDS_H(U\CPVZ^LK/5JG7W;6-M[P5?K^YMY?O?7W M;W=7?WO=V]S95:L[;W='R42I8)".9^93L;6MG67!H&99JJ#!%XQ!+RR+:197 MN*?MUNRA_\_>E_;$=6QK_Y46]][W)A)%:AZ<(TO$=G(<'2!Q2"S\!=4(&_? M[<$8__IW5>W=34.W&M905<]:42%C^T13;EU(""MI$*?" M(D>=188Z0ZC@/O!"KG#-PT2;DX/):'P'$=%WD6G^-G5K/:N'4K7%"L',4DZ# M0TKEM7H?,3(N:!0=M0$S'I)C7X/D=H7HV>@M=%M:*XG5+'*CL/440N7HJ:/@ M9T?>1D2/J[>+*T2.0^Q#*$J!$L2Y"4A'6S+-4B6C',Z;YE9-;Z^(B*:E):"Q M\7)5?Z@[[VA)JPP6%1M*W""<>PS(V!V,;;G.DHTR/(I28PTQ3R0$#8D@9R%RD#PQ)91(P6B 4[&N MV&+)XV_+,*T&6_$=YHR_5VV_BU+)K;;?H[8OEDI.1,)80]0+3CEKFB[T8L%'U=1VQ\ZT_PHKDD<]CK= 7PX65]UJ_'I-[DFMZ=9?])@ M15.,RF#/G?#<"N(BQ4FK: 47@&+NN@F:_T C=M*K80Q/ILKL$P"KK=W-\:R6 MPM'>::X3O^^X2IQ0"@%>P(@;^)LQ5,#?P.I K,=H?3Z*&/DD.,(L^R91 M*>1P8$)B<#93K+5]4I=?$$FLA,J*KM,VFW1YWUXM!&'NGN!>29&(Y8T0^5LFET<82 MGZZ]/:Y5S=NHYD7'@&E&I1 !*4!'!/.2D--.H$03H3%Z;&E>\>%FA53S>\A+ MO!J474&U5I7\Q+$]S471;Y.>>-X <]OUD1G P&B/_JA'NP68&P',VT7;+V!> ME?<*46DPX@2"#DL@$$GY+(.$()(E P"C;[T TFX$65W5O.UB1JN:=Z&:%VU_ MID_))Q80_%\B+L#L:\8L"IA1,/[$R5!4=#_4UE7%H,V^V$G#WT+-C<"FZU%/\ +)3"F"K'( M/>)*1? #/$:8V\@IL3 WF7Q W-72:)L#6$$]O8M-#:V>WJF>7G0*J-+>,1%0 M #<@)P1$+E7JD!\G-K6DSC/8JB?I\G+ )(_KVYKNRF'(X /! MR"M[7,&,E"!EQ\%(V-R ]O3:'8+4WTN\">H(,2P@$W%"/)J$C *_@O(8,;'> MA)!!2J\S=E?AR[55Y@GE(+YC&+@K=Z2%@0>$@8N^2C2":&Y]A@&*.,48:4]R M>3SM4@208+2& Q;C^GKZGS@:=?QD.(S]<>_.#?IOC>(#]#OV# M? PF8]:K>O1;#+H1!NTMNB+,@A%QP2$1,E^,RR2MU 7XFQXID=6]^,%@]Z'P<1UX\PKNUV4LW)C]M^/.$"K MC=J/[%)M#_I^BMMMV'=7H.X772XMHM1:$X!RY1$G,L'?<$122L.\I8D;7,(^ M?/L=;7>N0X^<'FK1M$73E4VFM6CZ &AZT44F41N1,^C6<)?Y 0RRS$IPD9WQ MR4G*-2EH*I:L^3U5-"V.]D_CO+U\QL9:=VU[T@-]\84.>]J1N7>X!=9EF7=Y)G?%A[+P:].#CI_\[ZHQGRXCK'7M\/!Q\ M!F4:Q^[I#?F1G6>&1QLRQQ4/)#CL<"(45-\23*78?UW\*(()6N90T8L(\ JT M'E1^6-+G[ZK1QS->9/+DB9&[\=_O3C^\#\>.VOOQ]NK-[(+9_ MVX;O?B1[7_XY^G#TYC.TMPR73_-$H[B:M3Y9(=5EOT.#'0L8M 95S& 6'0 @P-, M>V&H=K;_L;.34AS"MF/JO+*-!STRF/QG&S55[A2"AO/%%7I>J_#F0 M4$M!8IZ[^DGW^U(H?-O/" 8S7&3FI!H?%KG8 H3I=J$YF_[_)E4C456_\[L% MB1V>=C)ZK9\32M")+/AA]NC_^Z]<6N_GT9G\#2;CT=CVL[6Z(:X:'$BDRBB5 M&'H_J^>>>_'5Z_', [WHJMU_X$_D^W_]S''C/" M$D-&VGQBB@1D>3[1"+ZMLY)%;M/:2[ZQ&%\NX8"'J>+E<,^Q!3=FD-)YE*I/ MN'WHL .29/RP?*S&W_S!8>QFB>BDV)Q%BO6>NOH?N[ H.[#Y&PS7OY.KYKT+D!F'IYYX+\3,&D4FM,ZPWD\J/7U1>E!]2G^?%*% M\>$TCIE[L/$X\=DCUH%S.1E__9&Y-F9% 4U]'-S*IOS3BV>V)/1VL_G>M3K^JC"V-XC>Y?B=LI?4O_]36Z7WOW '2#VC-\ M 3%%'.:[H#5V59K2.1QF\/ZOR@0F4U2%$I8G#D&Q) I00S-.2%)B7ZV]W"W^ M%^C1JXS[_;S)W[Y<-L47%*B&9A^ME#BYF)SC5"KGA 9C$3UVPMA$OWT2[U6( M7T^&&6DR=(P/JV'H_!\85Q#3/ Z+%G8R!D>M@-ITD\ 4=\!9A$@RC,Y\OC\V MMW?__>;=9W TP5$<5^,)N(K@\PWC\63H#^TH=FY29BA1S PA1K-DN(G4$1T8 M\YI&HS17[":[!,_,[[M98\)W4G#HFVTR_%=L?_F;[+Q^P[>.MNB^YM+C:!B" M #.OY%F'' L$:>J\)$(S1>3:2[VXW6]6^0=DIX(HY=@.(?[I@EU>9JA5,78W M$14;B4E)*AJQXTY;;2UGPHI$HU1$X%94'E94Q#X&3TV BX:"BZ[FP#/*$22B M]TD1:[@.>0O[(M_ES63% /(,!Y.#PWG4FKEK)3J>@Q_ K(.A[7W=<[N1U!D& MP0 OC;8@B_*=<0\*6>I$R)J3)K$B_I*XF51_'X#]_ _@]%HIW\F>COIO%"V M\K=4_H[^!OG;I#N[GFWM>KJUN6]Y,"PEAZ)Q' $J:.1<9 @;8R.6AG*;NM9LG*DV3LN&TJG!K#45OBNLA._#H;PSWZGWAKC3SM_G=CC)ST 5Z4I M2@X\^S#P,G#KR[RG9A3B9U#0/OPXK$8?.W8T&OBJ!&\EH9&#P!RJ^ 9ELK1D MJ(G5ISKKUT1Z34[L537T\.N_H^WFA\\2(.?=L1+]P%/PZ@&@U;0I?CHA(YB0 MLW1@O@YWP:?A11"*VF+!LOS>S+CRD+P6Q*;$:=":,YRK=H(K[14QOEY9PNKJ M;=I#Z'N.#;>;!K46]=)\\Y>=S7T6L7+,,R0M!9>+$8PTA!LH2:&Y\U:#B[SV M4N&O,Y6QF!O,E]O-71># '5\0 4&,M (K+3SFVAL3P$M+(D8;O6!> M%DM'II;N&K+PASTM^6I E'_'W/$ZM6ZU#W0!+T[LJ![U;O<4YF\$ MV%) *OOC$"9VJY17*. F@!Y;3?VRPSR#&YW-;K>8S#I7U04_IG'30/1JI!SE M;&Z!T+.'&V.Z',DR>'9C61,;I#2*XXLO&D*[[6@RK)O?O.M2W,W@7&5LS@)7 MGII1_N0\W* 7I^_.K(!YT;.,0,G43C^RZP]*NJ]> M>)E!^S7>\[3=B,O7/?N=+0O 4^,1*U4XIUF&Y;,.\SSN%B.WL$R0 X+X^;BJ MAVU]EA6=\^5AHN'9DJB=I2AN:/%T(CX[[EI0FG-'1M&DB;51 ^ F'!K'GK'& ML6=7PEW3D%^'@]Z9&9PK?5QH5EKXN^DJ+-D^V9>2P[PXCP3/M152]O.M- A< M6&.)45XEO_:2+1K(\T@XE: P -$'T.@<#KJ "\-" Q([Y=)LYD TIU-7 #,O M@9;\/?QU=!S]I,Z!9XM[/!A]9U'">5>V4*F 6DTE_$F/Q%7API9=ODI9]S[# M4AR."S93]7O4GOE\%P.#B!Z7UEP?3![RU\79$F8]N[ M;T[WO?%<:$*1DCE-YF5 )@F/F-:.@/&)+*1,U'9)EJ*I5S"MJ 21ZKC.\%11WE/"*!KQ]8BDS.B?@F24$ZYSKBB0Z'FEC%\4TX?55B(VT41E93PUV2VAJY]I)< MDJ6_N%Q=+Y6?6[(>7%A SX &(4!QM?Z*Q^#CNCAL7#X\=?ENC%PZ%VSWT?F@ M##?$&TɎ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

J]K]RHEM/R Q#6PKYP;RJ_?8R9L(=8UFKVM^#:2ZS"/= "]Q%,G<86'IX*3"\.IDHW LMH7U$PX;=;G3MSK:JPWIWL4?:WX$!MU-O5, ]6."V MVMM;9\\+W)K9S0.P9DIMQ&A9<_GQ\LAB!BW;Z76V8 65*_K% 57O5C&#_0!4I[4Z M]_B08@:+"OAW4YMO^*7<])1*V(T:R#TT)UI/8$XM/N-_O:61CG\+U5. MS6( -^S^8X)B5=[47L"XV^C8W=+"^!@LG^OO%Q_.OI_+-D&!2([,_&G8O69C M"P.[TJI?'E#=UA;,H@+4\0&J,G_8_*FLACQF@K+1>83;^WBLAKV$;MON/4NI M107=V\*J]"'2EP%&[D#MO$N@>W[/^>*NQ\9CNKL\C\-TG9Z+&)?3;EL] M*/=:C"=1C(UJSW#L64JCS;"]]U>7)]]_?36SKH>G/^$ R34 M/&^-*6G6R8?/%Y?P^T\\KY0'&6-/U%^S3N%RVN]ZW6P/&4T:I4.3LUOAV=:O M\+"<\_41.[4'PK-.SG[]"'"],)JZ\P.YQNX?C<;NULG%1_R)]5L$P+S&2<[9 M(%#XY=5T@J-XX+G?KJ^NWMK&()-8G&H$I-[VULF7+Y=OK8_3I8-UC@9QFL^$ M..U:XQ&[;M1ZRW9=-ES7Z0MGWIT;TAQR$P,)/P,:V[ AQJD/8]Y0[5"QL%4Z M]N78C1ZJO'4;_G2Z/6HT1E"%?W:HM96%DRQ.E>-6-OT?\) 0/9F.AF-[B27' M>RWL0ZLZ$LK/'5L.0B#V-K^OK8W]O['9/#48K\UQ-I!Z]@OU>_W;YIVNG<:K M.7BZ93/DH^PXWEW<<;SJ'5Z*K52]PY?W#O]^?O4[Z%36MT_6M\OS[V?7%]^^ M7FV\ZWWI(IYOYNWYR6":T*AJY,)NZ 8/8/#@&)<;;A?.HW$!&\B=08-@KG". M TKZ!!'E&[!_5TT^HY%*@&Z!&M/.XQOHP4@_J"5'"JC)>@0-I!_#[DA!E@J3&,?<"!R;A'/?P:HGNXKFV-R"D +#"2<,#P:XB$>/X+QYG&<9 M@_SS056AL;^XB=]#7Y\JJ15B<\XF%_ M]SAYNT<=Y$%8U>HLL#9M(=_LU.K-UI,W.N_5^KWMVJ]IW_5K$AE?6%*7\Q6E MZ)IWV-]&+GA[>(F=8^- MHN[[!55$61%E*8AR,^'."37L(UTKKV 70OXR%F-_.G[L_(6YV4.ETVA>/_J8 MY4Z.:CIVK]7;IU$G%9[M(YXU>G:OV]DG/)N7+WE@953.[D;I[.*X;QZA+E=< M9Q^Y3K]M-UK=?>(Z%9[M(Y[UFG:K64FW<@'%:1VQ='O21K(E-TAE0NV1E1^# MX=9=8;A5%:V[!U*G60&I[$!J[P1"NQ<2%7JL2 MX7 !W.O:K7Y9VUE6\'T\ :\(0QZG9'C2,$5]?IQBE6&T\TPZ*W5_'EGPHF$[ MSE!Q(SF[T ME=TSVB<-7O3V34?G84!5K&*.+[MM]S:.Z%4>B_V!;\-NU2N/X\'"MXI55+&* M9XI5].Q^K^(_%1H<>:E;2-3L5J2PZE+D!I5?.("DJ[AM+&)MJA ML-JGC%CLGZ;^ 31T;,PNZRP>%;/81ZRWV]TM/9M[ZG[82R UVUN&CBH@O1B0 MMG3A[KW\J-!CO:R53GO3W@85#;]T$-=N;ZRH5T!Z82!M;/ >"J,];I?ZE0C@ MPUM;C3;B64W>V _]))7S>L3/B0B3+97X_35=&W:OM:GV4?D77AQ([>:FD<(* M2"^MQ.^F@F/WLJ5"C[7\[7:S7[G;2PZDCMVOO.UE!U+C6 .;Q^UM_R@FL1CX M- %5:>O'YG%O5QZ&LH-H51?T"D2[!M&F>OJA^( J[%BKOV6WXK%E!]&V*?$5 MB$J;$7,H3/:X'>UGXPAV\B?KZ-'0<@?_F?JQ\"P_3-WPULY48+#N(CI3''K=SW6B0 M>:2^]8:]N8Y>N15>/)N]OVTCI I(+P:D31ME'HKOIT*/]1IE-JIL]K(#J6,[ MC4VMJ0I(+\UH=T-&NV>T*W1UST\F@?OP+HQ"L1RCJB?W\\GCCK)N'X]A M8\<61>E5'KZR@VACM:$"T4N#:#?U/KM7&RKT6,_'TJTFQI0=2 ?%9C=7W,H- MG+ VKE6Q!7T=OXE;-[ 2D::!V%IIW5\K_2__U6LXC?>5,Z4"TXN":7/^4FX MS7#5"J^/$J\/$TR.W3BDXJZ#9SY/Z8'V3(^KP%IFL)XXS;>E@>A1^DD/"IT< MNU/?LHM(Q2?*#5AGVP3V"K!E!FRS;&)]]T+@N'W6%^&=2%+T5E.OR"@=B=CR MPT$T?E1>_$$13:>_92>-O>OV6 M'4(GW?[&GODR0N?@4QPK="YQZGT%H0U"@8UVQ7%*")@JJ;K@H$Y%+)+T2+NU MG#B=#12#$B?*'2IXNO4*/*4%S[%.P:NP8RWB;?6=BGC+"YYV?8-LM0H\+VWB M'2EOK7JR'/F3544$543XXT,-7H5&V32PXB9]M,R I$+P6B_K&.CZS08ZT,]8W+JRL*?NEL M\XT;H%0@>FD0'>N/%D!M_S M;6PY%[B*3%2(M<)UW:HB$X<+WFYK4PVX N[> +=?0L+=O5!XVNC$%G;/"]U% M=W[JK,K2>FL%49)8;IK&_LTT=6\"8:61%4;A !:)HP!^>VOYLL9F.S-I?QT# M)XTJO[BTP-F-T^99 '3P3<(KC%Z+W70J=E-:X!S0M/6#9S?'XM>>K]R9?NT9 MS>X#[%>$POH0Q9.(AQ4\FV$PE[+I\LJ$/:^?[_SE)IMN<].QV7MF]5>(?!R( MW.YMFB6S9XA\S.ZK;3L%';;[JN*0%8?<+'[C/'5G_Y+QR J5CP.5NZT#UUJ/ M6=CW2E@?M7MA_Y2QJC*[,Q9TY_6#:2J\S*4Q$3%U,UC$!>;7T"Y2#;V%2W?0GH[EX!JOADQ2W_M>.I*H:_Z02>M=/?N)>Y-$Z+1;^!-C MCP-TUL4OSW$:;&\5Z,WX_Z,X ]ZM.+V)A?OCU!W"9M^YP;W[D+SZ)7>FL1^> M%NYPC>/G033G_,/A-N?OK7%\9IF>&$@?Z3L0,2+&IV W;EFV8HUB,?SO5__E M][UF9RBZ-]Y-I]4:MMINJ^-TW4ZSUVPYSK#;_K_NJ[]=DPLX&EH?(G0!8\&" M^[=Y(-Z)%)A)UUL!A&LXNK"^P JCQ#J'SSWK2DQ2,;X1L=6LVU:CWFC 4<<3 M-X;OTLA:YQ?.# =8RAY>/(>1"/,Z@NNSOHL[$4Y%4JX=SV%<,9_+\D/XL%-9("81C!J'(@Y#U M1(3CR6OXL07'"."WR=MWUD*V/G;C6^!,J"46XCZ:\\K-*FY.6B5<6^!.$O%. M_?%>M;KV0SH\_>B]7%V*@/:G^M9=?4]C=0M>88!HSQ MI:K$0Q:^AJ_SD,_O'//YWU@?1FYX*U["]-V%3?]%>+ 5WUODW#B2K*P#2;YJ M-.U&?T7AY6[2K%:YR2L\VRL\<^Q.8T52?[GP;)X'^]"2\W8&C]([H]>M*"PU M4_D0C<AIV M9^,ZR?=],K,?*(=2_G]+3\]L5E+))![$\HW?EC/+VU+@,XS&LEC>E M+D&X:A3>1KA>,DUP1COWY_/M/"T L )SI-!:US8%?JKJ.;P YN$BX\G.>BCY;V[%/ M5$ KKEOJHR*H@?4A2M+DE\^_?M^LL*5\= Y8"J=8JW9%T[1MW;N)U>O5FF]L M[..EBY?@HXP]).Y8%,B\9LV^SX\]ZS]3("!X 1 5\0QV'ZCW^(%"3#0.3%Y$BX03JB/]TAG-1S)2OR0V >I#4D%ASQ'M@'_A?D MR\"?('"\W*+ \ 9 :$_',?: P)"P\'*O1'SG#S8M'"L=?:GC)/(XAB0%?'K= M<#JJ!&PCJ6K/8/6ZTI5$G!10C M&;6&\@KF[0A?D1T_%EA!8DKRA&C7.%YR5/1V)6A F&W]780@V /K+^YX\A[, M M"7_"2-B5L=AJA?*0BO_DZ'/[,$']? H%ZM]6:YT"I@,,C&C*(7"AS7PU,C M<2Q[=7/#5SOKO%I1#XHA$%2&2HT&^*R.>S_R!R,K(NT/Q1<0D36""X1U%VS> M6!)4;Z L7-!/DX)FO9C-7.2WZ 9)9) RDCN*T20:@$R%L]_[H,5K(3PF08K, M$%]RYP:P&UPN95Z+KT$+UT*SP2,*F,<#$_>..I;*L\#O PM^">^#JTC]L5(R M!,KY--$'"L!RBMU;?#V:(Y)\V!B2MZ:-*X Q*C7)-"#VE4F(S$8Y*I9T ;CL MQPB>1SLDW8@U&;GR+F#0$[:'75]J#+5T[ MA._6:Z?3UGH%_\(B?Q5S"* 9,8=T<#.2&$PZQ%?A5U=P37XR(A3'_KPH+,ZG M,7 $0Y,03 *OG49+;P!^KU@*_"0[2V+N">UK9!^9^DDH2"YAD MR%2_1T7:7$0=./3T*X?^3WR#?PA\'8EFO!KO3K+)53G%@/S*-OC]*OV M.,?:'F>'S&B!ZQ"3-%&KB\"B.Y$VQ=O#9;YS&\I,Q^C$_E,DTF8=@\U.PA!9 M&EV0+R](:HUOUS>JBSUE"J'CTC>6Z;1KK7YWF\8R[5ZMWVH]>?L3!XPO9[WV M)YM]UW>VZP"S:K.-]39T0.TIYJ=';':H$G85J;K*%+K*'!#*7F3J,MDK!M>O MFJP<0E)>9U4Q>KDZ7U1(MH](UMIU>Y5CJ"O[*&Y2"_8'^YWZR2CGE#R.VAAG MT[+)JGKIA2%TTNV_=,^&G;1-V(VJ!HHQ*&LJA+,5\>]OS?2)T]D MZJ2]A<' M3[>^$_ \D>C?F[K!;W,=<[85BAEU8-452+5,NL7F)-X?BQK^ A=4;NIM-[?L MAO5T-[1CQ:RBE8I6UK1"NIO6ZY:&5M:H%)&534Y/ES65*,2U,'MG?M!KB7-3 MA^9W$8RSEFRLF)7;Z6V5E?NHI-S7K7Y=OW5>/IQUZ\)/<>LR@!!WVZF_R=Z 6<_'@#9?*;<]OW. MF-D0H^?X@':-R2L3QR;3># BA'[=:YJ96)@UTZHUVF\ ?T,_BJVO$:9S8GXC M_+PKL[>ZG=G?=!;]J(_4$4UO1_2@A[>5;<":Q-%M[(YMF=B#J(5H#)]CH/@G M(R9F4.8NF/+;'$T0^XUO*_BE=3:]A2V8^5B>$&.DX2!0]Q]-TR1UF9&T:\WN M EAT"(#R=W^((/B N;!,M%2LF=B8@%'[:[+VBKG40E@8 #?VIV-.IW,'@WB* M&8J24]3@I91/=AM214X&YR!*D@5P[LY-8R0&:KS0ID_N8S\5I]%PJ#C6-'3' M$8A??)M\DC/Z$0_]))EB)AHG"W.^L4[&+7!#O/7Q9$4.V3Z@V\8".^_BJEF[ M9&[%W0 <3='LO$"YS+Y7:,H$JVL@NO."UW(_BZ@^;5A49&9.\UT@ U((19G3 MG4PS@O]5/$JX<4CI_B1]:G7K1K$EV(%+6?YB0 4Q^'1,^C78RXLK-K,K;KZ[,5LWG#1\9UF[OCN_ OH-NH97UYV 4Z? MMHKI;G,>6%:ZXL!NAP'\@K/A,.$8?D%JU]IO]EA,KZL)N M23Y_)ZWMP N_EB1I(EY@I0&Z!0@5(UW_S@IM0F5"\K:VSM3<9OI?=F\OFZ79 M[]=Z[:W&_[7[M4:C\?2)CTZMT^P^0Y9FNUEMMM-:_'654KIG*9552ND1G_]P M!A7./]_RYJ[+&Z"M=/V7Y.1/Q+ VZPY77]<&8AU-0<@XG@+Q'D=YFT^ZNR&S>689\A1"[0(BZW>LM'X%4 MBF&A>Y@_^*RWNHL#/U^CL=58M4WO8#\JEBIUNGNM"R7NCJ67]'%#U9(T%@>P_O_FMZ>Z3,M0\@OE!AW#YA7*>_ M/+2^#QAWX!&MDT;[I;NF'8R"O[ZVU6]6=/K&8 M7*Z7'3J[+=]4Z^=XL@J(52T"J[9G6^;&=1\7@ZA:!%:T)TYS8WM_IYA1$O5U>>=*WO-NFR'1BNN/EYWKUS^\MB94#*UG#&<- M+OMOGK-U5GXP.\U>Y\G)47SKAOY SF<&*@&"NT]'YM1E8UZTF@2;3'$\1P MZB*?G-MH;+\[AFTH:9=XV_>S$>%"H>JTGE.JV@92*W$ZC8O=\+X )P\"-S1% M:C0<(F[+%M.%H>ZJR?02BLM.^-JI-U^@]^: M7SET[X!9([M5E[I\P+CO_?>KU3S<<7JOUD7]:J=H-5N\'#:#>X(#]8&H'5R.Y#B!YU^G9O59IP M-;6[PK-'XUG#[CA[-1U^7E3QP&*#.P1(2:)\!S[&_4,T'HL8G9%'U@'-:=C] M7C7!O?Q0:O:WK$BNH/1B"495"[07J0I_ 7?N,HLNRPIYTCUT:NTU-C$G-0'5 MCM-F;8X'\L9-!#OCK1.CWH-#P2<^7UD%F#?=EJ[:=Y;F18;-"IO]+:L]*F ]%) MZC8K _#170.<9ODK.)L_L;<^5-+V'')DV%S,>! MS/VFW=IXAL.>X?(FYOG!13 W[7#V K MC>*B-B&?[!'6/#H;:XN6BL?RSKD* MH]/;-LUK['M>(/)E9G*)4WP>QU1GO:A4[RF'?.9/C8?/ZL8WO/A/NNF596I$ M.UDMEA\.@JD'"^M/J(HB=6^%G7UVI=.^;:J8TE]_-YQ\ S!L(LX1K E<7N(,5K MM;Y24!BCH7E\6I.CC++)#;[T+-I55+LNZ7)-Z-O2ZM=:;?.$F?)2QN<0=B[F=']3; M]$JL!]T)(#HLW"2*!++[XL8_1 H29"#RJL.(& 7]Z0YA)<^5?,H/81W2I!(L M[+X'%H/_Q2IN?X)']W*+ M\< (;3KA(AWXT_@X7G\8%'57L_;6%W60@%"03Y M\\+:[=P!I=;M]+3*O2]4HLZ9R',:DAT0XW6CYE@W^;KG=>AHT[)G+P;4#I5( MTC(T$[4KI9#L MW5K_C5YG=:LOU\/+P!<\V8Z@Q1:KEK\" M)/#]R!^,9",06"6U1@ 5>*\^.ATY,5\%1K5LM@+_\F,TT2>"S=1LY9IUD=^K M&R21(1)1;*+2FT0#GYH*W_NP,ZTRCTGM)5*Y_1,WC& M.S?VB5O@/0.TZ/&U=64\6 #&=^S>(EJ@0T%2(3LUY+5H3TFA#U.F7AF>!C;B MO>E X'^!O*<#N#EZZGWHI7_O(\-Y -Q6H+6)T M I$"G7-&;R"%-H!PKYU:5ZOPAD--$Q@\T-$/%.D,W5/*C09X&UB"'4S1)/7' MRAK,K%/D76$" DJ21L"HCO@=W8>$W=D:U'DLD<@?T#N'_D_5D@Q8CAO JWD? M+FRST]8MF/A\^F= %&JQPOZI?1(3?[$!%'YU!9#VDQ&S/H%>N, ZG\; Y0SK MXSE4[C+BW=R6;7E$ S T&G*XCX)%&(6G Q,W#M\F3L8P;O""(Z,LMJ]C06]*WEK\AGM)YG$T9WOL9OD M/+R+ ECD4J'Q%1K!'% [:9FG<@GWG+0X/+7+U8RO4E\SW?C!]M")A/J/K!T M-XVZTR6V!'_T]IL,EKOC,2D=+RD:"[@F5J7>+NYE>Y@6S4Q[L>D8Y?2?\!89 M- (SA)IS(F>E*_/EE0EU9>L:"<4.8X74F=+W&>NT:ZU^=YL^8^U>K=]:KVW5 M)LL"?3:=_I.W[JK7^D[G63;;6&]#!]2M:.TQM/O59*IJ,E9H,G9 *'N1:#"#/2M: MJ6AE34G7:>S7E-/-*L=R";,E"F\MC'//#W@M\6S6=.!O%Y&X)1LKIL4WZL5Q M8,^?%O^ZU<_>.B_QW;IU?4[CDTEHOK)+8@I[P\\"S)N)S52,&S? +(P%.?8J MB3U1QX0MTF0C^(G*\O#$4,1X)C.?SGS%$*C.FD1Q.@3:B50JX3# +#>,W:M, M'3^V./OW 2\C6R#AG,8@PEP<.:5MX7OU>SB%#\/LJ1LN/]C\E:0"9V>)"/!H M,=-SOT/S&U+N'$?7KBEV8>:22I&;3./!B(?X];(9?A)U6[5&^PT0:H@#]KY& M2"28OPH_Y^2+UTZW,_N;SJ(?]7$H8#2]'4G\O$F-#6#&R&WLCFVC5!7)%BJ_#_ M;'H+6S"SICS,6P)D" *%LN95M6O-[@+T[?#H5_[='W#;."1<@?D2[EZF,_TU M67M%6P(/"M!GIEE F*[:+:DN[GMGRAJXNU"QRSF?O*RW 1K4!CBV&0UE!1TU@ M9.9[HU.KOZE9FVV2"C3F+!=F98UZ-UB;""]I;/829ZV;:)HFUL*;<-:[B6:S MUGFC/ Q B(' 8CYR7+!W@\I5/*RU2U43(*D++JHQV&\+?T65\2V=]#L9I,=6 M1KPDZ5YV92)?+ZGYD>X:Q,9[@@I,(J]OV\S[+7+NLUM[V:3[?K_6:S>W2KKO MUQJ-QM/GL3NU3K/[#$GW[6:UVU]"M]W$,;:\>_MC9WJ0LMZ MH:N'41]N>&2-D/_V#MS2G79CQ6Z/=#?'[JQ($=B' $*%<_N%]Q[L"# M5LWE>2)5T.I @E9/E.FPQX[W9JL*BY07.NU^!9W20J>UJ9"H(E=''KFJVD<> M??M(,#GK6ZK_N^\B635;K:CEA:G%Z1U[:^(M@F_/13GE0Y!F>P^QHR0:G&H' M_,+;H=X8LQW:2M?;@U9#YK&.QTWKS0AW=XELW M] ?6%^$!;0%1 GW?IR.SM3!V+I2KJKGBR33!;D"RSZ> FU2=>;!/8BIBG;ML M6V/::C+R)W)M=3!^92STU&YN'?QGZG.SMYD&IK8:L3H6X4"8XZL' M$4X$QP9"\)*O40QO PP";A.ZN>'DJN4A-2+BZY>-&=,XZV6_I%DDW(KT7<-T/PHT38Z"[FUBN;$Y#[5(5"' C M^G)FKL^6C??\Y(=L^Z3F7!_@U30$V>O [W[T;_Q#I)' ' MYO5/XF@(%"I!F8?6Y<=+XTG54W(YE.:UIZ:VV/D!]]P]RIPSG\TEK_%IL9M5 M*&ZI2R LA]\34.2"6PR;7G= M-&;>\U[5&2VWUVH-N372UR_^WCZ[;AVH_^L M7#MK0IWQ$-U:O4")JO>R;6Q/X[F;)!% "]&?N.%B%FU(8=4[BXD_A*O,,5OF MOC$R2^8ZBAS6XY= F2_0R32[-RG4ANY=%%-;+G5AYOX4EX.?13&Q;X,S*9$C MX-X![<.OWGV?>'7;2M;'/KQHU?R-" 7S6&M/MQ@O;^ /F43MO M\\+T,'K-;:@M,_7(@[N?QC2*WH=[4@\/02+'Q!TE]#5@9BG-]_[[U>HNF$ZC M]6HY?6XY]N*%&K7.YV"_7?SS]XN/%]?_:YU]_6A].+N\N#[[S?I^?O7M]^\? MSJ\.EYU=C:)[5%) <;!\5$F KCWL]0@<8S 2WI3[G0[)-4UXL@+2 MANSZRV[EZVNMDI![.]IA[*O*)F_L&0^ MGY7,^]^X[+$)I5NVG2HAJ-=L1KC6B9^Q85,^\ 3EDZ;MM#8?1+JG8>U]!%##;NT(0(=5F[F")YQ( MIO VI]KE1SP]@D/L;W8J(F"G:DI47@ Y=GOC'H-/"*1CT!S.:7X/1?Q_#JA' M/0_QX;]I=B$Q$7;]PA\8&KES YZ2=60*1;?2)LH+G0WZ8Y5/DY")_B5G%JA2 MJ/@N6AG($.P9MF#+K)LDC7U*Z%B;@:RZM"KK^>4NJ-S4WK"=_J9];9_\CG:L M_%744E'+NM32Z6ZI1^^>6G*)V$^6J7&48XN;U=CB8QU;7):.P&N=3#6%C#*2579$F+Z0C8[NW("+4:25FH M- .#C6D^:F(1GLB$>LQDIJ=CX?FI-70'E.%=,ZXR<^QEGC]:'!.GN[6>SIO> M.CN3E]6;ICG"M79Q7?X%(6L^>;/&,NE#=N YP6>9(TDCZN\%7&%6Z!""/:(' M%-^(803?TD&B\)0V-#__')T;\2WF;X8Y%@%X46W #$@9]%17D0#0$5/' GU;?C)60$KF)^L6BS$0 MOB#U_/%TK#$EB)+$H@-8)U]^^_[6@*D<1LQE$]9%F$QC3!K.51? >>O6!!.4 M,0_YZ6H+2LCL?Y>!R0L=F#P81G\Q)];*@5B#*3K;,5M$NM>-6NL1+'592%@S MUDP>X;QMG\;.P\:1_E"%9PJ5C,Q(AY]$<3H$C3]2B?.QN)UR#4XRO4E -,"B MF"(,-!E,25"D0 ;)4,22[2WT#>';L+;K%"O/C'41\\B9Q&+MZ-&HB!EP=:',@:O9R2= F#PD6QXAPY,K: M4:Q1)4&K"RP5TP"C:Q)1B(N]U+>JLLD/$ [15V.53S\31-$&97,2CD% M"#1R/5"F,^:PF.I1DK::G0S/TL6'R9C*ZU;?1$0^)1 Q%S.C&FEPH[QY Y(W MJVF%MWT$Y=UXF6-+3#5?UJRO_[::]7OQX%@4BX^D;BA%&.QE.F"F_0\WG+KQ M Q/*=!))70"T4*HI&\KZ/EGT=F;P,J6.3J8Q:+\)E;^! BK55;[N7)6=6G00 M)>D3TD2)-=-/.B'F8#333W-R? J::6/67'\2-X!3ZZROLUIS-[K Z$_2:/ # MJ$*A;V-W;$O9[HGQI*A _A66G*9(@G0F3]R0N'_=;F8% MK6Z23,=9Q1QI+BZ5R5I3(AQC,;Z4$#A=Z+$@2D2(U:=AA,T((5$='.5 3C=_&,:"D.\_QJY,2GP'ZD#1@2:MCM!ZA5>SG.B7%8_?;81%E$1R94/&-,( MQ5_^J]=PNN\3ZN$1A?(W@%=@_@-O>Z5?BZ9I%6@'T:<&\_ MJ=D#"$+@50VCU8/2RMDIRB7=V:9,@G*7Z3T'K.\1_(,'"?][,F7\%/D!L,NZ MODI2)"@N167F(0 ?M;?!0 3HG$-[;82N:P/\)V=7W\$.OXT%N]_@)\:WK&8; M2)#YK1[D M7W^<7;ZU@+*9-LA2EHMIN-E60-T&J.!;'X#(TK8<9_92:+,*=IX6M#/W ML] M8+KZ."5*P5/_!_3Q%-L] ,JY06*2@5> ?:/6+UXG5N";=(*,ZW6CE>%(QML6 M$@Y;L=E+3=5!>5Y [;+ B)H*4_%(;/6^KGK>-EY84$O4^YX>K$<9B6]5D?AC MC<27CIU](M$**Y+:!_]E >KZ0/7*Y69R>A],'PIEP7F)2T@;"+@)B1B3QUCP MQ]C]@>QDX"?*4VRP%<4)8^GGX!7=A'SXN@. MK7OV,"$OO@6Y=XN>/Q"18/U,M-QF"[)M.'N*Q\ S"T\Z$;5I6+.NR>?M 65_1Y.QI+O[2-MF"5IC/O*7E&T!).)S& M*;:$\T/$9$8S1)C84])>8SX+7=-WD(,J?DT7[=2SF'XYKOH*]8A1% ";2_YJ MG5.?JYW?O'GC6ADR++A#3HQ #B)S>#)[BL70@V(DWW6VSP=^\I/,]B%,NT;5 M_K<(MJX_EFP%^ N<#?88/V3, )GKO0#V /^5?B#7X!6&,]O5^0[DZI=I,_0H M61J<^,"]RL;N3WH2V?=I&IV>_WIQ_?&,'ZE9WZ;QTB<,O7/F+L;N Y(5UB>! M)6BUP,P /@;6QKJL_S5=]T'DU\I^/PL0]OJMSZY7 M' S9E%PKC*S !ZM>)M%(V]"]<_U ]?R40G0)$N5[EBKM?P:,ATN$,@QEHD, M-CA&HM%&X_LBOZQCA#E78-_('XP4D-*^^:LIN*K[Z)"-[2TC=CT/5: MY\T*!Q?:],H.U41A'C4!W070X"8*/>5,SQ).CM5Y=K8DN"CO\#Z*?W#0@]13 M&Z@&&"JJBA^ MWA;(_])(7*CY*.T^EQ&;#EL!8'3S291'.7KC6 (]!P=4Z:7D.9NRXS-[@%K MTC^YSZM-]-)R:KTW>?*#CQIOEM =__/\IX[^.SW'U#1D U3:M>ZR_;,@F8^1O0T1_\SR^3@7MHB)I,/QT&XJ?L1[_?0F?#<"4QZ?.?F A5 M&*V^^A#LW6+WQ#NG1\6#);N-=?WL'.XC!7N8"6%!]\(>)0KW4(2O^&13S:@RLGT,;__<1,#9\- ]2D1/F+_, M)P)TLAC,.FD-G'O7[JT7 > 0+LY]Q4O%@ H#;Y=J)BCN$._'4YS",-H&J+> M9*:1&JDBUO>?I.1DZ2KLE8NFH$EP#-N K IF L(J7DF1\.R1669+.:P,"M#@ M\+$#AL"O%,**.&\NJXB:4%:W0?"HR5$&.-NY@5C0BD"6[6@=4#ZA^4*A+SRG M'NHUU_ (@'X*ECNJCID:B@HDR2U6X9P%>Z.4F,' S18,ODM.=6#)0+)<;6V8+I3PN6W5;-F8@TSZW+@'I#,@I)TAZMB5\^D"QKYD(111K58]40I>C-4:VJY&_"@_3^O>P$9M4 M%N3\8.K S-A6,A5FEI4,;VAW\00ME6G(KX,S _FAA#'B M!'#(7R*:3(#).12]3Q0O1SEXDPJ/YY(,<1,*D,ET,"HL3T6'>B("2"91^B-H:5A:GZR7LC@M#'G*1I$9BV&;E!2#<6(VW49,OY%5([2"'IB;FY%"=KI.N E^),3N. M(;!283-#HDHV$9)]DI#LL@*\K[AXW+'/PP40+IRS3S?.(TMHG[)&,";V&.,- MPDO4'4?3%'/.F2ED/U0CC"(%&T$333!D3HR IESI$1LD0R@T*?/78+>W>$+R MU(44!R*WK$M5")KZ,C:^F(R.,J6AO3BEP=M@#$E7CR&I$B%*L9673(38Z;"8 M[^=___VWL^MOW_]73XK!J3$?+_YU\?$<_OA^?G7]_>+#]<6WK[.38RK_WK)] M?BOHVJBH1B$*2B.+D.S:7'7,62+]Q:@NH^%EB!&L\(H2'5+)V?4TV6IZ\V^I M4LHB<"ZTT0HXZY YUR[*A)Q;"N4:*+:V>HSD)WHB4A$J!5/%2-%Q%7"&![QO MFD88=%7:,WK4I+/R!I1=%]0TVE6^5QIG:H+$QL1\TZN>I:EDSHWL#)Z//[^9 MRDI,%FPXD@K6\#VI\UE_9SLDD#KP[)*KUH&-N_.*.!](9P*A+&=J<48YUM0] MY*\>;\2=PJ-2R?43CEWBI2C#CQ044-O2A[\F?*7Y&PVY!1V6G)%KIGC5_"D8 M!L%!Z[G?%M?30# 9P15F4N+ !>L5%9@)WAO'4MJ3;S+O=R#:FW@SH1WO=:73SW].4 M*SXPS;;+\#M:4I4,EJK4+7-W2S0Q)'-;Q:6^*J7V3);;R)=F'1\^1&.I\&)0 M]^3KV<6'MY(&=48:-ILX92)0NSWY_NN'MY($."*PJ/Q0WCI&09 ](5>4 U?) M7X!:,C\"5@*&R'!@JIMH).'P!\+T)UG]6*;9SA+>SQCP?^+(0+S *+!^PTU1 M.&^^L:51+I=U!^>1Q]GX75A#BML^\)CS[SH+Y@-L!^ 6^J[U/V'T\_1_!%HH MLID(36Z4(SG)+L6*1;Q"I]]ML\=BS+1UDOT84&X@8H**%)G&.W)(/H8[X 25 M!XGF;GCKHUY'[5AX-.+)]=?SMSD6@L6LQ!K]= H8CLO=TSQ? M#H_+[4U#H-(3\+990%"=AS'"D[\MR"U.']) M,4 6?39\1U_F/\Y$D9PG3 XA>'3ILR."#"DIID//1CR7ACK3-55JT(\/63QE MB(P+_F\4_["N2!/X*-"Z5I4M"I\C#Z_J^U3!^;NAJEW[:8")E+9UB1DT_1[' M4/6ZAAHR@[C,DV[-X<&+,3:/HAEN&F4WKB?KITSL0Y=I0!Y&3E!;C"1N&"JT M5[.J694Y8$S <#-*/&N$;,F+)GA],4&:91(6GZH+0PF1TTHX.50)4G(LA>3_ M6FP6&'HQZ9'(T6X$MWZBEDZXID&N*IM1JBHK,N^4VH,HR(N0URM1(K28UXVCV;33ET;Z("?>;,-*V(YNFT(-.6F8$ZQSY+ ME/3!6I%9DJ2V8*&"LH94*R^&S3@-@7T#"8@U M#,6C].1VGL23VZQ7GMPC\>3NIO'#4F?N!3:$:NZN^F;^KOXYQ83D]1W4EF=5$7?J=K_X^J_SJ^LOYU^OK]C??O[K M]>'JP^N5K!BYQV8&,S?LR0I0%J=-RX+&9I96GD6,CWWVA4L$5..Z8.Q!UL69W*V!UAS280N!D,)0K5J*'(:30BZWH C\V"G MG&*7?.'E%L572I=(\6-*J3$.K;P2Y*:(0L%-7\'8G06'<5#S_-JM:[AH67%B M18?UNQNA%F*=)K15M87L\#>2I16S9K%C#ZKG->\F\S]$%= M#1/K5K]4;(6)62 &=2M@3G_TAZHQ8"R=UOP$!IN2Z9C+WD8/$U3U:28!.Y[& MV/$7UW?>Y%M&\UJY/21+&]-1I;3KJW1,>3YV4$DE-5?_0)F$^APW#S,9JQU= MW'; ;H1/U# (VY1,.75$XM( = '6E3 M!BB4V]W*/.[DBH+_DI;AG-G6*Y31F.=&/96(;ISW)5,^OBWJ[T@I;-,AW@@V MM-:NF0'A'B):+ D20Y$><-$$4<^5H^,HB(*6/.?(9&%>N%&=>/C<%>=+L>?5 M+(*O:\0T7ZVKY^Z09I:HP*VRJ< RKL/.G4O,B/8.IDGN_!.?Y_+M,BW?6G 5 M.RW'/^4B/1F_\[+-#LS-3O1FS^JT3P2WZG;:GOQ75N5]E>F& MYVKNI YB-5O6B?GIVZQTSQ/2Q@_9:E/-9ZQ1XZZ.B"@)7"GZ!5 M8,_A1\>W7^@;WE_ *JB8(C)>]I+0Q@ MR2\&@^E8QK&Y#'-,&K+J;4U9DN0SY[Y?F35 U2&Z'XKX"8 A:S3"U%6=C:F^ MSPJRY/?%!&E\&;9IN:=#@93(&K]DO30T+#+\.@CZ7]B&KYA?S(I&H.MM 8D^ M8?<6="9 ]\TK2JS>MQRV65:K_:K:X]BRX M%<1U2C23FN$:&Z6Z?7T#1U %OT!:RS' -+F#VE@'.C/C&_86S.[[NTHNV:7\ M8L"<\G^^1G*,<:$3=Z"@SNT1,YZ6Y<><+!%KPYQ8&[Y=(!G>6M& JG$\E;UB M%,T6_Z8+>N40:I#2!/1Z,P$"[G=F5<8-X)%V\)C>HI M&8)ZN(9YRUDU!JP\G/(X%E:#<@#@LK]$OUSM40$AEW[&V<3H/L?'R8[G6C<. MSHLT(\CG8=Y'&3/L/DW,L%/%#(\D9EBV,-3EV?=KZ^*B].&R;]C]VKKX^NG; M]R]G6(OR=/QK72+MOWJ"M^W0)^:4S2?V&XTSO.3V &N,7=CCO"\T( >QK_MF M9M,<)]GQ4:"S"YIRH65B$05BTF0VQ\LEP_>!]+2('%>LM7,+SATF 2R8QJ:R M4@?^CIU],O2'T48A=T+?>HM1&$8+.ZM67-:?*[)CUJ-/??1.V=E8TAF-.N 3<)" M@3LU&J(481G'P]SD(26!9WA_JH)^\%+2]$07H,(UY.-6I&,H7,8S0#9NE/=,N5;$0^A9N, -C.O&4CQA6 MX28:7\ R,7DG:?T6O'J2JH\S<^/(L-$IW MY8NX#UWP@KA OCW'D@N6'7^\Z!ZH_D\5RPEXA!<<2/8IIYO5<02@?R$KF[%I M4AQ3D^E<+@JL1[57V4ME%3"C@_"H,%NE[]NZ>Q#(>'9WN@I;,*NL5^RH9O 1 MN5?S591BD TNX[P8PA0#&Q/9=-IX3;?37/B:V0.92YFC#8!;Q)[VTPH:92)DTI M%EBD+'B')S )"VMN%=PIJ2J>F;3DQP5L2(I0M[,"WP&F(NGKQRXN:D:[_ T@ MM4@2-WZH648$07O[U/"&7$Z>49]/+FY@'V$T]@<\0H+2K+!G@)PW3!C'&"A# MGOAJ65'BASD(+R>CM:X2P\]@@E"@5HV[F/+H*4RK^??4NU4I>N; /+$"MDH MP."F8,!A;);FKP'^J JQ^;T'V#R2O0L['XU#4TK$) Y)L?Y$I6DNNCXY MKL==24-Q[^KT.J.4*&M($YCMN2A\H>M61=8GP+X2U5_ M,?^1<'1$!MNE'H/%+%,Y(>3.EY/$L.W>V%5C%6CNXH1Q0,VR=N',#W^J.\_Q MLG6 :W/;+'HEZP^XFPR57+HQJJZ9%8A<%[.M"-/1!#T/,S-[C7?15555*GF/ M<^])/,ZM=N5Q/A*/H;U-X*I6.K"WM"0LJE/[2.9A[ X6TS60]LRP?LRG B+]IGSHLTY>,&DW> MFNV*&.>X0Q)>/&^B4!"@,GQBDQR M/A>/1* O8I<401[4J=50$WPUZVN$P6C>AW;*P/4-LG9(S]F#^6__+Y7EMU(? M (L]/@62"MQ)(MZI/][#?<*F'M[Y(1$&_>@]W,BB;D%F@W M_+44C?U>K=WLH71,8_@_3[U8"LX:"W+9ANU3K^W+YOMUAK][OYLMMM:[V9_(7I@F@"J0S+][U>-[JM, M)?60F;QK3'Y:#E":0>B!&,Y0'A/=KC7W&?6"%.,+G*486Y=FG_L9Y:+,;&A6ED$BCR3O 1(M"AY;: M_1(\Y;,OQ-1=W,@EV=WZ"B21;GOF.I[XU>/7V8+&7UPEKF_6?G2WI$K:\=$%GJUAR4B?$>=B0(YF-,W^ZUG()B MF#=^GX1NZ#+JZU_%4X+W>4&Z5*SL J*OGPV.&\!O)ZCKSV2V@7NJYDTE=1 >GEA'?#Z>P.2$]D5XKNX: HVKQ,A?D[M4KI/ M9/9K$R[.BZ:82ZO.?VC^4L>QVXTME=.GNZP=VQ\[QHH]]KH^_065FUSZ]5J[ M>>344O'3Y?RTU=M47S@T#*GX:<5/GT^[+@VUK"KO>"K/VKS\PWR9%IQ>%6[A MBBO$DB!Z$X#&Z M9SJ1#9.2E"L=___VKJXY41X*_Y7,7NE,"P):M3NS,VC9M\[; MU8ZTNWM+-:W,6' !M^V_WYR$+RL@6A6PN6F=%F)"R'-.3LYY'F"6\DLK8RIA MK(!T:5&AL/ N_(J=B>EF,/?S%P\22P]=W+U%T?)JQ7%F^7)"R7*H>[6GVF4! MJ>12T!JAJENAZ.P["IVXX)U)N@B%MK1F-:)=#]=(MKH ?U$S\V$+?E%I$;D; M85P"3EJ9I>*HINKC>B"R H+OEL\9[BYL+RC,!DJ7"680]K#TJ' W,(KB/TM& M\.YBSYN#+DP@VTY)96@-MS\$6!]^ 0EKM/;SEWI;9S3HE$8*A.\"C>,G!V/& M@Z-C['.2-@XMAT5;S$])BG18D#-[3E94J/K':C(+)2BE[ 81C4*,Y4](.)2C M3I9(:]/+3"21CD.?DL>GNQ\>G\XQ>'S(("?GY,$!/]8E$W9Z2S %Y27W61D M?IV9#Z;WM>C^% MEFRD(S0;\MY))B32ZOYY-HA_W&GMG;JBTQ*41KYF$V,;%WF8*TI8QZK]OA[T M!G<4,H;W/WK:.,[ MQ904*Y'F*1KMI'.^C[:C//6[B7 MHOCR\B*0?@I/]E]1)=MPLDEQ13Q],AQQ:GB&*#7:4EOIBJ2__D=9)I\511(- M",HTNG+;'YLB"3./ )WZS!CQ81\_9G2]4]2'F7VD>J;@^PU".0F?P;@/V&E! M3"K\\QEBS/9A. C)[2"?T^#/&;:A_#%\^59;D2:):Y) G-/W=!%!O7=A3S]* MXJ(^DP9\K_?0 ;D'BAO$ G\!L-'CB?5PQ/N.7$\2<83.05/(B3Y2?D:'0PR=Q93=&-@\SV4K>1@ MP\$F !N9.R\<;)+!1OZ(\R)UT+V@"WW(Z6'R?9+2:E"L4*?V C98M['+@XNZ MC8L@+4@WG ?#PN[YZ'6.WP+$(;M"F:-,]5"&NS0<99)1YF N#8<@#D%1*5FC ME'Y.D!E=FN=TMZ*+'2@UNNC1L9]9S',]K)JM@>BL2QLNQ[Z/$,L=]5C MFI4#FMQ$8(!\G4O%*'N!.BK[%NC@#=F-+"'-N&;^[HUOZI?D0]V/S5HT^8"% MA8TY2'TB?8:QYWXE%R5=I4,,.11$'84:E/3ZS3= --C!,^@M 2W-%WR%F_]N MO#<]NYC3Q@2W:G]);P,=7G<_UO335:6-[_&86"CQJYS(=\H5XF8W@N2O TV!#NET2?Q=JL@.]7S>ETC@ORUI)9*;:KA2C=H/K:\$X;:J@_&M^.QFI:XO_IS-^& M6>1#J\K03N[-/+&)Z[U=[G]$!;.KPS2)KN@SO:AC]1K]$-#-:'B5!S:K:2%R MOYRGI7J;$L-4.A"D;P,>PU-X+< M"%8;;*HTJ%,V@O^K=P,-#0745W5]Q&W@26WX=&R9MK-N X-J2GHZYA" )P8P M2M]3)Q-@M(0\GBI91R/J]B;SN)9 (+7*D4&P(Q'@AE.DS\C.UY32TP#$!WOZ M1G[-O.?YMW]02P,$% @ S:A859R6V)T\$0 [+$ ! !C;F,M,C R M,C Y,S N>'-D[5UM=Z.Z$?Y^?X7J+]V><[T!VWD]-]OC),YNVB1V;6^W_72/ M#,)6%PM70%[ZZSL28(,! ;:S2TONV;MK&\TC:9Z1-!H&\=N?7Y8V>B+'?Z=/N-W^)(6NG=4KI_.%ASI:I[-]E5]TR'GOQ+2. MVYIVW&WWL&:TX?^3-M&PI1N:<7ZFSWZ=7Y@=W#G&YFG[Y/SLO-WKG.IM^&"U ML3&;6<>STZZFZQ+TQ;UPC0598@0=8^[%BWO96GC>ZN+HZ/GY^>-S]Z/#YT<= M3=./_O%P/Y%%6V%9F[+OB=(O,VY'Y;M'XO(,NR0J;C C4=H M1!&/AK.\DAT M5COO:E%9@405V)2Y'F;&&MOT>-M[71$W6P8N'XG+HAZMK>GMCMY"V/,XG?D> MN77X\H98V+>]RY;/_NUCFUJ4F$"M301YB0*QRQ[F<^(]XB5Q5]@@Q;W[] M" M0N5TN7*XAUA*TL+N3+;8Y9X4:Z& GGO'P)ZT.5'2A:*R_A+E1;$;$T_/S\_>A'&D]V"3'N0Y=OB8UOO MM+MZA6KS#*M\W?"M'9@QQY/RXI?PM]6*,LL)?H"?A/XN(B6.B17-1:EY+L-2 MY3\7F!O)5;7W($(9W:'S0GH*UQ$U+UO7#CAW+21^^SJ^RUW198U!V0@L@MNT MXY,&;A/\0>V-&]A&4NJWH^VR6RB^2\PA^R0_;YMU*!P640AN&41IN:0J,\7" M'R/=J30Z?)P,[^]N^M/!S57_OO]X/9A\&0RFD[):SI57:%Z7FN^ NB>@-Q*I M/@:%0BP4@+T3,IV,,(=>+8A'H9W[LI,$4U,E!G%YJM"'!/:?&DK=9 I_/PP> MIY/A[7 T&/>G=W!U!]IR@-24=36MIZ)L XJ&MV@#^T[6[?7P830>?!D\3N[^ M/ACTQX]WCY\G]\/)OMSEXZJI[&G:<7DJ$[6@J!KT053T/A2'MY/I\/JO7X;W M-X/Q9/"WKW?3?^Y):P:@FL]C33LISV<<_H\HJ."=Q@RM[[LZ5D%7$WRB::?[ M$?R^A*9GS_[DR^W]\-O>L_ :1TWBJ::=59AU 15)V 91->1SS.A_9"LP,X>P M?Y2?W9(4YS;J&K;C^IS ES@6 C"T06L0(WWCWSYU)9H+2KBA M3\3UJ 7^[D$*W$TR4HX?-Q<<[)E0A MIA9W#!\X-3QBWI"5 _HJRU9U7#6'Y[K @"83B2 UB812$,%\G MCN4]@_\$YCJ ^6;RLU$&R06B>>8WQ?.+9)N"N6JM+3=(:@6MWG8,0I?S,&\D<4 MP#1(^0/,&65S=T3X9 %S9$G5I\24BN_I\-^VXB,(!!A(@C1([1,R%P[9'8,% M:BG;4M;FTX)JU8/N4_OD$ 3%4!JD^VN'>6!XA!FT]&R>E%%K_%374[O:A'R# M=)T;^A#@-HFLRK&X2A3NBJXD5M>ZZ9CMSO&^)I*>&;RK1*P*04W>23<=K,T) M C:1&E4HKQ)#)8"41'5@E*6BM461P28REAWEJ\25$D+-$BQRJ?AM7KBPB>RD MXG_57) <:34G9]UT"#(ZS4?P\L/17M34?!FLA%.JI5;;>2)Z[FX[B; M$0Y.A\::2(AB"_^(N8B2/)$;XF%J'R HD$)4T=;3CGM5PP-MM*X"?0@K>6=3 MZD8\PFWZ-G&L]<[0L?JN2SQ72G%BBA! Z(E2XL(U?RGV_01K<1K19MJ(TMY-X0$1XG/AR(^"U1-]%DO'2 I(CH9 M;FX@K94CPE>OF\L"I1KA!ZM.:0JZWDM'87:/2+?1U6NL%)+*>S>6$NSMZ%3N M7X_:/(0'<4CS:+8;6IFMN$?X!-H2J^RMPR=8+/%K.7&$TF?NN.Y7Q@FVZ7\( MH,/ZZ\ZVI@11+8%J%XXUITZ1P*>H=FZ8E2MD9V48"+3KZ/DC*&)G)+.#8\']L/&!P4N1=Q+(DS MW>!,DSCP:QKJC8?$&[14;?^]7CKBN8_]QSJ -CT0YAJ@3A.HTRU4>27S3G8# MS3SS1G3FC[/7>_)$;,OAP:XJ&0X(2YK8VTRX#(^)X7-.V?P*N[2B6?^,EJG- M&':FJP\RVCV>ZG*K'BVEFN'";45(W#:IA*+F6:=.6\#;$F1=6\L[K% MP(X#LQ*DFE.QA]R!TV8/U.RLFLV-@NL%9G-"67:Y:EP?IBZU$1SWT@GAN:D^ MR?L/0?6(,D5NT+N%A*K8<;B7!%-S? *;C0H<-WN I[*S'HD'WB6A3_)&^PB_ MRG^AT ;"Y@D%V3(Y@ZXGC!WSCE>5KU[<+#ZU$9PWM-3T>2L_#'@GW@HU@)Q M $_0AC])[UPT0PQ_: @*6X*BIKQ;C&"P;YH2&]MTDZFQIU4H,97,=[6>7BIS M$'Y=5X)H/,>D@:2*++_-2BN^52,P7UY-5A=VU)D9A\FU-TA"?.=EH]??]7V9 M 81W;O;E9D<_)U-4S4:OIV<^]-]X#R9(FQT/OV8%_JK14@I*3=-I3\\Y1@ ^ M ')>M*^YS.TXA'*$U>R<]3JI&-V:G68/H_0)#A7O0.7**RGI:;U.*M26=1!$ M(TG9SFVO1DF>M)J0;J^3BI-EI<8WD(YT"!+&?BK1YXYLJ[^9 W)^F5E%Z:SQ)3= MP34!M'E;T7;'4I&+C6E,R8MW9<-*%N^>A6UWW;]RPF_82R^JI;BCFV2):^PN MQ)K\A&UQJTM-8:%8'3@T#/B)BY< ;EE<&.C[RL!G]VQB]I>.+TZ4S..S,E"5 MW@?79M@6;S.#"V1&O9(Z"7Y9.@SF)OY:K)'/H#>1'39D@QCDUV@]M"*P8GY9FJYI4S4(G<,ZUL(?68.O45R!"0T M4"!5W-G@#7;>C^[K"YBIW*S*EIMC@NV!*PY%5X_X$H(U&/.!\4'[YI^"72*C$!"VG'9$8%*8\*:?E[,(U(.;*=RDCKGOM+&

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ʒ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